Genes in Region
732576 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 10 | 18140424 | 18543557 | Human |
329843889 | LOC130003456 | ATAC-STARR-seq lymphoblastoid active region 3112 | 10 | 18471994 | 18472213 | Human |
151675307 | CACNB2-AS1 | CACNB2 antisense RNA 1 | 10 | 18512616 | 18539276 | Human |
151670104 | LOC124902387 | uncharacterized LOC124902387 | 10 | 18531849 | 18534796 | Human |
1344487 | NSUN6 | NOP2/Sun RNA methyltransferase 6 | 10 | 18545561 | 18659327 | Human |
155770406 | LOC127817345 | NANOG hESC enhancer GRCh37_chr10:18841481-18841982 | 10 | 18552552 | 18553053 | Human |
329824100 | LOC130003457 | ATAC-STARR-seq lymphoblastoid active region 3113 | 10 | 18627698 | 18627907 | Human |
329834625 | LOC130003458 | ATAC-STARR-seq lymphoblastoid active region 3114 | 10 | 18651727 | 18651826 | Human |
329826060 | LOC130003459 | ATAC-STARR-seq lymphoblastoid active region 3115 | 10 | 18658260 | 18658379 | Human |
329822471 | LOC130003460 | ATAC-STARR-seq lymphoblastoid active region 3116 | 10 | 18659080 | 18659209 | Human |
1313675 | ARL5B | ARF like GTPase 5B | 10 | 18659431 | 18681639 | Human |
329822058 | LOC130003461 | ATAC-STARR-seq lymphoblastoid silent region 2184 | 10 | 18659520 | 18659599 | Human |
38632225 | LOC105376440 | uncharacterized LOC105376440 | 10 | 18710294 | 18836543 | Human |
7205112 | AIFM1P1 | AIFM1 pseudogene 1 | 10 | 18735675 | 18738839 | Human |
155230380 | LOC126860874 | BRD4-independent group 4 enhancer GRCh37_chr10:19041189-19042388 | 10 | 18752260 | 18753459 | Human |
329329533 | LOC129390147 | MPRA-validated peak892 silencer | 10 | 18822256 | 18822456 | Human |
38635685 | LOC107984180 | uncharacterized LOC107984180 | 10 | 18929138 | 18930701 | Human |
1346421 | MALRD1 | MAM and LDL receptor class A domain containing 1 | 10 | 19046927 | 19734478 | Human |
7204912 | UBE2V2P1 | ubiquitin conjugating enzyme E2 V2 pseudogene 1 | 10 | 19051455 | 19052172 | Human |
155774488 | LOC127817346 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:19382617-19383196 | 10 | 19093688 | 19094267 | Human |
155766480 | LOC127817347 | OCT4-NANOG hESC enhancer GRCh37_chr10:19407977-19408618 | 10 | 19119048 | 19119689 | Human |
329343411 | LOC129662643 | ReSE screen-validated silencer GRCh37_chr10:19434186-19434381 | 10 | 19145257 | 19145452 | Human |
38614813 | LOC105376441 | uncharacterized LOC105376441 | 10 | 19155180 | 19160243 | Human |
155775205 | LOC127817348 | OCT4-NANOG hESC enhancer GRCh37_chr10:19704817-19705566 | 10 | 19415888 | 19416637 | Human |
38651810 | LOC102724082 | uncharacterized LOC102724082 | 10 | 19439493 | 19459292 | Human |
6769796 | HMGN1P20 | high mobility group nucleosome binding domain 1 pseudogene 20 | 10 | 19488998 | 19489697 | Human |
155752993 | LOC127817349 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:19799178-19799745 | 10 | 19510249 | 19510816 | Human |
16551184 | U3 | Small nucleolar RNA U3 | 10 | 19598247 | 19598463 | Human |
6481725 | RNA5SP303 | RNA, 5S ribosomal pseudogene 303 | 10 | 19633683 | 19633812 | Human |
16555787 | AL157895.1 | novel transcript, antisense to C10orf112 | 10 | 19710335 | 19728550 | Human |
151660483 | LOC124403918 | Sharpr-MPRA regulatory region 1632 | 10 | 19713840 | 19714134 | Human |
329342661 | LOC129390148 | MPRA-validated peak895 silencer | 10 | 19724427 | 19724627 | Human |
12790787 | MTND1P37 | MT-ND1 pseudogene 37 | 10 | 19747172 | 19747435 | Human |
2300516 | NMTRQ-CTG1-1 | nuclear-encoded mitochondrial tRNA-Gln (CTG) 1-1 | 10 | 19747679 | 19747753 | Human |
6482036 | MTND2P16 | MT-ND2 pseudogene 16 | 10 | 19747822 | 19748789 | Human |
10399696 | RNU6-1212P | RNA, U6 small nuclear 1212, pseudogene | 10 | 19792998 | 19793101 | Human |
16571026 | LOC124902388 | uncharacterized LOC124902388 | 10 | 19812372 | 19816228 | Human |
155765094 | LOC127817350 | H3K27ac hESC enhancer GRCh37_chr10:20104285-20105050 | 10 | 19815356 | 19816121 | Human |
1314300 | PLXDC2 | plexin domain containing 2 | 10 | 19816432 | 20289856 | Human |
155760144 | LOC127817351 | H3K27ac hESC enhancer GRCh37_chr10:20208919-20209420 | 10 | 19919990 | 19920491 | Human |
329815673 | LOC130003462 | ATAC-STARR-seq lymphoblastoid active region 3117 | 10 | 20003781 | 20003870 | Human |
329841157 | LOC130003463 | ATAC-STARR-seq lymphoblastoid active region 3118 | 10 | 20003951 | 20004110 | Human |
155779192 | LOC127817352 | NANOG hESC enhancer GRCh37_chr10:20408149-20408686 | 10 | 20119220 | 20119757 | Human |
155754140 | LOC127817353 | NANOG hESC enhancer GRCh37_chr10:20413464-20413975 | 10 | 20124535 | 20125046 | Human |
155778263 | LOC127817354 | OCT4-NANOG hESC enhancer GRCh37_chr10:20546341-20546868 | 10 | 20257412 | 20257939 | Human |
7204927 | AMD1P1 | adenosylmethionine decarboxylase 1 pseudogene 1 | 10 | 20350052 | 20351100 | Human |
155759582 | LOC127817355 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:20659563-20660207 | 10 | 20370634 | 20371278 | Human |
155755847 | LOC127817356 | OCT4-NANOG hESC enhancer GRCh37_chr10:20661486-20662107 | 10 | 20372557 | 20373178 | Human |
155768791 | LOC127817357 | H3K27ac hESC enhancer GRCh37_chr10:20716465-20716965 | 10 | 20427536 | 20428036 | Human |
5134067 | MIR4675 | microRNA 4675 | 10 | 20551970 | 20552046 | Human |
38637386 | LOC105376442 | uncharacterized LOC105376442 | 10 | 20597010 | 20611448 | Human |
155780887 | LOC127817358 | H3K27ac hESC enhancer GRCh37_chr10:20885982-20886482 | 10 | 20597053 | 20597553 | Human |
155755266 | LOC127817359 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:21045700-21046232 | 10 | 20756771 | 20757303 | Human |
155769031 | LOC127817360 | H3K4me1 hESC enhancer GRCh37_chr10:21046233-21046763 | 10 | 20757304 | 20757834 | Human |
1318016 | NEBL | nebulette | 10 | 20779973 | 21293050 | Human |
6482030 | MTND1P21 | MT-ND1 pseudogene 21 | 10 | 20804281 | 20804580 | Human |
155229543 | LOC126860875 | MED14-independent group 3 enhancer GRCh37_chr10:21105746-21106945 | 10 | 20816817 | 20818016 | Human |
38628362 | LOC102725112 | uncharacterized LOC102725112 | 10 | 20845589 | 20884942 | Human |
38624605 | LOC111946226 | Sharpr-MPRA regulatory region 670 | 10 | 20954520 | 20954814 | Human |
401826666 | LOC132089765 | Neanderthal introgressed variant-containing enhancer experimental_11562 | 10 | 20968669 | 20968838 | Human |
151676701 | LOC124902389 | uncharacterized LOC124902389 | 10 | 21002998 | 21018764 | Human |
329840021 | LOC130003464 | ATAC-STARR-seq lymphoblastoid active region 3119 | 10 | 21020632 | 21020791 | Human |
3302174 | EIF4BP2 | eukaryotic translation initiation factor 4B pseudogene 2 | 10 | 21028983 | 21030793 | Human |
329342469 | LOC129662644 | ReSE screen-validated silencer GRCh37_chr10:21322529-21322705 | 10 | 21033600 | 21033776 | Human |
329339454 | LOC129662645 | ReSE screen-validated silencer GRCh37_chr10:21373491-21373644 | 10 | 21084562 | 21084715 | Human |
38640868 | LOC111946227 | Sharpr-MPRA regulatory region 12489 | 10 | 21097600 | 21097894 | Human |
10450400 | NPM1P30 | nucleophosmin 1 pseudogene 30 | 10 | 21110586 | 21113847 | Human |
155778604 | LOC127817361 | NANOG hESC enhancer GRCh37_chr10:21448091-21448641 | 10 | 21159162 | 21159712 | Human |
155771877 | LOC127817362 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:21449895-21450799 | 10 | 21160966 | 21161870 | Human |
155754780 | LOC127817363 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:21450800-21451703 | 10 | 21161871 | 21162774 | Human |
155775887 | LOC127817364 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21462498-21463388 | 10 | 21173569 | 21174459 | Human |
7204913 | NEBL-AS1 | NEBL antisense RNA 1 | 10 | 21173990 | 21174923 | Human |
151660479 | LOC124403919 | Sharpr-MPRA regulatory region 12641 | 10 | 21185020 | 21185314 | Human |
7204786 | LUZP4P1 | leucine zipper protein 4 pseudogene 1 | 10 | 21247750 | 21248096 | Human |
329840154 | LOC130003465 | ATAC-STARR-seq lymphoblastoid active region 3120 | 10 | 21278873 | 21278992 | Human |
155753660 | LOC127817365 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21570748-21571426 | 10 | 21281819 | 21282497 | Human |
155758275 | LOC127817366 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:21571427-21572103 | 10 | 21282498 | 21283174 | Human |
155753937 | LOC127817367 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21574449-21575208 | 10 | 21285520 | 21286279 | Human |
155768937 | LOC127817368 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21575969-21576728 | 10 | 21287040 | 21287799 | Human |
155227564 | LOC126860876 | MED14-independent group 3 enhancer GRCh37_chr10:21581467-21582666 | 10 | 21292538 | 21293737 | Human |
155757492 | LOC127817369 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21585759-21586559 | 10 | 21296830 | 21297630 | Human |
329813152 | LOC130003466 | ATAC-STARR-seq lymphoblastoid active region 3121 | 10 | 21300749 | 21300828 | Human |
155756164 | LOC127817370 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:21598312-21598930 | 10 | 21309383 | 21310001 | Human |
2312691 | RNU6-15P | RNA, U6 small nuclear 15, pseudogene | 10 | 21321961 | 21322066 | Human |
155771613 | LOC127817371 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21625535-21626086 | 10 | 21336606 | 21337157 | Human |
13831087 | LINC02643 | long intergenic non-protein coding RNA 2643 | 10 | 21340233 | 21372950 | Human |
155759118 | LOC127817372 | H3K27ac hESC enhancer GRCh37_chr10:21645067-21645566 | 10 | 21356138 | 21356637 | Human |
155768196 | LOC127817373 | H3K27ac hESC enhancer GRCh37_chr10:21651599-21652196 | 10 | 21362670 | 21363267 | Human |
155777531 | LOC127817374 | H3K27ac hESC enhancer GRCh37_chr10:21652197-21652792 | 10 | 21363268 | 21363863 | Human |
126924993 | LOC121366046 | H3K27ac hESC enhancer GRCh37_chr10:21661731-21662232 | 10 | 21372802 | 21373303 | Human |
155773163 | LOC127817375 | H3K27ac hESC enhancer GRCh37_chr10:21674728-21675658 | 10 | 21385799 | 21386729 | Human |
7204942 | MRM3P1 | MRM3 pseudogene 1 | 10 | 21394013 | 21394591 | Human |
38641394 | LOC100420467 | glyoxalase domain containing 4 pseudogene | 10 | 21394016 | 21394528 | Human |
155763664 | LOC127817376 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:21692015-21692554 | 10 | 21403086 | 21403625 | Human |
151674323 | LOC124902390 | uncharacterized LOC124902390 | 10 | 21413356 | 21414758 | Human |
38659700 | LOC105376445 | uncharacterized LOC105376445 | 10 | 21414787 | 21418654 | Human |
155760382 | LOC127817377 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:21706197-21706710 | 10 | 21417268 | 21417781 | Human |
329340165 | LOC129662646 | ReSE screen-validated silencer GRCh37_chr10:21760456-21760650 | 10 | 21471527 | 21471721 | Human |
155767348 | LOC127817378 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr10:21761953-21762749 | 10 | 21473024 | 21473820 | Human |
151675540 | LOC124902598 | uncharacterized LOC124902598 | 10 | 21485638 | 21485722 | Human |
1348766 | MIR1915HG | MIR1915 host gene | 10 | 21492658 | 21497260 | Human |
155775985 | LOC127817379 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21783452-21784245 | 10 | 21494523 | 21495316 | Human |
329844622 | LOC130003467 | ATAC-STARR-seq lymphoblastoid silent region 2186 | 10 | 21495741 | 21496180 | Human |
329836958 | LOC130003468 | ATAC-STARR-seq lymphoblastoid silent region 2187 | 10 | 21496231 | 21496280 | Human |
329825512 | LOC130003469 | ATAC-STARR-seq lymphoblastoid silent region 2188 | 10 | 21496491 | 21496740 | Human |
2312986 | MIR1915 | microRNA 1915 | 10 | 21496562 | 21496641 | Human |
329340494 | LOC129662647 | ReSE screen-validated silencer GRCh37_chr10:21793394-21793626 | 10 | 21504465 | 21504697 | Human |
1606383 | SKIDA1 | SKI/DACH domain containing 1 | 10 | 21513475 | 21525682 | Human |
329824153 | LOC130003470 | ATAC-STARR-seq lymphoblastoid silent region 2189 | 10 | 21517298 | 21517457 | Human |
155767373 | LOC127817380 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21814003-21814646 | 10 | 21525074 | 21525717 | Human |
155777076 | LOC127817381 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21814647-21815290 | 10 | 21525718 | 21526436 | Human |
329820715 | LOC130003471 | ATAC-STARR-seq lymphoblastoid silent region 2191 | 10 | 21526557 | 21526706 | Human |
329837277 | LOC130003472 | ATAC-STARR-seq lymphoblastoid silent region 2192 | 10 | 21527152 | 21527271 | Human |
329339521 | LOC129662648 | ReSE screen-validated silencer GRCh37_chr10:21816390-21816548 | 10 | 21527282 | 21527619 | Human |
155765683 | LOC127817382 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:21817867-21818510 | 10 | 21528938 | 21529581 | Human |
1322026 | MLLT10 | MLLT10 histone lysine methyltransferase DOT1L cofactor | 10 | 21533756 | 21743630 | Human |
155780065 | LOC127817383 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21822730-21823443 | 10 | 21533801 | 21534514 | Human |
329835587 | LOC130003473 | ATAC-STARR-seq lymphoblastoid silent region 2196 | 10 | 21534600 | 21534939 | Human |
329816116 | LOC130003474 | ATAC-STARR-seq lymphoblastoid silent region 2197 | 10 | 21535080 | 21535169 | Human |
155753578 | LOC127817384 | H3K27ac hESC enhancer GRCh37_chr10:21824159-21824871 | 10 | 21535230 | 21535942 | Human |
155781071 | LOC127817385 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21825135-21825648 | 10 | 21536206 | 21536719 | Human |
329338840 | LOC129662649 | ReSE screen-validated silencer GRCh37_chr10:21840002-21840186 | 10 | 21551073 | 21551257 | Human |
155763271 | LOC127817386 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21844418-21845000 | 10 | 21555489 | 21556071 | Human |
10400498 | RNU6-306P | RNA, U6 small nuclear 306, pseudogene | 10 | 21564471 | 21564577 | Human |
38607267 | LOC100422524 | solute carrier family 4 member 8 pseudogene | 10 | 21580133 | 21580670 | Human |
7204785 | HNRNPRP1 | heterogeneous nuclear ribonucleoprotein R pseudogene 1 | 10 | 21623902 | 21626356 | Human |
10399650 | RNU6-1141P | RNA, U6 small nuclear 1141, pseudogene | 10 | 21661635 | 21661741 | Human |
155762320 | LOC127817387 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:21952461-21953111 | 10 | 21663532 | 21664182 | Human |
155755648 | LOC127817388 | H3K27ac hESC enhancer GRCh37_chr10:21954039-21954538 | 10 | 21665110 | 21665609 | Human |
151361257 | LOC124403920 | Sharpr-MPRA regulatory region 7684 | 10 | 21673680 | 21673974 | Human |
155757888 | LOC127817389 | H3K4me1 hESC enhancer GRCh37_chr10:21999974-22000474 | 10 | 21710976 | 21711545 | Human |
155754262 | LOC127817390 | NANOG hESC enhancer GRCh37_chr10:22015451-22015952 | 10 | 21726522 | 21727023 | Human |
38670166 | LOC107984214 | uncharacterized LOC107984214 | 10 | 21726523 | 21753628 | Human |
155770810 | LOC127817391 | H3K27ac hESC enhancer GRCh37_chr10:22036939-22037438 | 10 | 21748010 | 21748509 | Human |
38666803 | LOC111946228 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:22039902-22041101 | 10 | 21750973 | 21752584 | Human |
155768805 | LOC127817392 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22041514-22042174 | 10 | 21752585 | 21753245 | Human |
155769107 | LOC127817393 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22042835-22043494 | 10 | 21753906 | 21754565 | Human |
155768881 | LOC127817394 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22043495-22044154 | 10 | 21754566 | 21755225 | Human |
155758358 | LOC127817395 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22045403-22046279 | 10 | 21756474 | 21757350 | Human |
1318035 | DNAJC1 | DnaJ heat shock protein family (Hsp40) member C1 | 10 | 21756548 | 22003730 | Human |
10400579 | RN7SKP219 | RN7SK pseudogene 219 | 10 | 21785292 | 21785587 | Human |
155751925 | LOC127817396 | NANOG hESC enhancer GRCh37_chr10:22085326-22085864 | 10 | 21796397 | 21796935 | Human |
38607599 | LOC111946229 | Sharpr-MPRA regulatory region 11860 | 10 | 21807200 | 21807494 | Human |
155228260 | LOC126860877 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:22099351-22100550 | 10 | 21810422 | 21811621 | Human |
329340140 | LOC129390149 | MPRA-validated peak900 silencer | 10 | 21825567 | 21825767 | Human |
329329389 | LOC129390150 | MPRA-validated peak901 silencer | 10 | 21849707 | 21849907 | Human |
155771184 | LOC127817397 | NANOG hESC enhancer GRCh37_chr10:22157554-22158082 | 10 | 21868625 | 21869153 | Human |
329342631 | LOC129390151 | MPRA-validated peak902 silencer | 10 | 21888886 | 21889104 | Human |
329822910 | LOC130003475 | ATAC-STARR-seq lymphoblastoid active region 3123 | 10 | 21894676 | 21894845 | Human |
155771739 | LOC127817398 | H3K4me1 hESC enhancer GRCh37_chr10:22220654-22221154 | 10 | 21931725 | 21932225 | Human |
10399200 | RN7SKP37 | RN7SK pseudogene 37 | 10 | 21933143 | 21933381 | Human |
329828334 | LOC130003476 | ATAC-STARR-seq lymphoblastoid active region 3124 | 10 | 21989545 | 21989694 | Human |
155755264 | LOC127817399 | H3K27ac hESC enhancer GRCh37_chr10:22292323-22292823 | 10 | 22003364 | 22003983 | Human |
151660424 | LOC124403921 | Sharpr-MPRA regulatory region 4958 | 10 | 22014880 | 22015174 | Human |
38659713 | LOC106783576 | nonconserved acetylation island sequence 68 enhancer | 10 | 22022381 | 22022814 | Human |
38620454 | LOC111946230 | Sharpr-MPRA regulatory region 4688 | 10 | 22042600 | 22042894 | Human |
329339543 | LOC129662650 | ReSE screen-validated silencer GRCh37_chr10:22339665-22339854 | 10 | 22050736 | 22050925 | Human |
329340711 | LOC129390152 | MPRA-validated peak904 silencer | 10 | 22121227 | 22121427 | Human |
155765863 | LOC127817400 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22417997-22418608 | 10 | 22129068 | 22129679 | Human |
329825739 | LOC130003477 | ATAC-STARR-seq lymphoblastoid silent region 2200 | 10 | 22133954 | 22134003 | Human |
329821435 | LOC130003478 | ATAC-STARR-seq lymphoblastoid active region 3127 | 10 | 22134294 | 22134473 | Human |
7205113 | ADIPOR1P1 | adiponectin receptor 1 pseudogene 1 | 10 | 22164576 | 22165424 | Human |
329329860 | LOC129390153 | MPRA-validated peak905 silencer | 10 | 22170547 | 22170747 | Human |
329344249 | LOC129390154 | MPRA-validated peak906 silencer | 10 | 22173927 | 22174127 | Human |
5132975 | EBLN1 | endogenous Bornavirus like nucleoprotein 1 | 10 | 22208475 | 22218015 | Human |
2291752 | PSME2P6 | proteasome activator subunit 2 pseudogene 6 | 10 | 22225697 | 22226071 | Human |
329839073 | LOC130003479 | ATAC-STARR-seq lymphoblastoid silent region 2201 | 10 | 22229034 | 22229283 | Human |
2300894 | TRN-GTT2-3 | tRNA-Asn (anticodon GTT) 2-3 | 10 | 22229509 | 22229582 | Human |
151673424 | LOC124902391 | uncharacterized LOC124902391 | 10 | 22239847 | 22246083 | Human |
38624761 | LOC105376447 | uncharacterized LOC105376447 | 10 | 22247420 | 22258544 | Human |
329829996 | LOC130003480 | ATAC-STARR-seq lymphoblastoid active region 3128 | 10 | 22251376 | 22251455 | Human |
38657210 | LOC100130992 | uncharacterized LOC100130992 | 10 | 22252072 | 22258548 | Human |
329832670 | LOC130003481 | ATAC-STARR-seq lymphoblastoid silent region 2202 | 10 | 22252406 | 22252925 | Human |
329821822 | LOC130003482 | ATAC-STARR-seq lymphoblastoid silent region 2203 | 10 | 22253336 | 22253455 | Human |
155779674 | LOC127817401 | H3K4me1 hESC enhancer GRCh37_chr10:22542487-22543183 | 10 | 22253558 | 22254254 | Human |
2304412 | RPL31P45 | ribosomal protein L31 pseudogene 45 | 10 | 22266990 | 22267205 | Human |
155776468 | LOC127817402 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:22568695-22569196 | 10 | 22279766 | 22280267 | Human |
155779367 | LOC127817403 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:22569197-22569696 | 10 | 22280268 | 22280767 | Human |
329839080 | LOC130003483 | ATAC-STARR-seq lymphoblastoid silent region 2204 | 10 | 22316246 | 22316365 | Human |
1349755 | COMMD3 | COMM domain containing 3 | 10 | 22316388 | 22320306 | Human |
7243668 | COMMD3-BMI1 | COMMD3-BMI1 readthrough | 10 | 22316388 | 22331484 | Human |
329836890 | LOC130003484 | ATAC-STARR-seq lymphoblastoid active region 3129 | 10 | 22316636 | 22316935 | Human |
329840973 | LOC130003485 | ATAC-STARR-seq lymphoblastoid silent region 2205 | 10 | 22320584 | 22320843 | Human |
329842689 | LOC130003486 | ATAC-STARR-seq lymphoblastoid silent region 2206 | 10 | 22320904 | 22321073 | Human |
1348038 | BMI1 | BMI1 proto-oncogene, polycomb ring finger | 10 | 22321099 | 22331706 | Human |
329814753 | LOC130003487 | ATAC-STARR-seq lymphoblastoid silent region 2207 | 10 | 22321264 | 22321463 | Human |
329844162 | LOC130003488 | ATAC-STARR-seq lymphoblastoid silent region 2208 | 10 | 22325537 | 22325916 | Human |
155763042 | LOC127817404 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22629212-22629998 | 10 | 22340283 | 22341072 | Human |
329842038 | LOC130003489 | ATAC-STARR-seq lymphoblastoid active region 3130 | 10 | 22345345 | 22345564 | Human |
1313749 | SPAG6 | sperm associated antigen 6 | 10 | 22345496 | 22417610 | Human |
155770226 | LOC127817405 | H3K4me1 hESC enhancer GRCh37_chr10:22634454-22635270 | 10 | 22345525 | 22346341 | Human |
329820099 | LOC130003490 | ATAC-STARR-seq lymphoblastoid active region 3131 | 10 | 22378860 | 22379089 | Human |
155779464 | LOC127817406 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:22697232-22697772 | 10 | 22408303 | 22408843 | Human |
155765791 | LOC127817407 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:22697773-22698311 | 10 | 22408844 | 22409382 | Human |
38610682 | LINC03027 | long intergenic non-protein coding RNA 3027 | 10 | 22435425 | 22437929 | Human |
329814332 | LOC130003491 | ATAC-STARR-seq lymphoblastoid silent region 2210 | 10 | 22436677 | 22436856 | Human |
38628033 | LOC105376449 | uncharacterized LOC105376449 | 10 | 22437075 | 22462623 | Human |
155776480 | LOC127817408 | H3K4me1 hESC enhancer GRCh37_chr10:22726272-22726772 | 10 | 22437327 | 22437843 | Human |
155770898 | LOC127817409 | H3K4me1 hESC enhancer GRCh37_chr10:22726773-22727273 | 10 | 22437844 | 22438344 | Human |
38640176 | LOC105376450 | uncharacterized LOC105376450 | 10 | 22471451 | 22472577 | Human |
16570673 | AL513128.2 | novel pseudogene | 10 | 22475454 | 22478298 | Human |
329818559 | LOC130003492 | ATAC-STARR-seq lymphoblastoid active region 3134 | 10 | 22475794 | 22476083 | Human |
329829158 | LOC130003493 | ATAC-STARR-seq lymphoblastoid silent region 2211 | 10 | 22476204 | 22476273 | Human |
155760935 | LOC127817410 | H3K4me1 hESC enhancer GRCh37_chr10:22765793-22766476 | 10 | 22476864 | 22477547 | Human |
155755905 | LOC127817411 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22802372-22803008 | 10 | 22513443 | 22514079 | Human |
734348 | PIP4K2A | phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | 10 | 22534854 | 22714578 | Human |
155766112 | LOC127817412 | H3K27ac hESC enhancer GRCh37_chr10:22832411-22833042 | 10 | 22543482 | 22544113 | Human |
151669317 | LOC124902393 | uncharacterized LOC124902393 | 10 | 22554497 | 22555295 | Human |
2300522 | TRP-GGG1-1 | tRNA-Pro (GGG) 1-1 | 10 | 22563650 | 22563722 | Human |
329833044 | LOC130003494 | ATAC-STARR-seq lymphoblastoid active region 3135 | 10 | 22599125 | 22599174 | Human |
329814724 | LOC130003495 | ATAC-STARR-seq lymphoblastoid active region 3136 | 10 | 22601476 | 22601635 | Human |
329838236 | LOC130003496 | ATAC-STARR-seq lymphoblastoid active region 3137 | 10 | 22605093 | 22605242 | Human |
155762505 | LOC127817413 | NANOG hESC enhancer GRCh37_chr10:22899474-22900008 | 10 | 22610545 | 22611079 | Human |
155776988 | LOC127817414 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:22904391-22904959 | 10 | 22615462 | 22616209 | Human |
151660379 | LOC124403922 | Sharpr-MPRA regulatory region 2326 | 10 | 22618440 | 22618734 | Human |
155760047 | LOC127817415 | H3K27ac hESC enhancer GRCh37_chr10:22912555-22913055 | 10 | 22623626 | 22624126 | Human |
329828422 | LOC130003497 | ATAC-STARR-seq lymphoblastoid active region 3141 | 10 | 22637610 | 22637819 | Human |
329813153 | LOC130003498 | ATAC-STARR-seq lymphoblastoid active region 3142 | 10 | 22655414 | 22655483 | Human |
329840482 | LOC130003499 | ATAC-STARR-seq lymphoblastoid active region 3143 | 10 | 22682364 | 22682483 | Human |
329835988 | LOC130003500 | ATAC-STARR-seq lymphoblastoid active region 3144 | 10 | 22683224 | 22683443 | Human |
329830713 | LOC130003501 | ATAC-STARR-seq lymphoblastoid active region 3145 | 10 | 22683984 | 22684053 | Human |
155769983 | LOC127817416 | OCT4-NANOG hESC enhancer GRCh37_chr10:22979554-22980468 | 10 | 22690625 | 22691539 | Human |
38640580 | LOC110121476 | VISTA enhancer hs2048 | 10 | 22692966 | 22694360 | Human |
329831956 | LOC130003502 | ATAC-STARR-seq lymphoblastoid active region 3146 | 10 | 22700497 | 22700556 | Human |
329813559 | LOC130003503 | ATAC-STARR-seq lymphoblastoid active region 3147 | 10 | 22704376 | 22704435 | Human |
329833657 | LOC130003504 | ATAC-STARR-seq lymphoblastoid silent region 2212 | 10 | 22713314 | 22713423 | Human |
329818562 | LOC130003505 | ATAC-STARR-seq lymphoblastoid silent region 2213 | 10 | 22713724 | 22713843 | Human |
329839856 | LOC130003506 | ATAC-STARR-seq lymphoblastoid silent region 2214 | 10 | 22714014 | 22714093 | Human |
155780146 | LOC127817417 | hESC enhancers GRCh37_chr10:23003153-23003761 and GRCh37_chr10:23003762-23004369 | 10 | 22714224 | 22715440 | Human |
329838115 | LOC130003507 | ATAC-STARR-seq lymphoblastoid active region 3148 | 10 | 22723271 | 22723380 | Human |
10399226 | RNU6-413P | RNA, U6 small nuclear 413, pseudogene | 10 | 22787393 | 22787499 | Human |
155762118 | LOC127817419 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:23099405-23099995 | 10 | 22810476 | 22811066 | Human |
155772743 | LOC127817420 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:23099996-23100585 | 10 | 22811067 | 22811656 | Human |
155227779 | LOC126860878 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:23113377-23114576 | 10 | 22824448 | 22825647 | Human |
38613627 | LOC105376451 | uncharacterized LOC105376451 | 10 | 22854100 | 22868224 | Human |
155773700 | LOC127817421 | H3K4me1 hESC enhancer GRCh37_chr10:23164275-23164885 | 10 | 22875346 | 22875956 | Human |
1312695 | ARMC3 | armadillo repeat containing 3 | 10 | 22928053 | 23038523 | Human |
38622561 | LOC107984215 | uncharacterized LOC107984215 | 10 | 22995424 | 23095279 | Human |
6481726 | RNA5SP304 | RNA, 5S ribosomal pseudogene 304 | 10 | 22997255 | 22997358 | Human |
155769001 | LOC127817422 | H3K27ac hESC enhancer GRCh37_chr10:23341078-23341578 | 10 | 23052149 | 23052649 | Human |
155782146 | LOC127817423 | NANOG hESC enhancer GRCh37_chr10:23344706-23345245 | 10 | 23055777 | 23056316 | Human |
126924994 | LOC121366047 | Sharpr-MPRA regulatory region 11378 | 10 | 23068160 | 23068454 | Human |
329833085 | LOC130003508 | ATAC-STARR-seq lymphoblastoid active region 3149 | 10 | 23070700 | 23070809 | Human |
329819662 | LOC130003509 | ATAC-STARR-seq lymphoblastoid silent region 2216 | 10 | 23095387 | 23095856 | Human |
1345900 | MSRB2 | methionine sulfoxide reductase B2 | 10 | 23095579 | 23122013 | Human |
1354163 | YWHAZP3 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta pseudogene 3 | 10 | 23136883 | 23139778 | Human |
329838031 | LOC130003510 | ATAC-STARR-seq lymphoblastoid active region 3150 | 10 | 23157285 | 23157474 | Human |
16559403 | LOC124900299 | uncharacterized LOC124900299 | 10 | 23166985 | 23167101 | Human |
1346483 | PTF1A | pancreas associated transcription factor 1a | 10 | 23192312 | 23194245 | Human |
155771819 | LOC127817424 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:23484130-23484885 | 10 | 23195201 | 23195956 | Human |
1350054 | C10orf67 | chromosome 10 open reading frame 67 | 10 | 23201916 | 23344797 | Human |
329833843 | LOC130003511 | ATAC-STARR-seq lymphoblastoid active region 3151 | 10 | 23325277 | 23325326 | Human |
16552816 | C10orf67-AS1 | C10orf67 antisense RNA 1 | 10 | 23343957 | 23345161 | Human |
151660467 | LOC124403923 | Sharpr-MPRA regulatory region 3018 | 10 | 23345920 | 23346214 | Human |
151671046 | LOC124902591 | uncharacterized LOC124902591 | 10 | 23399530 | 23399599 | Human |
155775101 | LOC127817425 | NANOG hESC enhancer GRCh37_chr10:23698923-23699424 | 10 | 23409994 | 23410495 | Human |
329339747 | LOC129390155 | MPRA-validated peak907 silencer | 10 | 23412246 | 23412446 | Human |
329329580 | LOC129390156 | MPRA-validated peak908 silencer | 10 | 23412446 | 23412646 | Human |
38664469 | LOC108353817 | MIR1254-2-OTUD1 intergenic CAGE-defined monocyte enhancer | 10 | 23432157 | 23433219 | Human |
329835303 | LOC130003512 | ATAC-STARR-seq lymphoblastoid silent region 2217 | 10 | 23438804 | 23439393 | Human |
1344729 | OTUD1 | OTU deubiquitinase 1 | 10 | 23439075 | 23442377 | Human |
329843120 | LOC130003513 | ATAC-STARR-seq lymphoblastoid silent region 2218 | 10 | 23439444 | 23439783 | Human |
329814428 | LOC130003514 | ATAC-STARR-seq lymphoblastoid silent region 2219 | 10 | 23439924 | 23440293 | Human |
155227263 | LOC126860879 | MED14-independent group 3 enhancer GRCh37_chr10:23800961-23802160 | 10 | 23511862 | 23513231 | Human |
38606707 | LOC105376454 | uncharacterized LOC105376454 | 10 | 23543920 | 23586240 | Human |
1352431 | KIAA1217 | KIAA1217 | 10 | 23694727 | 24547843 | Human |
329827930 | LOC130003515 | ATAC-STARR-seq lymphoblastoid active region 3152 | 10 | 23702963 | 23703012 | Human |
329835745 | LOC130003516 | ATAC-STARR-seq lymphoblastoid silent region 2220 | 10 | 23742651 | 23742700 | Human |
329343889 | LOC129662651 | ReSE screen-validated silencer GRCh37_chr10:24113200-24113379 | 10 | 23824271 | 23824450 | Human |
155782781 | LOC127817426 | H3K27ac hESC enhancer GRCh37_chr10:24207043-24207938 | 10 | 23918114 | 23919009 | Human |
155782285 | LOC127817427 | H3K27ac hESC enhancer GRCh37_chr10:24207939-24208832 | 10 | 23919010 | 23919903 | Human |
155757520 | LOC127817428 | OCT4-NANOG hESC enhancer GRCh37_chr10:24385043-24385660 | 10 | 24096114 | 24096731 | Human |
11530063 | NUP35P1 | nucleoporin 35 pseudogene 1 | 10 | 24157822 | 24159343 | Human |
155782769 | LOC127817429 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:24491171-24491936 | 10 | 24202242 | 24203007 | Human |
155230575 | LOC126860880 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:24498253-24499452 | 10 | 24209324 | 24210523 | Human |
155759488 | LOC127817430 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:24503338-24503926 | 10 | 24214409 | 24214997 | Human |
155750193 | LOC127817431 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:24511600-24512328 | 10 | 24222671 | 24223399 | Human |
155754817 | LOC127817432 | H3K27ac hESC enhancer GRCh37_chr10:24526677-24527202 | 10 | 24237748 | 24238273 | Human |
1603073 | MIR603 | microRNA 603 | 10 | 24275685 | 24275781 | Human |
155228468 | LOC126860881 | BRD4-independent group 4 enhancer GRCh37_chr10:24581301-24582500 | 10 | 24292372 | 24293571 | Human |
329835416 | LOC130003517 | ATAC-STARR-seq lymphoblastoid active region 3154 | 10 | 24349437 | 24349496 | Human |
329829912 | LOC130003518 | ATAC-STARR-seq lymphoblastoid active region 3155 | 10 | 24360509 | 24360588 | Human |
329838700 | LOC130003519 | ATAC-STARR-seq lymphoblastoid active region 3156 | 10 | 24360619 | 24360678 | Human |
329340607 | LOC129662652 | ReSE screen-validated silencer GRCh37_chr10:24669872-24670068 | 10 | 24380943 | 24381139 | Human |
155226958 | LOC126860882 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:24671977-24673176 | 10 | 24383048 | 24384247 | Human |
151671859 | LOC124902395 | uncharacterized LOC124902395 | 10 | 24431391 | 24439466 | Human |
155230468 | LOC126860883 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:24721337-24722536 | 10 | 24432408 | 24434121 | Human |
329819867 | LOC130003520 | ATAC-STARR-seq lymphoblastoid active region 3159 | 10 | 24440794 | 24440843 | Human |
38667362 | LOC105376455 | uncharacterized LOC105376455 | 10 | 24454195 | 24466386 | Human |
155779739 | LOC127817433 | H3K4me1 hESC enhancer GRCh37_chr10:24751397-24751898 | 10 | 24462468 | 24462969 | Human |
401824843 | LOC132089766 | Neanderthal introgressed variant-containing enhancer experimental_11630 | 10 | 24491892 | 24492061 | Human |
155777302 | LOC127817434 | H3K27ac hESC enhancer GRCh37_chr10:24782535-24783036 | 10 | 24493606 | 24494107 | Human |
155776040 | LOC127817435 | H3K27ac hESC enhancer GRCh37_chr10:24783037-24783536 | 10 | 24494108 | 24494607 | Human |
155761634 | LOC127817436 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr10:24783692-24784472 | 10 | 24494763 | 24495543 | Human |
155760166 | LOC127817437 | H3K4me1 hESC enhancer GRCh37_chr10:24790381-24790881 | 10 | 24501452 | 24501952 | Human |
151668305 | LOC124902394 | uncharacterized LOC124902394 | 10 | 24525472 | 24526816 | Human |
155229326 | LOC126860884 | BRD4-independent group 4 enhancer GRCh37_chr10:24821078-24822277 | 10 | 24532149 | 24533348 | Human |
127338398 | LOC121811729 | Sharpr-MPRA regulatory region 10635 | 10 | 24541360 | 24541654 | Human |
329342006 | LOC129662653 | ReSE screen-validated silencer GRCh37_chr10:24847550-24847997 | 10 | 24558621 | 24559068 | Human |
155750275 | LOC127817438 | NANOG hESC enhancer GRCh37_chr10:24868778-24869279 | 10 | 24579849 | 24580350 | Human |
1322263 | ARHGAP21 | Rho GTPase activating protein 21 | 10 | 24583614 | 24723887 | Human |
329342225 | LOC129662654 | ReSE screen-validated silencer GRCh37_chr10:24901387-24901576 | 10 | 24612458 | 24612647 | Human |
6481728 | RNA5SP305 | RNA, 5S ribosomal pseudogene 305 | 10 | 24640166 | 24640284 | Human |
329842486 | LOC130003521 | ATAC-STARR-seq lymphoblastoid silent region 2222 | 10 | 24645914 | 24646003 | Human |
7204939 | COQ10BP1 | coenzyme Q10B pseudogene 1 | 10 | 24660541 | 24661054 | Human |
329841219 | LOC130003522 | ATAC-STARR-seq lymphoblastoid silent region 2223 | 10 | 24722667 | 24722976 | Human |
329820647 | LOC130003523 | ATAC-STARR-seq lymphoblastoid silent region 2224 | 10 | 24723037 | 24723396 | Human |
155771657 | LOC127817439 | H3K27ac hESC enhancer GRCh37_chr10:25012349-25013259 | 10 | 24723417 | 24724330 | Human |
329817113 | LOC130003524 | ATAC-STARR-seq lymphoblastoid silent region 2228 | 10 | 24724627 | 24725006 | Human |
38633466 | LOC105376456 | uncharacterized LOC105376456 | 10 | 24752989 | 24778174 | Human |
329341511 | LOC129390157 | MPRA-validated peak910 silencer | 10 | 24762347 | 24762547 | Human |
155763927 | LOC127817440 | OCT4-NANOG hESC enhancer GRCh37_chr10:25051766-25052318 | 10 | 24762837 | 24763389 | Human |
1320925 | PRTFDC1 | phosphoribosyl transferase domain containing 1 | 10 | 24848614 | 24952606 | Human |
329835850 | LOC130003525 | ATAC-STARR-seq lymphoblastoid active region 3160 | 10 | 24887629 | 24887838 | Human |
10450419 | RN7SKP241 | RN7SK pseudogene 241 | 10 | 24908522 | 24908812 | Human |
38671977 | LOC111464994 | NFE2L2 motif-containing MPRA enhancer 245 | 10 | 24921460 | 24921604 | Human |
1343746 | THNSL1 | threonine synthase like 1 | 10 | 24952364 | 25026664 | Human |
329821496 | LOC130003526 | ATAC-STARR-seq lymphoblastoid silent region 2229 | 10 | 24952767 | 24952956 | Human |
1320397 | ENKUR | enkurin, TRPC channel interacting protein | 10 | 24981985 | 25062327 | Human |
329820102 | LOC130003527 | ATAC-STARR-seq lymphoblastoid silent region 2230 | 10 | 25016164 | 25016213 | Human |
38630458 | LOC111946231 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:25305216-25305978 | 10 | 25016287 | 25017049 | Human |
329822174 | LOC130003528 | ATAC-STARR-seq lymphoblastoid active region 3161 | 10 | 25017254 | 25017333 | Human |
329845202 | LOC130003529 | ATAC-STARR-seq lymphoblastoid active region 3162 | 10 | 25036408 | 25036557 | Human |
155229813 | LOC126860885 | BRD4-independent group 4 enhancer GRCh37_chr10:25348855-25350054 | 10 | 25059926 | 25061125 | Human |
155227377 | LOC126860886 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:25350646-25351845 | 10 | 25061717 | 25062916 | Human |
155227498 | LOC126860887 | MED14-independent group 3 enhancer GRCh37_chr10:25356859-25358058 | 10 | 25067753 | 25069129 | Human |
155781888 | LOC127817441 | NANOG hESC enhancer GRCh37_chr10:25394727-25395330 | 10 | 25105798 | 25106401 | Human |
8699003 | LINC01516 | long intergenic non-protein coding RNA 1516 | 10 | 25113058 | 25161233 | Human |
329843383 | LOC130003530 | ATAC-STARR-seq lymphoblastoid silent region 2233 | 10 | 25113375 | 25113424 | Human |
6767363 | GPR158-AS1 | GPR158 antisense RNA 1 | 10 | 25158072 | 25176276 | Human |
1314117 | GPR158 | G protein-coupled receptor 158 | 10 | 25175001 | 25602229 | Human |
155766894 | LOC127817442 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:25542036-25542637 | 10 | 25253107 | 25253708 | Human |
10398890 | RN7SKP220 | RN7SK pseudogene 220 | 10 | 25393557 | 25393844 | Human |
126924915 | LOC121366048 | Sharpr-MPRA regulatory region 12818 | 10 | 25508500 | 25508794 | Human |
329342541 | LOC129390158 | MPRA-validated peak912 silencer | 10 | 25530526 | 25530726 | Human |
7205170 | GPN3P1 | GPN-loop GTPase 3 pseudogene 1 | 10 | 25647077 | 25648104 | Human |
7205361 | LINC00836 | long intergenic non-protein coding RNA 836 | 10 | 25651712 | 25732935 | Human |
7204960 | HIRAP1 | histone cell cycle regulator pseudogene 1 | 10 | 25691539 | 25692328 | Human |
155777243 | LOC127817443 | H3K4me1 hESC enhancer GRCh37_chr10:25983020-25983520 | 10 | 25694091 | 25694591 | Human |
155780011 | LOC127817444 | NANOG hESC enhancer GRCh37_chr10:26005209-26005710 | 10 | 25716280 | 25716781 | Human |
329342696 | LOC129662655 | ReSE screen-validated silencer GRCh37_chr10:26027519-26027690 | 10 | 25738590 | 25738761 | Human |
155770403 | LOC127817445 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:26055160-26055775 | 10 | 25766231 | 25766846 | Human |
155767580 | LOC127817446 | OCT4-NANOG hESC enhancer GRCh37_chr10:26063372-26063916 | 10 | 25774443 | 25774987 | Human |
6481729 | RNA5SP306 | RNA, 5S ribosomal pseudogene 306 | 10 | 25813811 | 25813917 | Human |
10400422 | RNU6-632P | RNA, U6 small nuclear 632, pseudogene | 10 | 25819363 | 25819426 | Human |
329824068 | LOC130003531 | ATAC-STARR-seq lymphoblastoid silent region 2234 | 10 | 25875665 | 25875844 | Human |
151675974 | LOC124902396 | uncharacterized LOC124902396 | 10 | 25882704 | 25897363 | Human |
151672799 | LOC124902397 | uncharacterized LOC124902397 | 10 | 25895603 | 25901925 | Human |
329836458 | LOC130003532 | ATAC-STARR-seq lymphoblastoid active region 3163 | 10 | 25901528 | 25901637 | Human |
38660994 | LOC105376460 | uncharacterized LOC105376460 | 10 | 25905933 | 25912032 | Human |
16553439 | AL358612.1 | novel transcript | 10 | 25924378 | 25933710 | Human |
1349635 | MYO3A | myosin IIIA | 10 | 25934229 | 26212532 | Human |
155750997 | LOC127817447 | NANOG hESC enhancer GRCh37_chr10:26263803-26264349 | 10 | 25974874 | 25975420 | Human |
155230154 | LOC126860888 | BRD4-independent group 4 enhancer GRCh37_chr10:26289384-26290583 | 10 | 26000455 | 26001654 | Human |
155227923 | LOC126860889 | BRD4-independent group 4 enhancer GRCh37_chr10:26290901-26292100 | 10 | 26001972 | 26003171 | Human |
155777307 | LOC127817448 | NANOG hESC enhancer GRCh37_chr10:26488725-26489248 | 10 | 26199796 | 26200319 | Human |
155769790 | LOC127817449 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr10:26502717-26503284 | 10 | 26213788 | 26214355 | Human |
155779457 | LOC127817450 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:26503285-26503850 | 10 | 26214356 | 26214921 | Human |
155751651 | LOC127817451 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:26503851-26504417 | 10 | 26214922 | 26215488 | Human |
733945 | GAD2 | glutamate decarboxylase 2 | 10 | 26216372 | 26304558 | Human |
155779471 | LOC127817452 | H3K4me1 hESC enhancer GRCh37_chr10:26507027-26507655 | 10 | 26218098 | 26218726 | Human |
329829531 | LOC130003533 | ATAC-STARR-seq lymphoblastoid active region 3164 | 10 | 26392423 | 26392482 | Human |
329843253 | LOC130003534 | ATAC-STARR-seq lymphoblastoid active region 3165 | 10 | 26430677 | 26431026 | Human |
155766328 | LOC127817453 | H3K4me1 hESC enhancer GRCh37_chr10:26726587-26727116 | 10 | 26437658 | 26438187 | Human |
1312445 | APBB1IP | amyloid beta precursor protein binding family B member 1 interacting protein | 10 | 26438341 | 26567803 | Human |
329829864 | LOC130003535 | ATAC-STARR-seq lymphoblastoid active region 3167 | 10 | 26438595 | 26438674 | Human |
329828679 | LOC130003536 | ATAC-STARR-seq lymphoblastoid silent region 2235 | 10 | 26465104 | 26465153 | Human |
329831240 | LOC130003537 | ATAC-STARR-seq lymphoblastoid active region 3168 | 10 | 26487223 | 26487272 | Human |
329342561 | LOC129662656 | ReSE screen-validated silencer GRCh37_chr10:26778915-26779063 | 10 | 26489986 | 26490134 | Human |
6481735 | RNA5SP307 | RNA, 5S ribosomal pseudogene 307 | 10 | 26509589 | 26509704 | Human |
329829376 | LOC130003538 | ATAC-STARR-seq lymphoblastoid silent region 2236 | 10 | 26529465 | 26529514 | Human |
329823942 | LOC130003539 | ATAC-STARR-seq lymphoblastoid active region 3169 | 10 | 26540751 | 26540820 | Human |
329816786 | LOC130003540 | ATAC-STARR-seq lymphoblastoid active region 3170 | 10 | 26551067 | 26551456 | Human |
38664010 | LINC03028 | long intergenic non-protein coding RNA 3028 | 10 | 26577686 | 26579307 | Human |
155756466 | LOC127817454 | H3K4me1 hESC enhancer GRCh37_chr10:26868178-26868678 | 10 | 26579249 | 26579749 | Human |
155765643 | LOC127817455 | H3K4me1 hESC enhancer GRCh37_chr10:26871445-26871944 | 10 | 26582516 | 26583015 | Human |
155764614 | LOC127817456 | H3K4me1 hESC enhancer GRCh37_chr10:26877727-26878226 | 10 | 26588798 | 26589297 | Human |
1345207 | FAM238A | family with sequence similarity 238 member A | 10 | 26589865 | 26594324 | Human |
155780208 | LOC127817457 | H3K4me1 hESC enhancer GRCh37_chr10:26882505-26883048 | 10 | 26593576 | 26594119 | Human |
38600995 | LOC102724202 | uncharacterized LOC102724202 | 10 | 26635888 | 26637669 | Human |
38625628 | LOC105376461 | uncharacterized LOC105376461 | 10 | 26637819 | 26642958 | Human |
7205184 | FAM238B | family with sequence similarity 238 member B | 10 | 26643108 | 26653454 | Human |
13463559 | SELENOOLP | selenoprotein O like, pseudogene | 10 | 26662924 | 26675775 | Human |
155762184 | LOC127817458 | H3K27ac hESC enhancer GRCh37_chr10:26986797-26987685 | 10 | 26697374 | 26698756 | Human |
1354063 | PDSS1 | decaprenyl diphosphate synthase subunit 1 | 10 | 26697701 | 26746798 | Human |
7204946 | HSPA8P3 | heat shock protein family A (Hsp70) member 8 pseudogene 3 | 10 | 26714632 | 26716055 | Human |
1604650 | ABI1 | abl interactor 1 | 10 | 26746596 | 26860958 | Human |
329818766 | LOC130003541 | ATAC-STARR-seq lymphoblastoid active region 3171 | 10 | 26755538 | 26755657 | Human |
329829840 | LOC130003542 | ATAC-STARR-seq lymphoblastoid active region 3172 | 10 | 26755748 | 26755807 | Human |
329829644 | LOC130003543 | ATAC-STARR-seq lymphoblastoid active region 3173 | 10 | 26780810 | 26780969 | Human |
329845083 | LOC130003544 | ATAC-STARR-seq lymphoblastoid active region 3174 | 10 | 26781080 | 26781209 | Human |
329826190 | LOC130003545 | ATAC-STARR-seq lymphoblastoid active region 3175 | 10 | 26781790 | 26781899 | Human |
155776426 | LOC127817459 | H3K27ac hESC enhancer GRCh37_chr10:27070945-27071686 | 10 | 26782016 | 26782757 | Human |
16552554 | LOC124900293 | small nucleolar RNA SNORA57 | 10 | 26789017 | 26789157 | Human |
10413709 | RNU6-946P | RNA, U6 small nuclear 946, pseudogene | 10 | 26790540 | 26790646 | Human |
329832170 | LOC130003546 | ATAC-STARR-seq lymphoblastoid silent region 2239 | 10 | 26790599 | 26790688 | Human |
329813429 | LOC130003547 | ATAC-STARR-seq lymphoblastoid silent region 2240 | 10 | 26858332 | 26858381 | Human |
329823637 | LOC130003548 | ATAC-STARR-seq lymphoblastoid silent region 2241 | 10 | 26860331 | 26860480 | Human |
329823472 | LOC130003549 | ATAC-STARR-seq lymphoblastoid silent region 2242 | 10 | 26860591 | 26860680 | Human |
329827862 | LOC130003550 | ATAC-STARR-seq lymphoblastoid active region 3176 | 10 | 26861001 | 26861200 | Human |
151673657 | LOC124902581 | small nucleolar RNA U13 | 10 | 26868165 | 26868264 | Human |
151674930 | LOC124902398 | uncharacterized LOC124902398 | 10 | 26885888 | 26887891 | Human |
155779082 | LOC127817460 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:27182897-27183512 | 10 | 26893968 | 26894583 | Human |
155776084 | LOC127817461 | H3K27ac hESC enhancer GRCh37_chr10:27183513-27184128 | 10 | 26894584 | 26895199 | Human |
329844432 | LOC130003551 | ATAC-STARR-seq lymphoblastoid active region 3177 | 10 | 26912252 | 26912301 | Human |
1353902 | FAM238C | family with sequence similarity 238 member C | 10 | 26931206 | 26942001 | Human |
401826811 | LOC132089767 | Neanderthal introgressed variant-containing enhancer experimental_11703 | 10 | 26939407 | 26939576 | Human |
401826386 | LOC132089768 | Neanderthal introgressed variant-containing enhancer experimental_11711 | 10 | 26939593 | 26939762 | Human |
1314711 | ANKRD26 | ankyrin repeat domain containing 26 | 10 | 26947582 | 27100494 | Human |
329819599 | LOC130003552 | ATAC-STARR-seq lymphoblastoid active region 3178 | 10 | 26971206 | 26971315 | Human |
401824970 | LOC132089769 | Neanderthal introgressed variant-containing enhancer experimental_11810 | 10 | 27049873 | 27050042 | Human |
155769375 | LOC127817462 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:27361449-27361982 | 10 | 27072520 | 27073053 | Human |
401825102 | LOC132089770 | Neanderthal introgressed variant-containing enhancer experimental_11814 | 10 | 27078017 | 27078186 | Human |
10413242 | RNU6-490P | RNA, U6 small nuclear 490, pseudogene | 10 | 27088321 | 27088427 | Human |
329841045 | LOC130003553 | ATAC-STARR-seq lymphoblastoid active region 3179 | 10 | 27099931 | 27099990 | Human |
329828827 | LOC130003554 | ATAC-STARR-seq lymphoblastoid silent region 2243 | 10 | 27100161 | 27100340 | Human |
733459 | YME1L1 | YME1 like 1 ATPase | 10 | 27110111 | 27154384 | Human |
401824991 | LOC132089771 | Neanderthal introgressed variant-containing enhancer experimental_11825 | 10 | 27135476 | 27135645 | Human |
1319386 | MASTL | microtubule associated serine/threonine kinase like | 10 | 27154479 | 27187953 | Human |
329831027 | LOC130003555 | ATAC-STARR-seq lymphoblastoid active region 3180 | 10 | 27155114 | 27155173 | Human |
329337434 | LOC129662657 | ReSE screen-validated silencer GRCh37_chr10:27444170-27444368 | 10 | 27155234 | 27155443 | Human |
329815882 | LOC130003556 | ATAC-STARR-seq lymphoblastoid active region 3181 | 10 | 27155794 | 27156043 | Human |
1319743 | ACBD5 | acyl-CoA binding domain containing 5 | 10 | 27182838 | 27242111 | Human |
10399752 | RNU2-24P | RNA, U2 small nuclear 24, pseudogene | 10 | 27193358 | 27193500 | Human |
2293287 | RNU7-12P | RNA, U7 small nuclear 12 pseudogene | 10 | 27232259 | 27232316 | Human |
155759951 | LOC127817463 | H3K27ac hESC enhancer GRCh37_chr10:27528778-27529280 | 10 | 27239849 | 27240351 | Human |
329823897 | LOC130003557 | ATAC-STARR-seq lymphoblastoid active region 3182 | 10 | 27240309 | 27240568 | Human |
329835018 | LOC130003558 | ATAC-STARR-seq lymphoblastoid silent region 2245 | 10 | 27240689 | 27240798 | Human |
329842003 | LOC130003559 | ATAC-STARR-seq lymphoblastoid active region 3183 | 10 | 27242019 | 27242268 | Human |
329816209 | LOC130003560 | ATAC-STARR-seq lymphoblastoid active region 3184 | 10 | 27242399 | 27242508 | Human |
329819801 | LOC130003561 | ATAC-STARR-seq lymphoblastoid active region 3185 | 10 | 27243274 | 27243543 | Human |
1606382 | LRRC37A6P | leucine rich repeat containing 37 member A6, pseudogene | 10 | 27245853 | 27252306 | Human |
329826373 | LOC130003562 | ATAC-STARR-seq lymphoblastoid active region 3186 | 10 | 27252288 | 27252447 | Human |
329832819 | LOC130003563 | ATAC-STARR-seq lymphoblastoid silent region 2246 | 10 | 27252488 | 27252717 | Human |
7204788 | ODAD2P1 | outer dynein arm docking complex subunit 2 pseudogene 1 | 10 | 27258762 | 27335055 | Human |
38610429 | LOC102724245 | uncharacterized LOC102724245 | 10 | 27297450 | 27307503 | Human |
10400264 | RNU6-666P | RNA, U6 small nuclear 666, pseudogene | 10 | 27315120 | 27315226 | Human |
10399137 | RNU6-452P | RNA, U6 small nuclear 452, pseudogene | 10 | 27335501 | 27335607 | Human |
14298787 | LINC02673 | long intergenic non-protein coding RNA 2673 | 10 | 27343436 | 27344917 | Human |
7204940 | FAM210CP | family with sequence similarity 210 member C, pseudogene | 10 | 27349515 | 27350310 | Human |
1347268 | TRIAP1P1 | TP53 regulated inhibitor of apoptosis 1 pseudogene 1 | 10 | 27376951 | 27378374 | Human |
401826324 | LOC132089772 | Neanderthal introgressed variant-containing enhancer experimental_11902 | 10 | 27384981 | 27385150 | Human |
1603484 | PTCHD3 | patched domain containing 3 (gene/pseudogene) | 10 | 27397121 | 27414347 | Human |
151660471 | LOC124403924 | Sharpr-MPRA regulatory region 9566 | 10 | 27413400 | 27413694 | Human |
155758218 | LOC127817464 | OCT4-NANOG hESC enhancer GRCh37_chr10:27754098-27754691 | 10 | 27465169 | 27465762 | Human |
329824732 | LOC130003564 | ATAC-STARR-seq lymphoblastoid active region 3187 | 10 | 27504000 | 27504269 | Human |
1318941 | RAB18 | RAB18, member RAS oncogene family | 10 | 27504304 | 27542239 | Human |
329835467 | LOC130003565 | ATAC-STARR-seq lymphoblastoid active region 3188 | 10 | 27504380 | 27504439 | Human |
151672592 | LOC124902399 | uncharacterized LOC124902399 | 10 | 27504445 | 27505092 | Human |
155776337 | LOC127817465 | H3K4me1 hESC enhancer GRCh37_chr10:27812349-27812850 | 10 | 27523420 | 27523921 | Human |
13838684 | LINC02680 | long intergenic non-protein coding RNA 2680 | 10 | 27566187 | 27584001 | Human |
155765823 | LOC127817466 | H3K27ac hESC enhancer GRCh37_chr10:27888237-27888738 | 10 | 27599308 | 27599809 | Human |
1313806 | MKX | mohawk homeobox | 10 | 27672874 | 27745819 | Human |
155229941 | LOC126860890 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:28023032-28024231 | 10 | 27734103 | 27735302 | Human |
329840603 | LOC130003566 | ATAC-STARR-seq lymphoblastoid silent region 2247 | 10 | 27742200 | 27742419 | Human |
329838635 | LOC130003567 | ATAC-STARR-seq lymphoblastoid silent region 2248 | 10 | 27742490 | 27742609 | Human |
329817348 | LOC130003568 | ATAC-STARR-seq lymphoblastoid active region 3189 | 10 | 27742890 | 27742959 | Human |
8661424 | MKX-AS1 | MKX antisense RNA 1 | 10 | 27744615 | 27767799 | Human |
155759061 | LOC127817467 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:28034239-28034829 | 10 | 27745310 | 27745900 | Human |
10400394 | RN7SKP132 | RN7SK pseudogene 132 | 10 | 27783846 | 27784053 | Human |
1315828 | ODAD2 | outer dynein arm docking complex subunit 2 | 10 | 27812168 | 27999675 | Human |
401825058 | LOC132089773 | Neanderthal introgressed variant-containing enhancer experimental_12116 | 10 | 27812441 | 27812610 | Human |
155760934 | LOC127817468 | OCT4-NANOG hESC enhancer GRCh37_chr10:28146458-28147081 | 10 | 27857529 | 27858152 | Human |
7204944 | RPL36AP55 | ribosomal protein L36a pseudogene 55 | 10 | 27905002 | 27905201 | Human |
155757358 | LOC127817469 | OCT4-NANOG hESC enhancer GRCh37_chr10:28200466-28201166 | 10 | 27911537 | 27912237 | Human |
38653272 | LOC112268060 | uncharacterized LOC112268060 | 10 | 27983196 | 27995151 | Human |
155227686 | LOC126860891 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:28283413-28284612 | 10 | 27994484 | 27995683 | Human |
1604460 | MRPS21P5 | mitochondrial ribosomal protein S21 pseudogene 5 | 10 | 28004666 | 28004935 | Human |
1344792 | MPP7 | MAGUK p55 scaffold protein 7 | 10 | 28050993 | 28335203 | Human |
10401731 | SNORD130 | small nucleolar RNA, C/D box 130 | 10 | 28073237 | 28073378 | Human |
155229253 | LOC126860892 | MED14-independent group 3 enhancer GRCh37_chr10:28377736-28378935 | 10 | 28088807 | 28090006 | Human |
155228696 | LOC126860893 | MED14-independent group 3 enhancer GRCh37_chr10:28408124-28409323 | 10 | 28119195 | 28120394 | Human |
155782161 | LOC127817470 | OCT4-NANOG hESC enhancer GRCh37_chr10:28500607-28501201 | 10 | 28211678 | 28212272 | Human |
151660484 | LOC124403925 | Sharpr-MPRA regulatory region 10737 | 10 | 28276420 | 28276714 | Human |
8551623 | MIR8086 | microRNA 8086 | 10 | 28289258 | 28289350 | Human |
329830642 | LOC130003569 | ATAC-STARR-seq lymphoblastoid silent region 2249 | 10 | 28302611 | 28303250 | Human |
13830995 | MPP7-DT | MPP7 divergent transcript | 10 | 28303169 | 28306271 | Human |
329835611 | LOC130003570 | ATAC-STARR-seq lymphoblastoid silent region 2250 | 10 | 28334345 | 28334394 | Human |
329838991 | LOC130003571 | ATAC-STARR-seq lymphoblastoid active region 3190 | 10 | 28335040 | 28335159 | Human |
329833171 | LOC130003572 | ATAC-STARR-seq lymphoblastoid active region 3191 | 10 | 28335430 | 28335479 | Human |
7204954 | ZNF101P1 | zinc finger protein 101 pseudogene 1 | 10 | 28339277 | 28341065 | Human |
16552542 | U3 | Small nucleolar RNA U3 | 10 | 28408039 | 28408251 | Human |
329832761 | LOC130003573 | ATAC-STARR-seq lymphoblastoid active region 3192 | 10 | 28432307 | 28432416 | Human |
13831041 | LINC02652 | long intergenic non-protein coding RNA 2652 | 10 | 28433008 | 28495813 | Human |
1601682 | RPSAP10 | ribosomal protein SA pseudogene 10 | 10 | 28436126 | 28437151 | Human |
38655100 | LOC107984216 | uncharacterized LOC107984216 | 10 | 28441162 | 28442373 | Human |
10399849 | RN7SKP39 | RN7SK pseudogene 39 | 10 | 28442575 | 28442896 | Human |
329339710 | LOC129662658 | ReSE screen-validated silencer GRCh37_chr10:28733718-28733938 | 10 | 28444789 | 28445009 | Human |
155770988 | LOC127817471 | NANOG hESC enhancer GRCh37_chr10:28782091-28782660 | 10 | 28493162 | 28493731 | Human |
155754832 | LOC127817472 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:28821447-28822130 | 10 | 28532372 | 28533311 | Human |
1605391 | WAC | WW domain containing adaptor with coiled-coil | 10 | 28532779 | 28623112 | Human |
329837938 | LOC130003574 | ATAC-STARR-seq lymphoblastoid silent region 2253 | 10 | 28533522 | 28533601 | Human |
7096862 | WAC-AS1 | WAC antisense RNA 1 (head to head) | 10 | 28519917 | 28532354 | Human |
329835065 | LOC130003575 | ATAC-STARR-seq lymphoblastoid silent region 2254 | 10 | 28533752 | 28533861 | Human |
329814478 | LOC130003576 | ATAC-STARR-seq lymphoblastoid silent region 2255 | 10 | 28533872 | 28534121 | Human |
329816517 | LOC130003577 | ATAC-STARR-seq lymphoblastoid silent region 2256 | 10 | 28628212 | 28628391 | Human |
10400418 | RNU4ATAC6P | RNA, U4atac small nuclear 6, pseudogene | 10 | 28652630 | 28652755 | Human |
155754956 | LOC127817473 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:28943960-28944522 | 10 | 28655031 | 28655593 | Human |
155765955 | LOC127817474 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:28946775-28947338 | 10 | 28657846 | 28658409 | Human |
7204809 | TPRKBP1 | TP53RK binding protein pseudogene 1 | 10 | 28658979 | 28659529 | Human |
10399942 | RNU6-1067P | RNA, U6 small nuclear 1067, pseudogene | 10 | 28667919 | 28668025 | Human |
155780913 | LOC127817475 | NANOG hESC enhancer GRCh37_chr10:28957669-28958170 | 10 | 28668740 | 28669241 | Human |
329821070 | LOC130003578 | ATAC-STARR-seq lymphoblastoid silent region 2257 | 10 | 28676989 | 28677548 | Human |
1346993 | BAMBI | BMP and activin membrane bound inhibitor | 10 | 28677521 | 28682932 | Human |
329341418 | LOC129662659 | ReSE screen-validated silencer GRCh37_chr10:28967203-28967347 | 10 | 28678274 | 28678418 | Human |
155770395 | LOC127817476 | H3K4me1 hESC enhancer GRCh37_chr10:28972804-28973712 | 10 | 28683875 | 28684783 | Human |
155766361 | LOC127817477 | H3K27ac hESC enhancer GRCh37_chr10:28989321-28989822 | 10 | 28700392 | 28700893 | Human |
38614653 | LOC105376470 | uncharacterized LOC105376470 | 10 | 28708029 | 28710966 | Human |
38608788 | LOC107984170 | uncharacterized LOC107984170 | 10 | 28713118 | 28726273 | Human |
155755491 | LOC127817478 | H3K4me1 hESC enhancer GRCh37_chr10:29010913-29011414 | 10 | 28721984 | 28722485 | Human |
151660429 | LOC124403926 | Sharpr-MPRA regulatory region 10738 | 10 | 28728420 | 28728714 | Human |
8699198 | LINC01517 | long intergenic non-protein coding RNA 1517 | 10 | 28743650 | 28808219 | Human |
10400168 | RNU6-270P | RNA, U6 small nuclear 270, pseudogene | 10 | 28760699 | 28760803 | Human |
7205377 | LINC00837 | long intergenic non-protein coding RNA 837 | 10 | 28789311 | 28796050 | Human |
7245990 | C10orf126 | chromosome 10 open reading frame 126 | 10 | 28846408 | 28881898 | Human |
6481734 | RNA5SP308 | RNA, 5S ribosomal pseudogene 308 | 10 | 28874393 | 28874507 | Human |
38614321 | LOC108004524 | heart enhancer 23 | 10 | 28880010 | 28880230 | Human |
2305611 | RPL21P93 | ribosomal protein L21 pseudogene 93 | 10 | 28898950 | 28899524 | Human |
155229832 | LOC126860894 | BRD4-independent group 4 enhancer GRCh37_chr10:29194458-29195657 | 10 | 28905529 | 28906728 | Human |
155779705 | LOC127817479 | H3K4me1 hESC enhancer GRCh37_chr10:29214143-29214841 | 10 | 28925214 | 28925912 | Human |
155228529 | LOC126860895 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:29274071-29275270 | 10 | 28985142 | 28986341 | Human |
151660364 | LOC124403927 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:29279785-29280984 | 10 | 28990856 | 28992094 | Human |
155773618 | LOC127817480 | NANOG hESC enhancer GRCh37_chr10:29299789-29300329 | 10 | 29010860 | 29011400 | Human |
38606059 | LOC107984174 | uncharacterized LOC107984174 | 10 | 29058055 | 29079588 | Human |
38624242 | LOC107984171 | uncharacterized LOC107984171 | 10 | 29093630 | 29104693 | Human |
155775134 | LOC127817481 | H3K27ac hESC enhancer GRCh37_chr10:29429294-29429794 | 10 | 29140365 | 29140865 | Human |
155774965 | LOC127817482 | H3K27ac hESC enhancer GRCh37_chr10:29429795-29430295 | 10 | 29140866 | 29141366 | Human |
155780122 | LOC127817483 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29448375-29449050 | 10 | 29159446 | 29160121 | Human |
329342854 | LOC129662660 | ReSE screen-validated silencer GRCh37_chr10:29495743-29495973 | 10 | 29206814 | 29207044 | Human |
38617618 | LOC105376472 | uncharacterized LOC105376472 | 10 | 29229433 | 29235901 | Human |
329840034 | LOC130003579 | ATAC-STARR-seq lymphoblastoid silent region 2258 | 10 | 29285635 | 29285704 | Human |
329815993 | LOC130003580 | ATAC-STARR-seq lymphoblastoid active region 3194 | 10 | 29285815 | 29285904 | Human |
1350038 | LYZL1 | lysozyme like 1 | 10 | 29289070 | 29318328 | Human |
155757479 | LOC127817484 | OCT4 hESC enhancer GRCh37_chr10:29591323-29591859 | 10 | 29302394 | 29302930 | Human |
151670574 | LOC124902400 | uncharacterized LOC124902400 | 10 | 29312562 | 29317664 | Human |
155229679 | LOC126860896 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:29633052-29634251 | 10 | 29344123 | 29345322 | Human |
155751505 | LOC127817485 | H3K4me1 hESC enhancer GRCh37_chr10:29655033-29655534 | 10 | 29366104 | 29366605 | Human |
155227536 | LOC126860897 | BRD4-independent group 4 enhancer GRCh37_chr10:29655751-29656950 | 10 | 29366606 | 29368021 | Human |
38623228 | LOC107984217 | uncharacterized LOC107984217 | 10 | 29367612 | 29374370 | Human |
38613119 | LOC105376473 | uncharacterized LOC105376473 | 10 | 29372987 | 29374919 | Human |
155778098 | LOC127817486 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29683525-29684039 | 10 | 29394596 | 29395110 | Human |
38657824 | LOC105376474 | uncharacterized LOC105376474 | 10 | 29405891 | 29409453 | Human |
8698716 | SVIL-AS1 | SVIL antisense RNA 1 | 10 | 29409534 | 29487856 | Human |
329822548 | LOC130003581 | ATAC-STARR-seq lymphoblastoid silent region 2259 | 10 | 29409916 | 29410055 | Human |
329844891 | LOC130003582 | ATAC-STARR-seq lymphoblastoid active region 3195 | 10 | 29412903 | 29412952 | Human |
7205322 | PTCHD3P1 | patched domain containing 3 pseudogene 1 | 10 | 29421476 | 29422238 | Human |
1314924 | SVIL | supervillin | 10 | 29457338 | 29736936 | Human |
155756799 | LOC127817487 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29761791-29762353 | 10 | 29472862 | 29473424 | Human |
155777184 | LOC127817488 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29762354-29762917 | 10 | 29473425 | 29473988 | Human |
155772264 | LOC127817489 | H3K4me1 hESC enhancer GRCh37_chr10:29766445-29766944 | 10 | 29477516 | 29478015 | Human |
155763192 | LOC127817490 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29767812-29768343 | 10 | 29478883 | 29479414 | Human |
155759436 | LOC127817491 | NANOG hESC enhancer GRCh37_chr10:29785287-29785788 | 10 | 29496358 | 29496859 | Human |
155228005 | LOC126860898 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:29790285-29791484 | 10 | 29501356 | 29502555 | Human |
151669230 | LOC124902401 | uncharacterized LOC124902401 | 10 | 29512849 | 29517279 | Human |
155778721 | LOC127817492 | H3K4me1 hESC enhancer GRCh37_chr10:29805146-29805646 | 10 | 29516217 | 29516717 | Human |
155757122 | LOC127817493 | H3K4me1 hESC enhancer GRCh37_chr10:29827039-29827540 | 10 | 29538110 | 29538611 | Human |
155763742 | LOC127817494 | H3K4me1 hESC enhancer GRCh37_chr10:29827541-29828040 | 10 | 29538612 | 29539111 | Human |
1603072 | MIR604 | microRNA 604 | 10 | 29545004 | 29545097 | Human |
155230653 | LOC126860899 | BRD4-independent group 4 enhancer GRCh37_chr10:29851081-29852280 | 10 | 29562152 | 29563351 | Human |
16551893 | SNORD115 | Small nucleolar RNA SNORD115 | 10 | 29575306 | 29575381 | Human |
155759708 | LOC127817495 | H3K4me1 hESC enhancer GRCh37_chr10:29872959-29873460 | 10 | 29584030 | 29584531 | Human |
155779431 | LOC127817496 | H3K4me1 hESC enhancer GRCh37_chr10:29873461-29873960 | 10 | 29584532 | 29585031 | Human |
155772955 | LOC127817497 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:29874238-29874738 | 10 | 29585309 | 29585809 | Human |
155761369 | LOC127817498 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:29874739-29875239 | 10 | 29585810 | 29586310 | Human |
2290228 | MIR938 | microRNA 938 | 10 | 29602264 | 29602346 | Human |
155781774 | LOC127817499 | H3K27ac hESC enhancer GRCh37_chr10:29907005-29907635 | 10 | 29618076 | 29618706 | Human |
155772503 | LOC127817500 | H3K27ac hESC enhancer GRCh37_chr10:29907636-29908265 | 10 | 29618707 | 29619336 | Human |
155774465 | LOC127817501 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:29910018-29910768 | 10 | 29621089 | 29621839 | Human |
151660427 | LOC124403928 | Sharpr-MPRA regulatory region 354 | 10 | 29634780 | 29635074 | Human |
155780718 | LOC127817502 | H3K27ac hESC enhancer GRCh37_chr10:29927951-29928452 | 10 | 29639022 | 29639523 | Human |
155227079 | LOC126860900 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:29947465-29948664 | 10 | 29658536 | 29659735 | Human |
155767412 | LOC127817503 | OCT4-NANOG hESC enhancer GRCh37_chr10:29956022-29956579 | 10 | 29667093 | 29667650 | Human |
155769886 | LOC127817504 | OCT4-NANOG hESC enhancer GRCh37_chr10:29977089-29977707 | 10 | 29688160 | 29688778 | Human |
1348595 | CKS1BP2 | CDC28 protein kinase regulatory subunit 1B pseudogene 2 | 10 | 29697935 | 29698646 | Human |
10399435 | RNU6-908P | RNA, U6 small nuclear 908, pseudogene | 10 | 29711915 | 29712008 | Human |
155769683 | LOC127817505 | H3K27ac hESC enhancer GRCh37_chr10:30024395-30024895 | 10 | 29735386 | 29736065 | Human |
151660448 | LOC124403929 | Sharpr-MPRA regulatory region 9997 | 10 | 29736320 | 29736614 | Human |
38614541 | LOC105376475 | uncharacterized LOC105376475 | 10 | 29781728 | 29784521 | Human |
38656013 | LOC105376476 | uncharacterized LOC105376476 | 10 | 29821117 | 29829111 | Human |
38616690 | LOC102724333 | uncharacterized LOC102724333 | 10 | 29838740 | 29839746 | Human |
38653609 | LOC107984172 | uncharacterized LOC107984172 | 10 | 29842742 | 29843300 | Human |
38635115 | LOC107984173 | uncharacterized LOC107984173 | 10 | 29861017 | 29862498 | Human |
155227985 | LOC126860901 | BRD4-independent group 4 enhancer GRCh37_chr10:30150443-30151642 | 10 | 29861514 | 29862713 | Human |
151669951 | LOC124902402 | uncharacterized LOC124902402 | 10 | 29861900 | 29863026 | Human |
151668091 | LOC124902403 | uncharacterized LOC124902403 | 10 | 29947146 | 29951694 | Human |
38643035 | LOC107984218 | uncharacterized LOC107984218 | 10 | 29992488 | 30001072 | Human |
329339359 | LOC129662661 | ReSE screen-validated silencer GRCh37_chr10:30287145-30287333 | 10 | 29998216 | 29998404 | Human |
1346091 | JCAD | junctional cadherin 5 associated | 10 | 30012803 | 30115494 | Human |
329845288 | LOC130003583 | ATAC-STARR-seq lymphoblastoid active region 3196 | 10 | 30027339 | 30027398 | Human |
329831754 | LOC130003584 | ATAC-STARR-seq lymphoblastoid active region 3197 | 10 | 30027579 | 30027648 | Human |
155750211 | LOC127817506 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30317296-30318025 | 10 | 30028367 | 30029096 | Human |
155760018 | LOC127817507 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30318026-30318754 | 10 | 30029097 | 30029825 | Human |
155759516 | LOC127817508 | OCT4-NANOG hESC enhancer GRCh37_chr10:30323522-30324118 | 10 | 30034593 | 30035189 | Human |
329340074 | LOC129662662 | ReSE screen-validated silencer GRCh37_chr10:30332840-30333112 | 10 | 30043911 | 30044183 | Human |
329818079 | LOC130003585 | ATAC-STARR-seq lymphoblastoid active region 3198 | 10 | 30047446 | 30047505 | Human |
329828612 | LOC130003586 | ATAC-STARR-seq lymphoblastoid active region 3199 | 10 | 30047516 | 30047625 | Human |
155758282 | LOC127817509 | NANOG hESC enhancer GRCh37_chr10:30345636-30346173 | 10 | 30056707 | 30057244 | Human |
38665797 | LOC101929256 | uncharacterized LOC101929256 | 10 | 30058838 | 30121081 | Human |
329835536 | LOC130003587 | ATAC-STARR-seq lymphoblastoid silent region 2263 | 10 | 30059529 | 30059698 | Human |
151660481 | LOC124403930 | Sharpr-MPRA regulatory region 14462 | 10 | 30063140 | 30063434 | Human |
329835886 | LOC130003588 | ATAC-STARR-seq lymphoblastoid active region 3200 | 10 | 30152021 | 30152070 | Human |
329824512 | LOC130003589 | ATAC-STARR-seq lymphoblastoid silent region 2264 | 10 | 30155593 | 30155652 | Human |
329827420 | LOC130003590 | ATAC-STARR-seq lymphoblastoid active region 3201 | 10 | 30160698 | 30160747 | Human |
155770606 | LOC127817510 | H3K4me1 hESC enhancer GRCh37_chr10:30451859-30452358 | 10 | 30162930 | 30163429 | Human |
38638015 | LOC105376477 | uncharacterized LOC105376477 | 10 | 30196825 | 30206302 | Human |
329832186 | LOC130003591 | ATAC-STARR-seq lymphoblastoid silent region 2265 | 10 | 30207508 | 30207687 | Human |
38613893 | LOC101929279 | uncharacterized LOC101929279 | 10 | 30211852 | 30232690 | Human |
329827301 | LOC130003592 | ATAC-STARR-seq lymphoblastoid silent region 2266 | 10 | 30220010 | 30220099 | Human |
329833240 | LOC130003593 | ATAC-STARR-seq lymphoblastoid active region 3202 | 10 | 30231059 | 30231198 | Human |
329832456 | LOC130003594 | ATAC-STARR-seq lymphoblastoid active region 3203 | 10 | 30285133 | 30285212 | Human |
10399919 | RNU6-598P | RNA, U6 small nuclear 598, pseudogene | 10 | 30299569 | 30299673 | Human |
6480160 | EEF1A1P39 | eukaryotic translation elongation factor 1 alpha 1 pseudogene 39 | 10 | 30301823 | 30302072 | Human |
1322070 | MTPAP | mitochondrial poly(A) polymerase | 10 | 30309801 | 30349278 | Human |
155750218 | LOC127817511 | H3K4me1 hESC enhancer GRCh37_chr10:30636687-30637187 | 10 | 30347758 | 30348258 | Human |
329839770 | LOC130003595 | ATAC-STARR-seq lymphoblastoid active region 3204 | 10 | 30348840 | 30348939 | Human |
329843497 | LOC130003596 | ATAC-STARR-seq lymphoblastoid active region 3205 | 10 | 30348950 | 30349019 | Human |
329838930 | LOC130003597 | ATAC-STARR-seq lymphoblastoid active region 3206 | 10 | 30349070 | 30349119 | Human |
329825171 | LOC130003598 | ATAC-STARR-seq lymphoblastoid active region 3207 | 10 | 30349150 | 30349289 | Human |
1348829 | DNM1P17 | dynamin 1 pseudogene 17 | 10 | 30357154 | 30358984 | Human |
155768867 | LOC127817512 | H3K4me1 hESC enhancer GRCh37_chr10:30648605-30649209 | 10 | 30359676 | 30360280 | Human |
7204787 | GOLGA2P6 | GOLGA2 pseudogene 6 | 10 | 30364327 | 30371907 | Human |
10413216 | RN7SL241P | RNA, 7SL, cytoplasmic 241, pseudogene | 10 | 30366064 | 30366299 | Human |
8550336 | MIR7162 | microRNA 7162 | 10 | 30368597 | 30368665 | Human |
155764665 | LOC127817513 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30661753-30662712 | 10 | 30372824 | 30373783 | Human |
155751596 | LOC127817514 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30662713-30663672 | 10 | 30373784 | 30374743 | Human |
7205013 | NIFKP1 | NIFK pseudogene 1 | 10 | 30380161 | 30381121 | Human |
1350463 | CCND3P1 | cyclin D3 pseudogene 1 | 10 | 30403194 | 30403821 | Human |
329820142 | LOC130003599 | ATAC-STARR-seq lymphoblastoid active region 3209 | 10 | 30418599 | 30418718 | Human |
329842191 | LOC130003600 | ATAC-STARR-seq lymphoblastoid active region 3210 | 10 | 30418759 | 30418828 | Human |
329843042 | LOC130003601 | ATAC-STARR-seq lymphoblastoid active region 3211 | 10 | 30431604 | 30431663 | Human |
155778507 | LOC127817515 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30721100-30721981 | 10 | 30432171 | 30433052 | Human |
329813840 | LOC130003602 | ATAC-STARR-seq lymphoblastoid active region 3212 | 10 | 30433724 | 30433863 | Human |
329828299 | LOC130003603 | ATAC-STARR-seq lymphoblastoid silent region 2267 | 10 | 30433904 | 30434143 | Human |
731488 | MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 10 | 30434021 | 30461833 | Human |
329835868 | LOC130003604 | ATAC-STARR-seq lymphoblastoid active region 3213 | 10 | 30434584 | 30434683 | Human |
329837225 | LOC130003605 | ATAC-STARR-seq lymphoblastoid active region 3214 | 10 | 30434974 | 30435023 | Human |
155773581 | LOC127817516 | H3K4me1 hESC enhancer GRCh37_chr10:30724077-30724614 | 10 | 30435148 | 30435685 | Human |
155762526 | LOC127817517 | H3K4me1 hESC enhancer GRCh37_chr10:30724615-30725150 | 10 | 30435686 | 30436221 | Human |
329815764 | LOC130003606 | ATAC-STARR-seq lymphoblastoid active region 3216 | 10 | 30437477 | 30437676 | Human |
329828023 | LOC130003607 | ATAC-STARR-seq lymphoblastoid active region 3217 | 10 | 30510630 | 30510859 | Human |
7205018 | HNRNPA1P32 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 32 | 10 | 30517656 | 30518926 | Human |
329819789 | LOC130003608 | ATAC-STARR-seq lymphoblastoid active region 3218 | 10 | 30529570 | 30529719 | Human |
38638425 | LOC105376478 | uncharacterized LOC105376478 | 10 | 30529663 | 30554608 | Human |
329827967 | LOC130003609 | ATAC-STARR-seq lymphoblastoid active region 3219 | 10 | 30529940 | 30530329 | Human |
155753561 | LOC127817518 | H3K27ac hESC enhancer GRCh37_chr10:30827242-30827742 | 10 | 30538313 | 30538813 | Human |
155763254 | LOC127817519 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30841700-30842312 | 10 | 30552771 | 30553383 | Human |
151660403 | LOC124403931 | Sharpr-MPRA regulatory region 6088 | 10 | 30553860 | 30554154 | Human |
10399642 | RN7SL63P | RNA, 7SL, cytoplasmic 63, pseudogene | 10 | 30555601 | 30555904 | Human |
155765604 | LOC127817520 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:30847997-30848576 | 10 | 30559068 | 30559647 | Human |
155770111 | LOC127817521 | NANOG hESC enhancer GRCh37_chr10:30862856-30863438 | 10 | 30573927 | 30574509 | Human |
38607106 | LOC105376479 | uncharacterized LOC105376479 | 10 | 30587686 | 30591159 | Human |
155761799 | LOC127817522 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:30885919-30886534 | 10 | 30596990 | 30597605 | Human |
155750796 | LOC127817523 | H3K27ac hESC enhancer GRCh37_chr10:30886535-30887149 | 10 | 30597606 | 30598220 | Human |
155770053 | LOC127817524 | H3K4me1 hESC enhancer GRCh37_chr10:30894172-30894987 | 10 | 30605243 | 30606058 | Human |
1343889 | LYZL2 | lysozyme like 2 | 10 | 30606221 | 30629753 | Human |
151668906 | LOC124902404 | uncharacterized LOC124902404 | 10 | 30615247 | 30616870 | Human |
155754460 | LOC127817525 | H3K4me1 hESC enhancer GRCh37_chr10:30932862-30933433 | 10 | 30643933 | 30644504 | Human |
155230493 | LOC126860902 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:30950154-30951353 | 10 | 30661225 | 30662424 | Human |
155228575 | LOC126860903 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:30970851-30972050 | 10 | 30681922 | 30683121 | Human |
155780464 | LOC127817526 | H3K27ac hESC enhancer GRCh37_chr10:30972911-30973410 | 10 | 30683982 | 30684481 | Human |
155767089 | LOC127817527 | NANOG hESC enhancer GRCh37_chr10:30976431-30976969 | 10 | 30687502 | 30688040 | Human |
7205019 | SVIL2P | supervillin family member 2, pseudogene | 10 | 30692274 | 30717013 | Human |
155229372 | LOC126860904 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:30984558-30985757 | 10 | 30695629 | 30696828 | Human |
329814710 | LOC130003610 | ATAC-STARR-seq lymphoblastoid active region 3221 | 10 | 30701920 | 30702059 | Human |
329841727 | LOC130003611 | ATAC-STARR-seq lymphoblastoid active region 3222 | 10 | 30702080 | 30702129 | Human |
329819815 | LOC130003612 | ATAC-STARR-seq lymphoblastoid active region 3223 | 10 | 30705066 | 30705125 | Human |
155769901 | LOC127817528 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:30994171-30994694 | 10 | 30705242 | 30705765 | Human |
13830991 | LINC02644 | long intergenic non-protein coding RNA 2644 | 10 | 30723219 | 30723740 | Human |
329834023 | LOC130003613 | ATAC-STARR-seq lymphoblastoid active region 3225 | 10 | 30737125 | 30737174 | Human |
329816767 | LOC130003614 | ATAC-STARR-seq lymphoblastoid active region 3226 | 10 | 30738329 | 30738418 | Human |
329834867 | LOC130003615 | ATAC-STARR-seq lymphoblastoid active region 3227 | 10 | 30738479 | 30738548 | Human |
329815757 | LOC130003616 | ATAC-STARR-seq lymphoblastoid active region 3228 | 10 | 30751316 | 30751375 | Human |
329826182 | LOC130003617 | ATAC-STARR-seq lymphoblastoid silent region 2268 | 10 | 30752110 | 30752159 | Human |
329843711 | LOC130003618 | ATAC-STARR-seq lymphoblastoid silent region 2269 | 10 | 30754734 | 30754833 | Human |
155753695 | LOC127817529 | H3K4me1 hESC enhancer GRCh37_chr10:31072075-31072575 | 10 | 30783146 | 30783646 | Human |
329837917 | LOC130003619 | ATAC-STARR-seq lymphoblastoid silent region 2270 | 10 | 30785133 | 30785442 | Human |
155757930 | LOC127817530 | H3K4me1 hESC enhancer GRCh37_chr10:31106665-31107586 | 10 | 30817736 | 30818657 | Human |
151670835 | LOC124902405 | uncharacterized LOC124902405 | 10 | 30820205 | 30821313 | Human |
1603538 | ZNF438 | zinc finger protein 438 | 10 | 30844632 | 31032411 | Human |
155779201 | LOC127817531 | H3K4me1 hESC enhancer GRCh37_chr10:31135691-31136191 | 10 | 30846762 | 30847262 | Human |
7204936 | DDX10P1 | DEAD-box helicase 10 pseudogene 1 | 10 | 30919008 | 30921130 | Human |
329339292 | LOC129390159 | MPRA-validated peak916 silencer | 10 | 30947047 | 30947247 | Human |
329838074 | LOC130003620 | ATAC-STARR-seq lymphoblastoid active region 3230 | 10 | 30959198 | 30959247 | Human |
329819177 | LOC130003621 | ATAC-STARR-seq lymphoblastoid active region 3231 | 10 | 30959368 | 30959597 | Human |
329836649 | LOC130003622 | ATAC-STARR-seq lymphoblastoid silent region 2271 | 10 | 31031527 | 31032086 | Human |
38619239 | LOC105376481 | uncharacterized LOC105376481 | 10 | 31032508 | 31155929 | Human |
329339409 | LOC129390160 | MPRA-validated peak918 silencer | 10 | 31039127 | 31039327 | Human |
329842712 | LOC130003623 | ATAC-STARR-seq lymphoblastoid active region 3232 | 10 | 31091167 | 31091356 | Human |
329822177 | LOC130003624 | ATAC-STARR-seq lymphoblastoid active region 3233 | 10 | 31101337 | 31101396 | Human |
329845264 | LOC130003625 | ATAC-STARR-seq lymphoblastoid active region 3234 | 10 | 31104992 | 31105111 | Human |
38600488 | LOC105376482 | uncharacterized LOC105376482 | 10 | 31129983 | 31134204 | Human |
329825478 | LOC130003626 | ATAC-STARR-seq lymphoblastoid silent region 2272 | 10 | 31133864 | 31134223 | Human |
38660385 | LOC105376483 | uncharacterized LOC105376483 | 10 | 31133900 | 31143842 | Human |
329841788 | LOC130003627 | ATAC-STARR-seq lymphoblastoid silent region 2273 | 10 | 31134284 | 31134333 | Human |
155776254 | LOC127817532 | H3K4me1 hESC enhancer GRCh37_chr10:31435102-31435653 | 10 | 31146173 | 31146724 | Human |
155759430 | LOC127817533 | H3K4me1 hESC enhancer GRCh37_chr10:31435654-31436204 | 10 | 31146725 | 31147275 | Human |
329838984 | LOC130003628 | ATAC-STARR-seq lymphoblastoid active region 3235 | 10 | 31149938 | 31150167 | Human |
13831277 | LINC02664 | long intergenic non-protein coding RNA 2664 | 10 | 31187883 | 31261552 | Human |
155773762 | LOC127817534 | H3K4me1 hESC enhancer GRCh37_chr10:31498085-31498585 | 10 | 31209156 | 31209656 | Human |
155227649 | LOC126860905 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:31531588-31532787 | 10 | 31242659 | 31243858 | Human |
6481730 | RNA5SP309 | RNA, 5S ribosomal pseudogene 309 | 10 | 31259599 | 31259704 | Human |
5134903 | ZEB1-AS1 | ZEB1 antisense RNA 1 | 10 | 31307717 | 31320447 | Human |
329823237 | LOC130003629 | ATAC-STARR-seq lymphoblastoid silent region 2274 | 10 | 31318411 | 31318470 | Human |
1299953 | ZEB1 | zinc finger E-box binding homeobox 1 | 10 | 31318417 | 31529804 | Human |
329842545 | LOC130003630 | ATAC-STARR-seq lymphoblastoid silent region 2275 | 10 | 31319211 | 31319660 | Human |
329831731 | LOC130003631 | ATAC-STARR-seq lymphoblastoid silent region 2276 | 10 | 31319701 | 31319790 | Human |
329821681 | LOC130003632 | ATAC-STARR-seq lymphoblastoid active region 3236 | 10 | 31341663 | 31341802 | Human |
6480955 | SPTLC1P1 | serine palmitoyltransferase long chain base subunit 1 pseudogene 1 | 10 | 31360913 | 31361214 | Human |
38655239 | LOC100505502 | POM121 transmembrane nucleoporin like, pseudogene | 10 | 31362799 | 31364049 | Human |
329814583 | LOC130003633 | ATAC-STARR-seq lymphoblastoid active region 3237 | 10 | 31384064 | 31384213 | Human |
329839577 | LOC130003634 | ATAC-STARR-seq lymphoblastoid active region 3238 | 10 | 31393982 | 31394031 | Human |
329832943 | LOC130003635 | ATAC-STARR-seq lymphoblastoid active region 3239 | 10 | 31394122 | 31394261 | Human |
155780036 | LOC127817535 | H3K27ac hESC enhancer GRCh37_chr10:31756459-31756960 | 10 | 31467530 | 31468031 | Human |
126924935 | LOC121366049 | Sharpr-MPRA regulatory region 3516 | 10 | 31468280 | 31468574 | Human |
329828290 | LOC130003636 | ATAC-STARR-seq lymphoblastoid active region 3240 | 10 | 31491307 | 31491426 | Human |
329340724 | LOC129390161 | MPRA-validated peak919 silencer | 10 | 31507527 | 31507727 | Human |
155751060 | LOC127817536 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:31797084-31797592 | 10 | 31508156 | 31508664 | Human |
155770138 | LOC127817537 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:31797593-31798099 | 10 | 31508665 | 31509171 | Human |
155763232 | LOC127817538 | H3K4me1 hESC enhancer GRCh37_chr10:31873359-31873859 | 10 | 31584431 | 31584931 | Human |
329843094 | LOC130003637 | ATAC-STARR-seq lymphoblastoid silent region 2277 | 10 | 31596999 | 31597048 | Human |
151670417 | LOC124906892 | uncharacterized LOC124906892 | 10 | 31602862 | 31606218 | Human |
38644156 | LOC105376484 | uncharacterized LOC105376484 | 10 | 31603034 | 31620973 | Human |
329842656 | LOC130003638 | ATAC-STARR-seq lymphoblastoid silent region 2278 | 10 | 31603274 | 31603863 | Human |
329826078 | LOC130003639 | ATAC-STARR-seq lymphoblastoid active region 3241 | 10 | 31617167 | 31617296 | Human |
1353618 | GLUD1P5 | glutamate dehydrogenase 1 pseudogene 5 | 10 | 31617611 | 31618201 | Human |
155778564 | LOC127817539 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:31954277-31955148 | 10 | 31665349 | 31666220 | Human |
155773583 | LOC127817540 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:31955149-31956018 | 10 | 31666221 | 31667090 | Human |
155776298 | LOC127817541 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:31966287-31966838 | 10 | 31677359 | 31677910 | Human |
13792511 | MACORIS | macrophage enriched lincRNA repressor of IFN-gamma signaling | 10 | 31693082 | 31707447 | Human |
155760791 | LOC127817542 | H3K4me1 hESC enhancer GRCh37_chr10:31983575-31984136 | 10 | 31694647 | 31695208 | Human |
155780933 | LOC127817543 | H3K4me1 hESC enhancer GRCh37_chr10:31984137-31984698 | 10 | 31695209 | 31695770 | Human |
329835229 | LOC130003640 | ATAC-STARR-seq lymphoblastoid active region 3242 | 10 | 31707696 | 31707885 | Human |
155774911 | LOC127817544 | H3K27ac hESC enhancer GRCh37_chr10:32048354-32049250 | 10 | 31759426 | 31760350 | Human |
329842189 | LOC130003641 | ATAC-STARR-seq lymphoblastoid active region 3243 | 10 | 31760431 | 31760520 | Human |
155780494 | LOC127817545 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:32054478-32055115 | 10 | 31765550 | 31766187 | Human |
155761329 | LOC127817546 | H3K4me1 hESC enhancer GRCh37_chr10:32062977-32063974 | 10 | 31774049 | 31775046 | Human |
1320676 | ARHGAP12 | Rho GTPase activating protein 12 | 10 | 31805398 | 31928876 | Human |
329329654 | LOC129390162 | MPRA-validated peak921 silencer | 10 | 31851388 | 31851588 | Human |
155754535 | LOC127817547 | H3K4me1 hESC enhancer GRCh37_chr10:32189989-32190489 | 10 | 31901061 | 31901561 | Human |
4888929 | HMGB1P7 | high mobility group box 1 pseudogene 7 | 10 | 31913149 | 31913754 | Human |
38648992 | LOC107984219 | uncharacterized LOC107984219 | 10 | 31922852 | 32020399 | Human |
329825192 | LOC130003642 | ATAC-STARR-seq lymphoblastoid silent region 2280 | 10 | 31928503 | 31929002 | Human |
155228590 | LOC126860906 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:32229391-32230590 | 10 | 31940463 | 31941662 | Human |
38616173 | LOC105376485 | uncharacterized LOC105376485 | 10 | 31980782 | 31996595 | Human |
2304646 | RPL34P19 | ribosomal protein L34 pseudogene 19 | 10 | 31984255 | 31984555 | Human |
10450709 | RN7SL825P | RNA, 7SL, cytoplasmic 825, pseudogene | 10 | 31992087 | 31992381 | Human |
155766644 | LOC127817548 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:32291606-32292421 | 10 | 32002678 | 32003493 | Human |
1344841 | KIF5B | kinesin family member 5B | 10 | 32009015 | 32056425 | Human |
155230143 | LOC126860907 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:32306942-32308141 | 10 | 32018014 | 32019213 | Human |
155229770 | LOC126860908 | BRD4-independent group 4 enhancer GRCh37_chr10:32337050-32338249 | 10 | 32048122 | 32049321 | Human |
329819064 | LOC130003643 | ATAC-STARR-seq lymphoblastoid active region 3244 | 10 | 32055799 | 32056008 | Human |
329838203 | LOC130003644 | ATAC-STARR-seq lymphoblastoid silent region 2281 | 10 | 32056339 | 32056528 | Human |
2304361 | RPS4XP11 | ribosomal protein S4X pseudogene 11 | 10 | 32102453 | 32103341 | Human |
155767115 | LOC127817549 | H3K27ac hESC enhancer GRCh37_chr10:32411889-32412388 | 10 | 32122961 | 32123460 | Human |
155772043 | LOC127817550 | H3K27ac hESC enhancer GRCh37_chr10:32428165-32428894 | 10 | 32139237 | 32139966 | Human |
329839270 | LOC130003645 | ATAC-STARR-seq lymphoblastoid silent region 2282 | 10 | 32143600 | 32143649 | Human |
329825835 | LOC130003646 | ATAC-STARR-seq lymphoblastoid silent region 2283 | 10 | 32143690 | 32143759 | Human |
151660370 | LOC124403932 | Sharpr-MPRA regulatory region 14665 | 10 | 32169481 | 32169775 | Human |
2293277 | RNU7-22P | RNA, U7 small nuclear 22 pseudogene | 10 | 32173685 | 32173743 | Human |
7205334 | PPIAP31 | peptidylprolyl isomerase A pseudogene 31 | 10 | 32188125 | 32188855 | Human |
329339004 | LOC129662663 | ReSE screen-validated silencer GRCh37_chr10:32485087-32485280 | 10 | 32196159 | 32196352 | Human |
38676156 | LOC111818964 | Sharpr-MPRA regulatory regions 2209 and 5551 | 10 | 32207501 | 32207835 | Human |
2304607 | RPS24P13 | ribosomal protein S24 pseudogene 13 | 10 | 32231780 | 32232283 | Human |
329342022 | LOC129662664 | ReSE screen-validated silencer GRCh37_chr10:32536341-32536558 | 10 | 32247413 | 32247630 | Human |
155768923 | LOC127817551 | H3K27ac hESC enhancer GRCh37_chr10:32542436-32542936 | 10 | 32253508 | 32254008 | Human |
329833015 | LOC130003647 | ATAC-STARR-seq lymphoblastoid silent region 2284 | 10 | 32256738 | 32256857 | Human |
1314407 | EPC1 | enhancer of polycomb homolog 1 | 10 | 32267751 | 32378769 | Human |
329836276 | LOC130003648 | ATAC-STARR-seq lymphoblastoid active region 3245 | 10 | 32317819 | 32317878 | Human |
329826991 | LOC130003649 | ATAC-STARR-seq lymphoblastoid silent region 2285 | 10 | 32332397 | 32332536 | Human |
329837035 | LOC130003650 | ATAC-STARR-seq lymphoblastoid silent region 2286 | 10 | 32346189 | 32346468 | Human |
329826129 | LOC130003651 | ATAC-STARR-seq lymphoblastoid active region 3246 | 10 | 32346689 | 32346788 | Human |
329821855 | LOC130003652 | ATAC-STARR-seq lymphoblastoid active region 3247 | 10 | 32346809 | 32346868 | Human |
329840795 | LOC130003653 | ATAC-STARR-seq lymphoblastoid silent region 2287 | 10 | 32347139 | 32347608 | Human |
16554389 | EPC1-AS1 | EPC1 antisense RNA 1 | 10 | 32347364 | 32374488 | Human |
329840221 | LOC130003654 | ATAC-STARR-seq lymphoblastoid silent region 2288 | 10 | 32347619 | 32347748 | Human |
155756562 | LOC127817552 | H3K27ac hESC enhancer GRCh37_chr10:32667292-32667792 | 10 | 32378364 | 32378864 | Human |
155777771 | LOC127817553 | H3K27ac hESC enhancer GRCh37_chr10:32667793-32668293 | 10 | 32378865 | 32379365 | Human |
329343370 | LOC129662665 | ReSE screen-validated silencer GRCh37_chr10:32668668-32668769 | 10 | 32379740 | 32379841 | Human |
10398946 | RNU6-1244P | RNA, U6 small nuclear 1244, pseudogene | 10 | 32394558 | 32394665 | Human |
38675857 | LOC101929431 | uncharacterized LOC101929431 | 10 | 32434354 | 32446056 | Human |
1346795 | CCDC7 | coiled-coil domain containing 7 | 10 | 32443324 | 32882864 | Human |
329832611 | LOC130003655 | ATAC-STARR-seq lymphoblastoid active region 3248 | 10 | 32445691 | 32446010 | Human |
329819947 | LOC130003656 | ATAC-STARR-seq lymphoblastoid silent region 2289 | 10 | 32446081 | 32446310 | Human |
329339601 | LOC129662666 | ReSE screen-validated silencer GRCh37_chr10:32790971-32791162 | 10 | 32502043 | 32502234 | Human |
3362449 | C1DP1 | C1D nuclear receptor corepressor pseudogene 1 | 10 | 32510628 | 32511796 | Human |
329341409 | LOC129662667 | ReSE screen-validated silencer GRCh37_chr10:32805360-32805595 | 10 | 32516432 | 32516667 | Human |
151674225 | LOC124902406 | uncharacterized LOC124902406 | 10 | 32750310 | 32762017 | Human |
155759629 | LOC127817554 | H3K4me1 hESC enhancer GRCh37_chr10:33176139-33176640 | 10 | 32887211 | 32887712 | Human |
155765472 | LOC127817555 | H3K4me1 hESC enhancer GRCh37_chr10:33176641-33177140 | 10 | 32887713 | 32888212 | Human |
736631 | ITGB1 | integrin subunit beta 1 | 10 | 32900318 | 32958230 | Human |
10401740 | SNORA86 | small nucleolar RNA, H/ACA box 86 | 10 | 32901334 | 32901472 | Human |
329819586 | LOC130003657 | ATAC-STARR-seq lymphoblastoid active region 3249 | 10 | 32938561 | 32938650 | Human |
4144672 | AK3P5 | AK3 pseudogene 5 | 10 | 32944282 | 32945201 | Human |
329343212 | LOC129662668 | ReSE screen-validated silencer GRCh37_chr10:33245856-33246017 | 10 | 32956928 | 32957089 | Human |
329831143 | LOC130003658 | ATAC-STARR-seq lymphoblastoid silent region 2290 | 10 | 32957483 | 32957932 | Human |
329817053 | LOC130003659 | ATAC-STARR-seq lymphoblastoid silent region 2291 | 10 | 32958003 | 32958582 | Human |
329827309 | LOC130003660 | ATAC-STARR-seq lymphoblastoid active region 3250 | 10 | 32958753 | 32958802 | Human |
155778068 | LOC127817556 | H3K27ac hESC enhancer GRCh37_chr10:33252634-33253444 | 10 | 32963706 | 32964516 | Human |
155758527 | LOC127817557 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:33269180-33269742 | 10 | 32980252 | 32980814 | Human |
155754166 | LOC127817558 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:33269743-33270305 | 10 | 32980815 | 32981377 | Human |
13210666 | ITGB1-DT | ITGB1 divergent transcript | 10 | 32982551 | 33082102 | Human |
155773453 | LOC127817559 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:33284303-33284803 | 10 | 32995375 | 32995875 | Human |
10450463 | MTND4LP11 | MT-ND4L pseudogene 11 | 10 | 33023368 | 33023647 | Human |
10412471 | RN7SL847P | RNA, 7SL, cytoplasmic 847, pseudogene | 10 | 33034655 | 33034924 | Human |
155769134 | LOC127817560 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:33338273-33338773 | 10 | 33049345 | 33049845 | Human |
2305629 | RPL7AP53 | ribosomal protein L7a pseudogene 53 | 10 | 33057555 | 33058432 | Human |
13782223 | IATPR | ITGB1 adjacent tumor promoting lncRNA | 10 | 33074026 | 33116807 | Human |
155754271 | LOC127817561 | H3K27ac hESC enhancer GRCh37_chr10:33364857-33365358 | 10 | 33075929 | 33076430 | Human |
155770260 | LOC127817562 | OCT4-NANOG hESC enhancer GRCh37_chr10:33384895-33385560 | 10 | 33095967 | 33096632 | Human |
155228165 | LOC126860909 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:33422695-33423894 | 10 | 33133767 | 33134966 | Human |
155753627 | LOC127817563 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:33460260-33460846 | 10 | 33171332 | 33171918 | Human |
733081 | NRP1 | neuropilin 1 | 10 | 33177493 | 33334667 | Human |
151671839 | LOC124902407 | uncharacterized LOC124902407 | 10 | 33208906 | 33213821 | Human |
155230160 | LOC126860910 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:33552654-33553853 | 10 | 33263726 | 33264925 | Human |
10413841 | RN7SL398P | RNA, 7SL, cytoplasmic 398, pseudogene | 10 | 33288304 | 33288601 | Human |
151660478 | LOC124403933 | Sharpr-MPRA regulatory region 15712 | 10 | 33327681 | 33327975 | Human |
155778788 | LOC127817564 | H3K4me1 hESC enhancer GRCh37_chr10:33682030-33682530 | 10 | 33393102 | 33393602 | Human |
155757783 | LOC127817565 | NANOG hESC enhancer GRCh37_chr10:33773681-33774220 | 10 | 33484753 | 33485292 | Human |
155778954 | LOC127817566 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:33804933-33805524 | 10 | 33516005 | 33516596 | Human |
151660394 | LOC124403934 | OCT4-NANOG hESC enhancer GRCh37_chr10:33808102-33808943 | 10 | 33519174 | 33520015 | Human |
38675463 | LOC105376489 | uncharacterized LOC105376489 | 10 | 33530768 | 33537188 | Human |
155756226 | LOC127817567 | NANOG hESC enhancer GRCh37_chr10:33855273-33855774 | 10 | 33566345 | 33566846 | Human |
13825340 | LINC02628 | long intergenic non-protein coding RNA 2628 | 10 | 33579012 | 33601030 | Human |
155752801 | LOC127817568 | H3K4me1 hESC enhancer GRCh37_chr10:33950959-33951459 | 10 | 33662031 | 33662531 | Human |
155228012 | LOC126860911 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:33979034-33980233 | 10 | 33690106 | 33691305 | Human |
155228848 | LOC126860912 | BRD4-independent group 4 enhancer GRCh37_chr10:33993045-33994244 | 10 | 33704117 | 33705316 | Human |
151671454 | LOC124902408 | uncharacterized LOC124902408 | 10 | 33705988 | 33709393 | Human |
7205393 | LINC00838 | long intergenic non-protein coding RNA 838 | 10 | 33759713 | 33772680 | Human |
155766845 | LOC127817569 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:34061547-34062270 | 10 | 33772619 | 33773342 | Human |
155781988 | LOC127817570 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:34062271-34062994 | 10 | 33773343 | 33774066 | Human |
329339879 | LOC129662669 | ReSE screen-validated silencer GRCh37_chr10:34072014-34072206 | 10 | 33783086 | 33783278 | Human |
2304879 | RPL23P11 | ribosomal protein L23 pseudogene 11 | 10 | 33864313 | 33864723 | Human |
155227121 | LOC126860913 | BRD4-independent group 4 enhancer GRCh37_chr10:34166034-34167233 | 10 | 33877106 | 33878305 | Human |
14394827 | LINC02629 | long intergenic non-protein coding RNA 2629 | 10 | 33904131 | 33917804 | Human |
155752219 | LOC127817571 | H3K4me1 hESC enhancer GRCh37_chr10:34318619-34319118 | 10 | 34029691 | 34030190 | Human |
155769078 | LOC127817572 | H3K27ac hESC enhancer GRCh37_chr10:34331971-34332472 | 10 | 34043043 | 34043544 | Human |
731593 | PARD3 | par-3 family cell polarity regulator | 10 | 34109561 | 34815296 | Human |
155767053 | LOC127817573 | H3K4me1 hESC enhancer GRCh37_chr10:34465469-34465970 | 10 | 34176541 | 34177042 | Human |
155782591 | LOC127817574 | H3K27ac hESC enhancer GRCh37_chr10:34471859-34472575 | 10 | 34182931 | 34183647 | Human |
151660431 | LOC124403935 | Sharpr-MPRA regulatory region 2386 | 10 | 34216301 | 34216595 | Human |
2300478 | TRL-CAA7-1 | tRNA-Leu (CAA) 7-1 | 10 | 34302488 | 34302555 | Human |
155774173 | LOC127817575 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:34641233-34641969 | 10 | 34352305 | 34353041 | Human |
329835560 | LOC130003661 | ATAC-STARR-seq lymphoblastoid active region 3253 | 10 | 34380977 | 34381106 | Human |
329339668 | LOC129390163 | MPRA-validated peak925 silencer | 10 | 34416858 | 34417058 | Human |
155227697 | LOC126860914 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:34715861-34717060 | 10 | 34426933 | 34428132 | Human |
155768219 | LOC127817576 | H3K27ac hESC enhancer GRCh37_chr10:34773554-34774054 | 10 | 34484626 | 34485126 | Human |
155769872 | LOC127817577 | H3K27ac hESC enhancer GRCh37_chr10:34774055-34774555 | 10 | 34485127 | 34485627 | Human |
6480901 | ELOBP4 | elongin B pseudogene 4 | 10 | 34488579 | 34488878 | Human |
155780037 | LOC127817578 | H3K4me1 hESC enhancer GRCh37_chr10:34777721-34778257 | 10 | 34488793 | 34489329 | Human |
155756442 | LOC127817579 | H3K27ac hESC enhancer GRCh37_chr10:34814928-34815683 | 10 | 34526000 | 34526755 | Human |
155782344 | LOC127817580 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:34817074-34817649 | 10 | 34528146 | 34528721 | Human |
329837406 | LOC130003662 | ATAC-STARR-seq lymphoblastoid active region 3254 | 10 | 34539880 | 34540169 | Human |
151660500 | LOC124403936 | Sharpr-MPRA regulatory region 15357 | 10 | 34637521 | 34637815 | Human |
329827450 | LOC130003663 | ATAC-STARR-seq lymphoblastoid active region 3255 | 10 | 34649254 | 34649353 | Human |
329823063 | LOC130003664 | ATAC-STARR-seq lymphoblastoid silent region 2292 | 10 | 34650297 | 34650496 | Human |
2304805 | RPL37P18 | ribosomal protein L37 pseudogene 18 | 10 | 34663877 | 34664101 | Human |
2304796 | RPS12P16 | ribosomal protein S12 pseudogene 16 | 10 | 34675613 | 34676128 | Human |
329844337 | LOC130003665 | ATAC-STARR-seq lymphoblastoid silent region 2293 | 10 | 34717076 | 34717215 | Human |
155764486 | LOC127817581 | H3K4me1 hESC enhancer GRCh37_chr10:35026216-35026716 | 10 | 34737288 | 34737788 | Human |
155766430 | LOC127817582 | H3K4me1 hESC enhancer GRCh37_chr10:35067774-35068274 | 10 | 34778846 | 34779346 | Human |
155758030 | LOC127817583 | H3K4me1 hESC enhancer GRCh37_chr10:35068275-35068775 | 10 | 34779347 | 34779847 | Human |
329829229 | LOC130003666 | ATAC-STARR-seq lymphoblastoid active region 3256 | 10 | 34780982 | 34781111 | Human |
329828672 | LOC130003667 | ATAC-STARR-seq lymphoblastoid active region 3257 | 10 | 34781322 | 34781381 | Human |
155772273 | LOC127817584 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:35081214-35081916 | 10 | 34792286 | 34792988 | Human |
155780801 | LOC127817585 | H3K4me1 hESC enhancer GRCh37_chr10:35081917-35082619 | 10 | 34792989 | 34793691 | Human |
151660369 | LOC124403937 | Sharpr-MPRA regulatory region 397 | 10 | 34809501 | 34809795 | Human |
329821099 | LOC130003668 | ATAC-STARR-seq lymphoblastoid silent region 2294 | 10 | 34814535 | 34814814 | Human |
329831238 | LOC130003669 | ATAC-STARR-seq lymphoblastoid silent region 2295 | 10 | 34815335 | 34815504 | Human |
329843473 | LOC130003670 | ATAC-STARR-seq lymphoblastoid silent region 2296 | 10 | 34815595 | 34815644 | Human |
7205337 | PARD3-DT | PARD3 divergent transcript | 10 | 34815768 | 34816422 | Human |
7205017 | SS18L2P1 | SS18 like 2 pseudogene 1 | 10 | 34875161 | 34876225 | Human |
155763398 | LOC127817586 | H3K4me1 hESC enhancer GRCh37_chr10:35207011-35207678 | 10 | 34918083 | 34918750 | Human |
329344103 | LOC129390164 | MPRA-validated peak927 silencer | 10 | 34922727 | 34922927 | Human |
10400698 | RNU6-847P | RNA, U6 small nuclear 847, pseudogene | 10 | 34926775 | 34926882 | Human |
10398847 | RNU6-193P | RNA, U6 small nuclear 193, pseudogene | 10 | 34942969 | 34943075 | Human |
155774625 | LOC127817587 | H3K4me1 hESC enhancer GRCh37_chr10:35247828-35248328 | 10 | 34958900 | 34959400 | Human |
155756574 | LOC127817588 | H3K4me1 hESC enhancer GRCh37_chr10:35248329-35248829 | 10 | 34959401 | 34959901 | Human |
7205014 | PRDX2P2 | peroxiredoxin 2 pseudogene 2 | 10 | 34965000 | 34966454 | Human |
13830977 | LINC02635 | long intergenic non-protein coding RNA 2635 | 10 | 34973018 | 34975578 | Human |
329339526 | LOC129390165 | MPRA-validated peak929 silencer | 10 | 34981587 | 34981787 | Human |
151668162 | LOC124902409 | uncharacterized LOC124902409 | 10 | 34993612 | 35006598 | Human |
1321670 | CUL2 | cullin 2 | 10 | 35008551 | 35127006 | Human |
155758425 | LOC127817589 | OCT4-NANOG hESC enhancer GRCh37_chr10:35301624-35302194 | 10 | 35012696 | 35013266 | Human |
4888791 | MIR3611 | microRNA 3611 | 10 | 35079598 | 35079680 | Human |
329821297 | LOC130003671 | ATAC-STARR-seq lymphoblastoid silent region 2297 | 10 | 35090112 | 35090241 | Human |
329820064 | LOC130003672 | ATAC-STARR-seq lymphoblastoid silent region 2298 | 10 | 35090262 | 35090461 | Human |
329337660 | LOC129662670 | ReSE screen-validated silencer GRCh37_chr10:35379443-35379631 | 10 | 35090515 | 35090761 | Human |
329838672 | LOC130003673 | ATAC-STARR-seq lymphoblastoid silent region 2299 | 10 | 35126734 | 35127253 | Human |
735941 | CREM | cAMP responsive element modulator | 10 | 35126846 | 35212958 | Human |
329833107 | LOC130003674 | ATAC-STARR-seq lymphoblastoid silent region 2300 | 10 | 35127314 | 35127453 | Human |
329827303 | LOC130003675 | ATAC-STARR-seq lymphoblastoid active region 3259 | 10 | 35127814 | 35127883 | Human |
329822411 | LOC130003676 | ATAC-STARR-seq lymphoblastoid silent region 2301 | 10 | 35133806 | 35133875 | Human |
2293222 | RNU7-77P | RNA, U7 small nuclear 77 pseudogene | 10 | 35135444 | 35135500 | Human |
329843222 | LOC130003677 | ATAC-STARR-seq lymphoblastoid active region 3260 | 10 | 35136548 | 35136597 | Human |
329820881 | LOC130003678 | ATAC-STARR-seq lymphoblastoid active region 3261 | 10 | 35149116 | 35149235 | Human |
329831403 | LOC130003679 | ATAC-STARR-seq lymphoblastoid active region 3262 | 10 | 35149396 | 35149455 | Human |
329814355 | LOC130003680 | ATAC-STARR-seq lymphoblastoid active region 3263 | 10 | 35149876 | 35149925 | Human |
3051013 | ATP6V1G1P4 | ATPase H+ transporting V1 subunit G1 pseudogene 4 | 10 | 35158306 | 35158637 | Human |
155771608 | LOC127817590 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:35500215-35500774 | 10 | 35211287 | 35211846 | Human |
155761921 | LOC127817591 | H3K4me1 hESC enhancer GRCh37_chr10:35503415-35503916 | 10 | 35214487 | 35214988 | Human |
329826250 | LOC130003681 | ATAC-STARR-seq lymphoblastoid silent region 2302 | 10 | 35218695 | 35218744 | Human |
13831005 | LINC02634 | long intergenic non-protein coding RNA 2634 | 10 | 35219889 | 35244679 | Human |
155781723 | LOC127817592 | H3K27ac hESC enhancer GRCh37_chr10:35517588-35518088 | 10 | 35228660 | 35229160 | Human |
10400133 | RNU6-794P | RNA, U6 small nuclear 794, pseudogene | 10 | 35231331 | 35231394 | Human |
1347341 | CCNY | cyclin Y | 10 | 35247025 | 35572667 | Human |
329338407 | LOC129662671 | ReSE screen-validated silencer GRCh37_chr10:35536556-35536734 | 10 | 35247628 | 35247806 | Human |
10400596 | RNU6-1167P | RNA, U6 small nuclear 1167, pseudogene | 10 | 35250959 | 35251052 | Human |
38668016 | LOC107984220 | uncharacterized LOC107984220 | 10 | 35296545 | 35306715 | Human |
155228541 | LOC126860915 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:35588522-35589721 | 10 | 35299594 | 35300793 | Human |
329826881 | LOC130003682 | ATAC-STARR-seq lymphoblastoid silent region 2304 | 10 | 35304817 | 35304876 | Human |
39939022 | CCNY-AS1 | CCNY antisense RNA 1 | 10 | 35314233 | 35336424 | Human |
38599411 | LOC111946232 | Sharpr-MPRA regulatory region 12265 | 10 | 35332241 | 35332535 | Human |
329816079 | LOC130003683 | ATAC-STARR-seq lymphoblastoid silent region 2305 | 10 | 35336135 | 35336874 | Human |
151361240 | LOC124403938 | Sharpr-MPRA regulatory region 1021 | 10 | 35379401 | 35379695 | Human |
151660384 | LOC124403939 | Sharpr-MPRA regulatory region 675 | 10 | 35393481 | 35393775 | Human |
329839520 | LOC130003684 | ATAC-STARR-seq lymphoblastoid silent region 2306 | 10 | 35433835 | 35433904 | Human |
151671337 | LOC124902410 | uncharacterized LOC124902410 | 10 | 35443411 | 35446988 | Human |
155782561 | LOC127817593 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:35736957-35737627 | 10 | 35448029 | 35448699 | Human |
329834212 | LOC130003685 | ATAC-STARR-seq lymphoblastoid silent region 2307 | 10 | 35451459 | 35451588 | Human |
155780417 | LOC127817594 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:35751098-35751642 | 10 | 35462170 | 35462714 | Human |
155775003 | LOC127817595 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:35751643-35752185 | 10 | 35462715 | 35463257 | Human |
155774333 | LOC127817596 | H3K4me1 hESC enhancer GRCh37_chr10:35752610-35753110 | 10 | 35463682 | 35464182 | Human |
329819469 | LOC130003686 | ATAC-STARR-seq lymphoblastoid active region 3264 | 10 | 35495592 | 35495641 | Human |
329817210 | LOC130003687 | ATAC-STARR-seq lymphoblastoid active region 3265 | 10 | 35498641 | 35498790 | Human |
155757755 | LOC127817597 | H3K27ac hESC enhancer GRCh37_chr10:35806272-35806772 | 10 | 35517344 | 35517844 | Human |
155773768 | LOC127817598 | H3K27ac hESC enhancer GRCh37_chr10:35806773-35807273 | 10 | 35517845 | 35518345 | Human |
155230407 | LOC126860916 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:35819404-35820603 | 10 | 35530476 | 35531675 | Human |
329835777 | LOC130003688 | ATAC-STARR-seq lymphoblastoid active region 3266 | 10 | 35564422 | 35564531 | Human |
329836414 | LOC130003689 | ATAC-STARR-seq lymphoblastoid active region 3267 | 10 | 35564592 | 35564701 | Human |
329822639 | LOC130003690 | ATAC-STARR-seq lymphoblastoid active region 3268 | 10 | 35564972 | 35565051 | Human |
38644837 | LOC107984221 | uncharacterized LOC107984221 | 10 | 35581447 | 35586346 | Human |
155761541 | LOC127817599 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:35883203-35883845 | 10 | 35594275 | 35594917 | Human |
329342459 | LOC129662672 | ReSE screen-validated silencer GRCh37_chr10:35889926-35890176 | 10 | 35600998 | 35601248 | Human |
1603351 | GJD4 | gap junction protein delta 4 | 10 | 35605341 | 35608935 | Human |
38638472 | LOC110121405 | VISTA enhancer hs1588 | 10 | 35636454 | 35638314 | Human |
1350514 | FZD8 | frizzled class receptor 8 | 10 | 35638247 | 35642296 | Human |
155756429 | LOC127817600 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:35927732-35928593 | 10 | 35638804 | 35639665 | Human |
151660454 | LOC124403940 | Sharpr-MPRA regulatory region 6098 | 10 | 35639921 | 35640215 | Human |
329841300 | LOC130003691 | ATAC-STARR-seq lymphoblastoid active region 3269 | 10 | 35640485 | 35640644 | Human |
329835649 | LOC130003692 | ATAC-STARR-seq lymphoblastoid silent region 2308 | 10 | 35640755 | 35640844 | Human |
5134851 | MIR4683 | microRNA 4683 | 10 | 35641172 | 35641252 | Human |
151675712 | LOC124902528 | zinc finger protein 469-like | 10 | 35641728 | 35642846 | Human |
38628311 | LOC105376494 | uncharacterized LOC105376494 | 10 | 35643315 | 35647828 | Human |
151672786 | LOC124902411 | uncharacterized LOC124902411 | 10 | 35657153 | 35666121 | Human |
329343274 | LOC129662673 | ReSE screen-validated silencer GRCh37_chr10:35952948-35953138 | 10 | 35664020 | 35664210 | Human |
155770661 | LOC127817601 | H3K4me1 hESC enhancer GRCh37_chr10:35958057-35958556 | 10 | 35669129 | 35669628 | Human |
38673587 | LOC110121399 | VISTA enhancer hs1567 | 10 | 35683964 | 35687004 | Human |
2305663 | RPL7P37 | ribosomal protein L7 pseudogene 37 | 10 | 35697275 | 35698109 | Human |
155765693 | LOC127817602 | H3K4me1 hESC enhancer GRCh37_chr10:35990312-35990819 | 10 | 35701384 | 35701891 | Human |
38666103 | LOC107984188 | uncharacterized LOC107984188 | 10 | 35714124 | 35727386 | Human |
38645760 | LOC110121406 | VISTA enhancer hs1589 | 10 | 35783344 | 35785363 | Human |
155230330 | LOC126860917 | BRD4-independent group 4 enhancer GRCh37_chr10:36084084-36085283 | 10 | 35795156 | 35796355 | Human |
13825345 | LINC02630 | long intergenic non-protein coding RNA 2630 | 10 | 35897206 | 35898878 | Human |
155780160 | LOC127817603 | NANOG hESC enhancer GRCh37_chr10:36238142-36239093 | 10 | 35949214 | 35950165 | Human |
155779859 | LOC127817604 | OCT4-NANOG hESC enhancer GRCh37_chr10:36262934-36263436 | 10 | 35974006 | 35974508 | Human |
329344058 | LOC129662674 | ReSE screen-validated silencer GRCh37_chr10:36291272-36291473 | 10 | 36002344 | 36002545 | Human |
38614086 | LOC107984222 | uncharacterized LOC107984222 | 10 | 36044404 | 36072441 | Human |
401825850 | LOC132090806 | Neanderthal introgressed variant-containing enhancer experimental_12178 | 10 | 36112528 | 36112697 | Human |
155771530 | LOC127817605 | NANOG hESC enhancer GRCh37_chr10:36476706-36477207 | 10 | 36187778 | 36188279 | Human |
155772510 | LOC127817606 | OCT4-NANOG hESC enhancer GRCh37_chr10:36484201-36484900 | 10 | 36195273 | 36195972 | Human |
155771116 | LOC127817607 | NANOG hESC enhancer GRCh37_chr10:36710833-36711334 | 10 | 36421905 | 36422406 | Human |
6482038 | MTND5P17 | MT-ND5 pseudogene 17 | 10 | 36432863 | 36434478 | Human |
6482039 | MTND4P18 | MT-ND4 pseudogene 18 | 10 | 36434691 | 36435174 | Human |
16567220 | LOC124900298 | small nucleolar RNA SNORA40 | 10 | 36438661 | 36438788 | Human |
155750570 | LOC127817608 | OCT4-NANOG hESC enhancer GRCh37_chr10:36737868-36738406 | 10 | 36448940 | 36449478 | Human |
155757533 | LOC127817609 | OCT4-NANOG hESC enhancer GRCh37_chr10:36738407-36738945 | 10 | 36449479 | 36450017 | Human |
155766815 | LOC127817610 | NANOG hESC enhancer GRCh37_chr10:36772950-36773451 | 10 | 36484022 | 36484523 | Human |
155227089 | LOC126860918 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:36782803-36784002 | 10 | 36493875 | 36495074 | Human |
1345300 | NAMPTP1 | nicotinamide phosphoribosyltransferase pseudogene 1 | 10 | 36521736 | 36524236 | Human |
155757023 | LOC127817611 | OCT4-NANOG hESC enhancer GRCh37_chr10:37014374-37014889 | 10 | 36725446 | 36725961 | Human |
38618166 | LOC110121348 | VISTA enhancer hs1334 | 10 | 36765817 | 36768296 | Human |
155766674 | LOC127817612 | H3K4me1 hESC enhancer GRCh37_chr10:37079549-37080050 | 10 | 36790621 | 36791122 | Human |
155770433 | LOC127817613 | H3K4me1 hESC enhancer GRCh37_chr10:37080051-37080550 | 10 | 36791123 | 36791622 | Human |
38643387 | LOC105376496 | uncharacterized LOC105376496 | 10 | 36917276 | 36943132 | Human |
7205281 | MKNK2P1 | MAP kinase interacting serine/threonine kinase 2 pseudogene 1 | 10 | 36944059 | 36944672 | Human |
7205015 | ARL6IP1P2 | ARF like GTPase 6 interacting protein 1 pseudogene 2 | 10 | 36994944 | 36995887 | Human |
1350593 | ANKRD30A | ankyrin repeat domain 30A | 10 | 37125598 | 37265894 | Human |
10413426 | RNU6-811P | RNA, U6 small nuclear 811, pseudogene | 10 | 37135237 | 37135343 | Human |
5128956 | ATP8A2P1 | ATPase phospholipid transporting 8A2 pseudogene 1 | 10 | 37248118 | 37264637 | Human |
10399343 | RN7SL314P | RNA, 7SL, cytoplasmic 314, pseudogene | 10 | 37297398 | 37297689 | Human |
151676018 | LOC124902412 | uncharacterized LOC124902412 | 10 | 37305410 | 37306964 | Human |
7252738 | LINC00993 | long intergenic non-protein coding RNA 993 | 10 | 37309186 | 37347029 | Human |
7205016 | TMEM161BP1 | transmembrane protein 161B pseudogene 1 | 10 | 37337414 | 37339771 | Human |
2923051 | VN1R53P | vomeronasal 1 receptor 53 pseudogene | 10 | 37348616 | 37349468 | Human |
38637036 | LOC107984175 | uncharacterized LOC107984175 | 10 | 37367355 | 37380301 | Human |
38636238 | LOC107984223 | uncharacterized LOC107984223 | 10 | 37395040 | 37430564 | Human |
38646762 | LOC105376497 | uncharacterized LOC105376497 | 10 | 37437573 | 37438734 | Human |
151676466 | LOC124902529 | protein GVQW1-like | 10 | 37455330 | 37463586 | Human |
329339440 | LOC129662675 | ReSE screen-validated silencer GRCh37_chr10:37749225-37749405 | 10 | 37460297 | 37460477 | Human |
7205142 | TACC1P1 | transforming acidic coiled-coil containing protein 1 pseudogene 1 | 10 | 37523010 | 37530758 | Human |
155778899 | LOC127817614 | NANOG hESC enhancer GRCh37_chr10:37824773-37825323 | 10 | 37535845 | 37536395 | Human |
6482029 | MTND1P18 | MT-ND1 pseudogene 18 | 10 | 37600796 | 37601368 | Human |
4105539 | MTRNR2L7 | MT-RNR2 like 7 (pseudogene) | 10 | 37601438 | 37602974 | Human |
151672188 | LOC124902599 | uncharacterized LOC124902599 | 10 | 37604341 | 37604412 | Human |
38622922 | LOC102724533 | uncharacterized LOC102724533 | 10 | 37619175 | 37632922 | Human |
38622764 | LOC105376498 | uncharacterized LOC105376498 | 10 | 37677073 | 37680308 | Human |
1349221 | ZNF248 | zinc finger protein 248 | 10 | 37758538 | 37858103 | Human |
7204955 | ZNF33BP1 | zinc finger protein 33B pseudogene 1 | 10 | 37793938 | 37795175 | Human |
1625805 | TLK2P2 | tousled like kinase 2 pseudogene 2 | 10 | 37818406 | 37820987 | Human |
329825393 | LOC130003693 | ATAC-STARR-seq lymphoblastoid active region 3270 | 10 | 37857103 | 37857162 | Human |
329338438 | LOC129662676 | ReSE screen-validated silencer GRCh37_chr10:38146408-38146784 | 10 | 37857480 | 37858102 | Human |
155882480 | ZNF248-AS1 | ZNF248 antisense RNA 1 | 10 | 37857749 | 37860666 | Human |
151670852 | LOC124902413 | uncharacterized LOC124902413 | 10 | 37872960 | 37873933 | Human |
155752279 | LOC127817615 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:38186151-38186679 | 10 | 37897223 | 37897751 | Human |
1344079 | ZNF25 | zinc finger protein 25 | 10 | 37949573 | 37976647 | Human |
329827300 | LOC130003694 | ATAC-STARR-seq lymphoblastoid active region 3271 | 10 | 37975531 | 37975620 | Human |
329817094 | LOC130003695 | ATAC-STARR-seq lymphoblastoid silent region 2310 | 10 | 37976211 | 37976620 | Human |
329840378 | LOC130003696 | ATAC-STARR-seq lymphoblastoid active region 3272 | 10 | 37976661 | 37976890 | Human |
13825349 | ZNF25-DT | ZNF25 divergent transcript | 10 | 37976755 | 38004555 | Human |
329343435 | LOC129662677 | ReSE screen-validated silencer GRCh37_chr10:38274009-38274157 | 10 | 37985081 | 37985229 | Human |
1351426 | ZNF33A | zinc finger protein 33A | 10 | 38010489 | 38067834 | Human |
329833467 | LOC130003697 | ATAC-STARR-seq lymphoblastoid active region 3273 | 10 | 38011198 | 38011377 | Human |
10400472 | RNU6-795P | RNA, U6 small nuclear 795, pseudogene | 10 | 38043873 | 38043975 | Human |
7205143 | EIF3LP3 | eukaryotic translation initiation factor 3 subunit L pseudogene 3 | 10 | 38079901 | 38080863 | Human |
1347597 | FXYD6P2 | FXYD domain containing ion transport regulator 6 pseudogene 2 | 10 | 38091566 | 38092127 | Human |
329826173 | LOC130003698 | ATAC-STARR-seq lymphoblastoid active region 3274 | 10 | 38094291 | 38094480 | Human |
1352896 | ZNF37A | zinc finger protein 37A | 10 | 38094337 | 38150293 | Human |
38634746 | LOC105376500 | uncharacterized LOC105376500 | 10 | 38154625 | 38169066 | Human |
15036898 | CCNYL4 | cyclin Y like 4 (pseudogene) | 10 | 38175671 | 38214345 | Human |
30306693 | PLD5P1 | PLD5 pseudogene 1 | 10 | 38310047 | 38333168 | Human |
155779512 | LOC127817616 | H3K27ac hESC enhancer GRCh37_chr10:38644965-38645522 | 10 | 38356037 | 38356594 | Human |
1347247 | HSD17B7P2 | hydroxysteroid 17-beta dehydrogenase 7 pseudogene 2 | 10 | 38356380 | 38378505 | Human |
1353969 | SEPTIN7P9 | septin 7 pseudogene 9 | 10 | 38383023 | 38402927 | Human |
155776743 | LOC127817617 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:38690995-38691866 | 10 | 38402067 | 38402938 | Human |
155766805 | LOC127817618 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:38691867-38692738 | 10 | 38402939 | 38403810 | Human |
38621088 | LOC101929540 | uncharacterized LOC101929540 | 10 | 38403165 | 38435338 | Human |
10412565 | RNU6-1118P | RNA, U6 small nuclear 1118, pseudogene | 10 | 38423625 | 38423728 | Human |
2302188 | LINC00999 | long intergenic non-protein coding RNA 999 | 10 | 38428146 | 38452153 | Human |
10755389 | SEPTIN14P10 | septin 14 pseudogene 10 | 10 | 38457679 | 38460266 | Human |
155778002 | LOC127817619 | OCT4-NANOG hESC enhancer GRCh37_chr10:38815532-38816393 | 10 | 38526604 | 38527465 | Human |
155780508 | LOC127817620 | NANOG hESC enhancer GRCh37_chr10:38876229-38876730 | 10 | 38583098 | 38583599 | Human |
155761420 | LOC127817621 | OCT4-NANOG hESC enhancer GRCh37_chr10:38877019-38877912 | 10 | 38583888 | 38584781 | Human |
155771983 | LOC127817622 | NANOG hESC enhancer GRCh37_chr10:38888420-38888921 | 10 | 38595289 | 38595790 | Human |
1351336 | ABCD1P2 | ATP binding cassette subfamily D member 1 pseudogene 2 | 10 | 38601416 | 38605602 | Human |
3231912 | PABPC1P12 | poly(A) binding protein cytoplasmic 1 pseudogene 12 | 10 | 38636572 | 38638282 | Human |
5553005 | SLC9B1P3 | solute carrier family 9 member B1 pseudogene 3 | 10 | 38640782 | 38689076 | Human |
4109585 | ACTR3BP5 | ACTR3B pseudogene 5 | 10 | 38696596 | 38698241 | Human |
10399784 | CHEK2P5 | CHEK2 pseudogene 5 | 10 | 38713195 | 38719382 | Human |
155779306 | LOC127817623 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39078401-39079356 | 10 | 38785270 | 38786225 | Human |
155769222 | LOC127817624 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39079357-39080312 | 10 | 38786226 | 38787181 | Human |
155750694 | LOC127817625 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39080313-39081269 | 10 | 38787182 | 38788138 | Human |
155778470 | LOC127817626 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39081270-39082225 | 10 | 38788139 | 38789094 | Human |
155765120 | LOC127817627 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39082226-39083182 | 10 | 38789095 | 38790051 | Human |
155782493 | LOC127817628 | OCT4-NANOG hESC enhancer GRCh37_chr10:39083183-39084137 | 10 | 38790052 | 38791006 | Human |
155778711 | LOC127817629 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39084353-39084932 | 10 | 38791222 | 38791801 | Human |
155778914 | LOC127817630 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39084933-39085511 | 10 | 38791802 | 38792380 | Human |
155766777 | LOC127817631 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39087250-39087828 | 10 | 38794119 | 38794697 | Human |
155771288 | LOC127817632 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39087829-39088407 | 10 | 38794698 | 38795276 | Human |
155767010 | LOC127817633 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39093648-39094354 | 10 | 38800517 | 38801223 | Human |
155767112 | LOC127817634 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39094355-39095059 | 10 | 38801224 | 38801928 | Human |
155772246 | LOC127817635 | OCT4-NANOG hESC enhancer GRCh37_chr10:39105055-39105978 | 10 | 38811924 | 38812847 | Human |
155751859 | LOC127817636 | OCT4-NANOG hESC enhancer GRCh37_chr10:39105990-39106606 | 10 | 38812859 | 38813475 | Human |
155758827 | LOC127817637 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39106701-39107674 | 10 | 38813570 | 38814543 | Human |
155769582 | LOC127817638 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39107675-39108648 | 10 | 38814544 | 38815517 | Human |
155778021 | LOC127817639 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39108649-39109622 | 10 | 38815518 | 38816491 | Human |
155779371 | LOC127817640 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39109623-39110594 | 10 | 38816492 | 38817463 | Human |
155761111 | LOC127817641 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39110595-39111568 | 10 | 38817464 | 38818437 | Human |
155753501 | LOC127817642 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39111569-39112541 | 10 | 38818438 | 38819410 | Human |
155773775 | LOC127817643 | OCT4-NANOG hESC enhancer GRCh37_chr10:39119899-39120836 | 10 | 38826768 | 38827705 | Human |
155765652 | LOC127817644 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39121025-39121526 | 10 | 38827894 | 38828395 | Human |
155750774 | LOC127817645 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39136121-39136968 | 10 | 38842990 | 38843837 | Human |
155757047 | LOC127817646 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39136969-39137816 | 10 | 38843838 | 38844685 | Human |
155774767 | LOC127817647 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:39137817-39138664 | 10 | 38844686 | 38845533 | Human |
155782394 | LOC127817648 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39138665-39139512 | 10 | 38845534 | 38846381 | Human |
155766520 | LOC127817649 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39139513-39140360 | 10 | 38846382 | 38847229 | Human |
155754598 | LOC127817650 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:39140361-39141208 | 10 | 38847230 | 38848077 | Human |
155772258 | LOC127817651 | OCT4-NANOG hESC enhancer GRCh37_chr10:39144910-39145906 | 10 | 38851779 | 38852775 | Human |
155750726 | LOC127817652 | OCT4-NANOG hESC enhancer GRCh37_chr10:39148911-39149634 | 10 | 38855780 | 38856503 | Human |
155775091 | LOC127817653 | OCT4-NANOG hESC enhancer GRCh37_chr10:39149801-39150685 | 10 | 38856670 | 38857554 | Human |
155764528 | LOC127817654 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42545591-42546107 | 10 | 41694102 | 41694618 | Human |
155768757 | LOC127817655 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42545075-42545590 | 10 | 41694619 | 41695134 | Human |
155755195 | LOC127817656 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42544558-42545074 | 10 | 41695135 | 41695651 | Human |
155755658 | LOC127817657 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42544042-42544557 | 10 | 41695652 | 41696167 | Human |
155756166 | LOC127817658 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42543525-42544041 | 10 | 41696168 | 41696684 | Human |
155781461 | LOC127817659 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42543009-42543524 | 10 | 41696685 | 41697200 | Human |
155776725 | LOC127817660 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42542491-42543008 | 10 | 41697201 | 41697718 | Human |
155764971 | LOC127817661 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42541247-42542196 | 10 | 41698013 | 41698962 | Human |
155770404 | LOC127817662 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42540297-42541246 | 10 | 41698963 | 41699912 | Human |
155764712 | LOC127817663 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42539347-42540296 | 10 | 41699913 | 41700862 | Human |
155750500 | LOC127817664 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42538395-42539346 | 10 | 41700863 | 41701814 | Human |
155772963 | LOC127817665 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42537445-42538394 | 10 | 41701815 | 41702764 | Human |
155763081 | LOC127817666 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42536495-42537444 | 10 | 41702765 | 41703714 | Human |
155775071 | LOC127817667 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42535545-42536494 | 10 | 41703715 | 41704664 | Human |
155767685 | LOC127817668 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42534593-42535544 | 10 | 41704665 | 41705616 | Human |
155751067 | LOC127817669 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42533643-42534592 | 10 | 41705617 | 41706566 | Human |
155770721 | LOC127817670 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42532693-42533642 | 10 | 41706567 | 41707516 | Human |
155756513 | LOC127817671 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42531743-42532692 | 10 | 41707517 | 41708466 | Human |
155765490 | LOC127817672 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42530791-42531742 | 10 | 41708467 | 41709418 | Human |
155773204 | LOC127817673 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42529841-42530790 | 10 | 41709419 | 41710368 | Human |
155781745 | LOC127817674 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42528889-42529840 | 10 | 41710369 | 41711320 | Human |
155766743 | LOC127817675 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42527939-42528888 | 10 | 41711321 | 41712270 | Human |
155752460 | LOC127817676 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42526987-42527938 | 10 | 41712271 | 41713222 | Human |
155779960 | LOC127817677 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42409382-42409954 | 10 | 41830255 | 41830827 | Human |
155773103 | LOC127817678 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42408808-42409381 | 10 | 41830828 | 41831401 | Human |
155780102 | LOC127817679 | OCT4-NANOG hESC enhancer GRCh37_chr10:42407978-42408555 | 10 | 41831654 | 41832231 | Human |
155767605 | LOC127817680 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42407001-42407866 | 10 | 41832343 | 41833208 | Human |
155760874 | LOC127817681 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42406133-42407000 | 10 | 41833209 | 41834076 | Human |
155759335 | LOC127817682 | NANOG hESC enhancer GRCh37_chr10:42405590-42406091 | 10 | 41834118 | 41834619 | Human |
155751646 | LOC127817683 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42403984-42404604 | 10 | 41835605 | 41836225 | Human |
155753716 | LOC127817684 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42402011-42402510 | 10 | 41837699 | 41838198 | Human |
155771719 | LOC127817685 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42401509-42402010 | 10 | 41838199 | 41838700 | Human |
155754021 | LOC127817686 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42400243-42401007 | 10 | 41839202 | 41839966 | Human |
155773387 | LOC127817687 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42399477-42400242 | 10 | 41839967 | 41840732 | Human |
155754672 | LOC127817688 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42398711-42399476 | 10 | 41840733 | 41841498 | Human |
155754721 | LOC127817689 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42397944-42398710 | 10 | 41841499 | 41842265 | Human |
155750882 | LOC127817690 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42396507-42397457 | 10 | 41842752 | 41843702 | Human |
155769960 | LOC127817691 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42395555-42396506 | 10 | 41843703 | 41844654 | Human |
155759566 | LOC127817692 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42394603-42395554 | 10 | 41844655 | 41845606 | Human |
155781678 | LOC127817693 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42393650-42394602 | 10 | 41845607 | 41846559 | Human |
155766982 | LOC127817694 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42392699-42393649 | 10 | 41846560 | 41847510 | Human |
155759399 | LOC127817695 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42391746-42392698 | 10 | 41847511 | 41848463 | Human |
155755027 | LOC127817696 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42390794-42391745 | 10 | 41848464 | 41849415 | Human |
155778950 | LOC127817697 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42389841-42390793 | 10 | 41849416 | 41850368 | Human |
155754605 | LOC127817698 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42388889-42389840 | 10 | 41850369 | 41851320 | Human |
155765966 | LOC127817699 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42387937-42388888 | 10 | 41851321 | 41852272 | Human |
155780658 | LOC127817700 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42386985-42387936 | 10 | 41852273 | 41853224 | Human |
155776122 | LOC127817701 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42386033-42386984 | 10 | 41853225 | 41854176 | Human |
155761409 | LOC127817702 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancers GRCh37_chr10:42385081-42386032 and GRCh37_chr10:42384129-42385080 | 10 | 41854177 | 41856080 | Human |
155767344 | LOC127817704 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42383177-42384128 | 10 | 41856081 | 41857032 | Human |
155752151 | LOC127817705 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42382224-42383176 | 10 | 41857033 | 41857985 | Human |
155780570 | LOC127817706 | OCT4-NANOG hESC enhancer GRCh37_chr10:42381502-42382100 | 10 | 41858109 | 41858707 | Human |
155779355 | LOC127817707 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42380529-42381409 | 10 | 41858800 | 41859680 | Human |
151660389 | LOC124403941 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42379647-42380528 | 10 | 41859681 | 41860562 | Human |
155766678 | LOC127817708 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42378765-42379646 | 10 | 41860563 | 41861444 | Human |
155759768 | LOC127817709 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42377882-42378764 | 10 | 41861445 | 41862327 | Human |
155754949 | LOC127817710 | OCT4-NANOG hESC enhancer GRCh37_chr10:42377001-42377881 | 10 | 41862328 | 41863208 | Human |
155772618 | LOC127817711 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42376118-42377000 | 10 | 41863209 | 41864091 | Human |
155756735 | LOC127817712 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42375236-42376117 | 10 | 41864092 | 41864973 | Human |
155768581 | LOC127817713 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42374353-42375235 | 10 | 41864974 | 41865856 | Human |
155773659 | LOC127817714 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42373471-42374352 | 10 | 41865857 | 41866738 | Human |
155773035 | LOC127817715 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42372589-42373470 | 10 | 41866739 | 41867620 | Human |
155763252 | LOC127817716 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42371707-42372588 | 10 | 41867621 | 41868502 | Human |
155767298 | LOC127817717 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42370825-42371706 | 10 | 41868503 | 41869384 | Human |
155750312 | LOC127817718 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42369943-42370824 | 10 | 41869385 | 41870266 | Human |
155778735 | LOC127817719 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42369061-42369942 | 10 | 41870267 | 41871148 | Human |
155781372 | LOC127817720 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42368179-42369060 | 10 | 41871149 | 41872030 | Human |
155769167 | LOC127817721 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42367296-42368178 | 10 | 41872031 | 41872913 | Human |
155761152 | LOC127817722 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42366481-42367259 | 10 | 41872950 | 41873728 | Human |
155756631 | LOC127817723 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42365701-42366480 | 10 | 41873729 | 41874508 | Human |
151660450 | LOC124403942 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42364921-42365700 | 10 | 41874509 | 41875288 | Human |
155778535 | LOC127817724 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42364140-42364920 | 10 | 41875289 | 41876069 | Human |
155764408 | LOC127817725 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42363361-42364139 | 10 | 41876070 | 41876848 | Human |
155767550 | LOC127817726 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42362580-42363360 | 10 | 41876849 | 41877629 | Human |
155775312 | LOC127817727 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42361800-42362579 | 10 | 41877630 | 41878409 | Human |
155770465 | LOC127817728 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42361019-42361799 | 10 | 41878410 | 41879190 | Human |
155782278 | LOC127817729 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42360239-42361018 | 10 | 41879191 | 41879970 | Human |
155762629 | LOC127817730 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42359459-42360238 | 10 | 41879971 | 41880750 | Human |
155769979 | LOC127817731 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42358679-42359458 | 10 | 41880751 | 41881530 | Human |
155762519 | LOC127817732 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42357899-42358678 | 10 | 41881531 | 41882310 | Human |
155751143 | LOC127817733 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42357119-42357898 | 10 | 41882311 | 41883090 | Human |
155772875 | LOC127817734 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42356339-42357118 | 10 | 41883091 | 41883870 | Human |
155780743 | LOC127817735 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:42355559-42356338 | 10 | 41883871 | 41884650 | Human |
155766902 | LOC127817736 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42596897-42597432 | 10 | 42101449 | 42101984 | Human |
155756891 | LOC127817737 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42597433-42597968 | 10 | 42101985 | 42102520 | Human |
155761448 | LOC127817738 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42597969-42598504 | 10 | 42102521 | 42103056 | Human |
155765884 | LOC127817739 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42598505-42599040 | 10 | 42103057 | 42103592 | Human |
155757353 | LOC127817740 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42599041-42599576 | 10 | 42103593 | 42104128 | Human |
155761946 | LOC127817741 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42599577-42600112 | 10 | 42104129 | 42104664 | Human |
155777273 | LOC127817742 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:42600113-42600648 | 10 | 42104665 | 42105200 | Human |
10398947 | KSR1P1 | kinase suppressor of ras 1 pseudogene 1 | 10 | 42149319 | 42149731 | Human |
155766768 | LOC127817743 | OCT4-NANOG hESC enhancer GRCh37_chr10:42661204-42662191 | 10 | 42165756 | 42166743 | Human |
155782221 | LOC127817744 | OCT4-NANOG hESC enhancer GRCh37_chr10:42663017-42663536 | 10 | 42167569 | 42168088 | Human |
155775666 | LOC127817745 | OCT4-NANOG hESC enhancer GRCh37_chr10:42663537-42664056 | 10 | 42168089 | 42168608 | Human |
155758803 | LOC127817746 | NANOG hESC enhancer GRCh37_chr10:42664057-42664575 | 10 | 42168609 | 42169127 | Human |
38639303 | LOC107984164 | formin-2-like | 10 | 42230355 | 42231287 | Human |
38644226 | LOC105378267 | uncharacterized LOC105378267 | 10 | 42234220 | 42242291 | Human |
38643340 | LOC101929373 | uncharacterized LOC101929373 | 10 | 42242512 | 42276842 | Human |
3322043 | PABPC1P8 | poly(A) binding protein cytoplasmic 1 pseudogene 8 | 10 | 42279529 | 42281242 | Human |
155755867 | LOC127817747 | OCT4-NANOG hESC enhancer GRCh37_chr10:42794470-42795297 | 10 | 42299022 | 42299849 | Human |
155779226 | LOC127817748 | NANOG hESC enhancer GRCh37_chr10:42796185-42796686 | 10 | 42300737 | 42301238 | Human |
155771711 | LOC127817749 | OCT4-NANOG hESC enhancer GRCh37_chr10:42796729-42797555 | 10 | 42301281 | 42302107 | Human |
155758440 | LOC127817750 | OCT4-NANOG hESC enhancer GRCh37_chr10:42798247-42798939 | 10 | 42302799 | 42303491 | Human |
155775103 | LOC127817751 | OCT4-NANOG hESC enhancer GRCh37_chr10:42816107-42816891 | 10 | 42320659 | 42321443 | Human |
16552184 | BX322639.1 | zinc finger protein pseudogene | 10 | 42331866 | 42368045 | Human |
329835615 | LOC130003699 | ATAC-STARR-seq lymphoblastoid active region 3276 | 10 | 42367572 | 42367621 | Human |
329824708 | LOC130003700 | ATAC-STARR-seq lymphoblastoid active region 3277 | 10 | 42367652 | 42367701 | Human |
329832406 | LOC130003701 | ATAC-STARR-seq lymphoblastoid active region 3278 | 10 | 42367722 | 42367921 | Human |
329835102 | LOC130003702 | ATAC-STARR-seq lymphoblastoid active region 3279 | 10 | 42367972 | 42368021 | Human |
1346524 | CCNYL2 | cyclin Y like 2 (pseudogene) | 10 | 42408174 | 42472240 | Human |
2303682 | LINC00839 | long intergenic non-protein coding RNA 839 | 10 | 42475491 | 42495337 | Human |
1606933 | ZNF37BP | zinc finger protein 37B, pseudogene | 10 | 42513510 | 42552870 | Human |
155775826 | LOC127817752 | H3K4me1 hESC enhancer GRCh37_chr10:43034693-43035194 | 10 | 42539245 | 42539746 | Human |
155765079 | LOC127817753 | H3K4me1 hESC enhancer GRCh37_chr10:43035195-43035694 | 10 | 42539747 | 42540246 | Human |
155750415 | LOC127817754 | H3K4me1 hESC enhancer GRCh37_chr10:43047054-43047592 | 10 | 42551606 | 42552144 | Human |
1349556 | FXYD6P1 | FXYD domain containing ion transport regulator 6 pseudogene 1 | 10 | 42555366 | 42555925 | Human |
1352708 | EIF3LP2 | eukaryotic translation initiation factor 3 subunit L pseudogene 2 | 10 | 42566676 | 42567653 | Human |
1347257 | ZNF33B | zinc finger protein 33B | 10 | 42574169 | 42638570 | Human |
10412550 | RNU6-1170P | RNA, U6 small nuclear 1170, pseudogene | 10 | 42605158 | 42605263 | Human |
155762045 | LOC127817755 | H3K27ac hESC enhancer GRCh37_chr10:43132780-43133648 | 10 | 42637332 | 42638200 | Human |
38671973 | LOC105378268 | uncharacterized LOC105378268 | 10 | 42638305 | 42645542 | Human |
329821414 | LOC130003703 | ATAC-STARR-seq lymphoblastoid silent region 2311 | 10 | 42638320 | 42638489 | Human |
151660455 | LOC124403943 | Sharpr-MPRA regulatory region 10386 | 10 | 42641581 | 42641875 | Human |
2923049 | VN1R54P | vomeronasal 1 receptor 54 pseudogene | 10 | 42660844 | 42661730 | Human |
8699066 | LINC01518 | long intergenic non-protein coding RNA 1518 | 10 | 42673013 | 42691759 | Human |
7205526 | CUBNP1 | cubilin pseudogene 1 | 10 | 42694371 | 42714576 | Human |
1347723 | RSU1P1 | Ras suppressor protein 1 pseudogene 1 | 10 | 42734707 | 42738820 | Human |
1602610 | DUXAP3 | double homeobox A pseudogene 3 | 10 | 42747154 | 42748731 | Human |
38621881 | LOC283028 | uncharacterized LOC283028 | 10 | 42751184 | 42755203 | Human |
38645264 | LOC105378269 | uncharacterized LOC105378269 | 10 | 42755142 | 42769621 | Human |
151660425 | LOC124403944 | Sharpr-MPRA regulatory region 13348 | 10 | 42755761 | 42756055 | Human |
155755067 | LOC127817756 | H3K4me1 hESC enhancer GRCh37_chr10:43264750-43265250 | 10 | 42769302 | 42769802 | Human |
155755828 | LOC127817757 | H3K4me1 hESC enhancer GRCh37_chr10:43265251-43265751 | 10 | 42769803 | 42770303 | Human |
329814964 | LOC130003704 | ATAC-STARR-seq lymphoblastoid active region 3281 | 10 | 42782626 | 42782975 | Human |
1345685 | BMS1 | BMS1 ribosome biogenesis factor | 10 | 42782795 | 42834937 | Human |
151671497 | LOC124902575 | small nucleolar RNA U13 | 10 | 42810227 | 42810330 | Human |
155777862 | LOC127817758 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43311987-43312910 | 10 | 42816539 | 42817462 | Human |
155760450 | LOC127817759 | H3K4me1 hESC enhancer GRCh37_chr10:43322605-43323486 | 10 | 42827157 | 42828038 | Human |
10400450 | RNU6-885P | RNA, U6 small nuclear 885, pseudogene | 10 | 42832447 | 42832550 | Human |
155769592 | LOC127817760 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43332057-43333007 | 10 | 42836609 | 42837559 | Human |
155777630 | LOC127817761 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43361281-43361914 | 10 | 42865833 | 42866466 | Human |
155766817 | LOC127817762 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43361915-43362548 | 10 | 42866467 | 42867100 | Human |
155781588 | LOC127817763 | H3K27ac hESC enhancer GRCh37_chr10:43366313-43366814 | 10 | 42870865 | 42871366 | Human |
155764000 | LOC127817764 | H3K27ac hESC enhancer GRCh37_chr10:43366815-43367314 | 10 | 42871367 | 42871866 | Human |
155774084 | LOC127817765 | H3K4me1 hESC enhancer GRCh37_chr10:43369982-43370710 | 10 | 42874534 | 42875262 | Human |
155782336 | LOC127817766 | H3K4me1 hESC enhancer GRCh37_chr10:43373919-43374419 | 10 | 42878471 | 42878971 | Human |
155781007 | LOC127817767 | H3K4me1 hESC enhancer GRCh37_chr10:43380976-43381476 | 10 | 42885528 | 42886028 | Human |
329342175 | LOC129662678 | ReSE screen-validated silencer GRCh37_chr10:43398966-43399195 | 10 | 42903518 | 42903747 | Human |
329343161 | LOC129662679 | ReSE screen-validated silencer GRCh37_chr10:43430829-43431004 | 10 | 42935381 | 42935556 | Human |
155767235 | LOC127817768 | H3K4me1 hESC enhancer GRCh37_chr10:43434211-43434711 | 10 | 42938763 | 42939263 | Human |
38616390 | LOC110121503 | VISTA enhancer hs2327 | 10 | 42951826 | 42953723 | Human |
155770921 | LOC127817769 | H3K4me1 hESC enhancer GRCh37_chr10:43455918-43456418 | 10 | 42960470 | 42960970 | Human |
155771794 | LOC127817770 | H3K4me1 hESC enhancer GRCh37_chr10:43465538-43466244 | 10 | 42970090 | 42970796 | Human |
155757449 | LOC127817771 | H3K4me1 hESC enhancer GRCh37_chr10:43469403-43470373 | 10 | 42973955 | 42974925 | Human |
38655550 | LOC111946237 | Sharpr-MPRA regulatory region 9590 | 10 | 42975621 | 42975915 | Human |
9588399 | LINC01264 | long intergenic non-protein coding RNA 1264 | 10 | 42979017 | 42981507 | Human |
38632966 | LOC110121506 | VISTA enhancer hs2497 | 10 | 42980637 | 42982237 | Human |
155773662 | LOC127817772 | H3K4me1 hESC enhancer GRCh37_chr10:43483113-43483758 | 10 | 42987665 | 42988310 | Human |
155754341 | LOC127817773 | H3K4me1 hESC enhancer GRCh37_chr10:43485513-43486245 | 10 | 42990065 | 42990797 | Human |
155773779 | LOC127817774 | H3K4me1 hESC enhancer GRCh37_chr10:43492878-43493378 | 10 | 42997430 | 42997930 | Human |
155778198 | LOC127817775 | H3K4me1 hESC enhancer GRCh37_chr10:43495973-43496668 | 10 | 43000525 | 43001220 | Human |
155762549 | LOC127817776 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:43507236-43508231 | 10 | 43011788 | 43012783 | Human |
155763420 | LOC127817777 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:43508232-43509226 | 10 | 43012784 | 43013778 | Human |
155778749 | LOC127817778 | H3K4me1 hESC enhancer GRCh37_chr10:43521134-43521642 | 10 | 43025686 | 43026194 | Human |
155765529 | LOC127817779 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:43521643-43522150 | 10 | 43026195 | 43026702 | Human |
155761325 | LOC127817780 | H3K4me1 hESC enhancer GRCh37_chr10:43522661-43523168 | 10 | 43027213 | 43027720 | Human |
155754543 | LOC127817781 | H3K4me1 hESC enhancer GRCh37_chr10:43535603-43536323 | 10 | 43040155 | 43040875 | Human |
155759165 | LOC127817782 | H3K4me1 hESC enhancer GRCh37_chr10:43539799-43540690 | 10 | 43044351 | 43045242 | Human |
155779902 | LOC127817783 | H3K4me1 hESC enhancer GRCh37_chr10:43540691-43541582 | 10 | 43045243 | 43046134 | Human |
155757183 | LOC127817784 | H3K4me1 hESC enhancer GRCh37_chr10:43544190-43544720 | 10 | 43048742 | 43049272 | Human |
38602751 | LOC110121507 | VISTA enhancer hs2498 | 10 | 43056442 | 43058441 | Human |
155769180 | LOC127817785 | H3K4me1 hESC enhancer GRCh37_chr10:43557619-43558120 | 10 | 43062171 | 43062672 | Human |
155750443 | LOC127817786 | H3K4me1 hESC enhancer GRCh37_chr10:43558121-43558620 | 10 | 43062673 | 43063172 | Human |
38659859 | LOC106736614 | RET 5' regulatory region | 10 | 43072914 | 43077291 | Human |
735296 | RET | ret proto-oncogene | 10 | 43077069 | 43130351 | Human |
155781762 | LOC127817787 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43572872-43573862 | 10 | 43077424 | 43078414 | Human |
155761638 | LOC127817788 | H3K4me1 hESC enhancer GRCh37_chr10:43580156-43580656 | 10 | 43084708 | 43085208 | Human |
38635417 | MCS+9.7 | RET intron 1 enhancer | 10 | 43086364 | 43087263 | Human |
38662607 | LOC110121502 | VISTA enhancer hs2326 | 10 | 43086364 | 43087440 | Human |
155772506 | LOC127817789 | H3K4me1 hESC enhancer GRCh37_chr10:43596873-43597372 | 10 | 43101425 | 43101924 | Human |
155758809 | LOC127817790 | H3K4me1 hESC enhancer GRCh37_chr10:43600219-43600970 | 10 | 43104771 | 43105522 | Human |
329822005 | LOC130003705 | ATAC-STARR-seq lymphoblastoid silent region 2313 | 10 | 43105522 | 43105751 | Human |
329824754 | LOC130003706 | ATAC-STARR-seq lymphoblastoid active region 3282 | 10 | 43106012 | 43106111 | Human |
6483867 | MIR5100 | microRNA 5100 | 10 | 42997563 | 42997681 | Human |
7490003 | PCAT5 | prostate cancer associated transcript 5 | 10 | 35778302 | 35800920 | Human |
2796115 | ZNF37CP | zinc finger protein 37C, pseudogene | 10 | 37883620 | 37884098 | Human |
3081780 | ZNF33CP | zinc finger protein 33C, pseudogene | 10 | 37894595 | 37896935 | Human |
3547159 | CICP9 | capicua transcriptional repressor pseudogene 9 | 10 | 38454007 | 38455839 | Human |
13825378 | LINC02632 | long intergenic non-protein coding RNA 2632 | 10 | 42696035 | 42706453 | Human |
13825387 | LINC02623 | long intergenic non-protein coding RNA 2623 | 10 | 42871521 | 42874060 | Human |
329338999 | LOC129662680 | ReSE screen-validated silencer GRCh37_chr10:43604510-43604673 | 10 | 43109062 | 43109225 | Human |
329814807 | LOC130003707 | ATAC-STARR-seq lymphoblastoid active region 3283 | 10 | 43120696 | 43120955 | Human |
329814093 | LOC130003708 | ATAC-STARR-seq lymphoblastoid active region 3284 | 10 | 43120966 | 43121025 | Human |
329832245 | LOC130003709 | ATAC-STARR-seq lymphoblastoid active region 3285 | 10 | 43121136 | 43121255 | Human |
329821612 | LOC130003710 | ATAC-STARR-seq lymphoblastoid active region 3286 | 10 | 43122006 | 43122055 | Human |
155775135 | LOC127817791 | NANOG-H3K4me1 hESC enhancer GRCh37_chr10:43625782-43626382 | 10 | 43130334 | 43130934 | Human |
155782083 | LOC127817792 | H3K4me1 hESC enhancer GRCh37_chr10:43626383-43626983 | 10 | 43130935 | 43131535 | Human |
329818623 | LOC130003711 | ATAC-STARR-seq lymphoblastoid silent region 2314 | 10 | 43134670 | 43134739 | Human |
39128280 | CSGALNACT2-DT | CSGALNACT2 divergent transcript | 10 | 43136824 | 43138393 | Human |
329833238 | LOC130003712 | ATAC-STARR-seq lymphoblastoid silent region 2315 | 10 | 43137742 | 43137941 | Human |
329817135 | LOC130003713 | ATAC-STARR-seq lymphoblastoid silent region 2316 | 10 | 43138072 | 43138131 | Human |
329819945 | LOC130003714 | ATAC-STARR-seq lymphoblastoid silent region 2317 | 10 | 43138302 | 43138801 | Human |
1604805 | CSGALNACT2 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 | 10 | 43138445 | 43185308 | Human |
329839807 | LOC130003715 | ATAC-STARR-seq lymphoblastoid silent region 2318 | 10 | 43138912 | 43138981 | Human |
155226942 | LOC126860919 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:43655229-43656428 | 10 | 43159781 | 43160980 | Human |
401825854 | LOC132089774 | Neanderthal introgressed variant-containing enhancer experimental_12290 | 10 | 43172865 | 43173034 | Human |
329344325 | LOC129662681 | ReSE screen-validated silencer GRCh37_chr10:43686663-43686892 | 10 | 43191215 | 43191444 | Human |
1314108 | RASGEF1A | RasGEF domain family member 1A | 10 | 43194535 | 43267065 | Human |
155782654 | LOC127817793 | H3K4me1 hESC enhancer GRCh37_chr10:43696895-43697396 | 10 | 43201447 | 43201948 | Human |
329813143 | LOC130003716 | ATAC-STARR-seq lymphoblastoid silent region 2319 | 10 | 43202212 | 43202401 | Human |
329813238 | LOC130003717 | ATAC-STARR-seq lymphoblastoid silent region 2320 | 10 | 43202742 | 43202791 | Human |
329832712 | LOC130003718 | ATAC-STARR-seq lymphoblastoid silent region 2321 | 10 | 43202922 | 43203161 | Human |
329841338 | LOC130003719 | ATAC-STARR-seq lymphoblastoid silent region 2322 | 10 | 43203202 | 43203261 | Human |
329832746 | LOC130003720 | ATAC-STARR-seq lymphoblastoid silent region 2323 | 10 | 43203812 | 43203981 | Human |
155759500 | LOC127817794 | H3K4me1 hESC enhancer GRCh37_chr10:43700051-43700884 | 10 | 43204603 | 43205436 | Human |
155773681 | LOC127817795 | H3K4me1 hESC enhancer GRCh37_chr10:43707013-43707615 | 10 | 43211565 | 43212167 | Human |
155764701 | LOC127817796 | H3K4me1 hESC enhancer GRCh37_chr10:43711759-43712514 | 10 | 43216311 | 43217066 | Human |
155763020 | LOC127817797 | H3K4me1 hESC enhancer GRCh37_chr10:43712515-43713270 | 10 | 43217067 | 43217822 | Human |
155780901 | LOC127817798 | H3K4me1 hESC enhancer GRCh37_chr10:43723488-43724298 | 10 | 43228040 | 43228850 | Human |
38653339 | LOC107984225 | uncharacterized LOC107984225 | 10 | 43230090 | 43232472 | Human |
155762971 | LOC127817799 | H3K4me1 hESC enhancer GRCh37_chr10:43726130-43726684 | 10 | 43230682 | 43231236 | Human |
401826113 | LOC132089775 | Neanderthal introgressed variant-containing enhancer experimental_12309 | 10 | 43249088 | 43249257 | Human |
155779275 | LOC127817800 | H3K4me1 hESC enhancer GRCh37_chr10:43744792-43745584 | 10 | 43249344 | 43250136 | Human |
155777582 | LOC127817801 | H3K4me1 hESC enhancer GRCh37_chr10:43745585-43746376 | 10 | 43250137 | 43250928 | Human |
329835304 | LOC130003721 | ATAC-STARR-seq lymphoblastoid silent region 2324 | 10 | 43255948 | 43256137 | Human |
155771223 | LOC127817802 | H3K4me1 hESC enhancer GRCh37_chr10:43754815-43755598 | 10 | 43259367 | 43260150 | Human |
155781809 | LOC127817803 | H3K4me1 hESC enhancer GRCh37_chr10:43761143-43762018 | 10 | 43265695 | 43266570 | Human |
155782868 | LOC127817804 | H3K4me1 hESC enhancer GRCh37_chr10:43778224-43778748 | 10 | 43282776 | 43283300 | Human |
155771768 | LOC127817805 | H3K4me1 hESC enhancer GRCh37_chr10:43781282-43781790 | 10 | 43285834 | 43286342 | Human |
155780179 | LOC127817806 | H3K4me1 hESC enhancer GRCh37_chr10:43789145-43789646 | 10 | 43293697 | 43294198 | Human |
155771255 | LOC127817807 | H3K4me1 hESC enhancer GRCh37_chr10:43789647-43790146 | 10 | 43294199 | 43294698 | Human |
329816676 | LOC130003722 | ATAC-STARR-seq lymphoblastoid active region 3287 | 10 | 43299639 | 43299688 | Human |
329841554 | LOC130003723 | ATAC-STARR-seq lymphoblastoid active region 3288 | 10 | 43299719 | 43299818 | Human |
155762043 | LOC127817808 | H3K4me1 hESC enhancer GRCh37_chr10:43812626-43813176 | 10 | 43317178 | 43317728 | Human |
155754481 | LOC127817809 | H3K4me1 hESC enhancer GRCh37_chr10:43813177-43813727 | 10 | 43317729 | 43318279 | Human |
155752770 | LOC127817810 | H3K4me1 hESC enhancer GRCh37_chr10:43813728-43814277 | 10 | 43318280 | 43318829 | Human |
38638883 | LOC105378271 | uncharacterized LOC105378271 | 10 | 43318398 | 43350306 | Human |
155775257 | LOC127817811 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43815195-43816027 | 10 | 43319747 | 43320579 | Human |
13831115 | LINC02633 | long intergenic non-protein coding RNA 2633 | 10 | 43322994 | 43327938 | Human |
155778490 | LOC127817812 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:43825470-43826141 | 10 | 43330022 | 43330693 | Human |
151675311 | LOC124902414 | uncharacterized LOC124902414 | 10 | 43334514 | 43336408 | Human |
155766973 | LOC127817813 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43833043-43833702 | 10 | 43337595 | 43338254 | Human |
155769772 | LOC127817814 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43834363-43835022 | 10 | 43338915 | 43339574 | Human |
155770035 | LOC127817815 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43835023-43835681 | 10 | 43339575 | 43340233 | Human |
10399250 | RNU6ATAC11P | RNA, U6atac small nuclear 11, pseudogene | 10 | 43341786 | 43341910 | Human |
38646298 | LOC107984226 | uncharacterized LOC107984226 | 10 | 43343222 | 43351218 | Human |
329836817 | LOC130003724 | ATAC-STARR-seq lymphoblastoid silent region 2325 | 10 | 43348552 | 43348711 | Human |
155773856 | LOC127817816 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43850991-43851698 | 10 | 43355543 | 43356250 | Human |
155764137 | LOC127817817 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43857038-43857950 | 10 | 43361590 | 43362502 | Human |
735874 | FXYD4 | FXYD domain containing ion transport regulator 4 | 10 | 43371636 | 43376335 | Human |
329813918 | LOC130003725 | ATAC-STARR-seq lymphoblastoid silent region 2326 | 10 | 43380801 | 43380850 | Human |
329815198 | LOC130003726 | ATAC-STARR-seq lymphoblastoid active region 3290 | 10 | 43384610 | 43384759 | Human |
329823414 | LOC130003727 | ATAC-STARR-seq lymphoblastoid active region 3291 | 10 | 43384780 | 43384859 | Human |
329823075 | LOC130003728 | ATAC-STARR-seq lymphoblastoid active region 3292 | 10 | 43384910 | 43384989 | Human |
1349083 | HNRNPF | heterogeneous nuclear ribonucleoprotein F | 10 | 43385618 | 43409186 | Human |
155762443 | LOC127817818 | H3K4me1 hESC enhancer GRCh37_chr10:43882175-43882676 | 10 | 43386727 | 43387228 | Human |
155770416 | LOC127817819 | H3K4me1 hESC enhancer GRCh37_chr10:43882677-43883176 | 10 | 43387229 | 43387728 | Human |
155756465 | LOC127817820 | H3K27ac hESC enhancer GRCh37_chr10:43890785-43891672 | 10 | 43395337 | 43396224 | Human |
329840719 | LOC130003729 | ATAC-STARR-seq lymphoblastoid active region 3293 | 10 | 43396397 | 43396666 | Human |
329827774 | LOC130003730 | ATAC-STARR-seq lymphoblastoid silent region 2327 | 10 | 43396787 | 43397246 | Human |
155762407 | LOC127817821 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:43893449-43894334 | 10 | 43398001 | 43398886 | Human |
329842948 | LOC130003731 | ATAC-STARR-seq lymphoblastoid active region 3294 | 10 | 43399425 | 43399564 | Human |
155761253 | LOC127817822 | OCT4-NANOG hESC enhancer GRCh37_chr10:43897064-43897583 | 10 | 43401616 | 43402135 | Human |
329818631 | LOC130003732 | ATAC-STARR-seq lymphoblastoid silent region 2328 | 10 | 43407156 | 43407525 | Human |
329815598 | LOC130003733 | ATAC-STARR-seq lymphoblastoid active region 3295 | 10 | 43407696 | 43407755 | Human |
155769411 | LOC127817823 | H3K27ac hESC enhancer GRCh37_chr10:43903361-43903964 | 10 | 43407896 | 43408516 | Human |
329825586 | LOC130003734 | ATAC-STARR-seq lymphoblastoid silent region 2329 | 10 | 43408806 | 43408925 | Human |
329828934 | LOC130003735 | ATAC-STARR-seq lymphoblastoid active region 3298 | 10 | 43409026 | 43409085 | Human |
329819461 | LOC130003736 | ATAC-STARR-seq lymphoblastoid silent region 2330 | 10 | 43409376 | 43409605 | Human |
151660437 | LOC124403945 | Sharpr-MPRA regulatory region 12153 | 10 | 43415581 | 43415875 | Human |
12738305 | SNORD3J | small nucleolar RNA, C/D box 3J | 10 | 43417250 | 43417440 | Human |
329830226 | LOC130003737 | ATAC-STARR-seq lymphoblastoid silent region 2331 | 10 | 43420422 | 43420681 | Human |
151667958 | LINC02916 | long intergenic non-protein coding RNA 2916 | 10 | 43420619 | 43423402 | Human |
155767099 | LOC127817824 | H3K27ac hESC enhancer GRCh37_chr10:43916126-43916862 | 10 | 43420678 | 43421414 | Human |
329820216 | LOC130003738 | ATAC-STARR-seq lymphoblastoid active region 3300 | 10 | 43436566 | 43436635 | Human |
329840113 | LOC130003739 | ATAC-STARR-seq lymphoblastoid silent region 2332 | 10 | 43436736 | 43437395 | Human |
1605144 | ZNF487 | zinc finger protein 487 | 10 | 43436848 | 43523894 | Human |
155752544 | LOC127817825 | H3K27ac-H3K4me1 hESC enhancers GRCh37_chr10:43950240-43951128 and GRCh37_chr10:43951129-43952017 | 10 | 43454792 | 43456569 | Human |
155755722 | LOC127817827 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr10:43953391-43953946 | 10 | 43457943 | 43458498 | Human |
10413226 | RNU7-193P | RNA, U7 small nuclear 193 pseudogene | 10 | 43458065 | 43458129 | Human |
155775594 | LOC127817828 | NANOG-H3K27ac hESC enhancer GRCh37_chr10:43959685-43960348 | 10 | 43464237 | 43464900 | Human |
16556427 | AL450326.2 | zinc finger protein pseudogene | 10 | 43523241 | 43525104 | Human |
155775204 | LOC127817829 | NANOG hESC enhancer GRCh37_chr10:44039642-44040155 | 10 | 43544194 | 43544707 | Human |
1351594 | ZNF239 | zinc finger protein 239 | 10 | 43556344 | 43574616 | Human |
329837546 | LOC130003740 | ATAC-STARR-seq lymphoblastoid silent region 2334 | 10 | 43574339 | 43574398 | Human |
329814365 | LOC130003741 | ATAC-STARR-seq lymphoblastoid active region 3303 | 10 | 43595556 | 43595635 | Human |
38622499 | LOC107984165 | coiled-coil-helix-coiled-coil-helix domain-containing protein 2-like | 10 | 43598240 | 43598963 | Human |
5489259 | CAP1P2 | CAP1 pseudogene 2 | 10 | 43604646 | 43606297 | Human |
329816012 | LOC130003742 | ATAC-STARR-seq lymphoblastoid active region 3304 | 10 | 43606144 | 43606193 | Human |
1349192 | ZNF485 | zinc finger protein 485 | 10 | 43606438 | 43617904 | Human |
329837247 | LOC130003743 | ATAC-STARR-seq lymphoblastoid silent region 2335 | 10 | 43606474 | 43606753 | Human |
1349832 | ZNF32-AS3 | ZNF32 antisense RNA 3 | 10 | 43628817 | 43674699 | Human |
151670553 | LOC124902416 | uncharacterized LOC124902416 | 10 | 43630782 | 43631484 | Human |
2304711 | RPL21P88 | ribosomal protein L21 pseudogene 88 | 10 | 43630947 | 43631414 | Human |
1350572 | ZNF32 | zinc finger protein 32 | 10 | 43643862 | 43648881 | Human |
1351199 | ZNF32-AS1 | ZNF32 antisense RNA 1 | 10 | 43643872 | 43645047 | Human |
155227676 | LOC126860920 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr10:44141084-44142283 | 10 | 43645636 | 43646835 | Human |
1346935 | ZNF32-AS2 | ZNF32 antisense RNA 2 | 10 | 43645942 | 43648019 | Human |
329840445 | LOC130003744 | ATAC-STARR-seq lymphoblastoid silent region 2336 | 10 | 43648387 | 43648906 | Human |
329339657 | LOC129662682 | ReSE screen-validated silencer GRCh37_chr10:44162766-44162945 | 10 | 43667318 | 43667497 | Human |
401826956 | LOC132089776 | Neanderthal introgressed variant-containing enhancer experimental_12364 | 10 | 43671222 | 43671391 | Human |
329813295 | LOC130003745 | ATAC-STARR-seq lymphoblastoid silent region 2337 | 10 | 43690165 | 43690264 | Human |
151668582 | LOC124902417 | uncharacterized LOC124902417 | 10 | 43690180 | 43695196 | Human |
401826143 | LOC132089777 | Neanderthal introgressed variant-containing enhancer experimental_12372 | 10 | 43699105 | 43699274 | Human |
25824875 | SPRING1P1 | SPRING1 pseudogene 1 | 10 | 43728168 | 43729122 | Human |
3476305 | UQCRHP3 | ubiquinol-cytochrome c reductase hinge protein pseudogene 3 | 10 | 43732265 | 43732700 | Human |
401825570 | LOC132090807 | Neanderthal introgressed variant-containing enhancer experimental_12424 | 10 | 43737047 | 43737216 | Human |
10400194 | ELOCP30 | elongin C pseudogene 30 | 10 | 43741275 | 43742421 | Human |
155753727 | LOC127817830 | H3K4me1 hESC enhancer GRCh37_chr10:44249197-44249908 | 10 | 43753749 | 43754460 | Human |
13831271 | LINC02658 | long intergenic non-protein coding RNA 2658 | 10 | 43777562 | 43778902 | Human |
38632776 | LOC105378275 | uncharacterized LOC105378275 | 10 | 43778946 | 43818744 | Human |
1350276 | HNRNPA3P1 | heterogeneous nuclear ribonucleoprotein A3 pseudogene 1 | 10 | 43787412 | 43790417 | Human |
329338451 | LOC129390166 | MPRA-validated peak936 silencer | 10 | 43816567 | 43816767 | Human |
401824906 | LOC132090808 | Neanderthal introgressed variant-containing enhancer experimental_12499 | 10 | 43842316 | 43842485 | Human |
1344034 | LINC00619 | long intergenic non-protein coding RNA 619 | 10 | 43845306 | 43850622 | Human |
7207708 | LINC00840 | long intergenic non-protein coding RNA 840 | 10 | 43859411 | 43895433 | Human |
155776234 | LOC127817831 | H3K4me1 hESC enhancer GRCh37_chr10:44358448-44358948 | 10 | 43863000 | 43863500 | Human |
155776336 | LOC127817832 | H3K4me1 hESC enhancer GRCh37_chr10:44358949-44359449 | 10 | 43863501 | 43864001 | Human |
401826129 | LOC132090809 | Neanderthal introgressed variant-containing enhancer experimental_12564 | 10 | 43864764 | 43864933 | Human |
151660409 | LOC124403946 | Sharpr-MPRA regulatory region 2960 | 10 | 43867161 | 43867455 | Human |
401826928 | LOC132089778 | Neanderthal introgressed variant-containing enhancer experimental_12586 | 10 | 43875696 | 43875865 | Human |
329339317 | LOC129662683 | ReSE screen-validated silencer GRCh37_chr10:44372279-44372466 | 10 | 43876831 | 43877018 | Human |
13831222 | LINC02659 | long intergenic non-protein coding RNA 2659 | 10 | 43901365 | 43912369 | Human |
7205527 | LINC00841 | long intergenic non-protein coding RNA 841 | 10 | 43909296 | 43981265 | Human |
155754231 | LOC127817833 | H3K4me1 hESC enhancer GRCh37_chr10:44475579-44476080 | 10 | 43980131 | 43980632 | Human |
155760302 | LOC127817834 | H3K4me1 hESC enhancer GRCh37_chr10:44476081-44476580 | 10 | 43980633 | 43981132 | Human |
155769076 | LOC127817835 | H3K4me1 hESC enhancer GRCh37_chr10:44501255-44501828 | 10 | 44005807 | 44006380 | Human |
329816844 | LOC130003746 | ATAC-STARR-seq lymphoblastoid active region 3305 | 10 | 44008367 | 44008686 | Human |
329817038 | LOC130003747 | ATAC-STARR-seq lymphoblastoid active region 3306 | 10 | 44010817 | 44010896 | Human |
155765309 | LOC127817836 | H3K4me1 hESC enhancer GRCh37_chr10:44510639-44511138 | 10 | 44015191 | 44015690 | Human |
155782019 | LOC127817837 | NANOG hESC enhancer GRCh37_chr10:44537391-44537911 | 10 | 44041943 | 44042463 | Human |
401825281 | LOC132089779 | Neanderthal introgressed variant-containing enhancer experimental_12630 | 10 | 44049042 | 44049211 | Human |
401825872 | LOC132089780 | Neanderthal introgressed variant-containing enhancer experimental_12643 | 10 | 44063655 | 44063824 | Human |
151668520 | LOC124902543 | uncharacterized LOC124902543 | 10 | 44105585 | 44130453 | Human |
155775090 | LOC127817838 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:44607592-44608157 | 10 | 44112144 | 44112709 | Human |
401824754 | LOC132089781 | Neanderthal introgressed variant-containing enhancer experimental_12798 | 10 | 44133362 | 44133531 | Human |
401826918 | LOC132089782 | Neanderthal introgressed variant-containing enhancer experimental_12804 | 10 | 44133819 | 44133988 | Human |
155227291 | LOC126860921 | MED14-independent group 3 enhancer GRCh37_chr10:44664362-44665561 | 10 | 44168914 | 44170113 | Human |
401825602 | LOC132089783 | Neanderthal introgressed variant-containing enhancer experimental_12892 | 10 | 44182386 | 44182555 | Human |
155781183 | LOC127817839 | H3K4me1 hESC enhancer GRCh37_chr10:44688953-44689454 | 10 | 44193505 | 44194006 | Human |
155773196 | LOC127817840 | H3K4me1 hESC enhancer GRCh37_chr10:44689455-44689954 | 10 | 44194007 | 44194506 | Human |
401826429 | LOC132090810 | Neanderthal introgressed variant-containing enhancer experimental_12920 | 10 | 44196187 | 44196356 | Human |
329832060 | LOC130003748 | ATAC-STARR-seq lymphoblastoid active region 3307 | 10 | 44198726 | 44198835 | Human |
155778254 | LOC127817841 | H3K4me1 hESC enhancer GRCh37_chr10:44703238-44703811 | 10 | 44207790 | 44208363 | Human |
155752211 | LOC127817842 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44728896-44729550 | 10 | 44233448 | 44234102 | Human |
155770725 | LOC127817843 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44729551-44730205 | 10 | 44234103 | 44234757 | Human |
155760889 | LOC127817844 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr10:44730206-44730859 | 10 | 44234758 | 44235411 | Human |
401824685 | LOC132089784 | Neanderthal introgressed variant-containing enhancer experimental_13072 | 10 | 44245844 | 44246013 | Human |
38625783 | LOC114827857 | VISTA enhancer hs2509 | 10 | 44260653 | 44262837 | Human |
329836292 | LOC130003749 | ATAC-STARR-seq lymphoblastoid active region 3311 | 10 | 44264530 | 44264589 | Human |
151676045 | LOC124902544 | uncharacterized LOC124902544 | 10 | 44293914 | 44351289 | Human |
155775143 | LOC127817845 | NANOG hESC enhancer GRCh37_chr10:44793368-44793869 | 10 | 44297920 | 44298421 | Human |
155228272 | LOC126860922 | P300/CBP strongly-dependent group 1 enhancer GRCh37_chr10:44796158-44797357 | 10 | 44300710 | 44301909 | Human |
329813883 | LOC130003750 | ATAC-STARR-seq lymphoblastoid active region 3312 | 10 | 44307655 | 44307864 | Human |
329342633 | LOC129662684 | ReSE screen-validated silencer GRCh37_chr10:44805333-44805502 | 10 | 44309885 | 44310054 | Human |
155753684 | LOC127817846 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44806263-44806765 | 10 | 44310815 | 44311317 | Human |
329839378 | LOC130003751 | ATAC-STARR-seq lymphoblastoid active region 3313 | 10 | 44312597 | 44312766 | Human |
329837295 | LOC130003752 | ATAC-STARR-seq lymphoblastoid silent region 2339 | 10 | 44316561 | 44316810 | Human |
329338689 | LOC129662685 | ReSE screen-validated silencer GRCh37_chr10:44821405-44821620 | 10 | 44325957 | 44326172 | Human |
155778540 | LOC127817847 | H3K27ac hESC enhancer GRCh37_chr10:44833715-44834216 | 10 | 44338267 | 44338768 | Human |
155770899 | LOC127817848 | H3K4me1 hESC enhancer GRCh37_chr10:44852471-44853402 | 10 | 44357023 | 44357954 | Human |
155778733 | LOC127817849 | H3K4me1 hESC enhancer GRCh37_chr10:44859545-44860046 | 10 | 44364097 | 44364598 | Human |
155776498 | LOC127817850 | H3K4me1 hESC enhancer GRCh37_chr10:44860047-44860546 | 10 | 44364599 | 44365098 | Human |
737223 | CXCL12 | C-X-C motif chemokine ligand 12 | 10 | 44370165 | 44385097 | Human |
155762784 | LOC127817851 | OCT4-NANOG-H3K27ac hESC enhancer GRCh37_chr10:44866272-44866820 | 10 | 44370824 | 44371372 | Human |
155767176 | LOC127817852 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44873825-44874771 | 10 | 44378377 | 44379323 | Human |
155759641 | LOC127817853 | NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44878101-44878794 | 10 | 44382653 | 44383346 | Human |
155756926 | LOC127817854 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44878795-44879488 | 10 | 44383347 | 44384040 | Human |
155755309 | LOC127817855 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44879489-44880180 | 10 | 44384041 | 44384732 | Human |
329820748 | LOC130003753 | ATAC-STARR-seq lymphoblastoid silent region 2340 | 10 | 44386626 | 44386835 | Human |
38670345 | LOC107984179 | uncharacterized LOC107984179 | 10 | 44389766 | 44401848 | Human |
155761934 | LOC127817856 | H3K4me1 hESC enhancer GRCh37_chr10:44890534-44891279 | 10 | 44395086 | 44395831 | Human |
155780030 | LOC127817857 | H3K4me1 hESC enhancer GRCh37_chr10:44891280-44892024 | 10 | 44395832 | 44396576 | Human |
155781013 | LOC127817858 | H3K4me1 hESC enhancer GRCh37_chr10:44894259-44895003 | 10 | 44398811 | 44399555 | Human |
155771039 | LOC127817859 | H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44895004-44895748 | 10 | 44399556 | 44400300 | Human |
155779493 | LOC127817860 | OCT4-NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr10:44895749-44896492 | 10 | 44400301 | 44401044 | Human |
2305501 | RPL9P21 | ribosomal protein L9 pseudogene 21 | 10 | 44414415 | 44415179 | Human |
9848093 | LINC02881 | long intergenic non-protein coding RNA 2881 | 10 | 44292750 | 44294649 | Human |
QTLs in Region (GRCh38)
597316506 | GWAS1412580_H | diastolic blood pressure, systolic blood pressure QTL GWAS1412580 (human) | | 0.000002 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19950530 | 19950531 | Human |
597291929 | GWAS1388003_H | body mass index QTL GWAS1388003 (human) | | 3e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34622951 | 34622952 | Human |
597316507 | GWAS1412581_H | diastolic blood pressure, systolic blood pressure QTL GWAS1412581 (human) | | 4e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19950566 | 19950567 | Human |
597255064 | GWAS1351138_H | age at first sexual intercourse measurement QTL GWAS1351138 (human) | | 1e-19 | age at first sexual intercourse measurement | | 10 | 22963922 | 22963928 | Human |
597291928 | GWAS1388002_H | body mass index QTL GWAS1388002 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33974725 | 33974726 | Human |
596988823 | GWAS1108342_H | memory performance QTL GWAS1108342 (human) | | 0.000006 | memory performance | | 10 | 22887883 | 22887884 | Human |
597615514 | GWAS1672374_H | prostate specific antigen amount QTL GWAS1672374 (human) | | 3e-18 | prostate specific antigen amount | | 10 | 23111464 | 23111465 | Human |
597263261 | GWAS1359335_H | 1-Methylhistidine measurement QTL GWAS1359335 (human) | | 0.000003 | 1-Methylhistidine measurement | | 10 | 33897477 | 33897478 | Human |
597615515 | GWAS1672375_H | prostate specific antigen amount QTL GWAS1672375 (human) | | 2e-25 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
597615513 | GWAS1672373_H | prostate specific antigen amount QTL GWAS1672373 (human) | | 4e-18 | prostate specific antigen amount | | 10 | 22031264 | 22031265 | Human |
597504917 | GWAS1600991_H | electrocardiography QTL GWAS1600991 (human) | | 4e-08 | electrocardiography | | 10 | 30003364 | 30003365 | Human |
597181329 | GWAS1277403_H | protein measurement QTL GWAS1277403 (human) | | 1e-16 | protein measurement | | 10 | 20309443 | 20309444 | Human |
597504916 | GWAS1600990_H | electrocardiography QTL GWAS1600990 (human) | | 7e-09 | electrocardiography | | 10 | 30003364 | 30003365 | Human |
597291925 | GWAS1387999_H | body mass index QTL GWAS1387999 (human) | | 5e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 19487899 | 19487900 | Human |
597164948 | GWAS1261022_H | myocardial infarction QTL GWAS1261022 (human) | | 1e-15 | myocardial infarction | | 10 | 43985246 | 43985247 | Human |
597480337 | GWAS1576411_H | schizophrenia QTL GWAS1576411 (human) | | 0.000005 | schizophrenia | | 10 | 23861388 | 23861389 | Human |
406960204 | GWAS609180_H | progressive supranuclear palsy QTL GWAS609180 (human) | | 0.0000003 | progressive supranuclear palsy | | 10 | 42845657 | 42845658 | Human |
597291927 | GWAS1388001_H | body mass index QTL GWAS1388001 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27029847 | 27029848 | Human |
597504915 | GWAS1600989_H | electrocardiography QTL GWAS1600989 (human) | | 4e-09 | electrocardiography | | 10 | 30003364 | 30003365 | Human |
597291926 | GWAS1388000_H | body mass index QTL GWAS1388000 (human) | | 4e-22 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21535690 | 21535691 | Human |
596988826 | GWAS1108345_H | memory performance, sex interaction measurement QTL GWAS1108345 (human) | | 0.000007 | memory performance, sex interaction measurement | | 10 | 27036190 | 27036191 | Human |
597595023 | GWAS1651883_H | eosinophil count QTL GWAS1651883 (human) | | 5e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26452245 | 26452246 | Human |
597111685 | GWAS1207759_H | Tinnitus, response to cisplatin QTL GWAS1207759 (human) | | 0.000003 | Tinnitus, response to cisplatin | | 10 | 22570882 | 22570883 | Human |
597361539 | GWAS1457613_H | neutrophil count, basophil count QTL GWAS1457613 (human) | | 7e-22 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 28491444 | 28491445 | Human |
597054350 | GWAS1150424_H | eosinophil count QTL GWAS1150424 (human) | | 2e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44364170 | 44364171 | Human |
597054348 | GWAS1150422_H | eosinophil count QTL GWAS1150422 (human) | | 1e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26446087 | 26446088 | Human |
597054349 | GWAS1150423_H | eosinophil count QTL GWAS1150423 (human) | | 7e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 34988300 | 34988301 | Human |
597054346 | GWAS1150420_H | eosinophil count QTL GWAS1150420 (human) | | 1e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24909758 | 24909759 | Human |
597054347 | GWAS1150421_H | eosinophil count QTL GWAS1150421 (human) | | 3e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26446058 | 26446059 | Human |
597107637 | GWAS1203711_H | reticulocyte measurement QTL GWAS1203711 (human) | | 2e-394 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 24929314 | 24929315 | Human |
597267387 | GWAS1363461_H | pulse pressure measurement QTL GWAS1363461 (human) | | 4e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028897 | 30028898 | Human |
597406655 | GWAS1502729_H | BMI-adjusted waist circumference QTL GWAS1502729 (human) | | 7e-09 | body size trait (VT:0100005) | | 10 | 27593896 | 27593897 | Human |
597341118 | GWAS1437192_H | systolic blood pressure QTL GWAS1437192 (human) | | 2e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27939936 | 27939937 | Human |
597275583 | GWAS1371657_H | right ventricular ejection fraction measurement QTL GWAS1371657 (human) | | 5e-08 | right ventricular ejection fraction measurement | | 10 | 29720411 | 29720412 | Human |
597341117 | GWAS1437191_H | systolic blood pressure QTL GWAS1437191 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 24380948 | 24380949 | Human |
597058481 | GWAS1154555_H | BMI-adjusted waist circumference QTL GWAS1154555 (human) | | 8e-10 | body size trait (VT:0100005) | | 10 | 32268664 | 32268665 | Human |
597345202 | GWAS1441276_H | body mass index QTL GWAS1441276 (human) | | 2e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21825498 | 21825499 | Human |
406968425 | GWAS617401_H | reticulocyte count QTL GWAS617401 (human) | | 8e-163 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24913109 | 24913110 | Human |
597345203 | GWAS1441277_H | body mass index QTL GWAS1441277 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27226635 | 27226636 | Human |
597345200 | GWAS1441274_H | body mass index QTL GWAS1441274 (human) | | 9e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20616340 | 20616341 | Human |
597255091 | GWAS1351165_H | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder QTL GWAS1351165 (human) | | 0.000001 | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder | | 10 | 36748480 | 36748481 | Human |
597345201 | GWAS1441275_H | body mass index QTL GWAS1441275 (human) | | 6e-24 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21541175 | 21541176 | Human |
597345204 | GWAS1441278_H | body mass index QTL GWAS1441278 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33568267 | 33568268 | Human |
596960165 | GWAS1079684_H | glomerular filtration rate QTL GWAS1079684 (human) | | 2e-09 | glomerular filtration rate | | 10 | 23581892 | 23581893 | Human |
597423018 | GWAS1519092_H | response to antipsychotic drug QTL GWAS1519092 (human) | | 0.000001 | response to antipsychotic drug | | 10 | 31693496 | 31693497 | Human |
596960166 | GWAS1079685_H | glomerular filtration rate QTL GWAS1079685 (human) | | 5e-08 | glomerular filtration rate | | 10 | 24637254 | 24637255 | Human |
596960167 | GWAS1079686_H | glomerular filtration rate QTL GWAS1079686 (human) | | 7e-16 | glomerular filtration rate | | 10 | 28590311 | 28590312 | Human |
596951970 | GWAS1071489_H | Red cell distribution width QTL GWAS1071489 (human) | | 7e-214 | Red cell distribution width | | 10 | 24569461 | 24569462 | Human |
597087136 | GWAS1183210_H | cortical thickness, neuroimaging measurement QTL GWAS1183210 (human) | | 1e-08 | cortical thickness, neuroimaging measurement | | 10 | 33976306 | 33976307 | Human |
597500838 | GWAS1596912_H | body mass index QTL GWAS1596912 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33571587 | 33571588 | Human |
597382055 | GWAS1478129_H | platelet count QTL GWAS1478129 (human) | | 1e-21 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 30215026 | 30215027 | Human |
596960168 | GWAS1079687_H | glomerular filtration rate QTL GWAS1079687 (human) | | 0.000009 | glomerular filtration rate | | 10 | 34771413 | 34771414 | Human |
597046187 | GWAS1142261_H | QT interval QTL GWAS1142261 (human) | | 2e-10 | QT interval | QT interval (CMO:0000235) | 10 | 38525887 | 38525888 | Human |
596960169 | GWAS1079688_H | glomerular filtration rate QTL GWAS1079688 (human) | | 2e-11 | glomerular filtration rate | | 10 | 43519331 | 43519332 | Human |
407103489 | GWAS752465_H | obsolete_prostate specific antigen measurement QTL GWAS752465 (human) | | 4e-11 | obsolete_prostate specific antigen measurement | | 10 | 23109519 | 23109520 | Human |
407218183 | GWAS867159_H | lymphocyte count QTL GWAS867159 (human) | | 2e-56 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24909758 | 24909759 | Human |
597439455 | GWAS1535529_H | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment QTL GWAS1535529 (human) | | 0.000002 | body size trait (VT:0100005) | | 10 | 31701695 | 31701696 | Human |
597218268 | GWAS1314342_H | heel bone mineral density QTL GWAS1314342 (human) | | 2e-22 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20041014 | 20041015 | Human |
597214173 | GWAS1310247_H | schizophrenia QTL GWAS1310247 (human) | | 5e-13 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
407087110 | GWAS736086_H | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count QTL GWAS736086 (human) | | 2e-08 | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, obsolete_red blood cell distribution width, basophil count, platelet count, eosinophil count | | 10 | 27068541 | 27068542 | Human |
597251039 | GWAS1347113_H | mean arterial pressure QTL GWAS1347113 (human) | | 0.000006 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 24544776 | 24544777 | Human |
597205983 | GWAS1302057_H | complement factor D measurement QTL GWAS1302057 (human) | | 1e-08 | complement protein amount (VT:0010033) | | 10 | 28635489 | 28635490 | Human |
597332944 | GWAS1429018_H | body mass index QTL GWAS1429018 (human) | | 7e-18 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21541175 | 21541176 | Human |
407222286 | GWAS871262_H | eosinophilic esophagitis QTL GWAS871262 (human) | | 0.0000003 | eosinophilic esophagitis | | 10 | 20576228 | 20576229 | Human |
597529553 | GWAS1625627_H | prostate specific antigen amount QTL GWAS1625627 (human) | | 5e-15 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
407218185 | GWAS867161_H | lymphocyte count QTL GWAS867161 (human) | | 7e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 30207976 | 30207977 | Human |
597136344 | GWAS1232418_H | neuroimaging measurement QTL GWAS1232418 (human) | | 5e-13 | neuroimaging measurement | | 10 | 34216900 | 34216901 | Human |
407218186 | GWAS867162_H | lymphocyte count QTL GWAS867162 (human) | | 6e-22 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44375898 | 44375899 | Human |
597140431 | GWAS1236505_H | QT interval QTL GWAS1236505 (human) | | 8e-10 | QT interval | QT interval (CMO:0000235) | 10 | 22855287 | 22855288 | Human |
597377986 | GWAS1474060_H | coronary artery disease QTL GWAS1474060 (human) | | 0.000002 | coronary artery disease | | 10 | 44258419 | 44258420 | Human |
597074893 | GWAS1170967_H | asthma QTL GWAS1170967 (human) | | 0.000002 | asthma | | 10 | 38470625 | 38470626 | Human |
597595075 | GWAS1651935_H | eosinophil count QTL GWAS1651935 (human) | | 5e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26462654 | 26462655 | Human |
597144567 | GWAS1240641_H | body mass index QTL GWAS1240641 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33730365 | 33730366 | Human |
597021687 | GWAS1117761_H | interleukin 10 measurement QTL GWAS1117761 (human) | | 0.000006 | interleukin 10 measurement | | 10 | 20741867 | 20741868 | Human |
596964336 | GWAS1083855_H | major depressive disorder QTL GWAS1083855 (human) | | 0.000004 | major depressive disorder | | 10 | 43241126 | 43241127 | Human |
597386237 | GWAS1482311_H | susceptibility to hepatitis A infection measurement QTL GWAS1482311 (human) | | 0.000002 | susceptibility to hepatitis A infection measurement | | 10 | 28344569 | 28344570 | Human |
597361661 | GWAS1457735_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS1457735 (human) | | 0.000005 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 10 | 29800065 | 29800066 | Human |
406947885 | GWAS596861_H | PR interval QTL GWAS596861 (human) | | 2e-08 | PR interval | PR interval (CMO:0000233) | 10 | 32559034 | 32559035 | Human |
597021688 | GWAS1117762_H | interleukin 10 measurement QTL GWAS1117762 (human) | | 0.000007 | interleukin 10 measurement | | 10 | 20926577 | 20926578 | Human |
597316599 | GWAS1412673_H | hippocampal volume QTL GWAS1412673 (human) | | 0.000003 | hippocampal volume | | 10 | 44240941 | 44240942 | Human |
597173225 | GWAS1269299_H | cytochrome c oxidase subunit 6C measurement QTL GWAS1269299 (human) | | 3e-55 | cytochrome c oxidase subunit 6C measurement | | 10 | 19936725 | 19936726 | Human |
597173228 | GWAS1269302_H | cytochrome c oxidase subunit 6C measurement QTL GWAS1269302 (human) | | 1e-10 | cytochrome c oxidase subunit 6C measurement | | 10 | 19829909 | 19829910 | Human |
597136353 | GWAS1232427_H | neuroimaging measurement QTL GWAS1232427 (human) | | 7e-13 | neuroimaging measurement | | 10 | 31850998 | 31850999 | Human |
407001140 | GWAS650116_H | malignant epithelial tumor of ovary QTL GWAS650116 (human) | | 3e-08 | malignant epithelial tumor of ovary | | 10 | 36880367 | 36880368 | Human |
407046343 | GWAS695319_H | interleukin-6 measurement QTL GWAS695319 (human) | | 0.000006 | interleukin-6 measurement | blood interleukin-6 level (CMO:0001926) | 10 | 26195225 | 26195226 | Human |
596960019 | GWAS1079538_H | glomerular filtration rate QTL GWAS1079538 (human) | | 9e-17 | glomerular filtration rate | | 10 | 28590311 | 28590312 | Human |
597152542 | GWAS1248616_H | executive function measurement QTL GWAS1248616 (human) | | 0.0000004 | executive function measurement | | 10 | 19939735 | 19939736 | Human |
597504791 | GWAS1600865_H | erucate (22:1n9) measurement QTL GWAS1600865 (human) | | 0.0000005 | erucate (22:1n9) measurement | | 10 | 33805823 | 33805824 | Human |
597488402 | GWAS1584476_H | ubiquinone measurement QTL GWAS1584476 (human) | | 1e-13 | ubiquinone measurement | | 10 | 26667051 | 26667052 | Human |
597291785 | GWAS1387859_H | asthma, endometriosis QTL GWAS1387859 (human) | | 6e-08 | asthma, endometriosis | | 10 | 21834839 | 21834840 | Human |
597504780 | GWAS1600854_H | insomnia QTL GWAS1600854 (human) | | 3e-11 | insomnia | | 10 | 21532989 | 21532990 | Human |
597291784 | GWAS1387858_H | asthma, endometriosis QTL GWAS1387858 (human) | | 7e-08 | asthma, endometriosis | | 10 | 21809772 | 21809773 | Human |
597291787 | GWAS1387861_H | asthma, endometriosis QTL GWAS1387861 (human) | | 9e-08 | asthma, endometriosis | | 10 | 21844864 | 21844865 | Human |
597291786 | GWAS1387860_H | asthma, endometriosis QTL GWAS1387860 (human) | | 8e-08 | asthma, endometriosis | | 10 | 21835334 | 21835335 | Human |
597291788 | GWAS1387862_H | asthma, endometriosis QTL GWAS1387862 (human) | | 9e-08 | asthma, endometriosis | | 10 | 21999203 | 21999204 | Human |
597041923 | GWAS1137997_H | cataract QTL GWAS1137997 (human) | | 4e-08 | cataract | | 10 | 28735201 | 28735202 | Human |
407230675 | GWAS879651_H | asthma, response to diisocyanate QTL GWAS879651 (human) | | 0.000005 | asthma, response to diisocyanate | | 10 | 24951155 | 24951156 | Human |
597291790 | GWAS1387864_H | asthma, endometriosis QTL GWAS1387864 (human) | | 2e-08 | asthma, endometriosis | | 10 | 21728616 | 21728617 | Human |
596960013 | GWAS1079532_H | glomerular filtration rate QTL GWAS1079532 (human) | | 2e-09 | glomerular filtration rate | | 10 | 34771413 | 34771414 | Human |
596960014 | GWAS1079533_H | glomerular filtration rate QTL GWAS1079533 (human) | | 3e-12 | glomerular filtration rate | | 10 | 43519331 | 43519332 | Human |
407222489 | GWAS871465_H | cholesteryl ester 18:3 measurement QTL GWAS871465 (human) | | 0.000009 | blood lipid amount (VT:0003949) | | 10 | 20409821 | 20409822 | Human |
407025887 | GWAS674863_H | systolic blood pressure QTL GWAS674863 (human) | | 0.000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18441439 | 18441440 | Human |
597291783 | GWAS1387857_H | asthma, endometriosis QTL GWAS1387857 (human) | | 6e-08 | asthma, endometriosis | | 10 | 21744013 | 21744014 | Human |
407079138 | GWAS728114_H | metabolic syndrome QTL GWAS728114 (human) | | 2e-08 | metabolic syndrome | | 10 | 21590155 | 21590156 | Human |
597123894 | GWAS1219968_H | clear cell renal carcinoma QTL GWAS1219968 (human) | | 3e-08 | clear cell renal carcinoma | | 10 | 30852153 | 30852154 | Human |
597226300 | GWAS1322374_H | smoking status measurement QTL GWAS1322374 (human) | | 6e-15 | smoking status measurement | | 10 | 21744013 | 21744014 | Human |
597226301 | GWAS1322375_H | smoking status measurement QTL GWAS1322375 (human) | | 2e-08 | smoking status measurement | | 10 | 36345196 | 36345197 | Human |
597611321 | GWAS1668181_H | neutrophil count QTL GWAS1668181 (human) | | 1e-18 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24922362 | 24922363 | Human |
597168959 | GWAS1265033_H | basophil count QTL GWAS1265033 (human) | | 4e-08 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 26451327 | 26451328 | Human |
406894823 | GWAS543799_H | unipolar depression QTL GWAS543799 (human) | | 0.000007 | unipolar depression | | 10 | 29002969 | 29002970 | Human |
407079147 | GWAS728123_H | gut microbiome measurement QTL GWAS728123 (human) | | 3e-13 | gut microbiome measurement | | 10 | 25317076 | 25317077 | Human |
597373747 | GWAS1469821_H | endometriosis QTL GWAS1469821 (human) | | 0.0000004 | endometriosis | | 10 | 44046117 | 44046118 | Human |
597578549 | GWAS1635409_H | morbid obesity QTL GWAS1635409 (human) | | 5e-12 | morbid obesity | | 10 | 21508343 | 21508344 | Human |
597513009 | GWAS1609083_H | diverticular disease QTL GWAS1609083 (human) | | 5e-12 | diverticular disease | | 10 | 36172639 | 36172640 | Human |
597115706 | GWAS1211780_H | electroencephalogram measurement QTL GWAS1211780 (human) | | 0.000004 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 10 | 26205810 | 26205811 | Human |
407001324 | GWAS650300_H | pulse pressure measurement QTL GWAS650300 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20240541 | 20240542 | Human |
597107512 | GWAS1203586_H | reticulocyte count QTL GWAS1203586 (human) | | 8e-390 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24929314 | 24929315 | Human |
597406507 | GWAS1502581_H | cortical thickness QTL GWAS1502581 (human) | | 1e-20 | cortical thickness | | 10 | 30828429 | 30828430 | Human |
597115684 | GWAS1211758_H | pulse pressure measurement QTL GWAS1211758 (human) | | 4e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 19645884 | 19645885 | Human |
596951847 | GWAS1071366_H | COVID-19 QTL GWAS1071366 (human) | | 0.0000002 | COVID-19 | | 10 | 30543771 | 30543772 | Human |
597283628 | GWAS1379702_H | hemoglobin A1 measurement QTL GWAS1379702 (human) | | 1e-10 | hemoglobin A1 measurement | | 10 | 26256259 | 26256260 | Human |
597529384 | GWAS1625458_H | X-12822 measurement QTL GWAS1625458 (human) | | 1e-09 | X-12822 measurement | | 10 | 26682950 | 26682951 | Human |
597508901 | GWAS1604975_H | metabolite measurement QTL GWAS1604975 (human) | | 5e-11 | metabolite measurement | | 10 | 42982973 | 42982974 | Human |
597037871 | GWAS1133945_H | mean arterial pressure, alcohol drinking QTL GWAS1133945 (human) | | 9e-14 | mean arterial pressure, alcohol drinking | mean arterial blood pressure (CMO:0000009) | 10 | 18430748 | 18430749 | Human |
597496614 | GWAS1592688_H | systolic blood pressure QTL GWAS1592688 (human) | | 0.000001 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 21475540 | 21475541 | Human |
596951848 | GWAS1071367_H | COVID-19 QTL GWAS1071367 (human) | | 0.0000008 | COVID-19 | | 10 | 31185614 | 31185615 | Human |
597029673 | GWAS1125747_H | waist-hip ratio QTL GWAS1125747 (human) | | 6e-13 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33879162 | 33879163 | Human |
597037864 | GWAS1133938_H | gut microbiome measurement QTL GWAS1133938 (human) | | 0.0000009 | gut microbiome measurement | | 10 | 20540747 | 20540748 | Human |
596955991 | GWAS1075510_H | lymphocyte measurement, neutrophil measurement QTL GWAS1075510 (human) | | 1e-10 | lymphocyte measurement, neutrophil measurement | | 10 | 28530477 | 28530478 | Human |
597058386 | GWAS1154460_H | basophil percentage of leukocytes QTL GWAS1154460 (human) | | 3e-17 | basophil quantity (VT:0002607) | blood basophil count to total leukocyte count ratio (CMO:0000368) | 10 | 26445589 | 26445590 | Human |
597095251 | GWAS1191325_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1191325 (human) | | 0.000002 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 10 | 20013643 | 20013644 | Human |
597226333 | GWAS1322407_H | heel bone mineral density QTL GWAS1322407 (human) | | 1e-99 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
597447507 | GWAS1543581_H | diet measurement, testosterone measurement QTL GWAS1543581 (human) | | 0.000007 | eating behavior trait (VT:0001431) | serum testosterone level (CMO:0000568) | 10 | 38714782 | 38714783 | Human |
597525324 | GWAS1621398_H | body mass index QTL GWAS1621398 (human) | | 8e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33571587 | 33571588 | Human |
597439311 | GWAS1535385_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1535385 (human) | | 0.000007 | peripheral arterial disease, traffic air pollution measurement | | 10 | 31194503 | 31194504 | Human |
597525323 | GWAS1621397_H | body mass index QTL GWAS1621397 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532645 | 21532646 | Human |
597525322 | GWAS1621396_H | body mass index QTL GWAS1621396 (human) | | 5e-33 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532345 | 21532346 | Human |
596976450 | GWAS1095969_H | Red cell distribution width QTL GWAS1095969 (human) | | 4e-62 | Red cell distribution width | | 10 | 24569461 | 24569462 | Human |
597033806 | GWAS1129880_H | blood protein measurement QTL GWAS1129880 (human) | | 0.000009 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 28366719 | 28366720 | Human |
406952090 | GWAS601066_H | systolic blood pressure QTL GWAS601066 (human) | | 6e-11 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18451703 | 18451704 | Human |
597152586 | GWAS1248660_H | executive function measurement QTL GWAS1248660 (human) | | 7e-08 | executive function measurement | | 10 | 19939735 | 19939736 | Human |
407369880 | GWAS1018856_H | pulmonary neuroendocrine tumor QTL GWAS1018856 (human) | | 1e-11 | pulmonary neuroendocrine tumor | | 10 | 35955481 | 35955482 | Human |
597615484 | GWAS1672344_H | systolic blood pressure QTL GWAS1672344 (human) | | 2e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18427013 | 18427014 | Human |
597271419 | GWAS1367493_H | systolic blood pressure QTL GWAS1367493 (human) | | 4e-58 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
597132149 | GWAS1228223_H | systolic blood pressure QTL GWAS1228223 (human) | | 0.000007 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 32301434 | 32301435 | Human |
597615485 | GWAS1672345_H | systolic blood pressure QTL GWAS1672345 (human) | | 2e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 30027279 | 30027280 | Human |
597132148 | GWAS1228222_H | systolic blood pressure QTL GWAS1228222 (human) | | 2e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 31816790 | 31816791 | Human |
597099380 | GWAS1195454_H | body mass index QTL GWAS1195454 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33974725 | 33974726 | Human |
597099379 | GWAS1195453_H | body mass index QTL GWAS1195453 (human) | | 2e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 22005758 | 22005759 | Human |
407115936 | GWAS764912_H | cognitive decline measurement QTL GWAS764912 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 10 | 29724174 | 29724175 | Human |
597132147 | GWAS1228221_H | systolic blood pressure QTL GWAS1228221 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 30197855 | 30197856 | Human |
597132146 | GWAS1228220_H | systolic blood pressure QTL GWAS1228220 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 30028144 | 30028145 | Human |
597099378 | GWAS1195452_H | body mass index QTL GWAS1195452 (human) | | 4e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33731498 | 33731499 | Human |
597099377 | GWAS1195451_H | body mass index QTL GWAS1195451 (human) | | 1e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21465833 | 21465834 | Human |
597132145 | GWAS1228219_H | systolic blood pressure QTL GWAS1228219 (human) | | 0.0000009 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 28635972 | 28635973 | Human |
597603192 | GWAS1660052_H | monocyte count QTL GWAS1660052 (human) | | 1e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44390354 | 44390355 | Human |
597132144 | GWAS1228218_H | systolic blood pressure QTL GWAS1228218 (human) | | 7e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27944540 | 27944541 | Human |
597021565 | GWAS1117639_H | ulcerative colitis QTL GWAS1117639 (human) | | 0.000005 | ulcerative colitis | | 10 | 30439172 | 30439173 | Human |
597058428 | GWAS1154502_H | multiple sclerosis QTL GWAS1154502 (human) | | 0.0000005 | multiple sclerosis | | 10 | 43252974 | 43252975 | Human |
597427063 | GWAS1523137_H | cardiac troponin I change measurement QTL GWAS1523137 (human) | | 0.0000007 | cardiac troponin I change measurement | | 10 | 28864953 | 28864954 | Human |
597373812 | GWAS1469886_H | preeclampsia QTL GWAS1469886 (human) | | 0.000006 | preeclampsia | | 10 | 28738294 | 28738295 | Human |
597214056 | GWAS1310130_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1310130 (human) | | 1e-10 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 18437289 | 18437290 | Human |
407382201 | GWAS1031177_H | obsolete_red blood cell distribution width QTL GWAS1031177 (human) | | 3e-213 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
597365609 | GWAS1461683_H | uterine fibroid QTL GWAS1461683 (human) | | 2e-10 | uterine fibroid | | 10 | 31679855 | 31679856 | Human |
597500783 | GWAS1596857_H | neuropilin-1 measurement QTL GWAS1596857 (human) | | 5e-115 | neuropilin-1 measurement | | 10 | 33194380 | 33194381 | Human |
406976691 | GWAS625667_H | myocardial infarction QTL GWAS625667 (human) | | 7e-09 | myocardial infarction | | 10 | 44280376 | 44280377 | Human |
596976486 | GWAS1096005_H | body height QTL GWAS1096005 (human) | | 2e-10 | body height | | 10 | 30831584 | 30831585 | Human |
597017440 | GWAS1113514_H | basophil count QTL GWAS1113514 (human) | | 3e-15 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 28491364 | 28491365 | Human |
407369905 | GWAS1018881_H | platelet component distribution width QTL GWAS1018881 (human) | | 3e-09 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 22887797 | 22887798 | Human |
597132143 | GWAS1228217_H | systolic blood pressure QTL GWAS1228217 (human) | | 7e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27624705 | 27624706 | Human |
597099375 | GWAS1195449_H | body mass index QTL GWAS1195449 (human) | | 8e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33568267 | 33568268 | Human |
597132142 | GWAS1228216_H | systolic blood pressure QTL GWAS1228216 (human) | | 7e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 24380948 | 24380949 | Human |
597132141 | GWAS1228215_H | systolic blood pressure QTL GWAS1228215 (human) | | 8e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 20748365 | 20748366 | Human |
597594980 | GWAS1651840_H | eosinophil count QTL GWAS1651840 (human) | | 4e-16 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26462654 | 26462655 | Human |
597132140 | GWAS1228214_H | systolic blood pressure QTL GWAS1228214 (human) | | 1e-90 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
597132139 | GWAS1228213_H | systolic blood pressure QTL GWAS1228213 (human) | | 1e-26 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18438972 | 18438973 | Human |
597209958 | GWAS1306032_H | blood protein measurement QTL GWAS1306032 (human) | | 2e-08 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 30334408 | 30334409 | Human |
407271608 | GWAS920584_H | migraine disorder, endometriosis QTL GWAS920584 (human) | | 0.000006 | migraine disorder, endometriosis | | 10 | 33195338 | 33195339 | Human |
597504669 | GWAS1600743_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1600743 (human) | | 0.0000003 | severe acute respiratory syndrome, COVID-19 | | 10 | 27957480 | 27957481 | Human |
597226139 | GWAS1322213_H | heel bone mineral density QTL GWAS1322213 (human) | | 5e-27 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
597226140 | GWAS1322214_H | heel bone mineral density QTL GWAS1322214 (human) | | 2e-23 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20090449 | 20090450 | Human |
597103250 | GWAS1199324_H | gut microbiome measurement QTL GWAS1199324 (human) | | 0.000008 | gut microbiome measurement | | 10 | 19545866 | 19545867 | Human |
406972740 | GWAS621716_H | obsolete_prostate specific antigen measurement QTL GWAS621716 (human) | | 1e-08 | obsolete_prostate specific antigen measurement | | 10 | 27805490 | 27805491 | Human |
597226142 | GWAS1322216_H | heel bone mineral density QTL GWAS1322216 (human) | | 2e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 21026624 | 21026625 | Human |
597226143 | GWAS1322217_H | heel bone mineral density QTL GWAS1322217 (human) | | 1e-44 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27599924 | 27599925 | Human |
596988573 | GWAS1108092_H | memory performance, sex interaction measurement QTL GWAS1108092 (human) | | 0.000007 | memory performance, sex interaction measurement | | 10 | 27036348 | 27036349 | Human |
597107357 | GWAS1203431_H | total cholesterol measurement QTL GWAS1203431 (human) | | 0.0000005 | total cholesterol measurement | blood total cholesterol level (CMO:0000051) | 10 | 20126458 | 20126459 | Human |
407386436 | GWAS1035412_H | obsolete_red blood cell distribution width QTL GWAS1035412 (human) | | 7e-214 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
597611152 | GWAS1668012_H | neutrophil count QTL GWAS1668012 (human) | | 6e-15 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24917483 | 24917484 | Human |
597611153 | GWAS1668013_H | neutrophil count QTL GWAS1668013 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28501052 | 28501053 | Human |
597238409 | GWAS1334483_H | monocyte count QTL GWAS1334483 (human) | | 2e-53 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24928854 | 24928855 | Human |
597172873 | GWAS1268947_H | torsin-1A-interacting protein 1 measurement QTL GWAS1268947 (human) | | 0.0000004 | torsin-1A-interacting protein 1 measurement | | 10 | 19868276 | 19868277 | Human |
407124311 | GWAS773287_H | response to candesartan QTL GWAS773287 (human) | | 0.0000003 | response to candesartan | | 10 | 26445658 | 26445659 | Human |
597578378 | GWAS1635238_H | prothrombin time measurement QTL GWAS1635238 (human) | | 8e-47 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19936725 | 19936726 | Human |
597250703 | GWAS1346777_H | clostridiales seropositivity QTL GWAS1346777 (human) | | 9e-09 | clostridiales seropositivity | | 10 | 18770916 | 18770917 | Human |
596988559 | GWAS1108078_H | memory performance, sex interaction measurement QTL GWAS1108078 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 27064629 | 27064630 | Human |
407222623 | GWAS871599_H | response to antineoplastic agent QTL GWAS871599 (human) | | 0.000004 | response to antineoplastic agent | | 10 | 29198436 | 29198437 | Human |
597451399 | GWAS1547473_H | bacteria seropositivity QTL GWAS1547473 (human) | | 4e-08 | bacteria seropositivity | | 10 | 26594430 | 26594431 | Human |
597607102 | GWAS1663962_H | systolic blood pressure QTL GWAS1663962 (human) | | 5e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18427013 | 18427014 | Human |
597099190 | GWAS1195264_H | body mass index QTL GWAS1195264 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20810655 | 20810656 | Human |
597099189 | GWAS1195263_H | body mass index QTL GWAS1195263 (human) | | 7e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20616340 | 20616341 | Human |
597291707 | GWAS1387781_H | size QTL GWAS1387781 (human) | | 9e-11 | size | | 10 | 28643416 | 28643417 | Human |
597115572 | GWAS1211646_H | Alzheimer's disease biomarker measurement QTL GWAS1211646 (human) | | 0.000002 | Alzheimer's disease biomarker measurement | | 10 | 20688226 | 20688227 | Human |
597099187 | GWAS1195261_H | body mass index QTL GWAS1195261 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33756263 | 33756264 | Human |
596959922 | GWAS1079441_H | glomerular filtration rate QTL GWAS1079441 (human) | | 2e-11 | glomerular filtration rate | | 10 | 23581892 | 23581893 | Human |
597533371 | GWAS1629445_H | forced expiratory volume QTL GWAS1629445 (human) | | 9e-12 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 10 | 31768178 | 31768179 | Human |
407071086 | GWAS720062_H | BMI-adjusted waist-hip ratio QTL GWAS720062 (human) | | 4e-19 | body size trait (VT:0100005) | | 10 | 32330644 | 32330645 | Human |
407370088 | GWAS1019064_H | emphysema pattern measurement QTL GWAS1019064 (human) | | 4e-08 | emphysema pattern measurement | | 10 | 29945261 | 29945262 | Human |
597099192 | GWAS1195266_H | body mass index QTL GWAS1195266 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34125937 | 34125938 | Human |
596964004 | GWAS1083523_H | major depressive disorder QTL GWAS1083523 (human) | | 0.000005 | major depressive disorder | | 10 | 33005847 | 33005848 | Human |
407370102 | GWAS1019078_H | monocyte percentage of leukocytes QTL GWAS1019078 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 22215681 | 22215682 | Human |
597181098 | GWAS1277172_H | T-cell surface glycoprotein CD3 epsilon chain measurement QTL GWAS1277172 (human) | | 1e-33 | T-cell surface glycoprotein CD3 epsilon chain measurement | | 10 | 19946534 | 19946535 | Human |
407144822 | GWAS793798_H | migraine disorder QTL GWAS793798 (human) | | 0.000003 | migraine disorder | | 10 | 33214251 | 33214252 | Human |
597291693 | GWAS1387767_H | asthma, endometriosis QTL GWAS1387767 (human) | | 5e-08 | asthma, endometriosis | | 10 | 21560840 | 21560841 | Human |
597508779 | GWAS1604853_H | QT interval QTL GWAS1604853 (human) | | 1e-09 | QT interval | QT interval (CMO:0000235) | 10 | 22874249 | 22874250 | Human |
597226144 | GWAS1322218_H | heel bone mineral density QTL GWAS1322218 (human) | | 1e-17 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27721259 | 27721260 | Human |
597226145 | GWAS1322219_H | heel bone mineral density QTL GWAS1322219 (human) | | 1e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27722299 | 27722300 | Human |
597226146 | GWAS1322220_H | heel bone mineral density QTL GWAS1322220 (human) | | 2e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28067868 | 28067869 | Human |
597226147 | GWAS1322221_H | heel bone mineral density QTL GWAS1322221 (human) | | 6e-44 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28146986 | 28146987 | Human |
597226148 | GWAS1322222_H | heel bone mineral density QTL GWAS1322222 (human) | | 8e-22 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28229888 | 28229897 | Human |
597414565 | GWAS1510639_H | blood protein measurement QTL GWAS1510639 (human) | | 0.0000004 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19741513 | 19741514 | Human |
597226150 | GWAS1322224_H | heel bone mineral density QTL GWAS1322224 (human) | | 3e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28721489 | 28721490 | Human |
597226151 | GWAS1322225_H | heel bone mineral density QTL GWAS1322225 (human) | | 6e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 29183619 | 29183620 | Human |
597189338 | GWAS1285412_H | sex hormone-binding globulin measurement QTL GWAS1285412 (human) | | 3e-08 | sex hormone-binding globulin measurement | | 10 | 30883069 | 30883070 | Human |
407275778 | GWAS924754_H | information processing speed QTL GWAS924754 (human) | | 0.000004 | information processing speed | | 10 | 43530557 | 43530558 | Human |
597107408 | GWAS1203482_H | Red cell distribution width QTL GWAS1203482 (human) | | 7e-27 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24934438 | 24934439 | Human |
597594835 | GWAS1651695_H | eosinophil count QTL GWAS1651695 (human) | | 6e-34 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26439005 | 26439006 | Human |
597148378 | GWAS1244452_H | high density lipoprotein cholesterol measurement QTL GWAS1244452 (human) | | 1e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33317261 | 33317262 | Human |
596964036 | GWAS1083555_H | major depressive disorder QTL GWAS1083555 (human) | | 0.000003 | major depressive disorder | | 10 | 33968684 | 33968685 | Human |
597041858 | GWAS1137932_H | retinal detachment, retinal break QTL GWAS1137932 (human) | | 0.000004 | retinal detachment, retinal break | | 10 | 20020556 | 20020557 | Human |
406956308 | GWAS605284_H | unipolar depression QTL GWAS605284 (human) | | 0.000003 | unipolar depression | | 10 | 33968684 | 33968685 | Human |
597107407 | GWAS1203481_H | Red cell distribution width QTL GWAS1203481 (human) | | 6e-177 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597275330 | GWAS1371404_H | age-related macular degeneration, COVID-19 QTL GWAS1371404 (human) | | 1e-08 | age-related macular degeneration, COVID-19 | | 10 | 24710664 | 24710665 | Human |
597578434 | GWAS1635294_H | prothrombin time measurement QTL GWAS1635294 (human) | | 3e-66 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
597332678 | GWAS1428752_H | atrial fibrillation QTL GWAS1428752 (human) | | 2e-16 | atrial fibrillation | | 10 | 20868692 | 20868693 | Human |
597492417 | GWAS1588491_H | breast density QTL GWAS1588491 (human) | | 0.000001 | breast density | | 10 | 23960559 | 23960560 | Human |
597340868 | GWAS1436942_H | serum gamma-glutamyl transferase measurement QTL GWAS1436942 (human) | | 6e-09 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 22585454 | 22585455 | Human |
597529283 | GWAS1625357_H | Ischemic stroke QTL GWAS1625357 (human) | | 0.00001 | Ischemic stroke | | 10 | 24569127 | 24569128 | Human |
596955851 | GWAS1075370_H | intraocular pressure measurement QTL GWAS1075370 (human) | | 1e-08 | intraocular pressure measurement | | 10 | 28669675 | 28669676 | Human |
597340869 | GWAS1436943_H | serum gamma-glutamyl transferase measurement QTL GWAS1436943 (human) | | 3e-21 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 34797422 | 34797423 | Human |
597054198 | GWAS1150272_H | white matter microstructure measurement QTL GWAS1150272 (human) | | 5e-08 | white matter microstructure measurement | | 10 | 18424641 | 18424642 | Human |
597340922 | GWAS1436996_H | sexual dimorphism measurement QTL GWAS1436996 (human) | | 7e-10 | sexual dimorphism measurement | | 10 | 21769208 | 21769209 | Human |
407058722 | GWAS707698_H | Tetralogy of Fallot QTL GWAS707698 (human) | | 0.0000002 | Tetralogy of Fallot | | 10 | 33186354 | 33186355 | Human |
597062386 | GWAS1158460_H | body mass index QTL GWAS1158460 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 28958379 | 28958380 | Human |
597062387 | GWAS1158461_H | body mass index QTL GWAS1158461 (human) | | 0.000004 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 23149918 | 23149919 | Human |
406956329 | GWAS605305_H | breast carcinoma QTL GWAS605305 (human) | | 4e-14 | mammary gland integrity trait (VT:0010552) | | 10 | 21744013 | 21744014 | Human |
597611254 | GWAS1668114_H | neutrophil count QTL GWAS1668114 (human) | | 2e-17 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28501052 | 28501053 | Human |
597164786 | GWAS1260860_H | angina pectoris QTL GWAS1260860 (human) | | 5e-09 | angina pectoris | | 10 | 44111411 | 44111413 | Human |
597611253 | GWAS1668113_H | neutrophil count QTL GWAS1668113 (human) | | 1e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24917483 | 24917484 | Human |
597377770 | GWAS1473844_H | type 2 diabetes mellitus QTL GWAS1473844 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 23198849 | 23198850 | Human |
597340905 | GWAS1436979_H | cartilage thickness measurement QTL GWAS1436979 (human) | | 2e-08 | cartilage morphology trait (VT:0000163) | hip circumference (CMO:0000014) | 10 | 32301434 | 32301435 | Human |
407009590 | GWAS658566_H | parental longevity QTL GWAS658566 (human) | | 0.000004 | total life span (VT:0001661) | | 10 | 30017875 | 30017876 | Human |
596984545 | GWAS1104064_H | telomere length QTL GWAS1104064 (human) | | 2e-09 | telomere length | | 10 | 32264184 | 32264185 | Human |
597029603 | GWAS1125677_H | blood protein measurement QTL GWAS1125677 (human) | | 1e-14 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 33196550 | 33196551 | Human |
407144755 | GWAS793731_H | PR interval QTL GWAS793731 (human) | | 0.000002 | PR interval | PR interval (CMO:0000233) | 10 | 35629304 | 35629305 | Human |
597603049 | GWAS1659909_H | drug use measurement, coronary artery disease QTL GWAS1659909 (human) | | 2e-24 | drug use measurement, coronary artery disease | | 10 | 44246262 | 44246263 | Human |
597246691 | GWAS1342765_H | schizophrenia, sex interaction measurement QTL GWAS1342765 (human) | | 0.000002 | schizophrenia, sex interaction measurement | | 10 | 36798243 | 36798244 | Human |
597242597 | GWAS1338671_H | aspartate aminotransferase measurement QTL GWAS1338671 (human) | | 0.0000003 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 21541175 | 21541176 | Human |
406907198 | GWAS556174_H | Tendinopathy QTL GWAS556174 (human) | | 0.0000002 | Tendinopathy | | 10 | 28175021 | 28175022 | Human |
407071170 | GWAS720146_H | urinary albumin to creatinine ratio QTL GWAS720146 (human) | | 4e-08 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 10 | 21862649 | 21862650 | Human |
597115413 | GWAS1211487_H | coronary artery disease QTL GWAS1211487 (human) | | 0.000006 | coronary artery disease | | 10 | 19168458 | 19168459 | Human |
597058068 | GWAS1154142_H | eosinophil count QTL GWAS1154142 (human) | | 5e-21 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44364170 | 44364171 | Human |
597230106 | GWAS1326180_H | mortality QTL GWAS1326180 (human) | | 0.0000008 | mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 29793048 | 29793049 | Human |
597266972 | GWAS1363046_H | cortical thickness QTL GWAS1363046 (human) | | 2e-08 | cortical thickness | | 10 | 33972018 | 33972019 | Human |
597058067 | GWAS1154141_H | eosinophil count QTL GWAS1154141 (human) | | 7e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 35071692 | 35071693 | Human |
597361181 | GWAS1457255_H | multiple sclerosis QTL GWAS1457255 (human) | | 1e-11 | multiple sclerosis | | 10 | 31101198 | 31101199 | Human |
597582361 | GWAS1639221_H | diastolic blood pressure QTL GWAS1639221 (human) | | 1e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18444352 | 18444353 | Human |
597316114 | GWAS1412188_H | diastolic blood pressure QTL GWAS1412188 (human) | | 4e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18438972 | 18438973 | Human |
406919628 | GWAS568604_H | diastolic blood pressure QTL GWAS568604 (human) | | 3e-12 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 30046591 | 30046592 | Human |
597385748 | GWAS1481822_H | cortical thickness, neuroimaging measurement QTL GWAS1481822 (human) | | 1e-08 | cortical thickness, neuroimaging measurement | | 10 | 30834006 | 30834007 | Human |
597164556 | GWAS1260630_H | gut microbiome measurement QTL GWAS1260630 (human) | | 7e-09 | gut microbiome measurement | | 10 | 36705503 | 36705504 | Human |
597037571 | GWAS1133645_H | pulse pressure measurement, alcohol drinking QTL GWAS1133645 (human) | | 2e-15 | pulse pressure measurement, alcohol drinking | pulse pressure (CMO:0000292) | 10 | 30046591 | 30046592 | Human |
597172736 | GWAS1268810_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1268810 (human) | | 1e-198 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42859493 | 42859494 | Human |
597127694 | GWAS1223768_H | eosinophilic esophagitis QTL GWAS1223768 (human) | | 4e-08 | eosinophilic esophagitis | | 10 | 35530442 | 35530443 | Human |
597021199 | GWAS1117273_H | Crohn's disease QTL GWAS1117273 (human) | | 4e-14 | intestine integrity trait (VT:0010554) | | 10 | 35177257 | 35177258 | Human |
597504514 | GWAS1600588_H | chronic obstructive pulmonary disease QTL GWAS1600588 (human) | | 2e-10 | lung integrity trait (VT:0010906) | | 10 | 32380191 | 32380192 | Human |
597029429 | GWAS1125503_H | body mass index QTL GWAS1125503 (human) | | 2e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33724579 | 33724580 | Human |
407226849 | GWAS875825_H | asthma, response to diisocyanate QTL GWAS875825 (human) | | 0.000002 | asthma, response to diisocyanate | | 10 | 27728643 | 27728644 | Human |
597205565 | GWAS1301639_H | frontal fibrosing alopecia QTL GWAS1301639 (human) | | 0.000003 | frontal fibrosing alopecia | | 10 | 24287330 | 24287331 | Human |
597246524 | GWAS1342598_H | central corneal thickness QTL GWAS1342598 (human) | | 3e-13 | central corneal thickness | | 10 | 43147362 | 43147363 | Human |
596976178 | GWAS1095697_H | body height QTL GWAS1095697 (human) | | 7e-09 | body height | | 10 | 34347892 | 34347893 | Human |
596967997 | GWAS1087516_H | prostate specific antigen amount QTL GWAS1087516 (human) | | 4e-11 | prostate specific antigen amount | | 10 | 23109519 | 23109520 | Human |
596967996 | GWAS1087515_H | prostate specific antigen amount QTL GWAS1087515 (human) | | 6e-20 | prostate specific antigen amount | | 10 | 22075050 | 22075051 | Human |
597602868 | GWAS1659728_H | type 2 diabetes mellitus QTL GWAS1659728 (human) | | 4e-08 | type 2 diabetes mellitus | | 10 | 33711784 | 33711785 | Human |
596967998 | GWAS1087517_H | prostate specific antigen amount QTL GWAS1087517 (human) | | 5e-15 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
597602869 | GWAS1659729_H | type 2 diabetes mellitus QTL GWAS1659729 (human) | | 2e-08 | type 2 diabetes mellitus | | 10 | 43547906 | 43547907 | Human |
597602867 | GWAS1659727_H | type 2 diabetes mellitus QTL GWAS1659727 (human) | | 1e-10 | type 2 diabetes mellitus | | 10 | 28914138 | 28914139 | Human |
407046636 | GWAS695612_H | physical activity QTL GWAS695612 (human) | | 0.000009 | physical activity | | 10 | 22558510 | 22558511 | Human |
597291563 | GWAS1387637_H | hypertension QTL GWAS1387637 (human) | | 5e-13 | hypertension | | 10 | 18439030 | 18439031 | Human |
596980263 | GWAS1099782_H | memory performance, sex interaction measurement QTL GWAS1099782 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 21125372 | 21125373 | Human |
407103993 | GWAS752969_H | FEV/FVC ratio QTL GWAS752969 (human) | | 8e-12 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 34191654 | 34191655 | Human |
596980267 | GWAS1099786_H | memory performance, sex interaction measurement QTL GWAS1099786 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 21129834 | 21129835 | Human |
597271079 | GWAS1367153_H | taste liking measurement QTL GWAS1367153 (human) | | 3e-11 | taste liking measurement | | 10 | 21516537 | 21516538 | Human |
597582369 | GWAS1639229_H | diastolic blood pressure QTL GWAS1639229 (human) | | 4e-29 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
597394011 | GWAS1490085_H | response to antidepressant QTL GWAS1490085 (human) | | 0.0000003 | response to antidepressant | | 10 | 38203832 | 38203833 | Human |
597320283 | GWAS1416357_H | otosclerosis QTL GWAS1416357 (human) | | 1e-15 | otosclerosis | | 10 | 30775253 | 30775254 | Human |
597394010 | GWAS1490084_H | response to antidepressant QTL GWAS1490084 (human) | | 2e-08 | response to antidepressant | | 10 | 38099649 | 38099650 | Human |
597369433 | GWAS1465507_H | parental longevity QTL GWAS1465507 (human) | | 0.000005 | total life span (VT:0001661) | | 10 | 21494705 | 21494706 | Human |
597168730 | GWAS1264804_H | alkaline phosphatase measurement QTL GWAS1264804 (human) | | 2e-08 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 22628520 | 22628521 | Human |
596963926 | GWAS1083445_H | major depressive disorder QTL GWAS1083445 (human) | | 0.000007 | major depressive disorder | | 10 | 29002969 | 29002970 | Human |
597439071 | GWAS1535145_H | suntan QTL GWAS1535145 (human) | | 0.000001 | suntan | | 10 | 23876027 | 23876028 | Human |
597168731 | GWAS1264805_H | alkaline phosphatase measurement QTL GWAS1264805 (human) | | 6e-19 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 25937989 | 25937990 | Human |
597242460 | GWAS1338534_H | retinal vasculature measurement QTL GWAS1338534 (human) | | 0.000008 | retina blood vessel morphology trait (VT:0002792) | | 10 | 32260293 | 32260294 | Human |
597492315 | GWAS1588389_H | osteoarthritis QTL GWAS1588389 (human) | | 0.0000001 | osteoarthritis | | 10 | 30692340 | 30692341 | Human |
597176912 | GWAS1272986_H | urate measurement QTL GWAS1272986 (human) | | 2e-08 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 19525115 | 19525116 | Human |
597095007 | GWAS1191081_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1191081 (human) | | 0.0000007 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 10 | 22089029 | 22089030 | Human |
596959839 | GWAS1079358_H | glomerular filtration rate QTL GWAS1079358 (human) | | 2e-09 | glomerular filtration rate | | 10 | 24637254 | 24637255 | Human |
597324373 | GWAS1420447_H | leucine measurement QTL GWAS1420447 (human) | | 3e-09 | leucine measurement | blood amino acid measurement (CMO:0003730) | 10 | 19625967 | 19625968 | Human |
406952334 | GWAS601310_H | parental longevity QTL GWAS601310 (human) | | 0.0000007 | total life span (VT:0001661) | | 10 | 33327109 | 33327110 | Human |
597107270 | GWAS1203344_H | reticulocyte count QTL GWAS1203344 (human) | | 3e-09 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 33200264 | 33200265 | Human |
597176906 | GWAS1272980_H | uridine diphosphate measurement QTL GWAS1272980 (human) | | 3e-08 | uridine diphosphate measurement | | 10 | 43618526 | 43618527 | Human |
597176909 | GWAS1272983_H | uridine diphosphate measurement QTL GWAS1272983 (human) | | 5e-08 | uridine diphosphate measurement | | 10 | 27378432 | 27378433 | Human |
597500484 | GWAS1596558_H | body mass index QTL GWAS1596558 (human) | | 1e-26 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532345 | 21532346 | Human |
597439045 | GWAS1535119_H | BMI-adjusted hip circumference QTL GWAS1535119 (human) | | 0.000004 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 27574960 | 27574961 | Human |
596963919 | GWAS1083438_H | major depressive disorder QTL GWAS1083438 (human) | | 0.000007 | major depressive disorder | | 10 | 33968684 | 33968685 | Human |
597340742 | GWAS1436816_H | systolic blood pressure QTL GWAS1436816 (human) | | 4e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 21709516 | 21709517 | Human |
596976245 | GWAS1095764_H | Crohn's disease QTL GWAS1095764 (human) | | 2e-09 | Crohn's disease | | 10 | 30410871 | 30410872 | Human |
597086839 | GWAS1182913_H | lymphocyte count QTL GWAS1182913 (human) | | 4e-21 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26445589 | 26445590 | Human |
596976246 | GWAS1095765_H | Crohn's disease QTL GWAS1095765 (human) | | 2e-21 | Crohn's disease | | 10 | 35241532 | 35241533 | Human |
597086842 | GWAS1182916_H | lymphocyte count QTL GWAS1182916 (human) | | 7e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26503215 | 26503216 | Human |
597135995 | GWAS1232069_H | fibromuscular dysplasia QTL GWAS1232069 (human) | | 0.0000008 | fibromuscular dysplasia | | 10 | 29703755 | 29703756 | Human |
597267060 | GWAS1363134_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1363134 (human) | | 7e-16 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 43108144 | 43108145 | Human |
406931887 | GWAS580863_H | pulse pressure measurement QTL GWAS580863 (human) | | 3e-44 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 42601433 | 42601434 | Human |
596955771 | GWAS1075290_H | dizziness QTL GWAS1075290 (human) | | 4e-08 | dizziness | | 10 | 21540233 | 21540234 | Human |
597361268 | GWAS1457342_H | granulocyte count QTL GWAS1457342 (human) | | 2e-23 | granulocyte quantity (VT:0000334) | blood granulocyte count (CMO:0000111) | 10 | 28491444 | 28491445 | Human |
597054054 | GWAS1150128_H | white matter microstructure measurement QTL GWAS1150128 (human) | | 3e-09 | white matter microstructure measurement | | 10 | 21583984 | 21583985 | Human |
407153077 | GWAS802053_H | heel bone mineral density QTL GWAS802053 (human) | | 1e-27 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20090449 | 20090450 | Human |
407153078 | GWAS802054_H | heel bone mineral density QTL GWAS802054 (human) | | 8e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27923936 | 27923937 | Human |
597115493 | GWAS1211567_H | electroencephalogram measurement QTL GWAS1211567 (human) | | 0.000008 | electroencephalogram measurement | brain activity measurement (CMO:0001737) | 10 | 37392145 | 37392146 | Human |
597148260 | GWAS1244334_H | high density lipoprotein cholesterol measurement QTL GWAS1244334 (human) | | 4e-09 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 21501547 | 21501548 | Human |
597045869 | GWAS1141943_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1141943 (human) | | 0.0000002 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 10 | 25793104 | 25793105 | Human |
597086826 | GWAS1182900_H | lymphocyte count QTL GWAS1182900 (human) | | 4e-09 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44392682 | 44392683 | Human |
597086824 | GWAS1182898_H | lymphocyte count QTL GWAS1182898 (human) | | 3e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 30203338 | 30203339 | Human |
597086825 | GWAS1182899_H | lymphocyte count QTL GWAS1182899 (human) | | 1e-47 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24929314 | 24929315 | Human |
597287526 | GWAS1383600_H | BMI-adjusted hip circumference QTL GWAS1383600 (human) | | 5e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 29154014 | 29154015 | Human |
406952382 | GWAS601358_H | parental longevity QTL GWAS601358 (human) | | 0.000007 | total life span (VT:0001661) | | 10 | 33185823 | 33185824 | Human |
407144891 | GWAS793867_H | schizophrenia QTL GWAS793867 (human) | | 0.000003 | schizophrenia | | 10 | 44331749 | 44331750 | Human |
597119381 | GWAS1215455_H | blood protein measurement QTL GWAS1215455 (human) | | 2e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19931917 | 19931918 | Human |
597619098 | GWAS1675958_H | body weight QTL GWAS1675958 (human) | | 2e-12 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 21508343 | 21508344 | Human |
597332380 | GWAS1428454_H | S-6-hydroxywarfarin measurement QTL GWAS1428454 (human) | | 0.000003 | S-6-hydroxywarfarin measurement | | 10 | 20992809 | 20992810 | Human |
596988307 | GWAS1107826_H | memory performance, sex interaction measurement QTL GWAS1107826 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 27036882 | 27036883 | Human |
597594520 | GWAS1651380_H | drug use measurement, myocardial infarction QTL GWAS1651380 (human) | | 2e-19 | drug use measurement, myocardial infarction | | 10 | 44247523 | 44247524 | Human |
597172626 | GWAS1268700_H | luminal B breast carcinoma, HER2 negative breast carcinoma, triple-negative breast cancer QTL GWAS1268700 (human) | | 2e-08 | luminal B breast carcinoma, HER2 negative breast carcinoma, triple-negative breast cancer | | 10 | 21643008 | 21643009 | Human |
597336464 | GWAS1432538_H | atrial fibrillation QTL GWAS1432538 (human) | | 1e-09 | atrial fibrillation | | 10 | 32483806 | 32483807 | Human |
407009874 | GWAS658850_H | gout, hyperuricemia QTL GWAS658850 (human) | | 0.000004 | gout, hyperuricemia | | 10 | 19534538 | 19534539 | Human |
597102983 | GWAS1199057_H | platelet crit QTL GWAS1199057 (human) | | 3e-21 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 27188019 | 27188020 | Human |
597021061 | GWAS1117135_H | inflammatory bowel disease QTL GWAS1117135 (human) | | 3e-12 | inflammatory bowel disease | | 10 | 30439172 | 30439173 | Human |
597102982 | GWAS1199056_H | platelet crit QTL GWAS1199056 (human) | | 6e-36 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 24934438 | 24934439 | Human |
597041540 | GWAS1137614_H | appendicular lean mass QTL GWAS1137614 (human) | | 5e-11 | appendicular lean mass | | 10 | 24767189 | 24767190 | Human |
597021063 | GWAS1117137_H | inflammatory bowel disease QTL GWAS1117137 (human) | | 6e-12 | inflammatory bowel disease | | 10 | 35177257 | 35177258 | Human |
597053829 | GWAS1149903_H | smoking status measurement QTL GWAS1149903 (human) | | 3e-08 | smoking status measurement | | 10 | 21605099 | 21605100 | Human |
597590410 | GWAS1647270_H | hypopituitarism QTL GWAS1647270 (human) | | 4e-11 | hypopituitarism | | 10 | 30681365 | 30681366 | Human |
597119362 | GWAS1215436_H | blood protein measurement QTL GWAS1215436 (human) | | 2e-25 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 33201235 | 33201236 | Human |
597410179 | GWAS1506253_H | BMI-adjusted waist-hip ratio QTL GWAS1506253 (human) | | 1e-11 | body size trait (VT:0100005) | | 10 | 27615392 | 27615393 | Human |
596959628 | GWAS1079147_H | glomerular filtration rate QTL GWAS1079147 (human) | | 0.0000006 | glomerular filtration rate | | 10 | 43519331 | 43519332 | Human |
597410178 | GWAS1506252_H | BMI-adjusted waist-hip ratio QTL GWAS1506252 (human) | | 9e-09 | body size trait (VT:0100005) | | 10 | 33172320 | 33172321 | Human |
596959624 | GWAS1079143_H | glomerular filtration rate QTL GWAS1079143 (human) | | 6e-08 | glomerular filtration rate | | 10 | 23581892 | 23581893 | Human |
596959625 | GWAS1079144_H | glomerular filtration rate QTL GWAS1079144 (human) | | 0.0000003 | glomerular filtration rate | | 10 | 24637254 | 24637255 | Human |
596959626 | GWAS1079145_H | glomerular filtration rate QTL GWAS1079145 (human) | | 3e-09 | glomerular filtration rate | | 10 | 28590311 | 28590312 | Human |
597410181 | GWAS1506255_H | BMI-adjusted waist-hip ratio QTL GWAS1506255 (human) | | 7e-16 | body size trait (VT:0100005) | | 10 | 33877770 | 33877771 | Human |
597102985 | GWAS1199059_H | platelet crit QTL GWAS1199059 (human) | | 6e-14 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 43487136 | 43487137 | Human |
597361028 | GWAS1457102_H | susceptibility to childhood ear infection measurement QTL GWAS1457102 (human) | | 5e-16 | response to infection trait (VT:0010434) | | 10 | 27611953 | 27611954 | Human |
597102984 | GWAS1199058_H | platelet crit QTL GWAS1199058 (human) | | 6e-11 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 30218259 | 30218260 | Human |
596959627 | GWAS1079146_H | glomerular filtration rate QTL GWAS1079146 (human) | | 3e-09 | glomerular filtration rate | | 10 | 34771413 | 34771414 | Human |
597295546 | GWAS1391620_H | ubiquinone measurement QTL GWAS1391620 (human) | | 2e-18 | ubiquinone measurement | | 10 | 26703306 | 26703307 | Human |
597389755 | GWAS1485829_H | Corneal astigmatism QTL GWAS1485829 (human) | | 0.0000003 | Corneal astigmatism | | 10 | 44254406 | 44254407 | Human |
597139894 | GWAS1235968_H | smoking initiation QTL GWAS1235968 (human) | | 1e-10 | smoking initiation | | 10 | 27113486 | 27113487 | Human |
597139893 | GWAS1235967_H | smoking initiation QTL GWAS1235967 (human) | | 1e-09 | smoking initiation | | 10 | 26755823 | 26755824 | Human |
597139892 | GWAS1235966_H | smoking initiation QTL GWAS1235966 (human) | | 3e-43 | smoking initiation | | 10 | 21852513 | 21852514 | Human |
597139891 | GWAS1235965_H | smoking initiation QTL GWAS1235965 (human) | | 9e-11 | smoking initiation | | 10 | 21714347 | 21714348 | Human |
597139890 | GWAS1235964_H | smoking initiation QTL GWAS1235964 (human) | | 2e-15 | smoking initiation | | 10 | 20882111 | 20882112 | Human |
597164478 | GWAS1260552_H | type 2 diabetes mellitus QTL GWAS1260552 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 23289248 | 23289249 | Human |
597377468 | GWAS1473542_H | lymphocyte count QTL GWAS1473542 (human) | | 8e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44363420 | 44363421 | Human |
597041599 | GWAS1137673_H | appendicular lean mass QTL GWAS1137673 (human) | | 2e-08 | appendicular lean mass | | 10 | 27621902 | 27621903 | Human |
407251562 | GWAS900538_H | mean corpuscular hemoglobin concentration QTL GWAS900538 (human) | | 8e-23 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24569461 | 24569462 | Human |
597176757 | GWAS1272831_H | obstructive sleep apnea QTL GWAS1272831 (human) | | 4e-08 | obstructive sleep apnea | | 10 | 33179086 | 33179087 | Human |
597021093 | GWAS1117167_H | Crohn's disease QTL GWAS1117167 (human) | | 5e-10 | intestine integrity trait (VT:0010554) | | 10 | 30439172 | 30439173 | Human |
597062052 | GWAS1158126_H | squamous cell lung carcinoma QTL GWAS1158126 (human) | | 0.000002 | squamous cell lung carcinoma | | 10 | 27156276 | 27156277 | Human |
597225900 | GWAS1321974_H | smoking status measurement QTL GWAS1321974 (human) | | 3e-18 | smoking status measurement | | 10 | 21744013 | 21744014 | Human |
597115346 | GWAS1211420_H | DNA methylation QTL GWAS1211420 (human) | | 5e-09 | DNA methylation | | 10 | 33973918 | 33973919 | Human |
597086675 | GWAS1182749_H | type 2 diabetes mellitus QTL GWAS1182749 (human) | | 6e-10 | type 2 diabetes mellitus | | 10 | 43531908 | 43531909 | Human |
597107152 | GWAS1203226_H | cortex volume change measurement QTL GWAS1203226 (human) | | 0.000007 | cortex volume change measurement | | 10 | 29260469 | 29260470 | Human |
597410257 | GWAS1506331_H | metabolic syndrome QTL GWAS1506331 (human) | | 3e-16 | metabolic syndrome | | 10 | 33681003 | 33681004 | Human |
597115356 | GWAS1211430_H | DNA methylation QTL GWAS1211430 (human) | | 4e-08 | DNA methylation | | 10 | 33967875 | 33967876 | Human |
597594576 | GWAS1651436_H | myocardial infarction QTL GWAS1651436 (human) | | 1e-20 | myocardial infarction | | 10 | 44247523 | 44247524 | Human |
597144007 | GWAS1240081_H | chronic obstructive pulmonary disease QTL GWAS1240081 (human) | | 5e-11 | lung integrity trait (VT:0010906) | | 10 | 20921794 | 20921795 | Human |
597606863 | GWAS1663723_H | Red cell distribution width QTL GWAS1663723 (human) | | 4e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 21531721 | 21531722 | Human |
597152196 | GWAS1248270_H | urate measurement, diet measurement QTL GWAS1248270 (human) | | 0.000002 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 24431515 | 24431516 | Human |
597606854 | GWAS1663714_H | Red cell distribution width QTL GWAS1663714 (human) | | 2e-117 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597447110 | GWAS1543184_H | BMI-adjusted waist circumference QTL GWAS1543184 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 27586077 | 27586078 | Human |
597213636 | GWAS1309710_H | gallstones QTL GWAS1309710 (human) | | 4e-12 | gallstones | | 10 | 21560840 | 21560841 | Human |
597037514 | GWAS1133588_H | systemising measurement QTL GWAS1133588 (human) | | 0.0000007 | systemising measurement | | 10 | 30506819 | 30506820 | Human |
596984311 | GWAS1103830_H | memory performance QTL GWAS1103830 (human) | | 0.00001 | memory performance | | 10 | 19819940 | 19819941 | Human |
597365247 | GWAS1461321_H | heel bone mineral density QTL GWAS1461321 (human) | | 3e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28938443 | 28938444 | Human |
597488120 | GWAS1584194_H | body weight QTL GWAS1584194 (human) | | 2e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 33688921 | 33688922 | Human |
597365246 | GWAS1461320_H | heel bone mineral density QTL GWAS1461320 (human) | | 3e-21 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28802794 | 28802795 | Human |
597365245 | GWAS1461319_H | heel bone mineral density QTL GWAS1461319 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27751894 | 27751895 | Human |
597365244 | GWAS1461318_H | heel bone mineral density QTL GWAS1461318 (human) | | 1e-41 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27593896 | 27593897 | Human |
597037564 | GWAS1133638_H | lung adenocarcinoma, family history of lung cancer QTL GWAS1133638 (human) | | 0.000003 | lung adenocarcinoma, family history of lung cancer | | 10 | 19065315 | 19065316 | Human |
597488119 | GWAS1584193_H | body weight QTL GWAS1584193 (human) | | 4e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 23752388 | 23752389 | Human |
407132712 | GWAS781688_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS781688 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 10 | 30402574 | 30402575 | Human |
597033467 | GWAS1129541_H | lean body mass QTL GWAS1129541 (human) | | 3e-12 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 24889935 | 24889936 | Human |
597402090 | GWAS1498164_H | gas trapping measurement QTL GWAS1498164 (human) | | 0.000001 | gas trapping measurement | abdominal fat pad weight to body weight ratio (CMO:0000095) | 10 | 28688081 | 28688082 | Human |
597357035 | GWAS1453109_H | rheumatoid arthritis QTL GWAS1453109 (human) | | 0.0000006 | rheumatoid arthritis | | 10 | 31126177 | 31126178 | Human |
597185005 | GWAS1281079_H | forced expiratory volume QTL GWAS1281079 (human) | | 1e-09 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 10 | 31839683 | 31839684 | Human |
597455338 | GWAS1551412_H | cardiac troponin I measurement QTL GWAS1551412 (human) | | 0.000008 | cardiac troponin I measurement | blood troponin level (CMO:0001283) | 10 | 33557169 | 33557170 | Human |
597369324 | GWAS1465398_H | disease progression measurement, Crohn's disease QTL GWAS1465398 (human) | | 0.000002 | intestine integrity trait (VT:0010554) | disease progression measurement (CMO:0001110) | 10 | 33378350 | 33378351 | Human |
597488107 | GWAS1584181_H | inflammatory bowel disease QTL GWAS1584181 (human) | | 8e-24 | inflammatory bowel disease | | 10 | 35241532 | 35241533 | Human |
596984302 | GWAS1103821_H | memory performance QTL GWAS1103821 (human) | | 0.000008 | memory performance | | 10 | 19810364 | 19810365 | Human |
407099966 | GWAS748942_H | obsolete_prostate specific antigen measurement QTL GWAS748942 (human) | | 6e-20 | obsolete_prostate specific antigen measurement | | 10 | 22075050 | 22075051 | Human |
597316071 | GWAS1412145_H | facial morphology QTL GWAS1412145 (human) | | 0.000009 | facial morphology trait (VT:0003743) | | 10 | 26289015 | 26289016 | Human |
596984298 | GWAS1103817_H | memory performance QTL GWAS1103817 (human) | | 0.000006 | memory performance | | 10 | 19806476 | 19806477 | Human |
597279001 | GWAS1375075_H | eosinophil count QTL GWAS1375075 (human) | | 2e-33 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26447219 | 26447220 | Human |
597279000 | GWAS1375074_H | eosinophil count QTL GWAS1375074 (human) | | 2e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24911876 | 24911877 | Human |
597279002 | GWAS1375076_H | eosinophil count QTL GWAS1375076 (human) | | 1e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 35207540 | 35207541 | Human |
597332254 | GWAS1428328_H | R-warfarin measurement QTL GWAS1428328 (human) | | 0.000007 | R-warfarin measurement | | 10 | 35195598 | 35195599 | Human |
597504280 | GWAS1600354_H | rheumatoid arthritis QTL GWAS1600354 (human) | | 2e-11 | rheumatoid arthritis | | 10 | 31097045 | 31097046 | Human |
597496088 | GWAS1592162_H | smoking initiation QTL GWAS1592162 (human) | | 5e-09 | smoking initiation | | 10 | 35645386 | 35645387 | Human |
597098768 | GWAS1194842_H | diverticular disease QTL GWAS1194842 (human) | | 0.0000004 | diverticular disease | | 10 | 24431559 | 24431560 | Human |
597586198 | GWAS1643058_H | eosinophil count QTL GWAS1643058 (human) | | 2e-31 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26452245 | 26452246 | Human |
597430549 | GWAS1526623_H | protein measurement QTL GWAS1526623 (human) | | 6e-12 | protein measurement | | 10 | 33197739 | 33197740 | Human |
596979999 | GWAS1099518_H | memory performance, sex interaction measurement QTL GWAS1099518 (human) | | 0.000005 | memory performance, sex interaction measurement | | 10 | 21124227 | 21124228 | Human |
406964939 | GWAS613915_H | reticulocyte count QTL GWAS613915 (human) | | 2e-163 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24913109 | 24913110 | Human |
597274898 | GWAS1370972_H | systolic blood pressure QTL GWAS1370972 (human) | | 3e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27941657 | 27941658 | Human |
597029150 | GWAS1125224_H | BMI-adjusted waist-hip ratio QTL GWAS1125224 (human) | | 6e-18 | body size trait (VT:0100005) | | 10 | 32268664 | 32268665 | Human |
597164311 | GWAS1260385_H | cleft lip QTL GWAS1260385 (human) | | 0.0000002 | cleft lip | | 10 | 22543130 | 22543131 | Human |
597029146 | GWAS1125220_H | Red cell distribution width QTL GWAS1125220 (human) | | 4e-62 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
407222986 | GWAS871962_H | triacylglycerol 52:2 measurement QTL GWAS871962 (human) | | 0.000001 | blood triglyceride amount (VT:0002644) | | 10 | 37395636 | 37395637 | Human |
597438732 | GWAS1534806_H | systemic lupus erythematosus QTL GWAS1534806 (human) | | 0.0000002 | systemic lupus erythematosus | | 10 | 22960180 | 22960181 | Human |
597483790 | GWAS1579864_H | mean fractional anisotropy measurement QTL GWAS1579864 (human) | | 3e-09 | mean fractional anisotropy measurement | | 10 | 21531722 | 21531723 | Human |
597262603 | GWAS1358677_H | asthma QTL GWAS1358677 (human) | | 2e-08 | asthma | | 10 | 43254252 | 43254253 | Human |
597229838 | GWAS1325912_H | vestibular neuronitis QTL GWAS1325912 (human) | | 1e-09 | vestibular neuronitis | | 10 | 37047661 | 37047662 | Human |
597479686 | GWAS1575760_H | heel bone mineral density QTL GWAS1575760 (human) | | 6e-44 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27587468 | 27587469 | Human |
406919898 | GWAS568874_H | neutrophil count QTL GWAS568874 (human) | | 0.000007 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 20385724 | 20385725 | Human |
597582082 | GWAS1638942_H | systolic blood pressure QTL GWAS1638942 (human) | | 2e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
597049610 | GWAS1145684_H | Red cell distribution width QTL GWAS1145684 (human) | | 1e-24 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24911662 | 24911663 | Human |
597029128 | GWAS1125202_H | sensory perception of sweet taste QTL GWAS1125202 (human) | | 0.000008 | sensory perception of sweet taste | | 10 | 24886694 | 24886695 | Human |
597049611 | GWAS1145685_H | Red cell distribution width QTL GWAS1145685 (human) | | 2e-09 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 25497603 | 25497604 | Human |
597049609 | GWAS1145683_H | Red cell distribution width QTL GWAS1145683 (human) | | 5e-215 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
406973153 | GWAS622129_H | bone mineral content measurement QTL GWAS622129 (human) | | 0.000005 | bone mineral content measurement | | 10 | 42860192 | 42860193 | Human |
597250360 | GWAS1346434_H | corneal resistance factor QTL GWAS1346434 (human) | | 6e-18 | corneal resistance factor | | 10 | 25531061 | 25531062 | Human |
597172537 | GWAS1268611_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1268611 (human) | | 2e-16 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 38818193 | 38818194 | Human |
597172538 | GWAS1268612_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1268612 (human) | | 2e-15 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 38479819 | 38479820 | Human |
597180731 | GWAS1276805_H | guanylyl cyclase-activating protein 1 measurement QTL GWAS1276805 (human) | | 7e-16 | guanylyl cyclase-activating protein 1 measurement | | 10 | 19931917 | 19931918 | Human |
597274940 | GWAS1371014_H | docosahexaenoic acid measurement QTL GWAS1371014 (human) | | 2e-08 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 21962451 | 21962452 | Human |
597451065 | GWAS1547139_H | Rubella virus seropositivity QTL GWAS1547139 (human) | | 3e-08 | Rubella virus seropositivity | | 10 | 24094319 | 24094320 | Human |
407124707 | GWAS773683_H | amino acid measurement QTL GWAS773683 (human) | | 0.000008 | amino acid measurement | | 10 | 27862006 | 27862007 | Human |
597107006 | GWAS1203080_H | protein measurement QTL GWAS1203080 (human) | | 3e-09 | protein measurement | | 10 | 19931461 | 19931462 | Human |
597074236 | GWAS1170310_H | major depressive disorder QTL GWAS1170310 (human) | | 0.000004 | major depressive disorder | | 10 | 43241126 | 43241127 | Human |
597332273 | GWAS1428347_H | S-6-hydroxywarfarin measurement QTL GWAS1428347 (human) | | 0.000002 | S-6-hydroxywarfarin measurement | | 10 | 43096346 | 43096347 | Human |
597332276 | GWAS1428350_H | S-6-hydroxywarfarin measurement QTL GWAS1428350 (human) | | 0.0000004 | S-6-hydroxywarfarin measurement | | 10 | 20506384 | 20506385 | Human |
597393716 | GWAS1489790_H | eosinophil count QTL GWAS1489790 (human) | | 1e-48 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491364 | 28491365 | Human |
597295402 | GWAS1391476_H | mean arterial pressure QTL GWAS1391476 (human) | | 1e-33 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 18439030 | 18439031 | Human |
597594412 | GWAS1651272_H | body mass index QTL GWAS1651272 (human) | | 2e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532345 | 21532346 | Human |
407059189 | GWAS708165_H | central corneal thickness QTL GWAS708165 (human) | | 1e-08 | central corneal thickness | | 10 | 25514095 | 25514096 | Human |
406964982 | GWAS613958_H | fatty acid measurement QTL GWAS613958 (human) | | 0.000002 | fatty acid measurement | | 10 | 29047920 | 29047921 | Human |
597266722 | GWAS1362796_H | eosinophil count QTL GWAS1362796 (human) | | 4e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26434838 | 26434839 | Human |
597430567 | GWAS1526641_H | intestinal permeability measurement QTL GWAS1526641 (human) | | 0.0000007 | intestine integrity trait (VT:0010554) | | 10 | 29374485 | 29374486 | Human |
597610786 | GWAS1667646_H | neutrophil count QTL GWAS1667646 (human) | | 9e-22 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597266725 | GWAS1362799_H | eosinophil count QTL GWAS1362799 (human) | | 1e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28599911 | 28599912 | Human |
597061931 | GWAS1158005_H | small cell lung carcinoma QTL GWAS1158005 (human) | | 0.000001 | small cell lung carcinoma | | 10 | 33497992 | 33497993 | Human |
597184857 | GWAS1280931_H | X-24588 measurement QTL GWAS1280931 (human) | | 2e-14 | X-24588 measurement | | 10 | 26708996 | 26708997 | Human |
407382665 | GWAS1031641_H | non-alcoholic fatty liver disease QTL GWAS1031641 (human) | | 0.0000005 | non-alcoholic fatty liver disease | | 10 | 33972178 | 33972179 | Human |
597582172 | GWAS1639032_H | systolic blood pressure QTL GWAS1639032 (human) | | 3e-35 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
407382666 | GWAS1031642_H | non-alcoholic fatty liver disease QTL GWAS1031642 (human) | | 0.0000006 | non-alcoholic fatty liver disease | | 10 | 33972351 | 33972352 | Human |
597066066 | GWAS1162140_H | breast carcinoma QTL GWAS1162140 (human) | | 0.000003 | mammary gland integrity trait (VT:0010552) | | 10 | 27189769 | 27189770 | Human |
597360989 | GWAS1457063_H | neutrophil count, eosinophil count QTL GWAS1457063 (human) | | 5e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491444 | 28491445 | Human |
597274961 | GWAS1371035_H | mean arterial pressure, major depressive disorder QTL GWAS1371035 (human) | | 5e-12 | mean arterial pressure, major depressive disorder | mean arterial blood pressure (CMO:0000009) | 10 | 18436124 | 18436125 | Human |
597029215 | GWAS1125289_H | BMI-adjusted waist-hip ratio QTL GWAS1125289 (human) | | 9e-08 | body size trait (VT:0100005) | | 10 | 33207055 | 33207056 | Human |
597348688 | GWAS1444762_H | coronary artery disease QTL GWAS1444762 (human) | | 2e-08 | coronary artery disease | | 10 | 44192332 | 44192333 | Human |
597582160 | GWAS1639020_H | diastolic blood pressure QTL GWAS1639020 (human) | | 1e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
597053766 | GWAS1149840_H | eosinophil count QTL GWAS1149840 (human) | | 2e-61 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26438525 | 26438526 | Human |
597053767 | GWAS1149841_H | eosinophil count QTL GWAS1149841 (human) | | 8e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 34988300 | 34988301 | Human |
597057860 | GWAS1153934_H | adolescent idiopathic scoliosis QTL GWAS1153934 (human) | | 5e-10 | adolescent idiopathic scoliosis | | 10 | 26745295 | 26745296 | Human |
597053765 | GWAS1149839_H | eosinophil count QTL GWAS1149839 (human) | | 8e-15 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24909758 | 24909759 | Human |
406891155 | GWAS540131_H | obesity QTL GWAS540131 (human) | | 0.0000009 | obesity | | 10 | 37693169 | 37693170 | Human |
407341715 | GWAS990691_H | renal carcinoma QTL GWAS990691 (human) | | 8e-10 | renal carcinoma | | 10 | 21619874 | 21619875 | Human |
597348686 | GWAS1444760_H | coronary artery disease QTL GWAS1444760 (human) | | 7e-09 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
597184845 | GWAS1280919_H | mitochondrial heteroplasmy measurement QTL GWAS1280919 (human) | | 5e-08 | mitochondrial heteroplasmy measurement | | 10 | 30299274 | 30299275 | Human |
597213518 | GWAS1309592_H | nicotine dependence symptom count, depressive symptom measurement QTL GWAS1309592 (human) | | 0.000004 | nicotine dependence symptom count, depressive symptom measurement | | 10 | 20286422 | 20286423 | Human |
597287246 | GWAS1383320_H | progression free survival, response to tyrosine kinase inhibitor QTL GWAS1383320 (human) | | 0.0000002 | progression free survival, response to tyrosine kinase inhibitor | survival measurement (CMO:0001021) | 10 | 19119730 | 19119731 | Human |
597066062 | GWAS1162136_H | breast carcinoma QTL GWAS1162136 (human) | | 1e-18 | mammary gland integrity trait (VT:0010552) | | 10 | 21545607 | 21545608 | Human |
597274945 | GWAS1371019_H | Alzheimer disease, polygenic risk score QTL GWAS1371019 (human) | | 4e-08 | Alzheimer disease, polygenic risk score | | 10 | 43126264 | 43126265 | Human |
597320003 | GWAS1416077_H | diastolic blood pressure, systolic blood pressure QTL GWAS1416077 (human) | | 8e-12 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 20225020 | 20225021 | Human |
596951373 | GWAS1070892_H | dementia QTL GWAS1070892 (human) | | 0.000003 | dementia | | 10 | 24406435 | 24406436 | Human |
597336384 | GWAS1432458_H | COVID-19 QTL GWAS1432458 (human) | | 0.000002 | COVID-19 | | 10 | 24869292 | 24869293 | Human |
597274946 | GWAS1371020_H | Alzheimer disease, polygenic risk score QTL GWAS1371020 (human) | | 3e-14 | Alzheimer disease, polygenic risk score | | 10 | 42857446 | 42857447 | Human |
597389639 | GWAS1485713_H | appendicular lean mass QTL GWAS1485713 (human) | | 8e-10 | appendicular lean mass | | 10 | 24570081 | 24570082 | Human |
597274948 | GWAS1371022_H | Alzheimer disease, polygenic risk score QTL GWAS1371022 (human) | | 7e-10 | Alzheimer disease, polygenic risk score | | 10 | 27671603 | 27671604 | Human |
597168453 | GWAS1264527_H | myocardial infarction QTL GWAS1264527 (human) | | 3e-08 | myocardial infarction | | 10 | 43985246 | 43985247 | Human |
597295428 | GWAS1391502_H | hematocrit QTL GWAS1391502 (human) | | 3e-08 | hematocrit | hematocrit (CMO:0000037) | 10 | 30038463 | 30038464 | Human |
597053768 | GWAS1149842_H | eosinophil count QTL GWAS1149842 (human) | | 2e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44364170 | 44364171 | Human |
597295482 | GWAS1391556_H | lymphocyte count QTL GWAS1391556 (human) | | 2e-35 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24931570 | 24931571 | Human |
597455228 | GWAS1551302_H | size QTL GWAS1551302 (human) | | 3e-10 | size | | 10 | 29202396 | 29202397 | Human |
597119351 | GWAS1215425_H | blood protein measurement QTL GWAS1215425 (human) | | 4e-40 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 33202258 | 33202259 | Human |
597467516 | GWAS1563590_H | blood protein measurement QTL GWAS1563590 (human) | | 0.000001 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 44288099 | 44288100 | Human |
597295483 | GWAS1391557_H | lymphocyte count QTL GWAS1391557 (human) | | 5e-14 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26439659 | 26439662 | Human |
597057904 | GWAS1153978_H | adolescent idiopathic scoliosis QTL GWAS1153978 (human) | | 1e-08 | adolescent idiopathic scoliosis | | 10 | 20701893 | 20701894 | Human |
597295484 | GWAS1391558_H | lymphocyte count QTL GWAS1391558 (human) | | 9e-16 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44382666 | 44382667 | Human |
597057905 | GWAS1153979_H | adolescent idiopathic scoliosis QTL GWAS1153979 (human) | | 2e-08 | adolescent idiopathic scoliosis | | 10 | 26732699 | 26732700 | Human |
597414258 | GWAS1510332_H | Abnormality of refraction QTL GWAS1510332 (human) | | 1e-08 | Abnormality of refraction | | 10 | 27584096 | 27584097 | Human |
407169709 | GWAS818685_H | FEV/FVC ratio QTL GWAS818685 (human) | | 8e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 29978881 | 29978882 | Human |
597414257 | GWAS1510331_H | Abnormality of refraction QTL GWAS1510331 (human) | | 5e-09 | Abnormality of refraction | | 10 | 21270955 | 21270956 | Human |
597066107 | GWAS1162181_H | breast carcinoma QTL GWAS1162181 (human) | | 5e-19 | mammary gland integrity trait (VT:0010552) | | 10 | 21863269 | 21863270 | Human |
597377396 | GWAS1473470_H | cholesteryl ester 20:5 measurement QTL GWAS1473470 (human) | | 0.0000009 | blood lipid amount (VT:0003949) | | 10 | 29997334 | 29997335 | Human |
597299562 | GWAS1395636_H | chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement QTL GWAS1395636 (human) | | 2e-12 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement | | 10 | 43148018 | 43148019 | Human |
406964912 | GWAS613888_H | neutrophil percentage of granulocytes QTL GWAS613888 (human) | | 5e-19 | neutrophil quantity (VT:0000222) | | 10 | 26447311 | 26447312 | Human |
597070183 | GWAS1166257_H | mosquito bite reaction size measurement QTL GWAS1166257 (human) | | 0.000003 | mosquito bite reaction size measurement | | 10 | 30526710 | 30526711 | Human |
597057903 | GWAS1153977_H | adolescent idiopathic scoliosis QTL GWAS1153977 (human) | | 7e-09 | adolescent idiopathic scoliosis | | 10 | 30885574 | 30885575 | Human |
597041517 | GWAS1137591_H | appendicular lean mass QTL GWAS1137591 (human) | | 5e-08 | appendicular lean mass | | 10 | 43247640 | 43247641 | Human |
597270887 | GWAS1366961_H | pulse pressure measurement QTL GWAS1366961 (human) | | 7e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 18439030 | 18439031 | Human |
596988053 | GWAS1107572_H | memory performance, sex interaction measurement QTL GWAS1107572 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 27050657 | 27050658 | Human |
597463198 | GWAS1559272_H | multiple sclerosis QTL GWAS1559272 (human) | | 6e-12 | multiple sclerosis | | 10 | 31126177 | 31126178 | Human |
597164186 | GWAS1260260_H | phenylacetate measurement QTL GWAS1260260 (human) | | 0.000009 | phenylacetate measurement | | 10 | 33277951 | 33277952 | Human |
597512345 | GWAS1608419_H | white matter microstructure measurement QTL GWAS1608419 (human) | | 4e-14 | white matter microstructure measurement | | 10 | 21756168 | 21756169 | Human |
597196956 | GWAS1293030_H | lean body mass QTL GWAS1293030 (human) | | 1e-08 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 22546994 | 22546995 | Human |
597512344 | GWAS1608418_H | white matter microstructure measurement QTL GWAS1608418 (human) | | 7e-22 | white matter microstructure measurement | | 10 | 21531721 | 21531722 | Human |
407145281 | GWAS794257_H | triacylglycerol 54:8 measurement QTL GWAS794257 (human) | | 0.000003 | blood triglyceride amount (VT:0002644) | | 10 | 43513461 | 43513462 | Human |
597115025 | GWAS1211099_H | systolic blood pressure QTL GWAS1211099 (human) | | 5e-17 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27944540 | 27944541 | Human |
597336221 | GWAS1432295_H | COVID-19 QTL GWAS1432295 (human) | | 0.000009 | COVID-19 | | 10 | 19315428 | 19315429 | Human |
597172368 | GWAS1268442_H | poly(A) RNA polymerase, mitochondrial measurement QTL GWAS1268442 (human) | | 5e-28 | poly(A) RNA polymerase, mitochondrial measurement | | 10 | 30339549 | 30339550 | Human |
597332112 | GWAS1428186_H | R-warfarin measurement QTL GWAS1428186 (human) | | 0.000002 | R-warfarin measurement | | 10 | 27457734 | 27457735 | Human |
597340305 | GWAS1436379_H | pulse pressure measurement QTL GWAS1436379 (human) | | 0.000002 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 24380948 | 24380949 | Human |
597287058 | GWAS1383132_H | Crohn's disease QTL GWAS1383132 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 10 | 30410871 | 30410872 | Human |
597049476 | GWAS1145550_H | breast carcinoma QTL GWAS1145550 (human) | | 4e-18 | mammary gland integrity trait (VT:0010552) | | 10 | 22026914 | 22026915 | Human |
597315721 | GWAS1411795_H | diastolic blood pressure QTL GWAS1411795 (human) | | 3e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27956491 | 27956492 | Human |
597614728 | GWAS1671588_H | benign prostatic hyperplasia QTL GWAS1671588 (human) | | 5e-17 | prostate integrity trait (VT:0010571) | | 10 | 22138360 | 22138361 | Human |
596955279 | GWAS1074798_H | triglyceride change measurement, response to antipsychotic drug QTL GWAS1074798 (human) | | 2e-11 | triglyceride change measurement, response to antipsychotic drug | | 10 | 24421013 | 24421014 | Human |
597336250 | GWAS1432324_H | COVID-19 QTL GWAS1432324 (human) | | 0.000008 | COVID-19 | | 10 | 19385406 | 19385407 | Human |
597369018 | GWAS1465092_H | waist-hip ratio QTL GWAS1465092 (human) | | 4e-12 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 27615392 | 27615393 | Human |
597373114 | GWAS1469188_H | multiple sclerosis QTL GWAS1469188 (human) | | 0.000003 | multiple sclerosis | | 10 | 31126177 | 31126178 | Human |
407120743 | GWAS769719_H | eosinophil count QTL GWAS769719 (human) | | 5e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24909758 | 24909759 | Human |
597221563 | GWAS1317637_H | HbA1c measurement QTL GWAS1317637 (human) | | 0.0000005 | HbA1c measurement | blood hemoglobin A1c level (CMO:0002786) | 10 | 26216893 | 26216894 | Human |
406911845 | GWAS560821_H | obesity QTL GWAS560821 (human) | | 0.0000001 | obesity | | 10 | 23569282 | 23569283 | Human |
597049520 | GWAS1145594_H | hypertension QTL GWAS1145594 (human) | | 1e-21 | hypertension | | 10 | 18439030 | 18439031 | Human |
597106865 | GWAS1202939_H | remission, hepatitis C virus infection QTL GWAS1202939 (human) | | 0.000002 | remission, hepatitis C virus infection | | 10 | 25389364 | 25389365 | Human |
597106864 | GWAS1202938_H | remission, hepatitis C virus infection QTL GWAS1202938 (human) | | 0.0000002 | remission, hepatitis C virus infection | | 10 | 18819130 | 18819131 | Human |
597086398 | GWAS1182472_H | type 2 diabetes mellitus QTL GWAS1182472 (human) | | 5e-08 | type 2 diabetes mellitus | | 10 | 33729802 | 33729803 | Human |
597606583 | GWAS1663443_H | overnutrition, obesity QTL GWAS1663443 (human) | | 8e-13 | overnutrition, obesity | | 10 | 21532345 | 21532346 | Human |
597344438 | GWAS1440512_H | immature granulocyte measurement QTL GWAS1440512 (human) | | 2e-16 | immature granulocyte measurement | | 10 | 24922362 | 24922363 | Human |
407120744 | GWAS769720_H | eosinophil count QTL GWAS769720 (human) | | 3e-53 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26446058 | 26446059 | Human |
597143737 | GWAS1239811_H | posterior thigh muscle fat infiltration measurement QTL GWAS1239811 (human) | | 2e-26 | posterior thigh muscle fat infiltration measurement | | 10 | 36169963 | 36169964 | Human |
406985591 | GWAS634567_H | reticulocyte count QTL GWAS634567 (human) | | 1e-505 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24929314 | 24929315 | Human |
596983971 | GWAS1103490_H | memory performance QTL GWAS1103490 (human) | | 0.000007 | memory performance | | 10 | 19822223 | 19822224 | Human |
406985593 | GWAS634569_H | reticulocyte count QTL GWAS634569 (human) | | 2e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 26438753 | 26438754 | Human |
597217446 | GWAS1313520_H | pulse pressure measurement QTL GWAS1313520 (human) | | 2e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31816790 | 31816791 | Human |
597094568 | GWAS1190642_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1190642 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 32879287 | 32879288 | Human |
597074134 | GWAS1170208_H | coronary artery disease QTL GWAS1170208 (human) | | 7e-08 | coronary artery disease | | 10 | 24544685 | 24544686 | Human |
407001858 | GWAS650834_H | systolic blood pressure QTL GWAS650834 (human) | | 0.000007 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 31995897 | 31995898 | Human |
597074135 | GWAS1170209_H | coronary artery disease QTL GWAS1170209 (human) | | 2e-17 | coronary artery disease | | 10 | 30034963 | 30034964 | Human |
597057748 | GWAS1153822_H | insulin measurement QTL GWAS1153822 (human) | | 0.0000001 | insulin measurement | pancreatic islet insulin release measurement (CMO:0001216) | 10 | 38691018 | 38691019 | Human |
597323996 | GWAS1420070_H | propionylcarnitine measurement QTL GWAS1420070 (human) | | 7e-10 | propionylcarnitine measurement | | 10 | 19449465 | 19449466 | Human |
597135569 | GWAS1231643_H | memory performance QTL GWAS1231643 (human) | | 0.00001 | memory performance | | 10 | 19829435 | 19829436 | Human |
597143760 | GWAS1239834_H | chronic obstructive pulmonary disease QTL GWAS1239834 (human) | | 2e-11 | lung integrity trait (VT:0010906) | | 10 | 29964321 | 29964322 | Human |
597422291 | GWAS1518365_H | type 1 diabetes mellitus QTL GWAS1518365 (human) | | 3e-15 | type 1 diabetes mellitus | | 10 | 33137219 | 33137220 | Human |
597176528 | GWAS1272602_H | body mass index QTL GWAS1272602 (human) | | 5e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34598495 | 34598496 | Human |
597614807 | GWAS1671667_H | Red cell distribution width QTL GWAS1671667 (human) | | 3e-61 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
406993675 | GWAS642651_H | intelligence QTL GWAS642651 (human) | | 0.000008 | intelligence | | 10 | 34600928 | 34600929 | Human |
597315795 | GWAS1411869_H | JT interval QTL GWAS1411869 (human) | | 5e-11 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 43359323 | 43359324 | Human |
596971743 | GWAS1091262_H | metastasis measurement, colorectal cancer QTL GWAS1091262 (human) | | 0.000003 | metastasis measurement, colorectal cancer | | 10 | 36110736 | 36110737 | Human |
407378691 | GWAS1027667_H | amblyopia QTL GWAS1027667 (human) | | 0.000002 | amblyopia | | 10 | 18920520 | 18920521 | Human |
597213395 | GWAS1309469_H | electrocardiography QTL GWAS1309469 (human) | | 3e-08 | electrocardiography | | 10 | 29047920 | 29047921 | Human |
407378692 | GWAS1027668_H | amblyopia QTL GWAS1027668 (human) | | 0.0000004 | amblyopia | | 10 | 19032587 | 19032588 | Human |
597074136 | GWAS1170210_H | coronary artery disease QTL GWAS1170210 (human) | | 0.000003 | coronary artery disease | | 10 | 33200961 | 33200962 | Human |
597074137 | GWAS1170211_H | coronary artery disease QTL GWAS1170211 (human) | | 0.0000005 | coronary artery disease | | 10 | 44083614 | 44083615 | Human |
597098693 | GWAS1194767_H | body mass index QTL GWAS1194767 (human) | | 8e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27071094 | 27071095 | Human |
597176523 | GWAS1272597_H | body mass index QTL GWAS1272597 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20810655 | 20810656 | Human |
597336270 | GWAS1432344_H | C-reactive protein measurement QTL GWAS1432344 (human) | | 6e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 21541175 | 21541176 | Human |
597176525 | GWAS1272599_H | body mass index QTL GWAS1272599 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27025515 | 27025516 | Human |
597479625 | GWAS1575699_H | mathematical ability QTL GWAS1575699 (human) | | 9e-09 | mathematical ability | | 10 | 31080941 | 31080942 | Human |
596955330 | GWAS1074849_H | illness severity status QTL GWAS1074849 (human) | | 3e-14 | illness severity status | | 10 | 21494705 | 21494706 | Human |
597176526 | GWAS1272600_H | body mass index QTL GWAS1272600 (human) | | 1e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33725725 | 33725726 | Human |
597176527 | GWAS1272601_H | body mass index QTL GWAS1272601 (human) | | 6e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33784901 | 33784902 | Human |
597172417 | GWAS1268491_H | protein measurement QTL GWAS1268491 (human) | | 9e-13 | protein measurement | | 10 | 38080890 | 38080891 | Human |
597336256 | GWAS1432330_H | COVID-19 QTL GWAS1432330 (human) | | 0.000003 | COVID-19 | | 10 | 25289578 | 25289579 | Human |
597278915 | GWAS1374989_H | COVID-19, coronary artery disease QTL GWAS1374989 (human) | | 3e-10 | COVID-19, coronary artery disease | | 10 | 44256820 | 44256821 | Human |
597508289 | GWAS1604363_H | high density lipoprotein cholesterol measurement QTL GWAS1604363 (human) | | 1e-23 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33341920 | 33341921 | Human |
597098696 | GWAS1194770_H | body mass index QTL GWAS1194770 (human) | | 5e-25 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21541175 | 21541176 | Human |
407022369 | GWAS671345_H | mental or behavioural disorder, attempted suicide QTL GWAS671345 (human) | | 0.000008 | mental or behavioural disorder, attempted suicide | | 10 | 30201775 | 30201776 | Human |
597143794 | GWAS1239868_H | serum gamma-glutamyl transferase measurement QTL GWAS1239868 (human) | | 6e-13 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 34734861 | 34734862 | Human |
597143793 | GWAS1239867_H | serum gamma-glutamyl transferase measurement QTL GWAS1239867 (human) | | 1e-11 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 31411556 | 31411557 | Human |
597094641 | GWAS1190715_H | trait in response to lamotrigine, maculopapular eruption, epilepsy QTL GWAS1190715 (human) | | 0.0000004 | brain integrity trait (VT:0010579) | | 10 | 27419100 | 27419101 | Human |
597045489 | GWAS1141563_H | refractive error QTL GWAS1141563 (human) | | 1e-08 | refractive error | | 10 | 30038463 | 30038464 | Human |
597401841 | GWAS1497915_H | physical activity measurement QTL GWAS1497915 (human) | | 4e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 10 | 21531721 | 21531722 | Human |
597487862 | GWAS1583936_H | COVID-19 QTL GWAS1583936 (human) | | 0.0000002 | COVID-19 | | 10 | 30543771 | 30543772 | Human |
597373168 | GWAS1469242_H | interleukin-6 measurement QTL GWAS1469242 (human) | | 0.000003 | interleukin-6 measurement | blood interleukin-6 level (CMO:0001926) | 10 | 23145815 | 23145816 | Human |
597487863 | GWAS1583937_H | COVID-19 QTL GWAS1583937 (human) | | 0.0000008 | COVID-19 | | 10 | 31185614 | 31185615 | Human |
597446892 | GWAS1542966_H | diet measurement, low density lipoprotein cholesterol measurement QTL GWAS1542966 (human) | | 0.000003 | eating behavior trait (VT:0001431) | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 34918225 | 34918226 | Human |
407124789 | GWAS773765_H | schizophrenia QTL GWAS773765 (human) | | 2e-12 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597221611 | GWAS1317685_H | central corneal thickness QTL GWAS1317685 (human) | | 3e-09 | central corneal thickness | | 10 | 24872332 | 24872333 | Human |
597270764 | GWAS1366838_H | type 2 diabetes mellitus QTL GWAS1366838 (human) | | 0.000002 | type 2 diabetes mellitus | | 10 | 26208775 | 26208776 | Human |
407001914 | GWAS650890_H | systolic blood pressure QTL GWAS650890 (human) | | 2e-20 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18448045 | 18448046 | Human |
597340386 | GWAS1436460_H | systolic blood pressure QTL GWAS1436460 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 21709516 | 21709517 | Human |
596963566 | GWAS1083085_H | orofacial cleft QTL GWAS1083085 (human) | | 0.000005 | orofacial cleft | | 10 | 29888959 | 29888960 | Human |
597479648 | GWAS1575722_H | neuroimaging measurement QTL GWAS1575722 (human) | | 3e-11 | neuroimaging measurement | | 10 | 21531723 | 21531724 | Human |
597176345 | GWAS1272419_H | Tinnitus QTL GWAS1272419 (human) | | 0.0000001 | Tinnitus | | 10 | 30511908 | 30511909 | Human |
597331999 | GWAS1428073_H | S-6-hydroxywarfarin measurement QTL GWAS1428073 (human) | | 0.000001 | S-6-hydroxywarfarin measurement | | 10 | 22929519 | 22929520 | Human |
407059403 | GWAS708379_H | heel bone mineral density QTL GWAS708379 (human) | | 7e-31 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
406957001 | GWAS605977_H | bronchopulmonary dysplasia QTL GWAS605977 (human) | | 0.000003 | bronchopulmonary dysplasia | | 10 | 20145851 | 20145852 | Human |
597200918 | GWAS1296992_H | memory performance, sex interaction measurement QTL GWAS1296992 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 27054029 | 27054030 | Human |
407059404 | GWAS708380_H | heel bone mineral density QTL GWAS708380 (human) | | 7e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 21026624 | 21026625 | Human |
597422089 | GWAS1518163_H | cortical thickness QTL GWAS1518163 (human) | | 3e-10 | cortical thickness | | 10 | 32001950 | 32001951 | Human |
597504014 | GWAS1600088_H | colorectal cancer QTL GWAS1600088 (human) | | 8e-08 | colorectal cancer | | 10 | 28808013 | 28808014 | Human |
597422088 | GWAS1518162_H | cortical thickness QTL GWAS1518162 (human) | | 1e-17 | cortical thickness | | 10 | 30828429 | 30828430 | Human |
596951040 | GWAS1070559_H | breast carcinoma QTL GWAS1070559 (human) | | 3e-13 | breast carcinoma | | 10 | 21533927 | 21533928 | Human |
597467144 | GWAS1563218_H | blood urea nitrogen measurement QTL GWAS1563218 (human) | | 2e-10 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 43342894 | 43342895 | Human |
597417998 | GWAS1514072_H | shigellosis QTL GWAS1514072 (human) | | 0.000002 | shigellosis | | 10 | 28047767 | 28047768 | Human |
597602315 | GWAS1659175_H | myocardial infarction QTL GWAS1659175 (human) | | 6e-19 | myocardial infarction | | 10 | 44249118 | 44249119 | Human |
597164046 | GWAS1260120_H | gut microbiome measurement QTL GWAS1260120 (human) | | 5e-08 | gut microbiome measurement | | 10 | 36605338 | 36605339 | Human |
597102592 | GWAS1198666_H | schizophrenia, intelligence, self reported educational attainment QTL GWAS1198666 (human) | | 5e-11 | schizophrenia, intelligence, self reported educational attainment | | 10 | 18444364 | 18444365 | Human |
597073933 | GWAS1170007_H | coronary artery disease QTL GWAS1170007 (human) | | 4e-24 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597422087 | GWAS1518161_H | cortical thickness QTL GWAS1518161 (human) | | 1e-17 | cortical thickness | | 10 | 21530895 | 21530896 | Human |
597123127 | GWAS1219201_H | blood protein measurement QTL GWAS1219201 (human) | | 1e-12 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19971440 | 19971441 | Human |
407145444 | GWAS794420_H | ejection fraction measurement QTL GWAS794420 (human) | | 0.000006 | ejection fraction measurement | ejection fraction (CMO:0000180) | 10 | 25302224 | 25302225 | Human |
597360699 | GWAS1456773_H | cannabis dependence measurement QTL GWAS1456773 (human) | | 0.000002 | cannabis dependence measurement | | 10 | 31692457 | 31692458 | Human |
596955189 | GWAS1074708_H | hypertension QTL GWAS1074708 (human) | | 2e-09 | hypertension | | 10 | 24931570 | 24931571 | Human |
596955191 | GWAS1074710_H | body mass index QTL GWAS1074710 (human) | | 3e-09 | body mass index | | 10 | 34622951 | 34622952 | Human |
597266492 | GWAS1362566_H | cup-to-disc ratio measurement QTL GWAS1362566 (human) | | 7e-16 | cup-to-disc ratio measurement | | 10 | 21148932 | 21148933 | Human |
597487673 | GWAS1583747_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1583747 (human) | | 1e-14 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42845214 | 42845215 | Human |
597090352 | GWAS1186426_H | mammographic density measurement QTL GWAS1186426 (human) | | 1e-08 | mammographic density measurement | | 10 | 27647633 | 27647634 | Human |
406977510 | GWAS626486_H | white matter microstructure measurement QTL GWAS626486 (human) | | 3e-08 | white matter microstructure measurement | | 10 | 21583984 | 21583985 | Human |
597237811 | GWAS1333885_H | neutrophil count QTL GWAS1333885 (human) | | 2e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 44384812 | 44384813 | Human |
597147704 | GWAS1243778_H | body mass index QTL GWAS1243778 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21478040 | 21478041 | Human |
597106727 | GWAS1202801_H | cerebral white matter volume change measurement, age at assessment QTL GWAS1202801 (human) | | 0.000004 | cerebral white matter volume change measurement, age at assessment | | 10 | 36349381 | 36349382 | Human |
597594159 | GWAS1651019_H | body mass index QTL GWAS1651019 (human) | | 3e-26 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532345 | 21532346 | Human |
407059442 | GWAS708418_H | central corneal thickness QTL GWAS708418 (human) | | 2e-08 | central corneal thickness | | 10 | 43149376 | 43149377 | Human |
597200939 | GWAS1297013_H | B-cell acute lymphoblastic leukemia, multiple sclerosis QTL GWAS1297013 (human) | | 1e-10 | leukocyte integrity trait (VT:0010898) | | 10 | 22189212 | 22189213 | Human |
597073957 | GWAS1170031_H | lobe attachment QTL GWAS1170031 (human) | | 2e-08 | lobe attachment | ear measurement (CMO:0002667) | 10 | 24217510 | 24217511 | Human |
597016609 | GWAS1112683_H | heel bone mineral density QTL GWAS1112683 (human) | | 0.0000004 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27587468 | 27587469 | Human |
597217312 | GWAS1313386_H | schizophrenia QTL GWAS1313386 (human) | | 3e-08 | schizophrenia | | 10 | 18587155 | 18587156 | Human |
597336096 | GWAS1432170_H | S-warfarin to R-warfarin ratio measurement QTL GWAS1432170 (human) | | 0.000009 | S-warfarin to R-warfarin ratio measurement | | 10 | 29973671 | 29973672 | Human |
597266466 | GWAS1362540_H | pulse pressure measurement QTL GWAS1362540 (human) | | 6e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30892947 | 30892948 | Human |
597225507 | GWAS1321581_H | smoking status measurement QTL GWAS1321581 (human) | | 1e-10 | smoking status measurement | | 10 | 36355804 | 36355805 | Human |
597016617 | GWAS1112691_H | heel bone mineral density QTL GWAS1112691 (human) | | 1e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27587468 | 27587469 | Human |
597110826 | GWAS1206900_H | protein measurement QTL GWAS1206900 (human) | | 3e-08 | protein measurement | | 10 | 22772333 | 22772334 | Human |
596979752 | GWAS1099271_H | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, basophil count, platelet count, eosinophil count QTL GWAS1099271 (human) | | 2e-08 | neutrophil count, mean platelet volume, leukocyte count, erythrocyte count, mean corpuscular hemoglobin concentration, mean corpuscular volume, monocyte count, basophil count, platelet count, eosinophil count | | 10 | 27068541 | 27068542 | Human |
596951124 | GWAS1070643_H | Red cell distribution width QTL GWAS1070643 (human) | | 3e-213 | Red cell distribution width | | 10 | 24569461 | 24569462 | Human |
597016661 | GWAS1112735_H | late-onset Alzheimers disease QTL GWAS1112735 (human) | | 0.000004 | late-onset Alzheimers disease | | 10 | 31115466 | 31115467 | Human |
597180510 | GWAS1276584_H | protein measurement QTL GWAS1276584 (human) | | 6e-28 | protein measurement | | 10 | 19946534 | 19946535 | Human |
597028946 | GWAS1125020_H | BMI-adjusted waist-hip ratio QTL GWAS1125020 (human) | | 9e-15 | body size trait (VT:0100005) | | 10 | 33878641 | 33878642 | Human |
597598292 | GWAS1655152_H | mean corpuscular hemoglobin concentration QTL GWAS1655152 (human) | | 8e-16 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24569461 | 24569462 | Human |
597180499 | GWAS1276573_H | protein measurement QTL GWAS1276573 (human) | | 4e-60 | protein measurement | | 10 | 19931917 | 19931918 | Human |
597311569 | GWAS1407643_H | vaginal microbiome measurement QTL GWAS1407643 (human) | | 0.000007 | vaginal microbiome measurement | | 10 | 25857524 | 25857525 | Human |
597180500 | GWAS1276574_H | protein measurement QTL GWAS1276574 (human) | | 1e-16 | protein measurement | | 10 | 19837138 | 19837139 | Human |
407124872 | GWAS773848_H | interleukin-6 measurement QTL GWAS773848 (human) | | 0.0000004 | interleukin-6 measurement | blood interleukin-6 level (CMO:0001926) | 10 | 25873837 | 25873838 | Human |
597106778 | GWAS1202852_H | amygdala volume change measurement, age at assessment QTL GWAS1202852 (human) | | 0.000005 | amygdala volume change measurement, age at assessment | | 10 | 26524974 | 26524975 | Human |
597393480 | GWAS1489554_H | high density lipoprotein cholesterol measurement QTL GWAS1489554 (human) | | 1e-08 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33159836 | 33159837 | Human |
596975681 | GWAS1095200_H | luminal B breast carcinoma, HER2 negative breast carcinoma, triple-negative breast cancer QTL GWAS1095200 (human) | | 2e-08 | luminal B breast carcinoma, HER2 negative breast carcinoma, triple-negative breast cancer | | 10 | 21643008 | 21643009 | Human |
597389391 | GWAS1485465_H | acute myeloid leukemia QTL GWAS1485465 (human) | | 0.000004 | leukocyte integrity trait (VT:0010898) | | 10 | 30124488 | 30124489 | Human |
597389390 | GWAS1485464_H | acute myeloid leukemia QTL GWAS1485464 (human) | | 0.0000002 | leukocyte integrity trait (VT:0010898) | | 10 | 30124488 | 30124489 | Human |
596951107 | GWAS1070626_H | COVID-19 QTL GWAS1070626 (human) | | 0.000003 | COVID-19 | | 10 | 23927227 | 23927228 | Human |
597307469 | GWAS1403543_H | spine bone mineral density QTL GWAS1403543 (human) | | 1e-12 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 28175824 | 28175825 | Human |
597114959 | GWAS1211033_H | intraocular pressure measurement QTL GWAS1211033 (human) | | 4e-08 | intraocular pressure measurement | | 10 | 24871573 | 24871574 | Human |
597381184 | GWAS1477258_H | prostate carcinoma, breast carcinoma, ovarian carcinoma QTL GWAS1477258 (human) | | 3e-10 | mammary gland integrity trait (VT:0010552) | | 10 | 22010574 | 22010575 | Human |
597151817 | GWAS1247891_H | diet measurement, testosterone measurement QTL GWAS1247891 (human) | | 0.000004 | eating behavior trait (VT:0001431) | serum testosterone level (CMO:0000568) | 10 | 38085505 | 38085506 | Human |
1643515 | BW287_H | Body Weight QTL 287 (human) | 2.45 | 0.0004 | Body weight | BMI | 10 | 18424110 | 44424110 | Human |
597110901 | GWAS1206975_H | DNA methylation QTL GWAS1206975 (human) | | 2e-08 | DNA methylation | | 10 | 21412806 | 21412807 | Human |
597160051 | GWAS1256125_H | lipid measurement QTL GWAS1256125 (human) | | 0.000007 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 25495623 | 25495624 | Human |
597459065 | GWAS1555139_H | hemoglobin measurement QTL GWAS1555139 (human) | | 4e-08 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 30064042 | 30064043 | Human |
597332092 | GWAS1428166_H | RS-6-hydroxywarfarin measurement QTL GWAS1428166 (human) | | 0.000007 | RS-6-hydroxywarfarin measurement | | 10 | 20383292 | 20383293 | Human |
406961063 | GWAS610039_H | reticulocyte count QTL GWAS610039 (human) | | 1e-205 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24929314 | 24929315 | Human |
597459066 | GWAS1555140_H | hemoglobin measurement QTL GWAS1555140 (human) | | 8e-17 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 44363233 | 44363234 | Human |
597602425 | GWAS1659285_H | calcium measurement QTL GWAS1659285 (human) | | 1e-14 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22103750 | 22103751 | Human |
597586028 | GWAS1642888_H | diastolic blood pressure change measurement QTL GWAS1642888 (human) | | 9e-24 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 30028144 | 30028145 | Human |
597024871 | GWAS1120945_H | colorectal adenoma QTL GWAS1120945 (human) | | 0.000009 | colorectal adenoma | | 10 | 35010157 | 35010158 | Human |
597586029 | GWAS1642889_H | diastolic blood pressure change measurement QTL GWAS1642889 (human) | | 9e-14 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 31085237 | 31085238 | Human |
596975718 | GWAS1095237_H | body height QTL GWAS1095237 (human) | | 5e-13 | body height | | 10 | 43608653 | 43608654 | Human |
596975712 | GWAS1095231_H | body height QTL GWAS1095231 (human) | | 3e-17 | body height | | 10 | 23485786 | 23485787 | Human |
597090400 | GWAS1186474_H | schizophrenia QTL GWAS1186474 (human) | | 8e-09 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597332077 | GWAS1428151_H | COVID-19, mortality QTL GWAS1428151 (human) | | 0.0000003 | COVID-19, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 28606315 | 28606316 | Human |
597475428 | GWAS1571502_H | amebiasis QTL GWAS1571502 (human) | | 6e-09 | amebiasis | | 10 | 35228707 | 35228708 | Human |
597110893 | GWAS1206967_H | diastolic blood pressure QTL GWAS1206967 (human) | | 7e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 32301434 | 32301435 | Human |
597313434 | GWAS1409508_H | cortical thickness QTL GWAS1409508 (human) | | 4e-12 | cortical thickness | | 10 | 34176277 | 34176278 | Human |
597419930 | GWAS1516004_H | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant QTL GWAS1516004 (human) | | 9e-09 | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant | | 10 | 38643144 | 38643145 | Human |
597022611 | GWAS1118685_H | acute myeloid leukemia QTL GWAS1118685 (human) | | 6e-15 | leukocyte integrity trait (VT:0010898) | | 10 | 20642110 | 20642111 | Human |
597223326 | GWAS1319400_H | cataract QTL GWAS1319400 (human) | | 2e-21 | cataract | | 10 | 28735201 | 28735202 | Human |
597022610 | GWAS1118684_H | acute myeloid leukemia QTL GWAS1118684 (human) | | 1e-17 | leukocyte integrity trait (VT:0010898) | | 10 | 20642110 | 20642111 | Human |
597022623 | GWAS1118697_H | acute myeloid leukemia QTL GWAS1118697 (human) | | 6e-15 | leukocyte integrity trait (VT:0010898) | | 10 | 21995211 | 21995212 | Human |
597120925 | GWAS1216999_H | blood protein measurement QTL GWAS1216999 (human) | | 2e-105 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 43147362 | 43147363 | Human |
596952991 | GWAS1072510_H | bone density QTL GWAS1072510 (human) | | 5e-12 | bone density | | 10 | 20090449 | 20090450 | Human |
597022622 | GWAS1118696_H | acute myeloid leukemia QTL GWAS1118696 (human) | | 4e-19 | leukocyte integrity trait (VT:0010898) | | 10 | 21995211 | 21995212 | Human |
597591955 | GWAS1648815_H | Urinary retention QTL GWAS1648815 (human) | | 3e-11 | Urinary retention | | 10 | 22024986 | 22024987 | Human |
407272523 | GWAS921499_H | migraine disorder, endometriosis QTL GWAS921499 (human) | | 0.000002 | migraine disorder, endometriosis | | 10 | 30795527 | 30795528 | Human |
597215126 | GWAS1311200_H | self reported educational attainment QTL GWAS1311200 (human) | | 1e-08 | self reported educational attainment | | 10 | 23654910 | 23654911 | Human |
597211030 | GWAS1307104_H | systolic blood pressure QTL GWAS1307104 (human) | | 0.0000005 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27238778 | 27238779 | Human |
597428114 | GWAS1524188_H | electrocardiography QTL GWAS1524188 (human) | | 8e-16 | electrocardiography | | 10 | 33323833 | 33323834 | Human |
597424011 | GWAS1520085_H | neutrophil count QTL GWAS1520085 (human) | | 3e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
406981715 | GWAS630691_H | white matter microstructure measurement QTL GWAS630691 (human) | | 8e-12 | white matter microstructure measurement | | 10 | 21623650 | 21623651 | Human |
597243787 | GWAS1339861_H | body fat percentage QTL GWAS1339861 (human) | | 2e-24 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 21541175 | 21541176 | Human |
597419918 | GWAS1515992_H | mathematical ability QTL GWAS1515992 (human) | | 8e-12 | mathematical ability | | 10 | 33387727 | 33387728 | Human |
597419917 | GWAS1515991_H | mathematical ability QTL GWAS1515991 (human) | | 3e-11 | mathematical ability | | 10 | 31091688 | 31091689 | Human |
597395341 | GWAS1491415_H | rheumatoid arthritis QTL GWAS1491415 (human) | | 9e-12 | rheumatoid arthritis | | 10 | 31122426 | 31122427 | Human |
597030786 | GWAS1126860_H | smoking initiation QTL GWAS1126860 (human) | | 2e-08 | smoking initiation | | 10 | 27108525 | 27108526 | Human |
597170049 | GWAS1266123_H | body mass index QTL GWAS1266123 (human) | | 4e-20 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21541175 | 21541176 | Human |
597063567 | GWAS1159641_H | body weight QTL GWAS1159641 (human) | | 0.000002 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 28958379 | 28958380 | Human |
597346179 | GWAS1442253_H | basophil measurement QTL GWAS1442253 (human) | | 1e-10 | basophil measurement | | 10 | 43198279 | 43198280 | Human |
597170050 | GWAS1266124_H | body mass index QTL GWAS1266124 (human) | | 8e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33725507 | 33725508 | Human |
597505921 | GWAS1601995_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1601995 (human) | | 1e-11 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 10 | 31097045 | 31097046 | Human |
597305274 | GWAS1401348_H | coronary artery disease QTL GWAS1401348 (human) | | 4e-08 | coronary artery disease | | 10 | 33227445 | 33227446 | Human |
597305273 | GWAS1401347_H | coronary artery disease QTL GWAS1401347 (human) | | 1e-08 | coronary artery disease | | 10 | 24765745 | 24765746 | Human |
597424056 | GWAS1520130_H | eosinophil count QTL GWAS1520130 (human) | | 1e-19 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491364 | 28491365 | Human |
597022640 | GWAS1118714_H | acute myeloid leukemia QTL GWAS1118714 (human) | | 2e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 33272646 | 33272647 | Human |
597465015 | GWAS1561089_H | waist-hip ratio QTL GWAS1561089 (human) | | 2e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33383956 | 33383957 | Human |
597022648 | GWAS1118722_H | alcohol dependence measurement QTL GWAS1118722 (human) | | 0.0000001 | response to alcohol trait (VT:0010489) | | 10 | 24740234 | 24740235 | Human |
597137337 | GWAS1233411_H | diastolic blood pressure, systolic blood pressure QTL GWAS1233411 (human) | | 2e-11 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 22519915 | 22519916 | Human |
597477298 | GWAS1573372_H | chronic obstructive pulmonary disease QTL GWAS1573372 (human) | | 0.000002 | lung integrity trait (VT:0010906) | | 10 | 26617637 | 26617638 | Human |
596952999 | GWAS1072518_H | size QTL GWAS1072518 (human) | | 9e-11 | size | | 10 | 28643416 | 28643417 | Human |
597415848 | GWAS1511922_H | dilated cardiomyopathy QTL GWAS1511922 (human) | | 2e-09 | heart integrity trait (VT:0010757) | | 10 | 29418622 | 29418623 | Human |
597432239 | GWAS1528313_H | sex hormone-binding globulin measurement QTL GWAS1528313 (human) | | 2e-09 | sex hormone-binding globulin measurement | | 10 | 31318286 | 31318287 | Human |
597022625 | GWAS1118699_H | acute myeloid leukemia QTL GWAS1118699 (human) | | 7e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 29608049 | 29608050 | Human |
597022624 | GWAS1118698_H | acute myeloid leukemia QTL GWAS1118698 (human) | | 0.000002 | leukocyte integrity trait (VT:0010898) | | 10 | 28170069 | 28170070 | Human |
597215137 | GWAS1311211_H | body mass index QTL GWAS1311211 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27028911 | 27028912 | Human |
597464997 | GWAS1561071_H | BMI-adjusted waist-hip ratio QTL GWAS1561071 (human) | | 1e-15 | body size trait (VT:0100005) | | 10 | 27615438 | 27615439 | Human |
597071831 | GWAS1167905_H | breast carcinoma QTL GWAS1167905 (human) | | 1e-14 | mammary gland integrity trait (VT:0010552) | | 10 | 21744013 | 21744014 | Human |
407079942 | GWAS728918_H | systolic blood pressure QTL GWAS728918 (human) | | 8e-34 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
407002116 | GWAS651092_H | systolic blood pressure QTL GWAS651092 (human) | | 0.0000009 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18448045 | 18448046 | Human |
597178320 | GWAS1274394_H | body mass index QTL GWAS1274394 (human) | | 2e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27028911 | 27028912 | Human |
597178321 | GWAS1274395_H | body mass index QTL GWAS1274395 (human) | | 5e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33677392 | 33677393 | Human |
597460950 | GWAS1557024_H | waist-hip ratio QTL GWAS1557024 (human) | | 2e-12 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 21533927 | 21533928 | Human |
597178322 | GWAS1274396_H | body mass index QTL GWAS1274396 (human) | | 4e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33784901 | 33784902 | Human |
597178323 | GWAS1274397_H | body mass index QTL GWAS1274397 (human) | | 6e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21384954 | 21384955 | Human |
597178324 | GWAS1274398_H | body mass index QTL GWAS1274398 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33974725 | 33974726 | Human |
597178325 | GWAS1274399_H | body mass index QTL GWAS1274399 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34154403 | 34154404 | Human |
597370838 | GWAS1466912_H | eosinophil count QTL GWAS1466912 (human) | | 2e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 43322411 | 43322412 | Human |
597071832 | GWAS1167906_H | breast carcinoma QTL GWAS1167906 (human) | | 6e-17 | mammary gland integrity trait (VT:0010552) | | 10 | 22026914 | 22026915 | Human |
597592016 | GWAS1648876_H | coronary artery disease QTL GWAS1648876 (human) | | 2e-13 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
597178326 | GWAS1274400_H | body mass index QTL GWAS1274400 (human) | | 7e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34281774 | 34281775 | Human |
597370837 | GWAS1466911_H | eosinophil count QTL GWAS1466911 (human) | | 6e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 35229101 | 35229102 | Human |
597407700 | GWAS1503774_H | body mass index QTL GWAS1503774 (human) | | 3e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 23752388 | 23752389 | Human |
597370836 | GWAS1466910_H | eosinophil count QTL GWAS1466910 (human) | | 2e-46 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491364 | 28491365 | Human |
597178327 | GWAS1274401_H | body mass index QTL GWAS1274401 (human) | | 3e-11 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34622951 | 34622952 | Human |
407223306 | GWAS872282_H | triacylglycerol 54:2 measurement QTL GWAS872282 (human) | | 0.0000009 | blood triglyceride amount (VT:0002644) | | 10 | 37395636 | 37395637 | Human |
597182408 | GWAS1278482_H | nidogen-1 measurement QTL GWAS1278482 (human) | | 3e-38 | nidogen-1 measurement | | 10 | 19931917 | 19931918 | Human |
596965312 | GWAS1084831_H | diet measurement, low density lipoprotein cholesterol measurement QTL GWAS1084831 (human) | | 0.000005 | diet measurement, low density lipoprotein cholesterol measurement | | 10 | 34918225 | 34918226 | Human |
597456836 | GWAS1552910_H | illness severity status QTL GWAS1552910 (human) | | 3e-14 | illness severity status | | 10 | 21494705 | 21494706 | Human |
597469125 | GWAS1565199_H | Achilles tendon injury QTL GWAS1565199 (human) | | 1e-10 | hindlimb integrity trait (VT:0010563) | | 10 | 28331214 | 28331215 | Human |
597379010 | GWAS1475084_H | anti-neutrophil antibody associated vasculitis QTL GWAS1475084 (human) | | 0.000009 | anti-neutrophil antibody associated vasculitis | | 10 | 35771381 | 35771382 | Human |
597616579 | GWAS1673439_H | diverticular disease QTL GWAS1673439 (human) | | 4e-31 | diverticular disease | | 10 | 25522506 | 25522507 | Human |
597239750 | GWAS1335824_H | lymphocyte count QTL GWAS1335824 (human) | | 1e-32 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24931570 | 24931571 | Human |
407059484 | GWAS708460_H | Parkinson disease, disease progression measurement QTL GWAS708460 (human) | | 0.000001 | Parkinson disease, disease progression measurement | disease progression measurement (CMO:0001110) | 10 | 33942102 | 33942103 | Human |
597485562 | GWAS1581636_H | rheumatoid arthritis QTL GWAS1581636 (human) | | 2e-09 | rheumatoid arthritis | | 10 | 31061565 | 31061566 | Human |
597145584 | GWAS1241658_H | Dupuytren Contracture QTL GWAS1241658 (human) | | 4e-08 | Dupuytren Contracture | | 10 | 35801595 | 35801596 | Human |
597239794 | GWAS1335868_H | basophil count QTL GWAS1335868 (human) | | 5e-08 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 44388182 | 44388183 | Human |
597227509 | GWAS1323583_H | type 2 diabetes mellitus QTL GWAS1323583 (human) | | 0.0000009 | type 2 diabetes mellitus | | 10 | 36349497 | 36349498 | Human |
597596145 | GWAS1653005_H | diastolic blood pressure QTL GWAS1653005 (human) | | 4e-19 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 30028144 | 30028145 | Human |
597256169 | GWAS1352243_H | schizophrenia QTL GWAS1352243 (human) | | 1e-09 | schizophrenia | | 10 | 21055844 | 21055845 | Human |
597075942 | GWAS1172016_H | childhood onset asthma QTL GWAS1172016 (human) | | 0.0000002 | childhood onset asthma | | 10 | 27452030 | 27452031 | Human |
597256175 | GWAS1352249_H | schizophrenia QTL GWAS1352249 (human) | | 3e-08 | schizophrenia | | 10 | 33751365 | 33751366 | Human |
597325794 | GWAS1421868_H | FEV/FVC ratio QTL GWAS1421868 (human) | | 7e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 20939599 | 20939600 | Human |
597596132 | GWAS1652992_H | drug use measurement, benign prostatic hyperplasia QTL GWAS1652992 (human) | | 5e-15 | prostate integrity trait (VT:0010571) | | 10 | 22024986 | 22024987 | Human |
597587940 | GWAS1644800_H | eosinophil count QTL GWAS1644800 (human) | | 5e-37 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26462654 | 26462655 | Human |
597587941 | GWAS1644801_H | eosinophil count QTL GWAS1644801 (human) | | 9e-12 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28508383 | 28508384 | Human |
597239781 | GWAS1335855_H | basophil count QTL GWAS1335855 (human) | | 6e-20 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 24931570 | 24931571 | Human |
597460764 | GWAS1556838_H | heel bone mineral density QTL GWAS1556838 (human) | | 6e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 29227587 | 29227588 | Human |
407022786 | GWAS671762_H | unipolar depression QTL GWAS671762 (human) | | 0.000005 | unipolar depression | | 10 | 33005847 | 33005848 | Human |
597317402 | GWAS1413476_H | metabolite measurement QTL GWAS1413476 (human) | | 0.000001 | metabolite measurement | | 10 | 34671360 | 34671361 | Human |
597075735 | GWAS1171809_H | heel bone mineral density QTL GWAS1171809 (human) | | 0.000009 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
597460765 | GWAS1556839_H | heel bone mineral density QTL GWAS1556839 (human) | | 3e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 31061248 | 31061249 | Human |
407366853 | GWAS1015829_H | gut microbiome measurement QTL GWAS1015829 (human) | | 1e-08 | gut microbiome measurement | | 10 | 29097977 | 29097978 | Human |
597460766 | GWAS1556840_H | heel bone mineral density QTL GWAS1556840 (human) | | 3e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 43871839 | 43871840 | Human |
407366852 | GWAS1015828_H | gut microbiome measurement QTL GWAS1015828 (human) | | 6e-09 | gut microbiome measurement | | 10 | 29099710 | 29099711 | Human |
596965136 | GWAS1084655_H | alkaline phosphatase measurement, diet measurement QTL GWAS1084655 (human) | | 0.000008 | alkaline phosphatase measurement, diet measurement | | 10 | 30588720 | 30588721 | Human |
407063749 | GWAS712725_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa QTL GWAS712725 (human) | | 1e-10 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | | 10 | 18437289 | 18437290 | Human |
597460763 | GWAS1556837_H | heel bone mineral density QTL GWAS1556837 (human) | | 4e-24 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28802794 | 28802795 | Human |
597370643 | GWAS1466717_H | waist-hip ratio QTL GWAS1466717 (human) | | 0.000006 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 31701695 | 31701696 | Human |
597268240 | GWAS1364314_H | taste liking measurement QTL GWAS1364314 (human) | | 4e-09 | taste liking measurement | | 10 | 20834896 | 20834897 | Human |
407059658 | GWAS708634_H | heel bone mineral density QTL GWAS708634 (human) | | 1e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27722299 | 27722300 | Human |
407059656 | GWAS708632_H | heel bone mineral density QTL GWAS708632 (human) | | 4e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 23319236 | 23319237 | Human |
597108506 | GWAS1204580_H | Hematochezia, response to radiation QTL GWAS1204580 (human) | | 0.0000002 | Hematochezia, response to radiation | | 10 | 30391095 | 30391096 | Human |
597075736 | GWAS1171810_H | heel bone mineral density QTL GWAS1171810 (human) | | 2e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28146986 | 28146987 | Human |
407059661 | GWAS708637_H | heel bone mineral density QTL GWAS708637 (human) | | 2e-20 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28222316 | 28222317 | Human |
407059660 | GWAS708636_H | heel bone mineral density QTL GWAS708636 (human) | | 1e-31 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28153912 | 28153913 | Human |
597075737 | GWAS1171811_H | heel bone mineral density QTL GWAS1171811 (human) | | 2e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
407059666 | GWAS708642_H | heel bone mineral density QTL GWAS708642 (human) | | 1e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 43379193 | 43379194 | Human |
407059665 | GWAS708641_H | heel bone mineral density QTL GWAS708641 (human) | | 1e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30882400 | 30882401 | Human |
407059664 | GWAS708640_H | heel bone mineral density QTL GWAS708640 (human) | | 7e-112 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
407129308 | GWAS778284_H | Alzheimer disease, psychotic symptoms QTL GWAS778284 (human) | | 0.000009 | Alzheimer disease, psychotic symptoms | | 10 | 28216015 | 28216016 | Human |
597526279 | GWAS1622353_H | pyruvate measurement QTL GWAS1622353 (human) | | 4e-08 | pyruvate measurement | blood pyruvate level (CMO:0002422) | 10 | 23516028 | 23516029 | Human |
597616389 | GWAS1673249_H | Abnormality of the urinary system QTL GWAS1673249 (human) | | 8e-12 | Abnormality of the urinary system | | 10 | 29987079 | 29987080 | Human |
597411641 | GWAS1507715_H | Alzheimer disease QTL GWAS1507715 (human) | | 0.000003 | Alzheimer disease | | 10 | 28354863 | 28354864 | Human |
597411646 | GWAS1507720_H | endometriosis QTL GWAS1507720 (human) | | 0.000002 | endometriosis | | 10 | 33013148 | 33013149 | Human |
597362493 | GWAS1458567_H | basophil count, eosinophil count QTL GWAS1458567 (human) | | 8e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491444 | 28491445 | Human |
406912234 | GWAS561210_H | obsolete Mendelian syndromes with cleft lip/palate QTL GWAS561210 (human) | | 0.000005 | obsolete Mendelian syndromes with cleft lip/palate | | 10 | 29888959 | 29888960 | Human |
597456691 | GWAS1552765_H | atopic eczema QTL GWAS1552765 (human) | | 0.000004 | atopic eczema | | 10 | 30810758 | 30810759 | Human |
597473070 | GWAS1569144_H | hemorrhoid QTL GWAS1569144 (human) | | 3e-11 | hemorrhoid | | 10 | 24041876 | 24041877 | Human |
407002359 | GWAS651335_H | diastolic blood pressure QTL GWAS651335 (human) | | 3e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18448045 | 18448046 | Human |
406990071 | GWAS639047_H | grip strength measurement QTL GWAS639047 (human) | | 2e-13 | grip strength measurement | | 10 | 21619874 | 21619875 | Human |
596952865 | GWAS1072384_H | bone density QTL GWAS1072384 (human) | | 1e-10 | bone density | | 10 | 28149716 | 28149718 | Human |
407002356 | GWAS651332_H | diastolic blood pressure QTL GWAS651332 (human) | | 3e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18448045 | 18448046 | Human |
597514021 | GWAS1610095_H | inflammatory bowel disease QTL GWAS1610095 (human) | | 0.000001 | inflammatory bowel disease | | 10 | 35259297 | 35259298 | Human |
407026936 | GWAS675912_H | sphingolipid measurement QTL GWAS675912 (human) | | 3e-09 | sphingolipid measurement | | 10 | 37219522 | 37219523 | Human |
596973355 | GWAS1092874_H | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder QTL GWAS1092874 (human) | | 0.000005 | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder | | 10 | 36748480 | 36748481 | Human |
597235547 | GWAS1331621_H | blood protein measurement QTL GWAS1331621 (human) | | 4e-48 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 42891918 | 42891919 | Human |
597108563 | GWAS1204637_H | self reported educational attainment QTL GWAS1204637 (human) | | 2e-10 | self reported educational attainment | | 10 | 31997014 | 31997015 | Human |
597452633 | GWAS1548707_H | size QTL GWAS1548707 (human) | | 7e-10 | size | | 10 | 27611953 | 27611954 | Human |
597108562 | GWAS1204636_H | self reported educational attainment QTL GWAS1204636 (human) | | 3e-08 | self reported educational attainment | | 10 | 28519056 | 28519057 | Human |
597428057 | GWAS1524131_H | renal carcinoma QTL GWAS1524131 (human) | | 1e-12 | renal carcinoma | | 10 | 31091502 | 31091503 | Human |
597235548 | GWAS1331622_H | blood protein measurement QTL GWAS1331622 (human) | | 5e-89 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 43100520 | 43100521 | Human |
597591896 | GWAS1648756_H | benign prostatic hyperplasia QTL GWAS1648756 (human) | | 1e-21 | prostate integrity trait (VT:0010571) | | 10 | 22138360 | 22138361 | Human |
597108561 | GWAS1204635_H | self reported educational attainment QTL GWAS1204635 (human) | | 3e-08 | self reported educational attainment | | 10 | 24285480 | 24285481 | Human |
597378897 | GWAS1474971_H | mean corpuscular hemoglobin QTL GWAS1474971 (human) | | 0.000006 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 37270652 | 37270653 | Human |
597206870 | GWAS1302944_H | Beta blocking agent use measurement QTL GWAS1302944 (human) | | 5e-11 | Beta blocking agent use measurement | | 10 | 18470608 | 18470609 | Human |
407026828 | GWAS675804_H | ankylosing spondylitis QTL GWAS675804 (human) | | 0.000004 | ankylosing spondylitis | | 10 | 19640584 | 19640585 | Human |
597108548 | GWAS1204622_H | self reported educational attainment QTL GWAS1204622 (human) | | 2e-12 | self reported educational attainment | | 10 | 34294707 | 34294708 | Human |
597079886 | GWAS1175960_H | Red cell distribution width QTL GWAS1175960 (human) | | 3e-213 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597075788 | GWAS1171862_H | Hirschsprung disease QTL GWAS1171862 (human) | | 4e-14 | Hirschsprung disease | | 10 | 43111408 | 43111409 | Human |
597387079 | GWAS1483153_H | susceptibility to pneumonia measurement QTL GWAS1483153 (human) | | 0.000008 | susceptibility to pneumonia measurement | | 10 | 19726478 | 19726479 | Human |
597182277 | GWAS1278351_H | pyruvate measurement QTL GWAS1278351 (human) | | 5e-09 | pyruvate measurement | blood pyruvate level (CMO:0002422) | 10 | 27446297 | 27446298 | Human |
597411654 | GWAS1507728_H | endometriosis QTL GWAS1507728 (human) | | 0.000001 | endometriosis | | 10 | 33051630 | 33051631 | Human |
597141322 | GWAS1237396_H | Inguinal hernia QTL GWAS1237396 (human) | | 8e-11 | Inguinal hernia | | 10 | 43167879 | 43167880 | Human |
407022748 | GWAS671724_H | serum IgG glycosylation measurement QTL GWAS671724 (human) | | 0.000007 | serum IgG glycosylation measurement | | 10 | 25591530 | 25591531 | Human |
597182278 | GWAS1278352_H | pyruvate measurement QTL GWAS1278352 (human) | | 2e-08 | pyruvate measurement | blood pyruvate level (CMO:0002422) | 10 | 36195843 | 36195844 | Human |
597149558 | GWAS1245632_H | endometriosis QTL GWAS1245632 (human) | | 4e-12 | endometriosis | | 10 | 21535798 | 21535799 | Human |
597055348 | GWAS1151422_H | rosacea severity measurement QTL GWAS1151422 (human) | | 0.000008 | rosacea severity measurement | | 10 | 26048212 | 26048213 | Human |
597370745 | GWAS1466819_H | respiratory quotient QTL GWAS1466819 (human) | | 0.000003 | respiratory quotient | | 10 | 28463177 | 28463178 | Human |
597165949 | GWAS1262023_H | open-angle glaucoma QTL GWAS1262023 (human) | | 1e-08 | open-angle glaucoma | | 10 | 24837283 | 24837284 | Human |
597362556 | GWAS1458630_H | spine bone mineral density QTL GWAS1458630 (human) | | 0.000004 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 32190421 | 32190422 | Human |
597501812 | GWAS1597886_H | rheumatoid arthritis QTL GWAS1597886 (human) | | 0.0000002 | rheumatoid arthritis | | 10 | 31097045 | 31097046 | Human |
407198892 | GWAS847868_H | gut microbiome measurement, bone density QTL GWAS847868 (human) | | 4e-08 | gut microbiome measurement, bone density | | 10 | 31676506 | 31676507 | Human |
406895787 | GWAS544763_H | pulse pressure measurement QTL GWAS544763 (human) | | 1e-19 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597174131 | GWAS1270205_H | Tinnitus, wellbeing measurement QTL GWAS1270205 (human) | | 0.000002 | wellness/fitness trait (VT:1000152) | | 10 | 30511908 | 30511909 | Human |
597112699 | GWAS1208773_H | intraocular pressure measurement QTL GWAS1208773 (human) | | 5e-11 | intraocular pressure measurement | | 10 | 25533431 | 25533432 | Human |
597387124 | GWAS1483198_H | androstenedione measurement, estrone measurement QTL GWAS1483198 (human) | | 0.000005 | blood hormone amount (VT:0005418) | | 10 | 23061174 | 23061175 | Human |
597362539 | GWAS1458613_H | neutrophil percentage of leukocytes QTL GWAS1458613 (human) | | 5e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 28531092 | 28531095 | Human |
597038948 | GWAS1135022_H | gut microbiome measurement QTL GWAS1135022 (human) | | 0.000003 | gut microbiome measurement | | 10 | 31380865 | 31380866 | Human |
597026663 | GWAS1122737_H | body mass index QTL GWAS1122737 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 34125937 | 34125938 | Human |
597038947 | GWAS1135021_H | gut microbiome measurement QTL GWAS1135021 (human) | | 0.000006 | gut microbiome measurement | | 10 | 29684014 | 29684015 | Human |
597206881 | GWAS1302955_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1302955 (human) | | 5e-15 | Agents acting on the renin-angiotensin system use measurement | | 10 | 18437125 | 18437126 | Human |
597325667 | GWAS1421741_H | triglyceride change measurement, response to antipsychotic drug QTL GWAS1421741 (human) | | 2e-11 | triglyceride change measurement, response to antipsychotic drug | blood triglyceride level (CMO:0000118) | 10 | 24421013 | 24421014 | Human |
597337952 | GWAS1434026_H | hypertension QTL GWAS1434026 (human) | | 2e-08 | hypertension | | 10 | 27939936 | 27939937 | Human |
597137259 | GWAS1233333_H | neuroimaging measurement QTL GWAS1233333 (human) | | 4e-14 | neuroimaging measurement | | 10 | 33179086 | 33179087 | Human |
407305400 | GWAS954376_H | asthma QTL GWAS954376 (human) | | 2e-08 | asthma | | 10 | 30512789 | 30512790 | Human |
597505693 | GWAS1601767_H | BMI-adjusted hip circumference QTL GWAS1601767 (human) | | 2e-13 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 27611953 | 27611954 | Human |
597268121 | GWAS1364195_H | low density lipoprotein cholesterol measurement QTL GWAS1364195 (human) | | 8e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 43423375 | 43423376 | Human |
597403295 | GWAS1499369_H | FEV/FVC ratio, response to bronchodilator QTL GWAS1499369 (human) | | 0.000004 | FEV/FVC ratio, response to bronchodilator | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 26338452 | 26338453 | Human |
597206672 | GWAS1302746_H | birth weight QTL GWAS1302746 (human) | | 4e-09 | birth weight | neonatal body weight (CMO:0002079) | 10 | 24767189 | 24767190 | Human |
597460628 | GWAS1556702_H | osteoarthritis QTL GWAS1556702 (human) | | 0.000004 | osteoarthritis | | 10 | 27592379 | 27592380 | Human |
407080266 | GWAS729242_H | unipolar depression, neuroticism measurement QTL GWAS729242 (human) | | 0.000004 | unipolar depression, neuroticism measurement | | 10 | 24565947 | 24565948 | Human |
597517974 | GWAS1614048_H | preeclampsia QTL GWAS1614048 (human) | | 0.000001 | preeclampsia | | 10 | 30818929 | 30818930 | Human |
597415568 | GWAS1511642_H | smoking status measurement QTL GWAS1511642 (human) | | 4e-08 | smoking status measurement | | 10 | 31133648 | 31133649 | Human |
597202580 | GWAS1298654_H | lean body mass QTL GWAS1298654 (human) | | 7e-13 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 24696764 | 24696765 | Human |
597501586 | GWAS1597660_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1597660 (human) | | 3e-09 | severe acute respiratory syndrome, COVID-19 | | 10 | 24050024 | 24050025 | Human |
597292681 | GWAS1388755_H | hypertension QTL GWAS1388755 (human) | | 2e-09 | hypertension | | 10 | 24931570 | 24931571 | Human |
597018244 | GWAS1114318_H | multiple sclerosis QTL GWAS1114318 (human) | | 3e-19 | multiple sclerosis | | 10 | 31106832 | 31106833 | Human |
597493384 | GWAS1589458_H | osteoarthritis QTL GWAS1589458 (human) | | 0.000001 | osteoarthritis | | 10 | 30692340 | 30692341 | Human |
596965004 | GWAS1084523_H | diet measurement, low density lipoprotein cholesterol measurement QTL GWAS1084523 (human) | | 0.000003 | diet measurement, low density lipoprotein cholesterol measurement | | 10 | 34918225 | 34918226 | Human |
597370502 | GWAS1466576_H | hemoglobin measurement QTL GWAS1466576 (human) | | 5e-19 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 44363233 | 44363234 | Human |
597370501 | GWAS1466575_H | hemoglobin measurement QTL GWAS1466575 (human) | | 4e-11 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 36173027 | 36173028 | Human |
597599873 | GWAS1656733_H | mean corpuscular hemoglobin concentration QTL GWAS1656733 (human) | | 1e-17 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24922362 | 24922363 | Human |
597386936 | GWAS1483010_H | macrophage inflammatory protein 1b measurement QTL GWAS1483010 (human) | | 0.000003 | chemokine amount (VT:0008721) | | 10 | 30726071 | 30726072 | Human |
597501625 | GWAS1597699_H | neuroimaging measurement QTL GWAS1597699 (human) | | 2e-36 | neuroimaging measurement | | 10 | 21510797 | 21510798 | Human |
597608122 | GWAS1664982_H | body weight QTL GWAS1664982 (human) | | 7e-20 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 21532345 | 21532346 | Human |
597317310 | GWAS1413384_H | cognitive function measurement QTL GWAS1413384 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 10 | 29112346 | 29112347 | Human |
597358270 | GWAS1454344_H | rheumatoid arthritis QTL GWAS1454344 (human) | | 1e-09 | rheumatoid arthritis | | 10 | 31126177 | 31126178 | Human |
597378740 | GWAS1474814_H | neutrophil count QTL GWAS1474814 (human) | | 1e-45 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597055140 | GWAS1151214_H | white matter microstructure measurement QTL GWAS1151214 (human) | | 5e-09 | white matter microstructure measurement | | 10 | 21583984 | 21583985 | Human |
597403311 | GWAS1499385_H | helix rolling QTL GWAS1499385 (human) | | 0.0000008 | helix rolling | ear measurement (CMO:0002667) | 10 | 42422028 | 42422029 | Human |
407129458 | GWAS778434_H | Hirschsprung disease QTL GWAS778434 (human) | | 4e-18 | Hirschsprung disease | | 10 | 43117161 | 43117162 | Human |
597444267 | GWAS1540341_H | lipid measurement QTL GWAS1540341 (human) | | 0.000008 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 21243156 | 21243157 | Human |
597108397 | GWAS1204471_H | major depressive disorder QTL GWAS1204471 (human) | | 0.0000001 | major depressive disorder | | 10 | 29945955 | 29945956 | Human |
597313190 | GWAS1409264_H | cortical thickness QTL GWAS1409264 (human) | | 1e-13 | cortical thickness | | 10 | 33179086 | 33179087 | Human |
596989608 | GWAS1109127_H | memory performance, sex interaction measurement QTL GWAS1109127 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 27054029 | 27054030 | Human |
597346010 | GWAS1442084_H | peak expiratory flow QTL GWAS1442084 (human) | | 2e-15 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 30024734 | 30024735 | Human |
597305050 | GWAS1401124_H | coronary artery disease QTL GWAS1401124 (human) | | 5e-24 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
596952789 | GWAS1072308_H | hypertension QTL GWAS1072308 (human) | | 5e-13 | hypertension | | 10 | 18439030 | 18439031 | Human |
597305051 | GWAS1401125_H | coronary artery disease QTL GWAS1401125 (human) | | 1e-24 | coronary artery disease | | 10 | 44245808 | 44245809 | Human |
597026519 | GWAS1122593_H | heel bone mineral density QTL GWAS1122593 (human) | | 7e-26 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20041014 | 20041015 | Human |
597026518 | GWAS1122592_H | heel bone mineral density QTL GWAS1122592 (human) | | 1e-27 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
596965079 | GWAS1084598_H | diet measurement, testosterone measurement QTL GWAS1084598 (human) | | 0.000007 | diet measurement, testosterone measurement | | 10 | 38714782 | 38714783 | Human |
597341918 | GWAS1437992_H | immature platelet measurement QTL GWAS1437992 (human) | | 9e-13 | immature platelet measurement | | 10 | 29768663 | 29768664 | Human |
596965073 | GWAS1084592_H | diet measurement, testosterone measurement QTL GWAS1084592 (human) | | 0.000004 | diet measurement, testosterone measurement | | 10 | 38085505 | 38085506 | Human |
597067475 | GWAS1163549_H | primary ovarian insufficiency QTL GWAS1163549 (human) | | 0.000002 | primary ovarian insufficiency | | 10 | 43608447 | 43608448 | Human |
597522139 | GWAS1618213_H | prostate cancer QTL GWAS1618213 (human) | | 0.0000002 | prostate cancer | | 10 | 24481359 | 24481360 | Human |
597026525 | GWAS1122599_H | heel bone mineral density QTL GWAS1122599 (human) | | 1e-41 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28151383 | 28151384 | Human |
597427924 | GWAS1523998_H | electrocardiography QTL GWAS1523998 (human) | | 2e-11 | electrocardiography | | 10 | 33233329 | 33233330 | Human |
597026524 | GWAS1122598_H | heel bone mineral density QTL GWAS1122598 (human) | | 3e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27858679 | 27858680 | Human |
597026527 | GWAS1122601_H | heel bone mineral density QTL GWAS1122601 (human) | | 6e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 29728119 | 29728120 | Human |
597026526 | GWAS1122600_H | heel bone mineral density QTL GWAS1122600 (human) | | 2e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 29469586 | 29469587 | Human |
597026521 | GWAS1122595_H | heel bone mineral density QTL GWAS1122595 (human) | | 2e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 21026624 | 21026625 | Human |
597026520 | GWAS1122594_H | heel bone mineral density QTL GWAS1122594 (human) | | 3e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20225020 | 20225021 | Human |
597026523 | GWAS1122597_H | heel bone mineral density QTL GWAS1122597 (human) | | 7e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27717882 | 27717883 | Human |
597096152 | GWAS1192226_H | coronary artery disease QTL GWAS1192226 (human) | | 0.000001 | coronary artery disease | | 10 | 44280376 | 44280377 | Human |
597026522 | GWAS1122596_H | heel bone mineral density QTL GWAS1122596 (human) | | 8e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 23312913 | 23312914 | Human |
407387416 | GWAS1036392_H | forced expiratory volume QTL GWAS1036392 (human) | | 0.000002 | forced expiratory volume | forced expiratory volume (CMO:0000254) | 10 | 30178249 | 30178250 | Human |
407055635 | GWAS704611_H | hemoglobin measurement QTL GWAS704611 (human) | | 6e-12 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 36184116 | 36184117 | Human |
597145285 | GWAS1241359_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1241359 (human) | | 0.000009 | severe acute respiratory syndrome, COVID-19 | | 10 | 19085029 | 19085030 | Human |
597100229 | GWAS1196303_H | urinary albumin to creatinine ratio QTL GWAS1196303 (human) | | 2e-09 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 10 | 21600209 | 21600210 | Human |
597280458 | GWAS1376532_H | QT interval QTL GWAS1376532 (human) | | 1e-13 | QT interval | QT interval (CMO:0000235) | 10 | 38076355 | 38076356 | Human |
597497543 | GWAS1593617_H | sex interaction measurement, atopy QTL GWAS1593617 (human) | | 9e-10 | sex interaction measurement, atopy | | 10 | 42527140 | 42527141 | Human |
597407424 | GWAS1503498_H | blood urea nitrogen measurement QTL GWAS1503498 (human) | | 7e-23 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28915058 | 28915059 | Human |
597157578 | GWAS1253652_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1253652 (human) | | 0.0000002 | lifestyle measurement, maximum cigarettes per day measurement | | 10 | 28734751 | 28734752 | Human |
597157577 | GWAS1253651_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1253651 (human) | | 0.0000004 | lifestyle measurement, maximum cigarettes per day measurement | | 10 | 18630117 | 18630118 | Human |
597038793 | GWAS1134867_H | gut microbiome measurement QTL GWAS1134867 (human) | | 0.000006 | gut microbiome measurement | | 10 | 24327918 | 24327919 | Human |
596965067 | GWAS1084586_H | diet measurement, testosterone measurement QTL GWAS1084586 (human) | | 0.000006 | diet measurement, testosterone measurement | | 10 | 38085505 | 38085506 | Human |
597120759 | GWAS1216833_H | gut microbiome measurement QTL GWAS1216833 (human) | | 0.0000005 | gut microbiome measurement | | 10 | 19991683 | 19991684 | Human |
597374715 | GWAS1470789_H | response to clozapine QTL GWAS1470789 (human) | | 0.0000003 | response to clozapine | | 10 | 31077342 | 31077343 | Human |
597427964 | GWAS1524038_H | urate measurement QTL GWAS1524038 (human) | | 7e-09 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 43449018 | 43449019 | Human |
597022452 | GWAS1118526_H | interleukin 17 measurement QTL GWAS1118526 (human) | | 0.000005 | blood interleukin-17 amount (VT:0008613) | | 10 | 37245131 | 37245132 | Human |
597038839 | GWAS1134913_H | gut microbiome measurement QTL GWAS1134913 (human) | | 0.000001 | gut microbiome measurement | | 10 | 44349649 | 44349650 | Human |
597513982 | GWAS1610056_H | glucose measurement QTL GWAS1610056 (human) | | 6e-10 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 26216567 | 26216568 | Human |
596977398 | GWAS1096917_H | diacylglycerol 36:2 measurement QTL GWAS1096917 (human) | | 0.0000006 | milk diacylglycerol amount (VT:0010385) | | 10 | 37395636 | 37395637 | Human |
597022451 | GWAS1118525_H | interleukin 17 measurement QTL GWAS1118525 (human) | | 0.000004 | blood interleukin-17 amount (VT:0008613) | | 10 | 37115738 | 37115739 | Human |
597178096 | GWAS1274170_H | body mass index QTL GWAS1274170 (human) | | 5e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20759753 | 20759754 | Human |
597178097 | GWAS1274171_H | body mass index QTL GWAS1274171 (human) | | 4e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20810655 | 20810656 | Human |
596965117 | GWAS1084636_H | diet measurement, testosterone measurement QTL GWAS1084636 (human) | | 0.000009 | diet measurement, testosterone measurement | | 10 | 38714782 | 38714783 | Human |
597178098 | GWAS1274172_H | body mass index QTL GWAS1274172 (human) | | 2e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21074527 | 21074528 | Human |
597034748 | GWAS1130822_H | cigarettes per day measurement QTL GWAS1130822 (human) | | 0.0000003 | cigarettes per day measurement | | 10 | 43129385 | 43129386 | Human |
597194484 | GWAS1290558_H | response to radiation, hearing loss, response to antineoplastic agent QTL GWAS1290558 (human) | | 0.000007 | response to radiation, hearing loss, response to antineoplastic agent | | 10 | 23416310 | 23416311 | Human |
597473009 | GWAS1569083_H | protein measurement QTL GWAS1569083 (human) | | 3e-08 | protein measurement | | 10 | 23498156 | 23498157 | Human |
597505776 | GWAS1601850_H | diastolic blood pressure, systolic blood pressure QTL GWAS1601850 (human) | | 4e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 32068832 | 32068833 | Human |
597034745 | GWAS1130819_H | cigarettes per day measurement QTL GWAS1130819 (human) | | 4e-08 | cigarettes per day measurement | | 10 | 43129385 | 43129386 | Human |
597063398 | GWAS1159472_H | BMI-adjusted waist circumference QTL GWAS1159472 (human) | | 0.000005 | body size trait (VT:0100005) | | 10 | 25998363 | 25998364 | Human |
406961459 | GWAS610435_H | neutrophil count, eosinophil count QTL GWAS610435 (human) | | 3e-32 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 10 | 24922362 | 24922363 | Human |
597505775 | GWAS1601849_H | diastolic blood pressure, systolic blood pressure QTL GWAS1601849 (human) | | 0.000006 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 29515238 | 29515239 | Human |
597321448 | GWAS1417522_H | JT interval QTL GWAS1417522 (human) | | 7e-11 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 43359323 | 43359324 | Human |
597083874 | GWAS1179948_H | coronary artery disease QTL GWAS1179948 (human) | | 6e-15 | coronary artery disease | | 10 | 30046193 | 30046194 | Human |
597026529 | GWAS1122603_H | heel bone mineral density QTL GWAS1122603 (human) | | 4e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 34735416 | 34735417 | Human |
597026528 | GWAS1122602_H | heel bone mineral density QTL GWAS1122602 (human) | | 1e-103 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
597083875 | GWAS1179949_H | coronary artery disease QTL GWAS1179949 (human) | | 1e-28 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597178095 | GWAS1274169_H | body mass index QTL GWAS1274169 (human) | | 8e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 19487899 | 19487900 | Human |
597305059 | GWAS1401133_H | coronary artery disease QTL GWAS1401133 (human) | | 1e-23 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
596965097 | GWAS1084616_H | urate measurement, diet measurement QTL GWAS1084616 (human) | | 0.000002 | urate measurement, diet measurement | | 10 | 24431515 | 24431516 | Human |
597268196 | GWAS1364270_H | facial width measurement QTL GWAS1364270 (human) | | 0.000009 | facial morphology trait (VT:0003743) | | 10 | 37136310 | 37136311 | Human |
597194470 | GWAS1290544_H | age at assessment, pelvic organ prolapse QTL GWAS1290544 (human) | | 0.000009 | age at assessment, pelvic organ prolapse | | 10 | 33322954 | 33322955 | Human |
597272089 | GWAS1368163_H | X-12063 measurement QTL GWAS1368163 (human) | | 5e-09 | X-12063 measurement | | 10 | 26973121 | 26973122 | Human |
406977993 | GWAS626969_H | schizophrenia QTL GWAS626969 (human) | | 4e-10 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597161500 | GWAS1257574_H | glutamine measurement QTL GWAS1257574 (human) | | 5e-08 | glutamine measurement | blood amino acid measurement (CMO:0003730) | 10 | 22637298 | 22637299 | Human |
597251604 | GWAS1347678_H | non-Hodgkins lymphoma QTL GWAS1347678 (human) | | 5e-11 | non-Hodgkins lymphoma | | 10 | 44178109 | 44178110 | Human |
597313034 | GWAS1409108_H | amyloid-beta measurement, Alzheimer's disease biomarker measurement QTL GWAS1409108 (human) | | 0.0000008 | amyloid-beta measurement, Alzheimer's disease biomarker measurement | | 10 | 19928731 | 19928732 | Human |
597104132 | GWAS1200206_H | myocardial infarction QTL GWAS1200206 (human) | | 7e-10 | myocardial infarction | | 10 | 30046193 | 30046194 | Human |
597345806 | GWAS1441880_H | immature granulocyte count QTL GWAS1441880 (human) | | 7e-25 | immature granulocyte count | | 10 | 24922362 | 24922363 | Human |
596973057 | GWAS1092576_H | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder QTL GWAS1092576 (human) | | 0.000001 | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder | | 10 | 36748480 | 36748481 | Human |
597104131 | GWAS1200205_H | myocardial infarction QTL GWAS1200205 (human) | | 2e-17 | myocardial infarction | | 10 | 44249867 | 44249868 | Human |
597018112 | GWAS1114186_H | eosinophil count QTL GWAS1114186 (human) | | 7e-51 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491364 | 28491365 | Human |
597304844 | GWAS1400918_H | neutrophil count QTL GWAS1400918 (human) | | 5e-57 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24909758 | 24909759 | Human |
597304845 | GWAS1400919_H | neutrophil count QTL GWAS1400919 (human) | | 9e-15 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 44384263 | 44384264 | Human |
597317122 | GWAS1413196_H | systolic blood pressure QTL GWAS1413196 (human) | | 4e-48 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
597390850 | GWAS1486924_H | adolescent idiopathic scoliosis QTL GWAS1486924 (human) | | 7e-33 | adolescent idiopathic scoliosis | | 10 | 23920195 | 23920196 | Human |
597091855 | GWAS1187929_H | hippocampal volume QTL GWAS1187929 (human) | | 0.000002 | hippocampal volume | | 10 | 28094004 | 28094005 | Human |
407010779 | GWAS659755_H | intelligence QTL GWAS659755 (human) | | 0.0000005 | intelligence | | 10 | 30207976 | 30207977 | Human |
597263876 | GWAS1359950_H | nidogen-2 measurement QTL GWAS1359950 (human) | | 4e-14 | nidogen-2 measurement | | 10 | 19946534 | 19946535 | Human |
597300743 | GWAS1396817_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1396817 (human) | | 1e-19 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42857446 | 42857447 | Human |
597182008 | GWAS1278082_H | cryptic phenotype measurement QTL GWAS1278082 (human) | | 2e-09 | cryptic phenotype measurement | | 10 | 21600154 | 21600155 | Human |
597231163 | GWAS1327237_H | multisite chronic pain QTL GWAS1327237 (human) | | 4e-08 | multisite chronic pain | | 10 | 21668300 | 21668301 | Human |
597374520 | GWAS1470594_H | multiple sclerosis QTL GWAS1470594 (human) | | 0.0000002 | multiple sclerosis | | 10 | 43318601 | 43318602 | Human |
597194300 | GWAS1290374_H | obsessive-compulsive disorder QTL GWAS1290374 (human) | | 0.00001 | obsessive-compulsive disorder | | 10 | 19113590 | 19113591 | Human |
597218878 | GWAS1314952_H | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder QTL GWAS1314952 (human) | | 0.000005 | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder | | 10 | 36748480 | 36748481 | Human |
597444148 | GWAS1540222_H | heart rate response to exercise QTL GWAS1540222 (human) | | 1e-08 | heart rate response to exercise | | 10 | 29531829 | 29531830 | Human |
597345840 | GWAS1441914_H | smoking initiation QTL GWAS1441914 (human) | | 9e-12 | smoking initiation | | 10 | 21605099 | 21605100 | Human |
596964926 | GWAS1084445_H | coronary artery disease QTL GWAS1084445 (human) | | 7e-09 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
407105000 | GWAS753976_H | FEV/FVC ratio QTL GWAS753976 (human) | | 3e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 29979841 | 29979842 | Human |
597128762 | GWAS1224836_H | memory performance QTL GWAS1224836 (human) | | 0.00001 | memory performance | | 10 | 19819940 | 19819941 | Human |
597362229 | GWAS1458303_H | dental caries QTL GWAS1458303 (human) | | 0.000003 | dental caries | | 10 | 32125059 | 32125060 | Human |
597120568 | GWAS1216642_H | Cleft palate, cleft lip QTL GWAS1216642 (human) | | 0.000003 | Cleft palate, cleft lip | | 10 | 28995857 | 28995858 | Human |
597251628 | GWAS1347702_H | bacteroides seropositivity QTL GWAS1347702 (human) | | 3e-09 | bacteroides seropositivity | | 10 | 20390566 | 20390567 | Human |
597337691 | GWAS1433765_H | systolic blood pressure QTL GWAS1433765 (human) | | 7e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 24380948 | 24380949 | Human |
597161555 | GWAS1257629_H | lipid measurement QTL GWAS1257629 (human) | | 0.000005 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 20310092 | 20310093 | Human |
597587546 | GWAS1644406_H | eosinophil count QTL GWAS1644406 (human) | | 9e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28518041 | 28518042 | Human |
597505625 | GWAS1601699_H | Alzheimer disease, polygenic risk score QTL GWAS1601699 (human) | | 2e-10 | Alzheimer disease, polygenic risk score | | 10 | 35035691 | 35035692 | Human |
597603931 | GWAS1660791_H | Red cell distribution width QTL GWAS1660791 (human) | | 2e-158 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597124701 | GWAS1220775_H | calcium measurement QTL GWAS1220775 (human) | | 1e-12 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22105914 | 22105915 | Human |
597296714 | GWAS1392788_H | nidogen-1 measurement QTL GWAS1392788 (human) | | 1e-14 | nidogen-1 measurement | | 10 | 19934521 | 19934522 | Human |
597231177 | GWAS1327251_H | triglyceride measurement, response to selective serotonin reuptake inhibitor QTL GWAS1327251 (human) | | 1e-08 | triglyceride measurement, response to selective serotonin reuptake inhibitor | blood triglyceride level (CMO:0000118) | 10 | 37398148 | 37398149 | Human |
597231176 | GWAS1327250_H | triglyceride measurement, response to selective serotonin reuptake inhibitor QTL GWAS1327250 (human) | | 5e-09 | triglyceride measurement, response to selective serotonin reuptake inhibitor | blood triglyceride level (CMO:0000118) | 10 | 20883064 | 20883065 | Human |
597587533 | GWAS1644393_H | eosinophil count QTL GWAS1644393 (human) | | 1e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26454922 | 26454923 | Human |
597440073 | GWAS1536147_H | susceptibility to childhood ear infection measurement QTL GWAS1536147 (human) | | 0.0000007 | response to infection trait (VT:0010434) | | 10 | 27611953 | 27611954 | Human |
597235265 | GWAS1331339_H | blood protein measurement QTL GWAS1331339 (human) | | 3e-15 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19928731 | 19928732 | Human |
597239363 | GWAS1335437_H | eosinophil count QTL GWAS1335437 (human) | | 7e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24909758 | 24909759 | Human |
597579331 | GWAS1636191_H | eosinophil count QTL GWAS1636191 (human) | | 9e-19 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26454922 | 26454923 | Human |
597022280 | GWAS1118354_H | interleukin 16 measurement QTL GWAS1118354 (human) | | 0.000005 | blood interleukin-16 amount (VT:0008631) | | 10 | 37585521 | 37585522 | Human |
597239367 | GWAS1335441_H | eosinophil count QTL GWAS1335441 (human) | | 4e-09 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44381051 | 44381052 | Human |
596964979 | GWAS1084498_H | coronary artery disease QTL GWAS1084498 (human) | | 2e-08 | coronary artery disease | | 10 | 44192332 | 44192333 | Human |
597583477 | GWAS1640337_H | mean corpuscular hemoglobin concentration QTL GWAS1640337 (human) | | 3e-12 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24922362 | 24922363 | Human |
597272183 | GWAS1368257_H | high density lipoprotein cholesterol measurement QTL GWAS1368257 (human) | | 1e-15 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33352221 | 33352222 | Human |
597419636 | GWAS1515710_H | Tinnitus, response to cisplatin QTL GWAS1515710 (human) | | 0.000006 | Tinnitus, response to cisplatin | | 10 | 31176968 | 31176969 | Human |
597038695 | GWAS1134769_H | apolipoprotein A 1 measurement QTL GWAS1134769 (human) | | 6e-10 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 33726753 | 33726754 | Human |
407227831 | GWAS876807_H | urate measurement QTL GWAS876807 (human) | | 0.0000004 | urate measurement | blood uric acid level (CMO:0000501) | 10 | 20970215 | 20970216 | Human |
596964967 | GWAS1084486_H | alkaline phosphatase measurement, diet measurement QTL GWAS1084486 (human) | | 0.000006 | alkaline phosphatase measurement, diet measurement | | 10 | 30573733 | 30573734 | Human |
597481064 | GWAS1577138_H | neutrophil count QTL GWAS1577138 (human) | | 8e-35 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597059171 | GWAS1155245_H | reaction time measurement QTL GWAS1155245 (human) | | 0.000002 | cognitive behavior trait (VT:0010450) | | 10 | 28395402 | 28395403 | Human |
597444196 | GWAS1540270_H | BMI-adjusted waist-hip ratio QTL GWAS1540270 (human) | | 3e-13 | body size trait (VT:0100005) | | 10 | 33877770 | 33877771 | Human |
597141101 | GWAS1237175_H | 5-methyluridine (ribothymidine) measurement QTL GWAS1237175 (human) | | 0.000001 | 5-methyluridine (ribothymidine) measurement | | 10 | 34710033 | 34710034 | Human |
597415526 | GWAS1511600_H | dilated cardiomyopathy QTL GWAS1511600 (human) | | 0.000002 | heart integrity trait (VT:0010757) | | 10 | 29418622 | 29418623 | Human |
597444195 | GWAS1540269_H | BMI-adjusted waist-hip ratio QTL GWAS1540269 (human) | | 6e-09 | body size trait (VT:0100005) | | 10 | 33871836 | 33871837 | Human |
597218713 | GWAS1314787_H | BMI-adjusted waist-hip ratio QTL GWAS1314787 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 32311126 | 32311127 | Human |
597620125 | GWAS1676985_H | Abnormal pupillary function QTL GWAS1676985 (human) | | 2e-11 | Abnormal pupillary function | | 10 | 43112646 | 43112647 | Human |
597312925 | GWAS1408999_H | diastolic blood pressure QTL GWAS1408999 (human) | | 4e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 21741274 | 21741275 | Human |
597501335 | GWAS1597409_H | diastolic blood pressure, systolic blood pressure QTL GWAS1597409 (human) | | 9e-16 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19776147 | 19776148 | Human |
597132701 | GWAS1228775_H | memory performance QTL GWAS1228775 (human) | | 0.000005 | memory performance | | 10 | 19808667 | 19808668 | Human |
596952474 | GWAS1071993_H | body mass index QTL GWAS1071993 (human) | | 3e-14 | body mass index | | 10 | 21748880 | 21748881 | Human |
597267849 | GWAS1363923_H | schizophrenia QTL GWAS1363923 (human) | | 0.000008 | schizophrenia | | 10 | 33320488 | 33320489 | Human |
597034368 | GWAS1130442_H | smoking behavior QTL GWAS1130442 (human) | | 1e-09 | smoking behavior | | 10 | 21999203 | 21999204 | Human |
407383632 | GWAS1032608_H | nicotine dependence symptom count QTL GWAS1032608 (human) | | 0.000002 | nicotine dependence symptom count | | 10 | 33924571 | 33924572 | Human |
597316996 | GWAS1413070_H | systolic blood pressure QTL GWAS1413070 (human) | | 2e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27956491 | 27956492 | Human |
597366203 | GWAS1462277_H | eosinophil percentage of leukocytes QTL GWAS1462277 (human) | | 9e-26 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 28491364 | 28491365 | Human |
597116341 | GWAS1212415_H | DNA methylation QTL GWAS1212415 (human) | | 3e-08 | DNA methylation | | 10 | 33971707 | 33971708 | Human |
597317042 | GWAS1413116_H | diastolic blood pressure, systolic blood pressure QTL GWAS1413116 (human) | | 2e-10 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 20225020 | 20225021 | Human |
406965864 | GWAS614840_H | response to radiation, prostate carcinoma, breast carcinoma QTL GWAS614840 (human) | | 0.000006 | mammary gland integrity trait (VT:0010552) | | 10 | 21147293 | 21147294 | Human |
406965867 | GWAS614843_H | response to radiation, breast carcinoma QTL GWAS614843 (human) | | 0.000008 | mammary gland integrity trait (VT:0010552) | | 10 | 21147293 | 21147294 | Human |
597218739 | GWAS1314813_H | glucose measurement QTL GWAS1314813 (human) | | 8e-14 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 26216893 | 26216894 | Human |
597595573 | GWAS1652433_H | drug use measurement, coronary artery disease QTL GWAS1652433 (human) | | 7e-26 | drug use measurement, coronary artery disease | | 10 | 44247070 | 44247071 | Human |
406969966 | GWAS618942_H | cannabis dependence measurement QTL GWAS618942 (human) | | 0.000001 | cannabis dependence measurement | | 10 | 43097361 | 43097362 | Human |
596968867 | GWAS1088386_H | body height QTL GWAS1088386 (human) | | 8e-11 | body height | | 10 | 31793730 | 31793731 | Human |
596968866 | GWAS1088385_H | body height QTL GWAS1088385 (human) | | 6e-15 | body height | | 10 | 29202607 | 29202608 | Human |
597579174 | GWAS1636034_H | overnutrition, obesity QTL GWAS1636034 (human) | | 7e-17 | overnutrition, obesity | | 10 | 21532345 | 21532346 | Human |
1300009 | BW22_H | Body weight QTL 22 (human) | 2.32 | | Body weight | body mass index | 10 | 18424110 | 44424110 | Human |
597091757 | GWAS1187831_H | femoral neck bone mineral density QTL GWAS1187831 (human) | | 7e-08 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 10 | 30610362 | 30610363 | Human |
597157291 | GWAS1253365_H | triglyceride:HDL cholesterol ratio QTL GWAS1253365 (human) | | 2e-08 | blood triglyceride amount (VT:0002644) | | 10 | 33317261 | 33317262 | Human |
597132714 | GWAS1228788_H | memory performance QTL GWAS1228788 (human) | | 0.000007 | memory performance | | 10 | 19822223 | 19822224 | Human |
597489058 | GWAS1585132_H | aspartate aminotransferase measurement QTL GWAS1585132 (human) | | 4e-08 | aspartate aminotransferase measurement | blood aspartate aminotransferase activity level (CMO:0000580) | 10 | 29417831 | 29417832 | Human |
407060092 | GWAS709068_H | neutrophil count QTL GWAS709068 (human) | | 4e-10 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 30218170 | 30218171 | Human |
597095895 | GWAS1191969_H | schizophrenia QTL GWAS1191969 (human) | | 1e-10 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597513692 | GWAS1609766_H | inflammatory bowel disease QTL GWAS1609766 (human) | | 6e-09 | inflammatory bowel disease | | 10 | 35259297 | 35259298 | Human |
597591515 | GWAS1648375_H | coronary atherosclerosis QTL GWAS1648375 (human) | | 6e-16 | coronary atherosclerosis | | 10 | 30028144 | 30028145 | Human |
597161425 | GWAS1257499_H | gut microbiome measurement QTL GWAS1257499 (human) | | 2e-08 | gut microbiome measurement | | 10 | 34016701 | 34016702 | Human |
597099984 | GWAS1196058_H | alkaline phosphatase measurement QTL GWAS1196058 (human) | | 3e-08 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 25759193 | 25759194 | Human |
597374419 | GWAS1470493_H | major depressive disorder QTL GWAS1470493 (human) | | 0.000005 | major depressive disorder | | 10 | 33005847 | 33005848 | Human |
597247447 | GWAS1343521_H | schizophrenia QTL GWAS1343521 (human) | | 0.000002 | schizophrenia | | 10 | 36754522 | 36754523 | Human |
597456333 | GWAS1552407_H | eosinophil count QTL GWAS1552407 (human) | | 4e-33 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28492438 | 28492439 | Human |
597333453 | GWAS1429527_H | S-6-hydroxywarfarin measurement QTL GWAS1429527 (human) | | 0.000002 | S-6-hydroxywarfarin measurement | | 10 | 20383292 | 20383293 | Human |
597349837 | GWAS1445911_H | restless legs syndrome QTL GWAS1445911 (human) | | 1e-14 | restless legs syndrome | | 10 | 34128907 | 34128908 | Human |
407051806 | GWAS700782_H | phosphoenolpyruvic acid measurement QTL GWAS700782 (human) | | 0.000003 | phosphoenolpyruvic acid measurement | | 10 | 28624042 | 28624043 | Human |
597116407 | GWAS1212481_H | reaction time measurement QTL GWAS1212481 (human) | | 0.0000005 | cognitive behavior trait (VT:0010450) | | 10 | 42893970 | 42893971 | Human |
597173757 | GWAS1269831_H | left ventricular mass index QTL GWAS1269831 (human) | | 8e-08 | left ventricular mass index | heart left ventricle weight to body weight ratio (CMO:0000530) | 10 | 18538957 | 18538958 | Human |
597087728 | GWAS1183802_H | reticulocyte measurement QTL GWAS1183802 (human) | | 4e-16 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 26438525 | 26438526 | Human |
597603832 | GWAS1660692_H | neutrophil count QTL GWAS1660692 (human) | | 4e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597206513 | GWAS1302587_H | lateral ventricle volume measurement QTL GWAS1302587 (human) | | 2e-08 | lateral ventricle volume measurement | | 10 | 21589215 | 21589216 | Human |
597325299 | GWAS1421373_H | color vision disorder QTL GWAS1421373 (human) | | 0.0000003 | color vision disorder | | 10 | 36412230 | 36412231 | Human |
597325296 | GWAS1421370_H | color vision disorder QTL GWAS1421370 (human) | | 0.0000002 | color vision disorder | | 10 | 33236590 | 33236591 | Human |
597034488 | GWAS1130562_H | low density lipoprotein cholesterol measurement QTL GWAS1130562 (human) | | 3e-09 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 18431916 | 18431917 | Human |
597255670 | GWAS1351744_H | heptachlor epoxide measurement QTL GWAS1351744 (human) | | 0.00001 | 2,4,5-trichlorophenol measurement | | 10 | 22603334 | 22603335 | Human |
597595629 | GWAS1652489_H | calcium measurement QTL GWAS1652489 (human) | | 2e-15 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22207976 | 22207977 | Human |
597177836 | GWAS1273910_H | junctophilin-1 measurement QTL GWAS1273910 (human) | | 1e-22 | junctophilin-1 measurement | | 10 | 19936725 | 19936726 | Human |
597390830 | GWAS1486904_H | hematocrit QTL GWAS1486904 (human) | | 5e-26 | hematocrit | hematocrit (CMO:0000037) | 10 | 44363233 | 44363234 | Human |
597390829 | GWAS1486903_H | hematocrit QTL GWAS1486903 (human) | | 1e-13 | hematocrit | hematocrit (CMO:0000037) | 10 | 36172832 | 36172833 | Human |
597087726 | GWAS1183800_H | reticulocyte measurement QTL GWAS1183800 (human) | | 2e-11 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 24590855 | 24590856 | Human |
597087727 | GWAS1183801_H | reticulocyte measurement QTL GWAS1183801 (human) | | 1e-308 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 24929314 | 24929315 | Human |
597349859 | GWAS1445933_H | electrocardiography QTL GWAS1445933 (human) | | 1e-17 | electrocardiography | | 10 | 33351102 | 33351103 | Human |
597439974 | GWAS1536048_H | BMI-adjusted hip circumference QTL GWAS1536048 (human) | | 0.0000009 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 44310557 | 44310558 | Human |
597267940 | GWAS1364014_H | facial height measurement QTL GWAS1364014 (human) | | 0.000004 | facial morphology trait (VT:0003743) | | 10 | 37464487 | 37464488 | Human |
597374237 | GWAS1470311_H | lymphocyte count QTL GWAS1470311 (human) | | 3e-28 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26423144 | 26423145 | Human |
597087504 | GWAS1183578_H | PR interval QTL GWAS1183578 (human) | | 5e-10 | PR interval | PR interval (CMO:0000233) | 10 | 32559034 | 32559035 | Human |
597181727 | GWAS1277801_H | phosphatidylinositol 5-phosphate 4-kinase type-2 alpha measurement QTL GWAS1277801 (human) | | 3e-57 | phosphatidylinositol 5-phosphate 4-kinase type-2 alpha measurement | | 10 | 22891690 | 22891691 | Human |
597325085 | GWAS1421159_H | coronary artery disease QTL GWAS1421159 (human) | | 2e-08 | coronary artery disease | | 10 | 31466991 | 31466992 | Human |
596968733 | GWAS1088252_H | systolic blood pressure QTL GWAS1088252 (human) | | 5e-13 | systolic blood pressure | | 10 | 18438972 | 18438973 | Human |
597243154 | GWAS1339228_H | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement QTL GWAS1339228 (human) | | 1e-21 | body fat mass (VT:0010482) | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 21541175 | 21541176 | Human |
406920906 | GWAS569882_H | pulse pressure measurement QTL GWAS569882 (human) | | 3e-15 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597583113 | GWAS1639973_H | mean corpuscular hemoglobin concentration QTL GWAS1639973 (human) | | 4e-14 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24922362 | 24922363 | Human |
597030157 | GWAS1126231_H | balding measurement QTL GWAS1126231 (human) | | 2e-27 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 32330644 | 32330645 | Human |
597161228 | GWAS1257302_H | lipid measurement QTL GWAS1257302 (human) | | 0.000008 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 25767754 | 25767755 | Human |
406896347 | GWAS545323_H | PR interval QTL GWAS545323 (human) | | 0.000004 | PR interval | PR interval (CMO:0000233) | 10 | 26005899 | 26005900 | Human |
597361976 | GWAS1458050_H | prostate specific antigen amount QTL GWAS1458050 (human) | | 1e-08 | prostate specific antigen amount | | 10 | 27805490 | 27805491 | Human |
407076582 | GWAS725558_H | pulse pressure measurement QTL GWAS725558 (human) | | 9e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20748365 | 20748366 | Human |
407076581 | GWAS725557_H | pulse pressure measurement QTL GWAS725557 (human) | | 8e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 18439030 | 18439031 | Human |
597603640 | GWAS1660500_H | type 2 diabetes mellitus QTL GWAS1660500 (human) | | 8e-13 | type 2 diabetes mellitus | | 10 | 26204863 | 26204864 | Human |
597071153 | GWAS1167227_H | mosquito bite reaction itch intensity measurement QTL GWAS1167227 (human) | | 0.000003 | mosquito bite reaction itch intensity measurement | | 10 | 30462242 | 30462243 | Human |
597603638 | GWAS1660498_H | type 2 diabetes mellitus QTL GWAS1660498 (human) | | 1e-08 | type 2 diabetes mellitus | | 10 | 23189705 | 23189706 | Human |
597603639 | GWAS1660499_H | type 2 diabetes mellitus QTL GWAS1660499 (human) | | 2e-11 | type 2 diabetes mellitus | | 10 | 23289248 | 23289249 | Human |
597304619 | GWAS1400693_H | neuropilin-1 measurement QTL GWAS1400693 (human) | | 7e-28 | neuropilin-1 measurement | | 10 | 33191785 | 33191786 | Human |
597181728 | GWAS1277802_H | protein measurement QTL GWAS1277802 (human) | | 3e-67 | protein measurement | | 10 | 22891690 | 22891691 | Human |
597136681 | GWAS1232755_H | response to cranial radiation therapy, short-term memory QTL GWAS1232755 (human) | | 0.000006 | response to cranial radiation therapy, short-term memory | | 10 | 19409203 | 19409204 | Human |
597144919 | GWAS1240993_H | low density lipoprotein cholesterol measurement QTL GWAS1240993 (human) | | 1e-08 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 18427013 | 18427014 | Human |
597443930 | GWAS1540004_H | lipid measurement QTL GWAS1540004 (human) | | 0.00001 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 37313836 | 37313837 | Human |
407027333 | GWAS676309_H | coronary artery disease QTL GWAS676309 (human) | | 4e-08 | coronary artery disease | | 10 | 30046193 | 30046194 | Human |
597275985 | GWAS1372059_H | Uterine leiomyoma QTL GWAS1372059 (human) | | 2e-10 | Uterine leiomyoma | | 10 | 21695031 | 21695032 | Human |
597157215 | GWAS1253289_H | open-angle glaucoma QTL GWAS1253289 (human) | | 2e-09 | open-angle glaucoma | | 10 | 24833650 | 24833651 | Human |
407051923 | GWAS700899_H | ovarian carcinoma QTL GWAS700899 (human) | | 2e-08 | ovarian carcinoma | | 10 | 21626690 | 21626691 | Human |
597267788 | GWAS1363862_H | aortic measurement QTL GWAS1363862 (human) | | 2e-08 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29788985 | 29788986 | Human |
407367312 | GWAS1016288_H | gestational age QTL GWAS1016288 (human) | | 0.000008 | gestational age | | 10 | 18801883 | 18801884 | Human |
407051924 | GWAS700900_H | ovarian carcinoma QTL GWAS700900 (human) | | 0.0000001 | ovarian carcinoma | | 10 | 21626690 | 21626691 | Human |
597083457 | GWAS1179531_H | neutrophil count QTL GWAS1179531 (human) | | 3e-09 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 22905324 | 22905325 | Human |
597402946 | GWAS1499020_H | ulcerative colitis QTL GWAS1499020 (human) | | 2e-08 | ulcerative colitis | | 10 | 35006503 | 35006504 | Human |
597206338 | GWAS1302412_H | ferritin measurement QTL GWAS1302412 (human) | | 0.000006 | ferritin measurement | | 10 | 25846910 | 25846911 | Human |
407129758 | GWAS778734_H | multiple sclerosis QTL GWAS778734 (human) | | 0.000008 | multiple sclerosis | | 10 | 29719734 | 29719735 | Human |
407170724 | GWAS819700_H | FEV/FVC ratio QTL GWAS819700 (human) | | 0.000003 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 32172247 | 32172249 | Human |
406970016 | GWAS618992_H | diastolic blood pressure QTL GWAS618992 (human) | | 8e-19 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18451703 | 18451704 | Human |
597067123 | GWAS1163197_H | susceptibility to measles measurement QTL GWAS1163197 (human) | | 0.000006 | susceptibility to measles measurement | | 10 | 20717817 | 20717818 | Human |
596956529 | GWAS1076048_H | aggressive periodontitis QTL GWAS1076048 (human) | | 0.000005 | aggressive periodontitis | | 10 | 37884551 | 37884552 | Human |
596952444 | GWAS1071963_H | size QTL GWAS1071963 (human) | | 3e-10 | size | | 10 | 29202396 | 29202397 | Human |
597456246 | GWAS1552320_H | asthma, endometriosis QTL GWAS1552320 (human) | | 0.0000004 | asthma, endometriosis | | 10 | 21379270 | 21379271 | Human |
597181815 | GWAS1277889_H | focal segmental glomerulosclerosis QTL GWAS1277889 (human) | | 0.0000004 | focal segmental glomerulosclerosis | | 10 | 32685527 | 32685528 | Human |
597456237 | GWAS1552311_H | asthma, endometriosis QTL GWAS1552311 (human) | | 8e-11 | asthma, endometriosis | | 10 | 21530895 | 21530896 | Human |
597378402 | GWAS1474476_H | HOMA-IR QTL GWAS1474476 (human) | | 0.000003 | HOMA-IR | Homeostatic Model Assessment of Insulin Resistance (CMO:0003002) | 10 | 24030986 | 24030987 | Human |
597312869 | GWAS1408943_H | electrocardiography QTL GWAS1408943 (human) | | 3e-08 | electrocardiography | | 10 | 38785260 | 38785261 | Human |
597222552 | GWAS1318626_H | respiratory symptom measurement, COVID-19 QTL GWAS1318626 (human) | | 0.000004 | respiratory symptom measurement, COVID-19 | respiratory system measurement (CMO:0000094) | 10 | 38296982 | 38296989 | Human |
597222553 | GWAS1318627_H | respiratory symptom measurement, COVID-19 QTL GWAS1318627 (human) | | 0.000008 | respiratory symptom measurement, COVID-19 | respiratory system measurement (CMO:0000094) | 10 | 38773942 | 38773943 | Human |
597103765 | GWAS1199839_H | amyloid-beta measurement QTL GWAS1199839 (human) | | 0.000006 | amyloid-beta measurement | | 10 | 24395882 | 24395883 | Human |
597054612 | GWAS1150686_H | systolic blood pressure QTL GWAS1150686 (human) | | 2e-14 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27908597 | 27908598 | Human |
597329049 | GWAS1425123_H | hypertension QTL GWAS1425123 (human) | | 1e-08 | hypertension | | 10 | 27939936 | 27939937 | Human |
597488792 | GWAS1584866_H | basophil count QTL GWAS1584866 (human) | | 1e-11 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 28491364 | 28491365 | Human |
597054611 | GWAS1150685_H | systolic blood pressure QTL GWAS1150685 (human) | | 3e-71 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
597103762 | GWAS1199836_H | male breast carcinoma QTL GWAS1199836 (human) | | 0.0000003 | male breast carcinoma | | 10 | 21668300 | 21668301 | Human |
597279900 | GWAS1375974_H | high density lipoprotein cholesterol measurement QTL GWAS1375974 (human) | | 5e-15 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33347171 | 33347172 | Human |
597435540 | GWAS1531614_H | body weight QTL GWAS1531614 (human) | | 4e-10 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 22659733 | 22659734 | Human |
597435541 | GWAS1531615_H | body weight QTL GWAS1531615 (human) | | 3e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 23843090 | 23843091 | Human |
597161118 | GWAS1257192_H | factor VIII measurement, coronary artery disease QTL GWAS1257192 (human) | | 1e-12 | tissue plasminogen activator measurement, coronary artery disease | blood plasminogen activator inhibitor 1 level (CMO:0003034) | 10 | 30028144 | 30028145 | Human |
597283987 | GWAS1380061_H | C-reactive protein measurement QTL GWAS1380061 (human) | | 3e-08 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 21584366 | 21584367 | Human |
597578901 | GWAS1635761_H | prothrombin time measurement QTL GWAS1635761 (human) | | 2e-36 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19936725 | 19936726 | Human |
597283989 | GWAS1380063_H | C-reactive protein measurement QTL GWAS1380063 (human) | | 6e-11 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 30408012 | 30408013 | Human |
597439628 | GWAS1535702_H | BMI-adjusted waist-hip ratio QTL GWAS1535702 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 31701695 | 31701696 | Human |
597386377 | GWAS1482451_H | testosterone measurement QTL GWAS1482451 (human) | | 0.000005 | testosterone measurement | serum testosterone level (CMO:0000568) | 10 | 31088634 | 31088635 | Human |
597030016 | GWAS1126090_H | coronary aneurysm QTL GWAS1126090 (human) | | 7e-09 | coronary aneurysm | | 10 | 20879174 | 20879175 | Human |
597599368 | GWAS1656228_H | prothrombin time measurement QTL GWAS1656228 (human) | | 2e-33 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
597447813 | GWAS1543887_H | diet measurement, testosterone measurement QTL GWAS1543887 (human) | | 0.000009 | eating behavior trait (VT:0001431) | serum testosterone level (CMO:0000568) | 10 | 38714782 | 38714783 | Human |
597595268 | GWAS1652128_H | coronary artery disease QTL GWAS1652128 (human) | | 1e-26 | coronary artery disease | | 10 | 44247070 | 44247071 | Human |
407146331 | GWAS795307_H | Hirschsprung disease QTL GWAS795307 (human) | | 6e-19 | Hirschsprung disease | | 10 | 43114918 | 43114919 | Human |
597275833 | GWAS1371907_H | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence QTL GWAS1371907 (human) | | 4e-08 | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | | 10 | 29280343 | 29280344 | Human |
597324987 | GWAS1421061_H | color vision disorder QTL GWAS1421061 (human) | | 0.000006 | color vision disorder | | 10 | 18431056 | 18431057 | Human |
597312699 | GWAS1408773_H | vaginal microbiome measurement QTL GWAS1408773 (human) | | 0.0000008 | vaginal microbiome measurement | | 10 | 43111408 | 43111409 | Human |
597132469 | GWAS1228543_H | memory performance QTL GWAS1228543 (human) | | 0.000003 | memory performance | | 10 | 19806476 | 19806477 | Human |
597267633 | GWAS1363707_H | large artery stroke QTL GWAS1363707 (human) | | 7e-12 | large artery stroke | | 10 | 30034963 | 30034964 | Human |
597312690 | GWAS1408764_H | electrocardiography QTL GWAS1408764 (human) | | 4e-08 | electrocardiography | | 10 | 38785260 | 38785261 | Human |
597132477 | GWAS1228551_H | memory performance QTL GWAS1228551 (human) | | 0.000004 | memory performance | | 10 | 19819940 | 19819941 | Human |
597345456 | GWAS1441530_H | neutrophil measurement QTL GWAS1441530 (human) | | 2e-14 | neutrophil measurement | | 10 | 28643143 | 28643144 | Human |
597443766 | GWAS1539840_H | BMI-adjusted hip circumference QTL GWAS1539840 (human) | | 3e-10 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 33877770 | 33877771 | Human |
597312689 | GWAS1408763_H | electrocardiography QTL GWAS1408763 (human) | | 5e-08 | electrocardiography | | 10 | 38785260 | 38785261 | Human |
597324983 | GWAS1421057_H | color vision disorder QTL GWAS1421057 (human) | | 0.000003 | color vision disorder | | 10 | 21070097 | 21070098 | Human |
597132473 | GWAS1228547_H | memory performance QTL GWAS1228547 (human) | | 0.000004 | memory performance | | 10 | 19810364 | 19810365 | Human |
597525682 | GWAS1621756_H | protein measurement QTL GWAS1621756 (human) | | 1e-13 | protein measurement | | 10 | 37812650 | 37812651 | Human |
597341355 | GWAS1437429_H | non-small cell lung carcinoma QTL GWAS1437429 (human) | | 0.000008 | non-small cell lung carcinoma | | 10 | 20789548 | 20789549 | Human |
597075108 | GWAS1171182_H | coronary artery disease QTL GWAS1171182 (human) | | 6e-13 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597410984 | GWAS1507058_H | colorectal cancer QTL GWAS1507058 (human) | | 0.000007 | colorectal cancer | | 10 | 33116647 | 33116648 | Human |
597075107 | GWAS1171181_H | coronary artery disease QTL GWAS1171181 (human) | | 4e-12 | coronary artery disease | | 10 | 30032669 | 30032670 | Human |
597050528 | GWAS1146602_H | C-reactive protein measurement QTL GWAS1146602 (human) | | 1e-09 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 21541175 | 21541176 | Human |
597312674 | GWAS1408748_H | total blood protein measurement QTL GWAS1408748 (human) | | 2e-08 | total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 30740823 | 30740824 | Human |
406978424 | GWAS627400_H | white matter microstructure measurement QTL GWAS627400 (human) | | 2e-09 | white matter microstructure measurement | | 10 | 21583984 | 21583985 | Human |
597316771 | GWAS1412845_H | hippocampal volume QTL GWAS1412845 (human) | | 0.000005 | hippocampal volume | | 10 | 24315158 | 24315159 | Human |
597611682 | GWAS1668542_H | sialolithiasis QTL GWAS1668542 (human) | | 3e-14 | sialolithiasis | | 10 | 26774627 | 26774628 | Human |
597370022 | GWAS1466096_H | FEV/FVC ratio QTL GWAS1466096 (human) | | 0.000007 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 28328706 | 28328707 | Human |
597611683 | GWAS1668543_H | sialolithiasis QTL GWAS1668543 (human) | | 3e-11 | sialolithiasis | | 10 | 35350667 | 35350668 | Human |
597468380 | GWAS1564454_H | Hirschsprung disease QTL GWAS1564454 (human) | | 2e-101 | Hirschsprung disease | | 10 | 43073439 | 43073440 | Human |
597415130 | GWAS1511204_H | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant QTL GWAS1511204 (human) | | 4e-08 | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to anticonvulsant | | 10 | 38643136 | 38643137 | Human |
597488862 | GWAS1584936_H | migraine disorder QTL GWAS1584936 (human) | | 8e-09 | migraine disorder | | 10 | 21533927 | 21533928 | Human |
597361881 | GWAS1457955_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS1457955 (human) | | 0.000008 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 10 | 29800065 | 29800066 | Human |
597468382 | GWAS1564456_H | Hirschsprung disease QTL GWAS1564456 (human) | | 0.0000006 | Hirschsprung disease | | 10 | 43063942 | 43063943 | Human |
597165277 | GWAS1261351_H | type 2 diabetes mellitus, major depressive disorder, coronary artery disease QTL GWAS1261351 (human) | | 0.0000004 | type 2 diabetes mellitus, major depressive disorder, coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597062877 | GWAS1158951_H | tuberculin skin test reactivity measurement, decreased susceptibility to bacterial infection QTL GWAS1158951 (human) | | 0.000006 | response to bacterial infection trait (VT:0010435) | | 10 | 44318888 | 44318889 | Human |
597472464 | GWAS1568538_H | pulmonary function measurement QTL GWAS1568538 (human) | | 0.000002 | pulmonary function measurement | | 10 | 20631052 | 20631053 | Human |
407023373 | GWAS672349_H | coronary artery disease QTL GWAS672349 (human) | | 1e-11 | coronary artery disease | | 10 | 30027143 | 30027144 | Human |
597615823 | GWAS1672683_H | prostate specific antigen amount QTL GWAS1672683 (human) | | 1e-16 | prostate specific antigen amount | | 10 | 22031264 | 22031265 | Human |
597230792 | GWAS1326866_H | ovarian carcinoma QTL GWAS1326866 (human) | | 0.000002 | ovarian carcinoma | | 10 | 25607085 | 25607092 | Human |
597615820 | GWAS1672680_H | prostate specific antigen amount QTL GWAS1672680 (human) | | 1e-18 | prostate specific antigen amount | | 10 | 22027183 | 22027184 | Human |
406974231 | GWAS623207_H | reticulocyte count QTL GWAS623207 (human) | | 4e-139 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24929314 | 24929315 | Human |
597337293 | GWAS1433367_H | systolic blood pressure QTL GWAS1433367 (human) | | 6e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27939936 | 27939937 | Human |
597402818 | GWAS1498892_H | coronary artery disease QTL GWAS1498892 (human) | | 1e-12 | coronary artery disease | | 10 | 44261659 | 44261660 | Human |
597394629 | GWAS1490703_H | heel bone mineral density QTL GWAS1490703 (human) | | 2e-10 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 43871839 | 43871840 | Human |
597099720 | GWAS1195794_H | cardiac arrhythmia QTL GWAS1195794 (human) | | 1e-09 | cardiac arrhythmia | | 10 | 20868692 | 20868693 | Human |
597615870 | GWAS1672730_H | prostate specific antigen amount QTL GWAS1672730 (human) | | 1e-18 | prostate specific antigen amount | | 10 | 23111464 | 23111465 | Human |
597615871 | GWAS1672731_H | prostate specific antigen amount QTL GWAS1672731 (human) | | 2e-23 | prostate specific antigen amount | | 10 | 27811674 | 27811675 | Human |
596952309 | GWAS1071828_H | bone density QTL GWAS1071828 (human) | | 1e-30 | bone density | | 10 | 30764353 | 30764354 | Human |
597615868 | GWAS1672728_H | prostate specific antigen amount QTL GWAS1672728 (human) | | 7e-17 | prostate specific antigen amount | | 10 | 23111464 | 23111465 | Human |
597615869 | GWAS1672729_H | prostate specific antigen amount QTL GWAS1672729 (human) | | 5e-25 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
597116147 | GWAS1212221_H | intraocular pressure measurement QTL GWAS1212221 (human) | | 4e-08 | intraocular pressure measurement | | 10 | 30178249 | 30178250 | Human |
597370100 | GWAS1466174_H | insomnia measurement QTL GWAS1466174 (human) | | 4e-10 | sleep behavior trait (VT:0001501) | | 10 | 21532989 | 21532990 | Human |
597591278 | GWAS1648138_H | fungal infectious disease QTL GWAS1648138 (human) | | 1e-11 | fungal infectious disease | | 10 | 24171811 | 24171812 | Human |
597619948 | GWAS1676808_H | body weight QTL GWAS1676808 (human) | | 3e-11 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 21508343 | 21508344 | Human |
406957875 | GWAS606851_H | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis QTL GWAS606851 (human) | | 5e-29 | intestine integrity trait (VT:0010554) | | 10 | 35177257 | 35177258 | Human |
597521643 | GWAS1617717_H | gestational diabetes QTL GWAS1617717 (human) | | 9e-08 | gestational diabetes | | 10 | 31072535 | 31072536 | Human |
407080756 | GWAS729732_H | congenital left-sided heart lesions, parental genotype effect measurement QTL GWAS729732 (human) | | 0.0000006 | congenital left-sided heart lesions, parental genotype effect measurement | | 10 | 30753565 | 30753566 | Human |
597058798 | GWAS1154872_H | FEV/FVC ratio QTL GWAS1154872 (human) | | 3e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 30985616 | 30985617 | Human |
597058799 | GWAS1154873_H | FEV/FVC ratio QTL GWAS1154873 (human) | | 7e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 34191654 | 34191655 | Human |
597144813 | GWAS1240887_H | low density lipoprotein cholesterol measurement QTL GWAS1240887 (human) | | 0.000003 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 18427013 | 18427014 | Human |
597058796 | GWAS1154870_H | FEV/FVC ratio QTL GWAS1154870 (human) | | 0.0000001 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 21517903 | 21517904 | Human |
597116141 | GWAS1212215_H | intraocular pressure measurement QTL GWAS1212215 (human) | | 2e-08 | intraocular pressure measurement | | 10 | 24877899 | 24877900 | Human |
597058797 | GWAS1154871_H | FEV/FVC ratio QTL GWAS1154871 (human) | | 1e-10 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 29964321 | 29964322 | Human |
597058794 | GWAS1154868_H | FEV/FVC ratio QTL GWAS1154868 (human) | | 9e-18 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 19872044 | 19872045 | Human |
596952296 | GWAS1071815_H | size QTL GWAS1071815 (human) | | 2e-13 | size | | 10 | 24889935 | 24889936 | Human |
597058795 | GWAS1154869_H | FEV/FVC ratio QTL GWAS1154869 (human) | | 2e-14 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 20921609 | 20921610 | Human |
597492960 | GWAS1589034_H | pulmonary tuberculosis QTL GWAS1589034 (human) | | 0.000005 | pulmonary tuberculosis | | 10 | 35238615 | 35238616 | Human |
597038312 | GWAS1134386_H | gut microbiome measurement QTL GWAS1134386 (human) | | 0.0000006 | gut microbiome measurement | | 10 | 27852516 | 27852517 | Human |
406970311 | GWAS619287_H | open-angle glaucoma QTL GWAS619287 (human) | | 0.0000006 | open-angle glaucoma | | 10 | 28116482 | 28116483 | Human |
596972572 | GWAS1092091_H | radiation-induced disorder QTL GWAS1092091 (human) | | 0.00001 | radiation-induced disorder | | 10 | 22890838 | 22890839 | Human |
597341200 | GWAS1437274_H | white matter microstructure measurement QTL GWAS1437274 (human) | | 4e-10 | white matter microstructure measurement | | 10 | 21541418 | 21541419 | Human |
597341201 | GWAS1437275_H | white matter microstructure measurement QTL GWAS1437275 (human) | | 9e-16 | white matter microstructure measurement | | 10 | 21966434 | 21966435 | Human |
597091357 | GWAS1187431_H | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration QTL GWAS1187431 (human) | | 4e-08 | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | | 10 | 24710664 | 24710665 | Human |
596976670 | GWAS1096189_H | body height QTL GWAS1096189 (human) | | 5e-13 | body height | | 10 | 25045977 | 25045978 | Human |
596964383 | GWAS1083902_H | gut microbiome measurement, bone density QTL GWAS1083902 (human) | | 4e-08 | gut microbiome measurement, bone density | | 10 | 31676506 | 31676507 | Human |
407146447 | GWAS795423_H | uridine diphosphate measurement QTL GWAS795423 (human) | | 0.000009 | uridine diphosphate measurement | | 10 | 32100496 | 32100497 | Human |
597337109 | GWAS1433183_H | pulse pressure measurement QTL GWAS1433183 (human) | | 9e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 22550699 | 22550700 | Human |
597582863 | GWAS1639723_H | mean corpuscular hemoglobin concentration QTL GWAS1639723 (human) | | 2e-11 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24922362 | 24922363 | Human |
597496846 | GWAS1592920_H | hip geometry QTL GWAS1592920 (human) | | 7e-16 | hip geometry | hip circumference (CMO:0000014) | 10 | 32301434 | 32301435 | Human |
596968449 | GWAS1087968_H | body mass index QTL GWAS1087968 (human) | | 2e-12 | body mass index | | 10 | 33671750 | 33671751 | Human |
597292033 | GWAS1388107_H | intraocular pressure measurement QTL GWAS1388107 (human) | | 1e-08 | intraocular pressure measurement | | 10 | 28669675 | 28669676 | Human |
597017615 | GWAS1113689_H | basophil count QTL GWAS1113689 (human) | | 8e-22 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 28491444 | 28491445 | Human |
597332993 | GWAS1429067_H | R-warfarin measurement QTL GWAS1429067 (human) | | 0.000008 | R-warfarin measurement | | 10 | 24774681 | 24774682 | Human |
406912988 | GWAS561964_H | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement QTL GWAS561964 (human) | | 0.000005 | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | | 10 | 36748480 | 36748481 | Human |
596968500 | GWAS1088019_H | systolic blood pressure QTL GWAS1088019 (human) | | 2e-12 | systolic blood pressure | | 10 | 27956491 | 27956492 | Human |
597587004 | GWAS1643864_H | eosinophil count QTL GWAS1643864 (human) | | 1e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28495554 | 28495555 | Human |
597201980 | GWAS1298054_H | restless legs syndrome QTL GWAS1298054 (human) | | 5e-09 | restless legs syndrome | | 10 | 21535798 | 21535799 | Human |
406982630 | GWAS631606_H | white matter microstructure measurement QTL GWAS631606 (human) | | 2e-09 | white matter microstructure measurement | | 10 | 21693376 | 21693377 | Human |
597587003 | GWAS1643863_H | eosinophil count QTL GWAS1643863 (human) | | 2e-40 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26447549 | 26447550 | Human |
597271615 | GWAS1367689_H | insomnia QTL GWAS1367689 (human) | | 4e-09 | insomnia | | 10 | 21485672 | 21485673 | Human |
597214256 | GWAS1310330_H | mathematical ability QTL GWAS1310330 (human) | | 4e-08 | mathematical ability | | 10 | 20022758 | 20022759 | Human |
597242929 | GWAS1339003_H | smoking status measurement QTL GWAS1339003 (human) | | 3e-09 | smoking status measurement | | 10 | 21695031 | 21695032 | Human |
597214257 | GWAS1310331_H | mathematical ability QTL GWAS1310331 (human) | | 2e-08 | mathematical ability | | 10 | 20287313 | 20287314 | Human |
597214258 | GWAS1310332_H | mathematical ability QTL GWAS1310332 (human) | | 1e-09 | mathematical ability | | 10 | 24275024 | 24275025 | Human |
597214259 | GWAS1310333_H | mathematical ability QTL GWAS1310333 (human) | | 8e-14 | mathematical ability | | 10 | 34277992 | 34277993 | Human |
597488690 | GWAS1584764_H | ubiquinone measurement QTL GWAS1584764 (human) | | 2e-08 | ubiquinone measurement | | 10 | 26667051 | 26667052 | Human |
597275693 | GWAS1371767_H | insomnia QTL GWAS1371767 (human) | | 5e-09 | insomnia | | 10 | 21984602 | 21984603 | Human |
596972585 | GWAS1092104_H | radiation-induced disorder QTL GWAS1092104 (human) | | 0.0000002 | radiation-induced disorder | | 10 | 30682334 | 30682335 | Human |
406953983 | GWAS602959_H | eosinophil count QTL GWAS602959 (human) | | 1e-22 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26447311 | 26447312 | Human |
597070888 | GWAS1166962_H | BMI-adjusted hip circumference QTL GWAS1166962 (human) | | 0.000002 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 34212304 | 34212305 | Human |
597492828 | GWAS1588902_H | COVID-19 QTL GWAS1588902 (human) | | 0.000006 | COVID-19 | | 10 | 27774793 | 27774794 | Human |
597181533 | GWAS1277607_H | surfeit locus protein 1 measurement QTL GWAS1277607 (human) | | 3e-14 | surfeit locus protein 1 measurement | | 10 | 19832227 | 19832228 | Human |
597181520 | GWAS1277594_H | surfeit locus protein 1 measurement QTL GWAS1277594 (human) | | 4e-39 | surfeit locus protein 1 measurement | | 10 | 19931917 | 19931918 | Human |
597058654 | GWAS1154728_H | vital capacity QTL GWAS1154728 (human) | | 1e-10 | vital capacity | | 10 | 21541175 | 21541176 | Human |
597238865 | GWAS1334939_H | monocyte count QTL GWAS1334939 (human) | | 1e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44384263 | 44384264 | Human |
597058655 | GWAS1154729_H | vital capacity QTL GWAS1154729 (human) | | 1e-12 | vital capacity | | 10 | 27908597 | 27908598 | Human |
407043977 | GWAS692953_H | breast carcinoma QTL GWAS692953 (human) | | 9e-16 | mammary gland integrity trait (VT:0010552) | | 10 | 22026914 | 22026915 | Human |
597283924 | GWAS1379998_H | diastolic blood pressure QTL GWAS1379998 (human) | | 1e-22 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
597406794 | GWAS1502868_H | coronary artery disease, factor VII measurement QTL GWAS1502868 (human) | | 9e-18 | factor XI measurement, coronary artery disease | | 10 | 44261109 | 44261110 | Human |
597271617 | GWAS1367691_H | insomnia QTL GWAS1367691 (human) | | 1e-12 | insomnia | | 10 | 21980918 | 21980919 | Human |
597271616 | GWAS1367690_H | insomnia QTL GWAS1367690 (human) | | 2e-08 | insomnia | | 10 | 21549451 | 21549452 | Human |
597271619 | GWAS1367693_H | insomnia QTL GWAS1367693 (human) | | 3e-08 | insomnia | | 10 | 30223276 | 30223277 | Human |
597271618 | GWAS1367692_H | insomnia QTL GWAS1367692 (human) | | 4e-13 | insomnia | | 10 | 24743151 | 24743152 | Human |
596968520 | GWAS1088039_H | systolic blood pressure QTL GWAS1088039 (human) | | 4e-48 | systolic blood pressure | | 10 | 18439030 | 18439031 | Human |
597271620 | GWAS1367694_H | insomnia QTL GWAS1367694 (human) | | 3e-09 | insomnia | | 10 | 43255004 | 43255005 | Human |
406982562 | GWAS631538_H | white matter microstructure measurement QTL GWAS631538 (human) | | 3e-09 | white matter microstructure measurement | | 10 | 24771958 | 24771959 | Human |
597042292 | GWAS1138366_H | triglyceride measurement, response to diuretic QTL GWAS1138366 (human) | | 0.0000007 | triglyceride measurement, response to diuretic | blood triglyceride level (CMO:0000118) | 10 | 24229251 | 24229252 | Human |
597042293 | GWAS1138367_H | triglyceride measurement, response to diuretic QTL GWAS1138367 (human) | | 1e-08 | triglyceride measurement, response to diuretic | blood triglyceride level (CMO:0000118) | 10 | 24245127 | 24245128 | Human |
597595261 | GWAS1652121_H | blood urea nitrogen measurement QTL GWAS1652121 (human) | | 4e-19 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28907726 | 28907727 | Human |
597333119 | GWAS1429193_H | renal agenesis, unilateral QTL GWAS1429193 (human) | | 0.000007 | renal agenesis, unilateral | | 10 | 43621601 | 43621602 | Human |
597349490 | GWAS1445564_H | body mass index QTL GWAS1445564 (human) | | 3e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21501547 | 21501548 | Human |
407154604 | GWAS803580_H | gut microbiome measurement QTL GWAS803580 (human) | | 0.000002 | gut microbiome measurement | | 10 | 31380865 | 31380866 | Human |
597345393 | GWAS1441467_H | color vision disorder QTL GWAS1441467 (human) | | 0.0000008 | color vision disorder | | 10 | 29109766 | 29109767 | Human |
597345397 | GWAS1441471_H | color vision disorder QTL GWAS1441471 (human) | | 0.000002 | color vision disorder | | 10 | 18536434 | 18536435 | Human |
407154603 | GWAS803579_H | gut microbiome measurement QTL GWAS803579 (human) | | 0.000002 | gut microbiome measurement | | 10 | 29684014 | 29684015 | Human |
597488755 | GWAS1584829_H | uterine fibroid QTL GWAS1584829 (human) | | 3e-08 | uterine fibroid | | 10 | 31624962 | 31624963 | Human |
597333102 | GWAS1429176_H | atrial fibrillation QTL GWAS1429176 (human) | | 1e-08 | atrial fibrillation | | 10 | 20913431 | 20913432 | Human |
597058658 | GWAS1154732_H | vital capacity QTL GWAS1154732 (human) | | 1e-08 | vital capacity | | 10 | 34201926 | 34201927 | Human |
597283949 | GWAS1380023_H | eosinophil count QTL GWAS1380023 (human) | | 7e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44374792 | 44374793 | Human |
597120098 | GWAS1216172_H | lymphocyte count QTL GWAS1216172 (human) | | 1e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26503215 | 26503216 | Human |
597058656 | GWAS1154730_H | vital capacity QTL GWAS1154730 (human) | | 1e-08 | vital capacity | | 10 | 29279848 | 29279849 | Human |
597058657 | GWAS1154731_H | vital capacity QTL GWAS1154731 (human) | | 6e-09 | vital capacity | | 10 | 30992321 | 30992322 | Human |
597492842 | GWAS1588916_H | COVID-19 QTL GWAS1588916 (human) | | 0.000008 | COVID-19 | | 10 | 31777652 | 31777653 | Human |
597345389 | GWAS1441463_H | color vision disorder QTL GWAS1441463 (human) | | 3e-08 | color vision disorder | | 10 | 43220593 | 43220594 | Human |
597333089 | GWAS1429163_H | atrial fibrillation QTL GWAS1429163 (human) | | 2e-10 | atrial fibrillation | | 10 | 20868692 | 20868693 | Human |
597247078 | GWAS1343152_H | schizophrenia, sex interaction measurement QTL GWAS1343152 (human) | | 0.000004 | schizophrenia, sex interaction measurement | | 10 | 36748480 | 36748481 | Human |
406913088 | GWAS562064_H | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement QTL GWAS562064 (human) | | 0.000001 | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | | 10 | 36748480 | 36748481 | Human |
406999115 | GWAS648091_H | adolescent idiopathic scoliosis QTL GWAS648091 (human) | | 0.000004 | adolescent idiopathic scoliosis | | 10 | 27112127 | 27112128 | Human |
597318550 | GWAS1414624_H | diet measurement QTL GWAS1414624 (human) | | 1e-28 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21809772 | 21809773 | Human |
597146523 | GWAS1242597_H | prostate carcinoma QTL GWAS1242597 (human) | | 5e-09 | prostate carcinoma | | 10 | 27858653 | 27858654 | Human |
597027738 | GWAS1123812_H | waist-hip ratio QTL GWAS1123812 (human) | | 2e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 21619874 | 21619875 | Human |
597371785 | GWAS1467859_H | birth weight QTL GWAS1467859 (human) | | 0.000006 | birth weight | neonatal body weight (CMO:0002079) | 10 | 43963266 | 43963267 | Human |
597433230 | GWAS1529304_H | protein measurement QTL GWAS1529304 (human) | | 6e-10 | protein measurement | | 10 | 44386657 | 44386658 | Human |
406929495 | GWAS578471_H | pulse pressure measurement QTL GWAS578471 (human) | | 7e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20224618 | 20224619 | Human |
597584776 | GWAS1641636_H | drug use measurement, benign prostatic hyperplasia QTL GWAS1641636 (human) | | 8e-16 | prostate integrity trait (VT:0010571) | | 10 | 22024986 | 22024987 | Human |
597048206 | GWAS1144280_H | BMI-adjusted waist-hip ratio QTL GWAS1144280 (human) | | 1e-08 | body size trait (VT:0100005) | | 10 | 33368310 | 33368311 | Human |
597404545 | GWAS1500619_H | amygdala volume change measurement, age at assessment QTL GWAS1500619 (human) | | 0.000009 | amygdala volume change measurement, age at assessment | | 10 | 25693930 | 25693931 | Human |
406962267 | GWAS611243_H | response to vaccine QTL GWAS611243 (human) | | 1e-10 | response to vaccine | | 10 | 27736842 | 27736843 | Human |
597461894 | GWAS1557968_H | rheumatoid arthritis QTL GWAS1557968 (human) | | 0.000008 | rheumatoid arthritis | | 10 | 31126177 | 31126178 | Human |
597302149 | GWAS1398223_H | torsin-1A-interacting protein 1 measurement QTL GWAS1398223 (human) | | 6e-15 | torsin-1A-interacting protein 1 measurement | | 10 | 19936725 | 19936726 | Human |
597048247 | GWAS1144321_H | BMI-adjusted waist-hip ratio QTL GWAS1144321 (human) | | 1e-12 | body size trait (VT:0100005) | | 10 | 32268664 | 32268665 | Human |
597138353 | GWAS1234427_H | diastolic blood pressure QTL GWAS1234427 (human) | | 2e-82 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
407253088 | GWAS902064_H | unipolar depression, alcohol dependence QTL GWAS902064 (human) | | 0.000006 | unipolar depression, alcohol dependence | | 10 | 23381413 | 23381414 | Human |
597138352 | GWAS1234426_H | diastolic blood pressure QTL GWAS1234426 (human) | | 9e-23 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18438972 | 18438973 | Human |
597048241 | GWAS1144315_H | BMI-adjusted waist-hip ratio QTL GWAS1144315 (human) | | 5e-08 | body size trait (VT:0100005) | | 10 | 24617214 | 24617215 | Human |
597441457 | GWAS1537531_H | lifestyle measurement, maximum cigarettes per day measurement QTL GWAS1537531 (human) | | 0.0000003 | lifestyle measurement, maximum cigarettes per day measurement | | 10 | 32239506 | 32239507 | Human |
597019579 | GWAS1115653_H | smoking status measurement, diastolic blood pressure QTL GWAS1115653 (human) | | 0.000004 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 36024569 | 36024570 | Human |
597048249 | GWAS1144323_H | BMI-adjusted waist-hip ratio QTL GWAS1144323 (human) | | 3e-11 | body size trait (VT:0100005) | | 10 | 33270391 | 33270392 | Human |
407269494 | GWAS918470_H | coronary artery disease QTL GWAS918470 (human) | | 7e-09 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
597334955 | GWAS1431029_H | COVID-19 QTL GWAS1431029 (human) | | 0.0000009 | COVID-19 | | 10 | 24886670 | 24886671 | Human |
597273517 | GWAS1369591_H | schizophrenia QTL GWAS1369591 (human) | | 0.000002 | schizophrenia | | 10 | 18537290 | 18537291 | Human |
596966304 | GWAS1085823_H | diastolic blood pressure QTL GWAS1085823 (human) | | 3e-11 | diastolic blood pressure | | 10 | 27956491 | 27956492 | Human |
596962210 | GWAS1081729_H | brain measurement QTL GWAS1081729 (human) | | 2e-18 | brain measurement | | 10 | 21531721 | 21531722 | Human |
596962211 | GWAS1081730_H | brain measurement QTL GWAS1081730 (human) | | 4e-09 | brain measurement | | 10 | 24955463 | 24955464 | Human |
407339120 | GWAS988096_H | waist-hip ratio QTL GWAS988096 (human) | | 2e-14 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 32268664 | 32268665 | Human |
597380003 | GWAS1476077_H | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy QTL GWAS1476077 (human) | | 8e-09 | response to viral infection trait (VT:0010439) | | 10 | 44368720 | 44368721 | Human |
597236640 | GWAS1332714_H | eosinophil count QTL GWAS1332714 (human) | | 6e-25 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26446058 | 26446059 | Human |
597162924 | GWAS1258998_H | factor XI measurement, venous thromboembolism QTL GWAS1258998 (human) | | 1e-12 | factor XI measurement, venous thromboembolism | | 10 | 18703947 | 18703948 | Human |
596949973 | GWAS1069492_H | susceptibility to childhood ear infection measurement QTL GWAS1069492 (human) | | 5e-16 | susceptibility to childhood ear infection measurement | | 10 | 27611953 | 27611954 | Human |
407019526 | GWAS668502_H | sudden cardiac arrest QTL GWAS668502 (human) | | 0.0000004 | sudden cardiac arrest | | 10 | 18661626 | 18661627 | Human |
407289857 | GWAS938833_H | mean arterial pressure, unipolar depression QTL GWAS938833 (human) | | 5e-12 | mean arterial pressure, unipolar depression | | 10 | 18436124 | 18436125 | Human |
597597143 | GWAS1654003_H | prothrombin time measurement QTL GWAS1654003 (human) | | 3e-45 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
597101533 | GWAS1197607_H | multisite chronic pain QTL GWAS1197607 (human) | | 3e-08 | educational attainment | | 10 | 21668300 | 21668301 | Human |
597380048 | GWAS1476122_H | phosphoenolpyruvic acid measurement QTL GWAS1476122 (human) | | 0.000006 | phosphoenolpyruvic acid measurement | | 10 | 28498865 | 28498866 | Human |
407130132 | GWAS779108_H | wellbeing measurement QTL GWAS779108 (human) | | 0.000004 | wellness/fitness trait (VT:1000152) | | 10 | 27988740 | 27988741 | Human |
597162949 | GWAS1259023_H | lipid measurement QTL GWAS1259023 (human) | | 0.000004 | lipid measurement | blood lipid measurement (CMO:0000050) | 10 | 20494912 | 20494913 | Human |
597093314 | GWAS1189388_H | inflammatory bowel disease QTL GWAS1189388 (human) | | 2e-25 | inflammatory bowel disease | | 10 | 35177257 | 35177258 | Human |
407072788 | GWAS721764_H | urinary albumin to creatinine ratio QTL GWAS721764 (human) | | 2e-08 | urine albumin amount (VT:0002871) | urine albumin level to urine creatinine level ratio (CMO:0000384) | 10 | 21862649 | 21862650 | Human |
597040078 | GWAS1136152_H | diet measurement QTL GWAS1136152 (human) | | 2e-19 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21594501 | 21594502 | Human |
597154765 | GWAS1250839_H | BMI-adjusted waist-hip ratio QTL GWAS1250839 (human) | | 2e-10 | body size trait (VT:0100005) | | 10 | 33879162 | 33879163 | Human |
597154764 | GWAS1250838_H | BMI-adjusted waist-hip ratio QTL GWAS1250838 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 33192550 | 33192551 | Human |
597236677 | GWAS1332751_H | Vertigo QTL GWAS1332751 (human) | | 0.0000003 | Vertigo | | 10 | 18902658 | 18902659 | Human |
597130187 | GWAS1226261_H | memory performance QTL GWAS1226261 (human) | | 0.000008 | memory performance | | 10 | 25581343 | 25581344 | Human |
596954056 | GWAS1073575_H | dementia QTL GWAS1073575 (human) | | 0.000008 | dementia | | 10 | 28055865 | 28055866 | Human |
407158808 | GWAS807784_H | pulse pressure measurement QTL GWAS807784 (human) | | 7e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 32001058 | 32001059 | Human |
597154763 | GWAS1250837_H | BMI-adjusted waist-hip ratio QTL GWAS1250837 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 33195649 | 33195650 | Human |
597130186 | GWAS1226260_H | memory performance QTL GWAS1226260 (human) | | 0.000007 | memory performance | | 10 | 25581070 | 25581071 | Human |
597191621 | GWAS1287695_H | anthropometric measurement QTL GWAS1287695 (human) | | 2e-12 | anthropometric measurement | body morphological measurement (CMO:0000021) | 10 | 27623892 | 27623893 | Human |
597236679 | GWAS1332753_H | Vertigo QTL GWAS1332753 (human) | | 0.000006 | Vertigo | | 10 | 29693087 | 29693088 | Human |
597134281 | GWAS1230355_H | memory performance, sex interaction measurement QTL GWAS1230355 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 33218133 | 33218134 | Human |
597236678 | GWAS1332752_H | Vertigo QTL GWAS1332752 (human) | | 0.000006 | Vertigo | | 10 | 26814866 | 26814867 | Human |
407052323 | GWAS701299_H | post-traumatic stress disorder QTL GWAS701299 (human) | | 2e-09 | post-traumatic stress disorder | | 10 | 24927877 | 24927878 | Human |
597273593 | GWAS1369667_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1369667 (human) | | 1e-17 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42848427 | 42848428 | Human |
597273592 | GWAS1369666_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1369666 (human) | | 3e-23 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 43084776 | 43084777 | Human |
597601272 | GWAS1658132_H | blood urea nitrogen measurement QTL GWAS1658132 (human) | | 1e-12 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28908944 | 28908945 | Human |
597064703 | GWAS1160777_H | bone fracture QTL GWAS1160777 (human) | | 4e-08 | bone fracture | | 10 | 29570927 | 29570928 | Human |
597273587 | GWAS1369661_H | nidogen-1 measurement QTL GWAS1369661 (human) | | 6e-17 | nidogen-1 measurement | | 10 | 19936725 | 19936726 | Human |
596958206 | GWAS1077725_H | Red cell distribution width QTL GWAS1077725 (human) | | 2e-09 | Red cell distribution width | | 10 | 25497603 | 25497604 | Human |
597109755 | GWAS1205829_H | self reported educational attainment QTL GWAS1205829 (human) | | 2e-09 | self reported educational attainment | | 10 | 23664796 | 23664797 | Human |
597490672 | GWAS1586746_H | metabolite measurement QTL GWAS1586746 (human) | | 0.000005 | metabolite measurement | | 10 | 30238363 | 30238364 | Human |
596958201 | GWAS1077720_H | Red cell distribution width QTL GWAS1077720 (human) | | 5e-215 | Red cell distribution width | | 10 | 24569461 | 24569462 | Human |
597109753 | GWAS1205827_H | self reported educational attainment QTL GWAS1205827 (human) | | 2e-08 | taste liking measurement | | 10 | 21668300 | 21668301 | Human |
596958202 | GWAS1077721_H | Red cell distribution width QTL GWAS1077721 (human) | | 1e-24 | Red cell distribution width | | 10 | 24911662 | 24911663 | Human |
597117924 | GWAS1213998_H | DNA methylation QTL GWAS1213998 (human) | | 8e-09 | DNA methylation | | 10 | 29740058 | 29740059 | Human |
597531625 | GWAS1627699_H | body mass index QTL GWAS1627699 (human) | | 2e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33698401 | 33698402 | Human |
597404654 | GWAS1500728_H | retinopathy, type 2 diabetes mellitus QTL GWAS1500728 (human) | | 1e-08 | retinopathy, type 2 diabetes mellitus | | 10 | 30703953 | 30703954 | Human |
597343213 | GWAS1439287_H | Back pain QTL GWAS1439287 (human) | | 1e-15 | Back pain | | 10 | 27612430 | 27612431 | Human |
597257187 | GWAS1353261_H | schizophrenia QTL GWAS1353261 (human) | | 0.0000004 | schizophrenia | | 10 | 33397685 | 33397686 | Human |
406913216 | GWAS562192_H | unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement QTL GWAS562192 (human) | | 0.000004 | schizophrenia, sex interaction measurement | | 10 | 36748480 | 36748481 | Human |
597162772 | GWAS1258846_H | tetradecanedioate measurement QTL GWAS1258846 (human) | | 0.000003 | tetradecanedioate measurement | | 10 | 27013843 | 27013844 | Human |
597449503 | GWAS1545577_H | alkaline phosphatase measurement, diet measurement QTL GWAS1545577 (human) | | 0.000006 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 30573733 | 30573734 | Human |
597400351 | GWAS1496425_H | anti-drug antibody measurement QTL GWAS1496425 (human) | | 0.000004 | anti-drug antibody measurement | | 10 | 44325939 | 44325940 | Human |
597404446 | GWAS1500520_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1500520 (human) | | 0.0000005 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 10 | 23782077 | 23782078 | Human |
597031699 | GWAS1127773_H | attempted suicide QTL GWAS1127773 (human) | | 0.000002 | attempted suicide | | 10 | 32657081 | 32657082 | Human |
597322512 | GWAS1418586_H | colorectal cancer QTL GWAS1418586 (human) | | 3e-09 | colorectal cancer | | 10 | 29002627 | 29002628 | Human |
597076762 | GWAS1172836_H | Henoch-Schoenlein purpura QTL GWAS1172836 (human) | | 0.000009 | Henoch-Schoenlein purpura | | 10 | 18889952 | 18889953 | Human |
597601042 | GWAS1657902_H | glycerol measurement QTL GWAS1657902 (human) | | 0.000007 | glycerol measurement | blood glycerol level (CMO:0002679) | 10 | 22291354 | 22291355 | Human |
407027917 | GWAS676893_H | sexual dysfunction QTL GWAS676893 (human) | | 0.000002 | sexual dysfunction | | 10 | 32346044 | 32346045 | Human |
597105413 | GWAS1201487_H | non-high density lipoprotein cholesterol measurement QTL GWAS1201487 (human) | | 0.0000004 | non-high density lipoprotein cholesterol measurement | blood non-high density lipoprotein cholesterol level (CMO:0003967) | 10 | 20126458 | 20126459 | Human |
597068546 | GWAS1164620_H | autism spectrum disorder, schizophrenia QTL GWAS1164620 (human) | | 3e-10 | autism spectrum disorder, schizophrenia | | 10 | 18456176 | 18456177 | Human |
597314318 | GWAS1410392_H | triglyceride measurement QTL GWAS1410392 (human) | | 1e-08 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 33347171 | 33347172 | Human |
597076736 | GWAS1172810_H | acute lymphoblastic leukemia QTL GWAS1172810 (human) | | 3e-20 | leukocyte integrity trait (VT:0010898) | | 10 | 22557806 | 22557807 | Human |
597334790 | GWAS1430864_H | susceptibility to influenza measurement QTL GWAS1430864 (human) | | 0.000003 | susceptibility to influenza measurement | | 10 | 20058158 | 20058159 | Human |
597175044 | GWAS1271118_H | carbonic anhydrase-related protein 10 measurement QTL GWAS1271118 (human) | | 7e-14 | carbonic anhydrase-related protein 10 measurement | | 10 | 28698544 | 28698545 | Human |
597125899 | GWAS1221973_H | appendicular lean mass QTL GWAS1221973 (human) | | 6e-11 | appendicular lean mass | | 10 | 37413507 | 37413508 | Human |
597367558 | GWAS1463632_H | BMI-adjusted waist-hip ratio QTL GWAS1463632 (human) | | 2e-14 | body size trait (VT:0100005) | | 10 | 33876771 | 33876772 | Human |
597125898 | GWAS1221972_H | appendicular lean mass QTL GWAS1221972 (human) | | 6e-11 | appendicular lean mass | | 10 | 34246093 | 34246094 | Human |
406954206 | GWAS603182_H | platelet crit QTL GWAS603182 (human) | | 7e-13 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 24911876 | 24911877 | Human |
407093474 | GWAS742450_H | remission, hepatitis C virus infection QTL GWAS742450 (human) | | 0.0000002 | remission, hepatitis C virus infection | | 10 | 25385685 | 25385686 | Human |
597506878 | GWAS1602952_H | aortic measurement QTL GWAS1602952 (human) | | 3e-11 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29877054 | 29877055 | Human |
597596986 | GWAS1653846_H | prothrombin time measurement QTL GWAS1653846 (human) | | 8e-66 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
597392189 | GWAS1488263_H | BMI-adjusted waist circumference QTL GWAS1488263 (human) | | 6e-09 | body size trait (VT:0100005) | | 10 | 27591261 | 27591262 | Human |
597281588 | GWAS1377662_H | QT interval QTL GWAS1377662 (human) | | 9e-10 | QT interval | QT interval (CMO:0000235) | 10 | 43359323 | 43359324 | Human |
597506866 | GWAS1602940_H | aortic measurement QTL GWAS1602940 (human) | | 2e-20 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29878080 | 29878081 | Human |
407060723 | GWAS709699_H | inflammatory bowel disease QTL GWAS709699 (human) | | 6e-11 | inflammatory bowel disease | | 10 | 30439172 | 30439173 | Human |
597404462 | GWAS1500536_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1500536 (human) | | 0.000007 | 3-hydroxypropylmercapturic acid measurement | | 10 | 24068862 | 24068863 | Human |
597437220 | GWAS1533294_H | colorectal health QTL GWAS1533294 (human) | | 0.000009 | colorectal health | | 10 | 22871891 | 22871892 | Human |
597277476 | GWAS1373550_H | posterior urethral valve QTL GWAS1373550 (human) | | 0.0000001 | posterior urethral valve | | 10 | 41863786 | 41863787 | Human |
407109882 | GWAS758858_H | waist-hip ratio QTL GWAS758858 (human) | | 9e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33270391 | 33270392 | Human |
597334872 | GWAS1430946_H | R-warfarin measurement QTL GWAS1430946 (human) | | 0.000009 | R-warfarin measurement | | 10 | 38206971 | 38206972 | Human |
597031763 | GWAS1127837_H | attempted suicide QTL GWAS1127837 (human) | | 3e-08 | attempted suicide | | 10 | 18666008 | 18666009 | Human |
597597016 | GWAS1653876_H | eosinophil count QTL GWAS1653876 (human) | | 2e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26452245 | 26452246 | Human |
597338960 | GWAS1435034_H | diastolic blood pressure QTL GWAS1435034 (human) | | 6e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27939936 | 27939937 | Human |
597224275 | GWAS1320349_H | pneumonia, COVID-19 QTL GWAS1320349 (human) | | 0.000005 | pneumonia, COVID-19 | | 10 | 38296982 | 38296989 | Human |
597400407 | GWAS1496481_H | gut microbiome measurement QTL GWAS1496481 (human) | | 0.000007 | gut microbiome measurement | | 10 | 27601902 | 27601903 | Human |
597330773 | GWAS1426847_H | colorectal cancer QTL GWAS1426847 (human) | | 0.000003 | colorectal cancer | | 10 | 43986659 | 43986660 | Human |
597027653 | GWAS1123727_H | body mass index QTL GWAS1123727 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33568267 | 33568268 | Human |
597326667 | GWAS1422741_H | color vision disorder QTL GWAS1422741 (human) | | 3e-08 | color vision disorder | | 10 | 19284125 | 19284126 | Human |
597027652 | GWAS1123726_H | body mass index QTL GWAS1123726 (human) | | 1e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 27229452 | 27229453 | Human |
597044039 | GWAS1140113_H | Corneal astigmatism QTL GWAS1140113 (human) | | 0.000002 | Corneal astigmatism | | 10 | 34160538 | 34160539 | Human |
407060625 | GWAS709601_H | neutrophil count QTL GWAS709601 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 30215779 | 30215780 | Human |
597285706 | GWAS1381780_H | ulcerative colitis QTL GWAS1381780 (human) | | 1e-08 | ulcerative colitis | | 10 | 30410871 | 30410872 | Human |
597326665 | GWAS1422739_H | color vision disorder QTL GWAS1422739 (human) | | 0.000005 | color vision disorder | | 10 | 36080877 | 36080878 | Human |
406962325 | GWAS611301_H | response to vaccine QTL GWAS611301 (human) | | 4e-09 | response to vaccine | | 10 | 25629950 | 25629951 | Human |
597207885 | GWAS1303959_H | complement factor D measurement QTL GWAS1303959 (human) | | 2e-08 | complement protein amount (VT:0010033) | | 10 | 28635489 | 28635490 | Human |
597035843 | GWAS1131917_H | intraocular pressure measurement QTL GWAS1131917 (human) | | 0.000002 | intraocular pressure measurement | | 10 | 31748302 | 31748303 | Human |
597326671 | GWAS1422745_H | color vision disorder QTL GWAS1422745 (human) | | 5e-08 | color vision disorder | | 10 | 33279648 | 33279649 | Human |
597027651 | GWAS1123725_H | body mass index QTL GWAS1123725 (human) | | 2e-25 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21541175 | 21541176 | Human |
597502795 | GWAS1598869_H | COVID-19 QTL GWAS1598869 (human) | | 7e-09 | COVID-19 | | 10 | 32968396 | 32968397 | Human |
597027650 | GWAS1123724_H | body mass index QTL GWAS1123724 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20616340 | 20616341 | Human |
597326669 | GWAS1422743_H | color vision disorder QTL GWAS1422743 (human) | | 4e-08 | color vision disorder | | 10 | 42888245 | 42888246 | Human |
407048346 | GWAS697322_H | neuropsychological test QTL GWAS697322 (human) | | 0.0000004 | neuropsychological test | | 10 | 24346027 | 24346028 | Human |
597326662 | GWAS1422736_H | color vision disorder QTL GWAS1422736 (human) | | 1e-08 | color vision disorder | | 10 | 19409568 | 19409569 | Human |
597506881 | GWAS1602955_H | aortic measurement QTL GWAS1602955 (human) | | 3e-14 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29878080 | 29878081 | Human |
597326663 | GWAS1422737_H | color vision disorder QTL GWAS1422737 (human) | | 0.000003 | color vision disorder | | 10 | 19115057 | 19115058 | Human |
597506880 | GWAS1602954_H | aortic measurement QTL GWAS1602954 (human) | | 2e-14 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29877054 | 29877055 | Human |
597048139 | GWAS1144213_H | BMI-adjusted waist-hip ratio QTL GWAS1144213 (human) | | 3e-09 | body size trait (VT:0100005) | | 10 | 33195649 | 33195650 | Human |
597326660 | GWAS1422734_H | color vision disorder QTL GWAS1422734 (human) | | 0.000002 | color vision disorder | | 10 | 23574148 | 23574149 | Human |
597347141 | GWAS1443215_H | drug use measurement QTL GWAS1443215 (human) | | 1e-11 | drug use measurement | | 10 | 21640805 | 21640806 | Human |
597437309 | GWAS1533383_H | blood urea nitrogen measurement QTL GWAS1533383 (human) | | 4e-09 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 43335324 | 43335325 | Human |
407060647 | GWAS709623_H | gut microbiome measurement QTL GWAS709623 (human) | | 0.000007 | gut microbiome measurement | | 10 | 19657754 | 19657755 | Human |
597494649 | GWAS1590723_H | R-warfarin measurement QTL GWAS1590723 (human) | | 0.000006 | R-warfarin measurement | | 10 | 42519663 | 42519664 | Human |
597445497 | GWAS1541571_H | lifestyle measurement, depressive symptom measurement QTL GWAS1541571 (human) | | 2e-08 | lifestyle measurement, depressive symptom measurement | | 10 | 21265077 | 21265078 | Human |
597199728 | GWAS1295802_H | memory performance, sex interaction measurement QTL GWAS1295802 (human) | | 0.000007 | memory performance, sex interaction measurement | | 10 | 27036190 | 27036191 | Human |
597318518 | GWAS1414592_H | diastolic blood pressure, systolic blood pressure QTL GWAS1414592 (human) | | 4e-11 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 22519915 | 22519916 | Human |
597142374 | GWAS1238448_H | educational attainment QTL GWAS1238448 (human) | | 3e-15 | educational attainment | | 10 | 18439070 | 18439071 | Human |
597220202 | GWAS1316276_H | corneal resistance factor QTL GWAS1316276 (human) | | 4e-12 | corneal resistance factor | | 10 | 24879291 | 24879292 | Human |
597220203 | GWAS1316277_H | corneal resistance factor QTL GWAS1316277 (human) | | 3e-21 | corneal resistance factor | | 10 | 25534020 | 25534021 | Human |
597338985 | GWAS1435059_H | mean arterial pressure QTL GWAS1435059 (human) | | 0.000002 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 29788743 | 29788744 | Human |
597199725 | GWAS1295799_H | memory performance, sex interaction measurement QTL GWAS1295799 (human) | | 0.000007 | memory performance, sex interaction measurement | | 10 | 27036348 | 27036349 | Human |
597113697 | GWAS1209771_H | erythrocyte count QTL GWAS1209771 (human) | | 6e-09 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 38594169 | 38594170 | Human |
597199716 | GWAS1295790_H | memory performance, sex interaction measurement QTL GWAS1295790 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 27064629 | 27064630 | Human |
597121686 | GWAS1217760_H | blood protein measurement QTL GWAS1217760 (human) | | 3e-20 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19931917 | 19931918 | Human |
597047956 | GWAS1144030_H | cardiovascular disease QTL GWAS1144030 (human) | | 6e-08 | cardiovascular disease | | 10 | 27963710 | 27963711 | Human |
597047955 | GWAS1144029_H | cardiovascular disease QTL GWAS1144029 (human) | | 2e-20 | cardiovascular disease | | 10 | 18439030 | 18439031 | Human |
597363346 | GWAS1459420_H | hepcidin:ferritin ratio QTL GWAS1459420 (human) | | 0.000008 | hepcidin:ferritin ratio | | 10 | 38366004 | 38366005 | Human |
597473942 | GWAS1570016_H | breast carcinoma QTL GWAS1570016 (human) | | 3e-13 | mammary gland integrity trait (VT:0010552) | | 10 | 21533927 | 21533928 | Human |
597269143 | GWAS1365217_H | taste liking measurement QTL GWAS1365217 (human) | | 3e-10 | taste liking measurement | | 10 | 21640250 | 21640251 | Human |
596966043 | GWAS1085562_H | systolic blood pressure QTL GWAS1085562 (human) | | 1e-08 | systolic blood pressure | | 10 | 21485672 | 21485673 | Human |
597105304 | GWAS1201378_H | total brain volume change measurement, age at assessment QTL GWAS1201378 (human) | | 0.0000002 | total brain volume change measurement, age at assessment | | 10 | 36589269 | 36589270 | Human |
597252744 | GWAS1348818_H | schizophrenia QTL GWAS1348818 (human) | | 1e-11 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597191307 | GWAS1287381_H | alcohol use disorder measurement QTL GWAS1287381 (human) | | 2e-08 | alcohol use disorder measurement | | 10 | 18480274 | 18480275 | Human |
597338761 | GWAS1434835_H | systolic blood pressure QTL GWAS1434835 (human) | | 0.000002 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19556932 | 19556933 | Human |
597125761 | GWAS1221835_H | appendicular lean mass QTL GWAS1221835 (human) | | 1e-23 | appendicular lean mass | | 10 | 28677304 | 28677305 | Human |
597363341 | GWAS1459415_H | platelet component distribution width QTL GWAS1459415 (human) | | 2e-09 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 32380142 | 32380143 | Human |
597125760 | GWAS1221834_H | appendicular lean mass QTL GWAS1221834 (human) | | 3e-40 | appendicular lean mass | | 10 | 24889935 | 24889936 | Human |
597088897 | GWAS1184971_H | gastric carcinoma QTL GWAS1184971 (human) | | 0.000008 | stomach integrity trait (VT:0010603) | | 10 | 37513604 | 37513605 | Human |
597334658 | GWAS1430732_H | COVID-19 QTL GWAS1430732 (human) | | 0.000006 | COVID-19 | | 10 | 25289578 | 25289579 | Human |
597375623 | GWAS1471697_H | serum IgG glycosylation measurement QTL GWAS1471697 (human) | | 0.000002 | serum IgG glycosylation measurement | | 10 | 23014324 | 23014325 | Human |
597465728 | GWAS1561802_H | blood urea nitrogen measurement QTL GWAS1561802 (human) | | 2e-11 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28907726 | 28907727 | Human |
597240453 | GWAS1336527_H | aging QTL GWAS1336527 (human) | | 6e-18 | aging | | 10 | 37875836 | 37875837 | Human |
597056139 | GWAS1152213_H | basophil count QTL GWAS1152213 (human) | | 3e-26 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 26445589 | 26445590 | Human |
597461634 | GWAS1557708_H | rheumatoid arthritis QTL GWAS1557708 (human) | | 0.0000002 | rheumatoid arthritis | | 10 | 31126177 | 31126178 | Human |
597076617 | GWAS1172691_H | lobe attachment QTL GWAS1172691 (human) | | 9e-68 | lobe attachment | ear measurement (CMO:0002667) | 10 | 24210995 | 24210996 | Human |
597469880 | GWAS1565954_H | eye colour measurement QTL GWAS1565954 (human) | | 0.000008 | eye colour measurement | eye morphological measurement (CMO:0003080) | 10 | 29340037 | 29340038 | Human |
597506744 | GWAS1602818_H | smoking initiation QTL GWAS1602818 (human) | | 3e-11 | smoking initiation | | 10 | 31064371 | 31064372 | Human |
597228223 | GWAS1324297_H | response to aromatase inhibitor QTL GWAS1324297 (human) | | 0.0000005 | response to aromatase inhibitor | | 10 | 29653623 | 29653624 | Human |
597101232 | GWAS1197306_H | sex hormone-binding globulin measurement QTL GWAS1197306 (human) | | 3e-09 | sex hormone-binding globulin measurement | | 10 | 30882697 | 30882698 | Human |
597338802 | GWAS1434876_H | pulse pressure measurement QTL GWAS1434876 (human) | | 2e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 22550699 | 22550700 | Human |
597207728 | GWAS1303802_H | glucagon-like peptide-1 measurement QTL GWAS1303802 (human) | | 2e-08 | glucagon-like peptide-1 measurement | blood glucagon-like peptide 1 level (CMO:0003637) | 10 | 31746697 | 31746698 | Human |
597355187 | GWAS1451261_H | urgency urinary incontinence QTL GWAS1451261 (human) | | 0.0000008 | urgency urinary incontinence | | 10 | 25118280 | 25118281 | Human |
597150398 | GWAS1246472_H | prostate carcinoma QTL GWAS1246472 (human) | | 1e-09 | prostate carcinoma | | 10 | 27858653 | 27858654 | Human |
597506743 | GWAS1602817_H | smoking initiation QTL GWAS1602817 (human) | | 3e-10 | smoking initiation | | 10 | 24005138 | 24005139 | Human |
597375665 | GWAS1471739_H | ulcerative colitis QTL GWAS1471739 (human) | | 7e-10 | ulcerative colitis | | 10 | 35265126 | 35265127 | Human |
597334705 | GWAS1430779_H | R-warfarin measurement QTL GWAS1430779 (human) | | 0.0000003 | R-warfarin measurement | | 10 | 38833425 | 38833426 | Human |
597076666 | GWAS1172740_H | lobe attachment QTL GWAS1172740 (human) | | 6e-10 | lobe attachment | ear measurement (CMO:0002667) | 10 | 33895135 | 33895136 | Human |
597076664 | GWAS1172738_H | lobe attachment QTL GWAS1172738 (human) | | 0.000004 | lobe attachment | ear measurement (CMO:0002667) | 10 | 24311079 | 24311080 | Human |
597076665 | GWAS1172739_H | lobe attachment QTL GWAS1172739 (human) | | 0.000003 | lobe attachment | ear measurement (CMO:0002667) | 10 | 33183892 | 33183893 | Human |
597387947 | GWAS1484021_H | Henoch-Schoenlein purpura QTL GWAS1484021 (human) | | 0.000009 | Henoch-Schoenlein purpura | | 10 | 18724467 | 18724468 | Human |
597461677 | GWAS1557751_H | heel bone mineral density QTL GWAS1557751 (human) | | 6e-45 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27586077 | 27586078 | Human |
597146277 | GWAS1242351_H | Antihypertensive use measurement QTL GWAS1242351 (human) | | 2e-26 | Antihypertensive use measurement | | 10 | 18439030 | 18439031 | Human |
597461678 | GWAS1557752_H | heel bone mineral density QTL GWAS1557752 (human) | | 2e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28479421 | 28479422 | Human |
597514921 | GWAS1610995_H | glucose measurement QTL GWAS1610995 (human) | | 3e-09 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 26216567 | 26216568 | Human |
597334700 | GWAS1430774_H | R-warfarin measurement QTL GWAS1430774 (human) | | 0.000002 | R-warfarin measurement | | 10 | 38725654 | 38725655 | Human |
597469867 | GWAS1565941_H | ovarian carcinoma QTL GWAS1565941 (human) | | 3e-10 | ovarian carcinoma | | 10 | 28484549 | 28484550 | Human |
597359267 | GWAS1455341_H | pulse pressure measurement QTL GWAS1455341 (human) | | 1e-09 | body height | pulse pressure (CMO:0000292) | 10 | 31793730 | 31793731 | Human |
597383899 | GWAS1479973_H | body mass index QTL GWAS1479973 (human) | | 4e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33681003 | 33681004 | Human |
596957910 | GWAS1077429_H | renal carcinoma QTL GWAS1077429 (human) | | 8e-10 | renal carcinoma | | 10 | 21619874 | 21619875 | Human |
597600987 | GWAS1657847_H | blood urea nitrogen measurement QTL GWAS1657847 (human) | | 8e-17 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28908944 | 28908945 | Human |
596957905 | GWAS1077424_H | pulse pressure measurement QTL GWAS1077424 (human) | | 1e-09 | pulse pressure measurement | | 10 | 31793730 | 31793731 | Human |
597191391 | GWAS1287465_H | age-related macular degeneration QTL GWAS1287465 (human) | | 0.000003 | age-related macular degeneration | | 10 | 28503981 | 28503982 | Human |
597252830 | GWAS1348904_H | androgenetic alopecia QTL GWAS1348904 (human) | | 0.000005 | androgenetic alopecia | | 10 | 36614888 | 36614889 | Human |
597027549 | GWAS1123623_H | lower urinary tract symptom, benign prostatic hyperplasia QTL GWAS1123623 (human) | | 1e-22 | prostate integrity trait (VT:0010571) | | 10 | 22138360 | 22138361 | Human |
597134046 | GWAS1230120_H | memory performance, sex interaction measurement QTL GWAS1230120 (human) | | 0.000005 | memory performance, sex interaction measurement | | 10 | 21124227 | 21124228 | Human |
597220055 | GWAS1316129_H | lung cancer QTL GWAS1316129 (human) | | 0.0000003 | lung cancer | | 10 | 20545511 | 20545512 | Human |
407023890 | GWAS672866_H | acute lymphoblastic leukemia QTL GWAS672866 (human) | | 0.000009 | leukocyte integrity trait (VT:0010898) | | 10 | 34529060 | 34529061 | Human |
597600975 | GWAS1657835_H | formate measurement QTL GWAS1657835 (human) | | 0.000005 | formate measurement | | 10 | 21700077 | 21700078 | Human |
596974272 | GWAS1093791_H | neurofilament light chain measurement QTL GWAS1093791 (human) | | 0.0000004 | neurofilament light chain measurement | | 10 | 24344856 | 24344857 | Human |
407023898 | GWAS672874_H | C-reactive protein measurement QTL GWAS672874 (human) | | 0.000006 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 18470700 | 18470701 | Human |
597203648 | GWAS1299722_H | neuroticism measurement QTL GWAS1299722 (human) | | 4e-09 | neuroticism measurement | | 10 | 22674000 | 22674001 | Human |
597600967 | GWAS1657827_H | body mass index QTL GWAS1657827 (human) | | 5e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21531721 | 21531722 | Human |
597609154 | GWAS1666014_H | heart disease QTL GWAS1666014 (human) | | 4e-13 | heart disease | | 10 | 30028144 | 30028145 | Human |
597375685 | GWAS1471759_H | Crohn's disease QTL GWAS1471759 (human) | | 1e-09 | intestine integrity trait (VT:0010554) | | 10 | 35246767 | 35246768 | Human |
597166840 | GWAS1262914_H | body weight QTL GWAS1262914 (human) | | 2e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 43110454 | 43110455 | Human |
597023478 | GWAS1119552_H | breast carcinoma QTL GWAS1119552 (human) | | 0.0000002 | mammary gland integrity trait (VT:0010552) | | 10 | 22681806 | 22681807 | Human |
597375743 | GWAS1471817_H | migraine disorder QTL GWAS1471817 (human) | | 0.0000005 | migraine disorder | | 10 | 29798430 | 29798431 | Human |
597117681 | GWAS1213755_H | mathematical ability QTL GWAS1213755 (human) | | 6e-09 | mathematical ability | | 10 | 21033929 | 21033930 | Human |
597265137 | GWAS1361211_H | 1-stearoylglycerophosphocholine measurement QTL GWAS1361211 (human) | | 0.000004 | 2-stearoylglycerophosphocholine measurement | | 10 | 19590656 | 19590657 | Human |
597097211 | GWAS1193285_H | diverticular disease QTL GWAS1193285 (human) | | 5e-16 | diverticular disease | | 10 | 25522506 | 25522507 | Human |
597039864 | GWAS1135938_H | diet measurement QTL GWAS1135938 (human) | | 1e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21982155 | 21982156 | Human |
597134054 | GWAS1230128_H | memory performance, sex interaction measurement QTL GWAS1230128 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 21125372 | 21125373 | Human |
597510894 | GWAS1606968_H | DNA methylation QTL GWAS1606968 (human) | | 1e-08 | DNA methylation | | 10 | 21174811 | 21174812 | Human |
597392111 | GWAS1488185_H | schizophrenia QTL GWAS1488185 (human) | | 0.000004 | schizophrenia | | 10 | 32004006 | 32004007 | Human |
597117666 | GWAS1213740_H | intraocular pressure measurement QTL GWAS1213740 (human) | | 6e-09 | intraocular pressure measurement | | 10 | 28669675 | 28669676 | Human |
407167282 | GWAS816258_H | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer QTL GWAS816258 (human) | | 2e-08 | pancreas integrity trait (VT:0010560) | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 26969741 | 26969742 | Human |
597117664 | GWAS1213738_H | intraocular pressure measurement QTL GWAS1213738 (human) | | 5e-09 | intraocular pressure measurement | | 10 | 25532389 | 25532390 | Human |
597207776 | GWAS1303850_H | grip strength measurement QTL GWAS1303850 (human) | | 4e-16 | grip strength measurement | | 10 | 21627799 | 21627800 | Human |
597617381 | GWAS1674241_H | diverticular disease QTL GWAS1674241 (human) | | 7e-37 | diverticular disease | | 10 | 25522506 | 25522507 | Human |
407343419 | GWAS992395_H | mean corpuscular hemoglobin QTL GWAS992395 (human) | | 1e-16 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 24569461 | 24569462 | Human |
597023467 | GWAS1119541_H | breast carcinoma QTL GWAS1119541 (human) | | 0.000001 | mammary gland integrity trait (VT:0010552) | | 10 | 38856846 | 38856847 | Human |
597134056 | GWAS1230130_H | memory performance, sex interaction measurement QTL GWAS1230130 (human) | | 0.000006 | memory performance, sex interaction measurement | | 10 | 21129834 | 21129835 | Human |
597158632 | GWAS1254706_H | dementia QTL GWAS1254706 (human) | | 0.000008 | dementia | | 10 | 28055865 | 28055866 | Human |
597498397 | GWAS1594471_H | Uterine leiomyoma QTL GWAS1594471 (human) | | 4e-13 | Uterine leiomyoma | | 10 | 31666087 | 31666088 | Human |
597408280 | GWAS1504354_H | triple-negative breast cancer, luminal A breast carcinoma QTL GWAS1504354 (human) | | 2e-13 | triple-negative breast cancer, luminal A breast carcinoma | | 10 | 21533927 | 21533928 | Human |
597367324 | GWAS1463398_H | hematocrit QTL GWAS1463398 (human) | | 7e-20 | hematocrit | hematocrit (CMO:0000037) | 10 | 44363233 | 44363234 | Human |
407015880 | GWAS664856_H | neutrophil count QTL GWAS664856 (human) | | 1e-23 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 44384812 | 44384813 | Human |
597326356 | GWAS1422430_H | coronary artery calcification QTL GWAS1422430 (human) | | 8e-08 | coronary artery calcification | | 10 | 44023204 | 44023205 | Human |
597277206 | GWAS1373280_H | Alzheimer disease, polygenic risk score QTL GWAS1373280 (human) | | 3e-08 | Alzheimer disease, polygenic risk score | | 10 | 42838446 | 42838447 | Human |
597457420 | GWAS1553494_H | diastolic blood pressure QTL GWAS1553494 (human) | | 8e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27956491 | 27956492 | Human |
597510669 | GWAS1606743_H | type 2 diabetes mellitus QTL GWAS1606743 (human) | | 1e-18 | type 2 diabetes mellitus | | 10 | 31977821 | 31977822 | Human |
597056006 | GWAS1152080_H | asthma exacerbation measurement QTL GWAS1152080 (human) | | 0.000008 | asthma exacerbation measurement | | 10 | 36165947 | 36165948 | Human |
597305866 | GWAS1401940_H | platelet count QTL GWAS1401940 (human) | | 2e-08 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 43387894 | 43387895 | Human |
597457421 | GWAS1553495_H | diastolic blood pressure QTL GWAS1553495 (human) | | 1e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 28635972 | 28635973 | Human |
597170697 | GWAS1266771_H | aortic measurement QTL GWAS1266771 (human) | | 3e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29881558 | 29881559 | Human |
597428749 | GWAS1524823_H | protein measurement QTL GWAS1524823 (human) | | 1e-11 | protein measurement | | 10 | 43080166 | 43080167 | Human |
597600780 | GWAS1657640_H | 3-hydroxybutyrate measurement QTL GWAS1657640 (human) | | 0.000003 | urine ketone body amount (VT:0010724) | | 10 | 20579598 | 20579599 | Human |
597457422 | GWAS1553496_H | diastolic blood pressure QTL GWAS1553496 (human) | | 2e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 30029020 | 30029021 | Human |
597305864 | GWAS1401938_H | platelet count QTL GWAS1401938 (human) | | 3e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 30222269 | 30222270 | Human |
597334536 | GWAS1430610_H | R-warfarin measurement QTL GWAS1430610 (human) | | 0.0000003 | R-warfarin measurement | | 10 | 34963636 | 34963637 | Human |
597457423 | GWAS1553497_H | diastolic blood pressure QTL GWAS1553497 (human) | | 4e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 32301434 | 32301435 | Human |
597457416 | GWAS1553490_H | diastolic blood pressure QTL GWAS1553490 (human) | | 1e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18448206 | 18448207 | Human |
597457417 | GWAS1553491_H | diastolic blood pressure QTL GWAS1553491 (human) | | 3e-13 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18502051 | 18502052 | Human |
597436937 | GWAS1533011_H | colorectal health QTL GWAS1533011 (human) | | 0.000004 | colorectal health | | 10 | 33419222 | 33419223 | Human |
597457418 | GWAS1553492_H | diastolic blood pressure QTL GWAS1553492 (human) | | 6e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27639397 | 27639398 | Human |
597457419 | GWAS1553493_H | diastolic blood pressure QTL GWAS1553493 (human) | | 7e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27714630 | 27714631 | Human |
597121551 | GWAS1217625_H | cleft lip QTL GWAS1217625 (human) | | 0.000009 | cleft lip | | 10 | 29990417 | 29990418 | Human |
597457413 | GWAS1553487_H | diastolic blood pressure QTL GWAS1553487 (human) | | 7e-63 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18437125 | 18437126 | Human |
597457414 | GWAS1553488_H | diastolic blood pressure QTL GWAS1553488 (human) | | 2e-21 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18438972 | 18438973 | Human |
597170690 | GWAS1266764_H | aortic measurement QTL GWAS1266764 (human) | | 2e-08 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29880724 | 29880725 | Human |
597457415 | GWAS1553489_H | diastolic blood pressure QTL GWAS1553489 (human) | | 2e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18440926 | 18440927 | Human |
597305862 | GWAS1401936_H | platelet count QTL GWAS1401936 (human) | | 5e-18 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 24934438 | 24934439 | Human |
597305863 | GWAS1401937_H | platelet count QTL GWAS1401937 (human) | | 5e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 27103612 | 27103613 | Human |
597228037 | GWAS1324111_H | response to aromatase inhibitor QTL GWAS1324111 (human) | | 0.0000006 | response to aromatase inhibitor | | 10 | 29647954 | 29647955 | Human |
597096968 | GWAS1193042_H | bipolar disorder QTL GWAS1193042 (human) | | 2e-08 | bipolar disorder | | 10 | 18454538 | 18454539 | Human |
407044573 | GWAS693549_H | antioxidant measurement QTL GWAS693549 (human) | | 0.000007 | antioxidant measurement | | 10 | 28099221 | 28099222 | Human |
597518909 | GWAS1614983_H | educational attainment QTL GWAS1614983 (human) | | 3e-10 | educational attainment | | 10 | 30675360 | 30675361 | Human |
597518908 | GWAS1614982_H | educational attainment QTL GWAS1614982 (human) | | 5e-09 | educational attainment | | 10 | 23992997 | 23992998 | Human |
597391929 | GWAS1488003_H | body fat percentage QTL GWAS1488003 (human) | | 1e-08 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 21530895 | 21530896 | Human |
597424697 | GWAS1520771_H | major depressive disorder QTL GWAS1520771 (human) | | 0.000008 | major depressive disorder | | 10 | 25694445 | 25694446 | Human |
597424696 | GWAS1520770_H | major depressive disorder QTL GWAS1520770 (human) | | 0.000004 | major depressive disorder | | 10 | 25693234 | 25693235 | Human |
597518910 | GWAS1614984_H | educational attainment QTL GWAS1614984 (human) | | 2e-09 | educational attainment | | 10 | 31797060 | 31797061 | Human |
597371455 | GWAS1467529_H | body composition measurement QTL GWAS1467529 (human) | | 0.000003 | body composition measurement | | 10 | 24822981 | 24822982 | Human |
407060967 | GWAS709943_H | platelet count QTL GWAS709943 (human) | | 8e-17 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 27184306 | 27184307 | Human |
407126496 | GWAS775472_H | periodontitis QTL GWAS775472 (human) | | 0.000002 | periodontitis | | 10 | 36596993 | 36596994 | Human |
407306732 | GWAS955708_H | lymphocyte count QTL GWAS955708 (human) | | 1e-59 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24929314 | 24929315 | Human |
597330487 | GWAS1426561_H | body mass index QTL GWAS1426561 (human) | | 1e-08 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 20616340 | 20616341 | Human |
597264951 | GWAS1361025_H | taste liking measurement QTL GWAS1361025 (human) | | 3e-10 | taste liking measurement | | 10 | 20834896 | 20834897 | Human |
597236279 | GWAS1332353_H | biological sex QTL GWAS1332353 (human) | | 3e-11 | biological sex | | 10 | 33202258 | 33202259 | Human |
597449263 | GWAS1545337_H | alkaline phosphatase measurement, diet measurement QTL GWAS1545337 (human) | | 0.000008 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 30588720 | 30588721 | Human |
597031462 | GWAS1127536_H | waist-hip ratio QTL GWAS1127536 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33207055 | 33207056 | Human |
597047843 | GWAS1143917_H | C-reactive protein measurement QTL GWAS1143917 (human) | | 4e-12 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 30400387 | 30400388 | Human |
597465642 | GWAS1561716_H | alcohol dependence, major depressive disorder QTL GWAS1561716 (human) | | 0.000006 | alcohol dependence, major depressive disorder | | 10 | 23381413 | 23381414 | Human |
597084716 | GWAS1180790_H | platelet count QTL GWAS1180790 (human) | | 1e-25 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 24909758 | 24909759 | Human |
597084717 | GWAS1180791_H | platelet count QTL GWAS1180791 (human) | | 4e-16 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 27188019 | 27188020 | Human |
597240359 | GWAS1336433_H | retinal vasculature measurement QTL GWAS1336433 (human) | | 0.000004 | retina blood vessel morphology trait (VT:0002792) | | 10 | 22155307 | 22155308 | Human |
597031467 | GWAS1127541_H | waist-hip ratio QTL GWAS1127541 (human) | | 3e-10 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 32102181 | 32102182 | Human |
597056086 | GWAS1152160_H | adolescent idiopathic scoliosis QTL GWAS1152160 (human) | | 6e-16 | adolescent idiopathic scoliosis | | 10 | 29118558 | 29118559 | Human |
597056087 | GWAS1152161_H | adolescent idiopathic scoliosis QTL GWAS1152161 (human) | | 2e-15 | adolescent idiopathic scoliosis | | 10 | 21996442 | 21996443 | Human |
407204228 | GWAS853204_H | unipolar depression QTL GWAS853204 (human) | | 0.000008 | unipolar depression | | 10 | 25694445 | 25694446 | Human |
597621343 | GWAS1678203_H | heart conduction disease QTL GWAS1678203 (human) | | 2e-11 | heart conduction disease | | 10 | 27638983 | 27638984 | Human |
597322334 | GWAS1418408_H | systolic blood pressure QTL GWAS1418408 (human) | | 5e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18438972 | 18438973 | Human |
597310046 | GWAS1406120_H | systolic blood pressure QTL GWAS1406120 (human) | | 1e-37 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18439030 | 18439031 | Human |
407204224 | GWAS853200_H | unipolar depression QTL GWAS853200 (human) | | 0.000004 | unipolar depression | | 10 | 25693234 | 25693235 | Human |
597584472 | GWAS1641332_H | benign prostatic hyperplasia QTL GWAS1641332 (human) | | 9e-17 | prostate integrity trait (VT:0010571) | | 10 | 22038392 | 22038393 | Human |
597506651 | GWAS1602725_H | C-reactive protein measurement QTL GWAS1602725 (human) | | 2e-11 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 30419512 | 30419513 | Human |
597056093 | GWAS1152167_H | adolescent idiopathic scoliosis QTL GWAS1152167 (human) | | 3e-12 | adolescent idiopathic scoliosis | | 10 | 29050941 | 29050942 | Human |
597178965 | GWAS1275039_H | sex interaction measurement, atopy QTL GWAS1275039 (human) | | 2e-09 | sex interaction measurement, atopy | | 10 | 42638205 | 42638206 | Human |
597367371 | GWAS1463445_H | nephrotic syndrome QTL GWAS1463445 (human) | | 0.000004 | nephrotic syndrome | | 10 | 31101198 | 31101199 | Human |
407015824 | GWAS664800_H | neutrophil count QTL GWAS664800 (human) | | 4e-87 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24925121 | 24925122 | Human |
597326402 | GWAS1422476_H | FEV/FVC ratio QTL GWAS1422476 (human) | | 2e-13 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 19927318 | 19927319 | Human |
597494341 | GWAS1590415_H | APOE carrier status, dementia QTL GWAS1590415 (human) | | 0.000008 | APOE carrier status, dementia | | 10 | 28681914 | 28681915 | Human |
597281401 | GWAS1377475_H | Uterine leiomyoma, breast carcinoma QTL GWAS1377475 (human) | | 4e-09 | mammary gland integrity trait (VT:0010552) | | 10 | 21595802 | 21595803 | Human |
597609087 | GWAS1665947_H | digestive system disease QTL GWAS1665947 (human) | | 3e-11 | digestive system disease | | 10 | 33257400 | 33257401 | Human |
597109365 | GWAS1205439_H | mathematical ability QTL GWAS1205439 (human) | | 1e-09 | mathematical ability | | 10 | 34279104 | 34279105 | Human |
597326456 | GWAS1422530_H | color vision disorder QTL GWAS1422530 (human) | | 0.000004 | color vision disorder | | 10 | 42589288 | 42589289 | Human |
597281402 | GWAS1377476_H | Uterine leiomyoma, breast carcinoma QTL GWAS1377476 (human) | | 2e-23 | mammary gland integrity trait (VT:0010552) | | 10 | 21744013 | 21744014 | Human |
597109364 | GWAS1205438_H | mathematical ability QTL GWAS1205438 (human) | | 4e-08 | mathematical ability | | 10 | 24275024 | 24275025 | Human |
597232250 | GWAS1328324_H | response to peginterferon alfa-2a QTL GWAS1328324 (human) | | 0.000009 | response to peginterferon alfa-2a | | 10 | 27013843 | 27013844 | Human |
596966001 | GWAS1085520_H | body mass index QTL GWAS1085520 (human) | | 3e-21 | body mass index | | 10 | 21540233 | 21540234 | Human |
597125759 | GWAS1221833_H | appendicular lean mass QTL GWAS1221833 (human) | | 8e-14 | appendicular lean mass | | 10 | 24717003 | 24717004 | Human |
597076604 | GWAS1172678_H | multiple myeloma QTL GWAS1172678 (human) | | 2e-08 | multiple myeloma | | 10 | 28567890 | 28567891 | Human |
597326448 | GWAS1422522_H | color vision disorder QTL GWAS1422522 (human) | | 0.000001 | color vision disorder | | 10 | 32409172 | 32409173 | Human |
597129852 | GWAS1225926_H | cortical thickness QTL GWAS1225926 (human) | | 3e-11 | cortical thickness | | 10 | 34176277 | 34176278 | Human |
597613170 | GWAS1670030_H | Red cell distribution width QTL GWAS1670030 (human) | | 2e-83 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597129851 | GWAS1225925_H | cortical thickness QTL GWAS1225925 (human) | | 2e-14 | cortical thickness | | 10 | 33179086 | 33179087 | Human |
597129850 | GWAS1225924_H | cortical thickness QTL GWAS1225924 (human) | | 7e-12 | cortical thickness | | 10 | 24754064 | 24754065 | Human |
597129849 | GWAS1225923_H | cortical thickness QTL GWAS1225923 (human) | | 6e-13 | cortical thickness | | 10 | 19792543 | 19792544 | Human |
597326452 | GWAS1422526_H | color vision disorder QTL GWAS1422526 (human) | | 0.000002 | color vision disorder | | 10 | 43429041 | 43429042 | Human |
406921646 | GWAS570622_H | balding measurement QTL GWAS570622 (human) | | 9e-25 | hair amount (VT:0000416) | coat/hair morphological measurement (CMO:0001807) | 10 | 32330644 | 32330645 | Human |
597486188 | GWAS1582262_H | radiation-induced disorder QTL GWAS1582262 (human) | | 0.0000002 | radiation-induced disorder | | 10 | 30682334 | 30682335 | Human |
597318251 | GWAS1414325_H | risk-taking behaviour QTL GWAS1414325 (human) | | 5e-08 | risk-taking behaviour | | 10 | 26755823 | 26755824 | Human |
597101157 | GWAS1197231_H | gut microbiome measurement QTL GWAS1197231 (human) | | 0.000003 | gut microbiome measurement | | 10 | 34165526 | 34165527 | Human |
597322348 | GWAS1418422_H | systolic blood pressure QTL GWAS1418422 (human) | | 1e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 21485672 | 21485673 | Human |
597465706 | GWAS1561780_H | smoking initiation QTL GWAS1561780 (human) | | 8e-11 | smoking initiation | | 10 | 21494705 | 21494706 | Human |
597056096 | GWAS1152170_H | adolescent idiopathic scoliosis QTL GWAS1152170 (human) | | 7e-11 | adolescent idiopathic scoliosis | | 10 | 22810494 | 22810495 | Human |
407224765 | GWAS873741_H | migraine disorder QTL GWAS873741 (human) | | 0.000004 | migraine disorder | | 10 | 29075768 | 29075769 | Human |
597039722 | GWAS1135796_H | apolipoprotein A 1 measurement QTL GWAS1135796 (human) | | 5e-13 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 33358163 | 33358164 | Human |
597596769 | GWAS1653629_H | eosinophil count QTL GWAS1653629 (human) | | 2e-20 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26462654 | 26462655 | Human |
597035415 | GWAS1131489_H | high density lipoprotein cholesterol measurement QTL GWAS1131489 (human) | | 2e-15 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33358163 | 33358164 | Human |
597223834 | GWAS1319908_H | bipolar disorder QTL GWAS1319908 (human) | | 3e-09 | bipolar disorder | | 10 | 18437056 | 18437057 | Human |
407167559 | GWAS816535_H | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer QTL GWAS816535 (human) | | 0.000005 | pancreas integrity trait (VT:0010560) | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 26969741 | 26969742 | Human |
597219741 | GWAS1315815_H | corneal resistance factor QTL GWAS1315815 (human) | | 1e-16 | corneal resistance factor | | 10 | 43147362 | 43147363 | Human |
407401038 | GWAS1050014_H | unipolar depression QTL GWAS1050014 (human) | | 0.0000001 | unipolar depression | | 10 | 29945955 | 29945956 | Human |
597256592 | GWAS1352666_H | BMI-adjusted waist-hip ratio QTL GWAS1352666 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 33192550 | 33192551 | Human |
597027225 | GWAS1123299_H | proliferative diabetic retinopathy QTL GWAS1123299 (human) | | 0.000001 | proliferative diabetic retinopathy | | 10 | 36782685 | 36782686 | Human |
597203349 | GWAS1299423_H | white matter integrity QTL GWAS1299423 (human) | | 3e-10 | white matter integrity | | 10 | 21541175 | 21541176 | Human |
597330315 | GWAS1426389_H | able to hear with hearing aids QTL GWAS1426389 (human) | | 0.0000002 | able to hear with hearing aids | | 10 | 33244742 | 33244743 | Human |
597379465 | GWAS1475539_H | platelet count QTL GWAS1475539 (human) | | 2e-22 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 30215026 | 30215027 | Human |
597268876 | GWAS1364950_H | taste liking measurement QTL GWAS1364950 (human) | | 2e-12 | taste liking measurement | | 10 | 21516537 | 21516538 | Human |
597207437 | GWAS1303511_H | grip strength measurement QTL GWAS1303511 (human) | | 2e-13 | grip strength measurement | | 10 | 21619874 | 21619875 | Human |
597580166 | GWAS1637026_H | lymphocyte count QTL GWAS1637026 (human) | | 4e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24922362 | 24922363 | Human |
597490053 | GWAS1586127_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1586127 (human) | | 0.0000003 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 10 | 31097045 | 31097046 | Human |
597399938 | GWAS1496012_H | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement QTL GWAS1496012 (human) | | 8e-14 | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | | 10 | 31122426 | 31122427 | Human |
597387653 | GWAS1483727_H | diet measurement QTL GWAS1483727 (human) | | 0.0000006 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 44302506 | 44302507 | Human |
597285305 | GWAS1381379_H | serum gamma-glutamyl transferase measurement QTL GWAS1381379 (human) | | 4e-10 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 31474247 | 31474248 | Human |
597285304 | GWAS1381378_H | serum gamma-glutamyl transferase measurement QTL GWAS1381378 (human) | | 4e-08 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 29973482 | 29973483 | Human |
597285306 | GWAS1381380_H | serum gamma-glutamyl transferase measurement QTL GWAS1381380 (human) | | 3e-20 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 34734850 | 34734851 | Human |
597416382 | GWAS1512456_H | mathematical ability QTL GWAS1512456 (human) | | 4e-11 | mathematical ability | | 10 | 33387727 | 33387728 | Human |
597416381 | GWAS1512455_H | mathematical ability QTL GWAS1512455 (human) | | 3e-08 | mathematical ability | | 10 | 31309452 | 31309453 | Human |
597277118 | GWAS1373192_H | age-related macular degeneration, COVID-19 QTL GWAS1373192 (human) | | 8e-09 | age-related macular degeneration, COVID-19 | | 10 | 24710664 | 24710665 | Human |
596949436 | GWAS1068955_H | prostate specific antigen amount QTL GWAS1068955 (human) | | 1e-14 | prostate specific antigen amount | | 10 | 22292652 | 22292653 | Human |
597055934 | GWAS1152008_H | eosinophil count QTL GWAS1152008 (human) | | 1e-63 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26438525 | 26438526 | Human |
597162429 | GWAS1258503_H | docosahexaenoic acid measurement QTL GWAS1258503 (human) | | 8e-09 | fatty acid amount (VT:0010046) | blood free fatty acids level (CMO:0000117) | 10 | 21962451 | 21962452 | Human |
597604789 | GWAS1661649_H | Red cell distribution width QTL GWAS1661649 (human) | | 2e-12 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597055933 | GWAS1152007_H | eosinophil count QTL GWAS1152007 (human) | | 2e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 24909758 | 24909759 | Human |
406917740 | GWAS566716_H | cup-to-disc ratio measurement QTL GWAS566716 (human) | | 9e-12 | cup-to-disc ratio measurement | | 10 | 21148932 | 21148933 | Human |
597223861 | GWAS1319935_H | BMI-adjusted waist circumference QTL GWAS1319935 (human) | | 3e-08 | body size trait (VT:0100005) | | 10 | 24831239 | 24831240 | Human |
596978107 | GWAS1097626_H | hypertension QTL GWAS1097626 (human) | | 1e-23 | hypertension | | 10 | 18439030 | 18439031 | Human |
597371317 | GWAS1467391_H | mean corpuscular hemoglobin QTL GWAS1467391 (human) | | 2e-08 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 28784519 | 28784520 | Human |
597612974 | GWAS1669834_H | Red cell distribution width QTL GWAS1669834 (human) | | 1e-40 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597436845 | GWAS1532919_H | p-cresol sulfate measurement QTL GWAS1532919 (human) | | 0.000005 | p-cresol sulfate measurement | | 10 | 26367897 | 26367898 | Human |
597526956 | GWAS1623030_H | diverticulitis QTL GWAS1623030 (human) | | 0.0000007 | diverticulitis | | 10 | 29745448 | 29745449 | Human |
597498281 | GWAS1594355_H | smoking initiation QTL GWAS1594355 (human) | | 1e-09 | smoking initiation | | 10 | 21712203 | 21712224 | Human |
597498282 | GWAS1594356_H | smoking initiation QTL GWAS1594356 (human) | | 1e-10 | smoking initiation | | 10 | 24005138 | 24005139 | Human |
597326242 | GWAS1422316_H | color vision disorder QTL GWAS1422316 (human) | | 0.00001 | color vision disorder | | 10 | 26723490 | 26723491 | Human |
597207461 | GWAS1303535_H | response to TNF antagonist, joint damage measurement QTL GWAS1303535 (human) | | 6e-08 | response to TNF antagonist, joint damage measurement | | 10 | 21051164 | 21051165 | Human |
597219800 | GWAS1315874_H | alkaline phosphatase measurement QTL GWAS1315874 (human) | | 2e-10 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 26194337 | 26194338 | Human |
597486045 | GWAS1582119_H | hematocrit QTL GWAS1582119 (human) | | 4e-17 | hematocrit | hematocrit (CMO:0000037) | 10 | 44363233 | 44363234 | Human |
596978135 | GWAS1097654_H | ulcerative colitis QTL GWAS1097654 (human) | | 4e-10 | ulcerative colitis | | 10 | 35241532 | 35241533 | Human |
596978134 | GWAS1097653_H | ulcerative colitis QTL GWAS1097653 (human) | | 1e-08 | ulcerative colitis | | 10 | 30410871 | 30410872 | Human |
596974032 | GWAS1093551_H | neuroticism measurement, major depressive disorder QTL GWAS1093551 (human) | | 0.000004 | neuroticism measurement, major depressive disorder | | 10 | 24565947 | 24565948 | Human |
597367260 | GWAS1463334_H | pulse pressure measurement QTL GWAS1463334 (human) | | 1e-38 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 42481398 | 42481399 | Human |
597072350 | GWAS1168424_H | prothrombin time measurement QTL GWAS1168424 (human) | | 4e-19 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
406970893 | GWAS619869_H | obsolete_prostate specific antigen measurement QTL GWAS619869 (human) | | 1e-14 | obsolete_prostate specific antigen measurement | | 10 | 22292652 | 22292653 | Human |
597055960 | GWAS1152034_H | asthma exacerbation measurement QTL GWAS1152034 (human) | | 0.000003 | asthma exacerbation measurement | | 10 | 18821570 | 18821571 | Human |
597436883 | GWAS1532957_H | cholelithiasis QTL GWAS1532957 (human) | | 1e-08 | cholelithiasis | | 10 | 31083038 | 31083039 | Human |
407347732 | GWAS996708_H | obsolete_red blood cell distribution width QTL GWAS996708 (human) | | 4e-62 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
597334478 | GWAS1430552_H | COVID-19 QTL GWAS1430552 (human) | | 0.000009 | COVID-19 | | 10 | 20480567 | 20480568 | Human |
407081495 | GWAS730471_H | unipolar depression QTL GWAS730471 (human) | | 0.000004 | unipolar depression | | 10 | 43241126 | 43241127 | Human |
596978114 | GWAS1097633_H | hypertension QTL GWAS1097633 (human) | | 3e-10 | hypertension | | 10 | 18438972 | 18438973 | Human |
597600713 | GWAS1657573_H | metabolite measurement QTL GWAS1657573 (human) | | 0.000002 | metabolite measurement | | 10 | 20944667 | 20944668 | Human |
597334466 | GWAS1430540_H | COVID-19 QTL GWAS1430540 (human) | | 0.000004 | COVID-19 | | 10 | 20480567 | 20480568 | Human |
407220765 | GWAS869741_H | eosinophil percentage of leukocytes QTL GWAS869741 (human) | | 5e-11 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 44364170 | 44364171 | Human |
407220764 | GWAS869740_H | eosinophil percentage of leukocytes QTL GWAS869740 (human) | | 9e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 34988300 | 34988301 | Human |
597469638 | GWAS1565712_H | abdominal fat cell number QTL GWAS1565712 (human) | | 8e-08 | abdominal fat cell number | | 10 | 23781242 | 23781243 | Human |
597170626 | GWAS1266700_H | chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement QTL GWAS1266700 (human) | | 2e-34 | chondroitin sulfate N-acetylgalactosaminyltransferase 2 measurement | | 10 | 43159110 | 43159111 | Human |
597215683 | GWAS1311757_H | cathepsin L1 measurement QTL GWAS1311757 (human) | | 9e-10 | cathepsin L1 measurement | | 10 | 19910567 | 19910568 | Human |
597457345 | GWAS1553419_H | Crohn's disease QTL GWAS1553419 (human) | | 2e-21 | intestine integrity trait (VT:0010554) | | 10 | 35241532 | 35241533 | Human |
597170630 | GWAS1266704_H | cell growth regulator with EF hand domain protein 1 measurement QTL GWAS1266704 (human) | | 7e-35 | cell growth regulator with EF hand domain protein 1 measurement | | 10 | 19931917 | 19931918 | Human |
597391813 | GWAS1487887_H | Crohn's disease QTL GWAS1487887 (human) | | 1e-26 | intestine integrity trait (VT:0010554) | | 10 | 35006503 | 35006504 | Human |
597477827 | GWAS1573901_H | empathy measurement QTL GWAS1573901 (human) | | 0.0000009 | empathy measurement | | 10 | 28523182 | 28523183 | Human |
597109238 | GWAS1205312_H | self reported educational attainment QTL GWAS1205312 (human) | | 8e-10 | self reported educational attainment | | 10 | 23664796 | 23664797 | Human |
597109237 | GWAS1205311_H | self reported educational attainment QTL GWAS1205311 (human) | | 2e-09 | self reported educational attainment | | 10 | 21668300 | 21668301 | Human |
597109236 | GWAS1205310_H | self reported educational attainment QTL GWAS1205310 (human) | | 7e-09 | self reported educational attainment | | 10 | 20287313 | 20287314 | Human |
597109235 | GWAS1205309_H | self reported educational attainment QTL GWAS1205309 (human) | | 3e-08 | self reported educational attainment | | 10 | 20022758 | 20022759 | Human |
597027313 | GWAS1123387_H | diabetic retinopathy QTL GWAS1123387 (human) | | 0.000002 | diabetic retinopathy | | 10 | 25446883 | 25446884 | Human |
597355005 | GWAS1451079_H | C-reactive protein measurement QTL GWAS1451079 (human) | | 0.000003 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 31679801 | 31679802 | Human |
597391859 | GWAS1487933_H | adolescent idiopathic scoliosis QTL GWAS1487933 (human) | | 3e-13 | adolescent idiopathic scoliosis | | 10 | 43843209 | 43843210 | Human |
597211633 | GWAS1307707_H | Strabismus QTL GWAS1307707 (human) | | 0.000003 | Strabismus | | 10 | 24433017 | 24433018 | Human |
597113341 | GWAS1209415_H | amyloid-beta measurement QTL GWAS1209415 (human) | | 0.0000003 | amyloid-beta measurement | | 10 | 24395882 | 24395883 | Human |
597379568 | GWAS1475642_H | serum IgG glycosylation measurement QTL GWAS1475642 (human) | | 0.000007 | serum IgG glycosylation measurement | | 10 | 25713319 | 25713320 | Human |
407069231 | GWAS718207_H | waist-hip ratio QTL GWAS718207 (human) | | 2e-14 | waist-hip ratio | | 10 | 21619874 | 21619875 | Human |
597371383 | GWAS1467457_H | sarcoidosis, Crohn's disease QTL GWAS1467457 (human) | | 0.000004 | intestine integrity trait (VT:0010554) | | 10 | 23376509 | 23376510 | Human |
407249448 | GWAS898424_H | mean corpuscular hemoglobin concentration QTL GWAS898424 (human) | | 2e-21 | mean corpuscular hemoglobin concentration | mean corpuscular hemoglobin concentration (CMO:0000291) | 10 | 24569461 | 24569462 | Human |
597027300 | GWAS1123374_H | schizophrenia QTL GWAS1123374 (human) | | 7e-11 | schizophrenia | | 10 | 18445599 | 18445600 | Human |
597309931 | GWAS1406005_H | body mass index QTL GWAS1406005 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33671750 | 33671751 | Human |
597133797 | GWAS1229871_H | memory performance, sex interaction measurement QTL GWAS1229871 (human) | | 0.000004 | memory performance, sex interaction measurement | | 10 | 33196609 | 33196610 | Human |
597604842 | GWAS1661702_H | prostate specific antigen amount QTL GWAS1661702 (human) | | 5e-26 | prostate specific antigen amount | | 10 | 27811674 | 27811675 | Human |
597391840 | GWAS1487914_H | adolescent idiopathic scoliosis QTL GWAS1487914 (human) | | 1e-12 | adolescent idiopathic scoliosis | | 10 | 26408365 | 26408366 | Human |
407368251 | GWAS1017227_H | bipolar disorder QTL GWAS1017227 (human) | | 0.000008 | bipolar disorder | | 10 | 20503405 | 20503406 | Human |
597391847 | GWAS1487921_H | BMI-adjusted waist circumference QTL GWAS1487921 (human) | | 4e-10 | body size trait (VT:0100005) | | 10 | 35942238 | 35942239 | Human |
597162474 | GWAS1258548_H | peptide measurement QTL GWAS1258548 (human) | | 0.000002 | peptide metabolism trait (VT:0010634) | | 10 | 35435526 | 35435527 | Human |
597367268 | GWAS1463342_H | pulse pressure measurement QTL GWAS1463342 (human) | | 7e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 42301264 | 42301265 | Human |
597191143 | GWAS1287217_H | hippocampal CA3 volume QTL GWAS1287217 (human) | | 5e-08 | hippocampal CA3 volume | | 10 | 43729975 | 43729976 | Human |
597338597 | GWAS1434671_H | age at diagnosis, osteonecrosis QTL GWAS1434671 (human) | | 0.000002 | age at diagnosis, osteonecrosis | | 10 | 44069746 | 44069747 | Human |
407384777 | GWAS1033753_H | lymphocyte count QTL GWAS1033753 (human) | | 3e-12 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 30197204 | 30197205 | Human |
597141779 | GWAS1237853_H | neuroimaging measurement QTL GWAS1237853 (human) | | 2e-08 | neuroimaging measurement | | 10 | 44147975 | 44147976 | Human |
597580057 | GWAS1636917_H | lymphocyte count QTL GWAS1636917 (human) | | 4e-18 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24925121 | 24925122 | Human |
597092638 | GWAS1188712_H | inflammatory bowel disease QTL GWAS1188712 (human) | | 2e-11 | inflammatory bowel disease | | 10 | 30402574 | 30402575 | Human |
597342486 | GWAS1438560_H | aging QTL GWAS1438560 (human) | | 5e-08 | aging | | 10 | 21594501 | 21594502 | Human |
407384774 | GWAS1033750_H | Tourette syndrome QTL GWAS1033750 (human) | | 0.0000006 | Tourette syndrome | | 10 | 23416522 | 23416523 | Human |
407077581 | GWAS726557_H | pulse pressure measurement QTL GWAS726557 (human) | | 3e-28 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597027079 | GWAS1123153_H | lower urinary tract symptom, benign prostatic hyperplasia QTL GWAS1123153 (human) | | 2e-18 | prostate integrity trait (VT:0010571) | | 10 | 22138360 | 22138361 | Human |
597379328 | GWAS1475402_H | pancreatitis QTL GWAS1475402 (human) | | 0.0000008 | pancreas integrity trait (VT:0010560) | | 10 | 30230903 | 30230904 | Human |
597248262 | GWAS1344336_H | lymphocyte:monocyte ratio QTL GWAS1344336 (human) | | 5e-08 | leukocyte quantity (VT:0000217) | | 10 | 22109066 | 22109067 | Human |
597125428 | GWAS1221502_H | renal carcinoma QTL GWAS1221502 (human) | | 8e-10 | renal carcinoma | | 10 | 21619874 | 21619875 | Human |
597080371 | GWAS1176445_H | Red cell distribution width QTL GWAS1176445 (human) | | 7e-214 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597170482 | GWAS1266556_H | aortic measurement QTL GWAS1266556 (human) | | 1e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29880724 | 29880725 | Human |
597375285 | GWAS1471359_H | migraine disorder, endometriosis QTL GWAS1471359 (human) | | 0.0000005 | migraine disorder, endometriosis | | 10 | 21532989 | 21532990 | Human |
597027108 | GWAS1123182_H | lower urinary tract symptom, benign prostatic hyperplasia QTL GWAS1123182 (human) | | 5e-13 | prostate integrity trait (VT:0010571) | | 10 | 22021369 | 22021370 | Human |
597027110 | GWAS1123184_H | lower urinary tract symptom, benign prostatic hyperplasia QTL GWAS1123184 (human) | | 2e-15 | prostate integrity trait (VT:0010571) | | 10 | 22021369 | 22021370 | Human |
406946548 | GWAS595524_H | malignant epithelial tumor of ovary QTL GWAS595524 (human) | | 1e-09 | malignant epithelial tumor of ovary | | 10 | 21626690 | 21626691 | Human |
597371182 | GWAS1467256_H | lymphocyte count QTL GWAS1467256 (human) | | 5e-29 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26423144 | 26423145 | Human |
597391662 | GWAS1487736_H | retinal detachment, retinal break QTL GWAS1487736 (human) | | 0.000005 | retinal detachment, retinal break | | 10 | 27775991 | 27775992 | Human |
597276972 | GWAS1373046_H | Alzheimer disease, polygenic risk score QTL GWAS1373046 (human) | | 2e-15 | Alzheimer disease, polygenic risk score | | 10 | 36851588 | 36851597 | Human |
596957484 | GWAS1077003_H | thyroid stimulating hormone measurement QTL GWAS1077003 (human) | | 5e-08 | thyroid stimulating hormone measurement | | 10 | 24201065 | 24201066 | Human |
597276961 | GWAS1373035_H | Alzheimer disease, polygenic risk score QTL GWAS1373035 (human) | | 5e-08 | Alzheimer disease, polygenic risk score | | 10 | 36974254 | 36974255 | Human |
597457189 | GWAS1553263_H | lymphocyte measurement, neutrophil measurement QTL GWAS1553263 (human) | | 1e-10 | lymphocyte measurement, neutrophil measurement | | 10 | 28530477 | 28530478 | Human |
597506343 | GWAS1602417_H | Antihypertensive use measurement QTL GWAS1602417 (human) | | 3e-09 | Antihypertensive use measurement | | 10 | 21475540 | 21475541 | Human |
597301543 | GWAS1397617_H | cadherin-7 measurement QTL GWAS1397617 (human) | | 1e-21 | cadherin-7 measurement | | 10 | 19971440 | 19971441 | Human |
597023018 | GWAS1119092_H | alcohol dependence, major depressive disorder QTL GWAS1119092 (human) | | 0.000009 | alcohol dependence, major depressive disorder | | 10 | 33274965 | 33274966 | Human |
596961622 | GWAS1081141_H | metabolic syndrome QTL GWAS1081141 (human) | | 3e-11 | metabolic syndrome | | 10 | 20616340 | 20616341 | Human |
596961623 | GWAS1081142_H | metabolic syndrome QTL GWAS1081142 (human) | | 9e-11 | metabolic syndrome | | 10 | 20759753 | 20759754 | Human |
597457247 | GWAS1553321_H | ulcerative colitis QTL GWAS1553321 (human) | | 4e-10 | ulcerative colitis | | 10 | 35241532 | 35241533 | Human |
597608795 | GWAS1665655_H | diverticular disease QTL GWAS1665655 (human) | | 2e-35 | diverticular disease | | 10 | 25522506 | 25522507 | Human |
597178719 | GWAS1274793_H | protein measurement QTL GWAS1274793 (human) | | 4e-19 | protein measurement | | 10 | 19937743 | 19937744 | Human |
597403996 | GWAS1500070_H | protein measurement QTL GWAS1500070 (human) | | 3e-08 | protein measurement | | 10 | 22960289 | 22960290 | Human |
597109087 | GWAS1205161_H | mathematical ability QTL GWAS1205161 (human) | | 3e-08 | mathematical ability | | 10 | 21058489 | 21058490 | Human |
596961628 | GWAS1081147_H | metabolic syndrome QTL GWAS1081147 (human) | | 1e-13 | metabolic syndrome | | 10 | 33783775 | 33783776 | Human |
597264720 | GWAS1360794_H | valine measurement QTL GWAS1360794 (human) | | 2e-09 | valine measurement | blood amino acid measurement (CMO:0003730) | 10 | 19625967 | 19625968 | Human |
597207378 | GWAS1303452_H | electrocardiography QTL GWAS1303452 (human) | | 5e-09 | electrocardiography | | 10 | 32071260 | 32071261 | Human |
597207379 | GWAS1303453_H | electrocardiography QTL GWAS1303453 (human) | | 4e-08 | electrocardiography | | 10 | 32071260 | 32071261 | Human |
596961624 | GWAS1081143_H | metabolic syndrome QTL GWAS1081143 (human) | | 2e-17 | metabolic syndrome | | 10 | 21560840 | 21560841 | Human |
596957528 | GWAS1077047_H | thyroid peroxidase antibody measurement QTL GWAS1077047 (human) | | 1e-08 | thyroid peroxidase antibody measurement | | 10 | 30792967 | 30792968 | Human |
407335563 | GWAS984539_H | eosinophil count QTL GWAS984539 (human) | | 4e-18 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44364170 | 44364171 | Human |
597088603 | GWAS1184677_H | mean reticulocyte volume QTL GWAS1184677 (human) | | 2e-17 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 24569461 | 24569462 | Human |
596961625 | GWAS1081144_H | metabolic syndrome QTL GWAS1081144 (human) | | 2e-08 | metabolic syndrome | | 10 | 33368310 | 33368311 | Human |
596961626 | GWAS1081145_H | metabolic syndrome QTL GWAS1081145 (human) | | 1e-12 | metabolic syndrome | | 10 | 33578096 | 33578097 | Human |
597326165 | GWAS1422239_H | differentiated thyroid carcinoma QTL GWAS1422239 (human) | | 0.0000002 | differentiated thyroid carcinoma | | 10 | 22503563 | 22503564 | Human |
596961627 | GWAS1081146_H | metabolic syndrome QTL GWAS1081146 (human) | | 3e-16 | metabolic syndrome | | 10 | 33681003 | 33681004 | Human |
407159445 | GWAS808421_H | gut microbiome measurement QTL GWAS808421 (human) | | 0.000005 | gut microbiome measurement | | 10 | 24327918 | 24327919 | Human |
597080388 | GWAS1176462_H | bipolar disorder QTL GWAS1176462 (human) | | 8e-09 | bipolar disorder | | 10 | 18439070 | 18439071 | Human |
597604680 | GWAS1661540_H | neuroendocrine neoplasm QTL GWAS1661540 (human) | | 2e-13 | neuroendocrine neoplasm | | 10 | 28051359 | 28051360 | Human |
597268814 | GWAS1364888_H | taste liking measurement QTL GWAS1364888 (human) | | 1e-09 | taste liking measurement | | 10 | 20890752 | 20890753 | Human |
597457220 | GWAS1553294_H | physical activity measurement QTL GWAS1553294 (human) | | 1e-09 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 10 | 21531721 | 21531722 | Human |
597076303 | GWAS1172377_H | heel bone mineral density QTL GWAS1172377 (human) | | 0.0000007 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28146986 | 28146987 | Human |
597076298 | GWAS1172372_H | heel bone mineral density QTL GWAS1172372 (human) | | 4e-09 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20041014 | 20041015 | Human |
597621059 | GWAS1677919_H | corneal edema QTL GWAS1677919 (human) | | 3e-12 | corneal edema | | 10 | 24740238 | 24740239 | Human |
597076296 | GWAS1172370_H | heel bone mineral density QTL GWAS1172370 (human) | | 5e-08 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
406975135 | GWAS624111_H | suicide behaviour measurement QTL GWAS624111 (human) | | 0.000002 | suicide behaviour measurement | | 10 | 32704340 | 32704341 | Human |
597489986 | GWAS1586060_H | body composition measurement QTL GWAS1586060 (human) | | 3e-30 | body composition measurement | | 10 | 36173608 | 36173609 | Human |
597293433 | GWAS1389507_H | size QTL GWAS1389507 (human) | | 2e-13 | size | | 10 | 24889935 | 24889936 | Human |
596949364 | GWAS1068883_H | Red cell distribution width QTL GWAS1068883 (human) | | 6e-16 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24934438 | 24934439 | Human |
596949363 | GWAS1068882_H | Red cell distribution width QTL GWAS1068882 (human) | | 9e-70 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
597092721 | GWAS1188795_H | Crohn's disease QTL GWAS1188795 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 10 | 30439172 | 30439173 | Human |
597358963 | GWAS1455037_H | pulse pressure measurement QTL GWAS1455037 (human) | | 0.0000001 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31123632 | 31123633 | Human |
597432689 | GWAS1528763_H | protein measurement QTL GWAS1528763 (human) | | 1e-11 | protein measurement | | 10 | 19816294 | 19816295 | Human |
597358964 | GWAS1455038_H | pulse pressure measurement QTL GWAS1455038 (human) | | 0.0000005 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31123632 | 31123633 | Human |
597596528 | GWAS1653388_H | eosinophil count QTL GWAS1653388 (human) | | 4e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 44387717 | 44387718 | Human |
407007917 | GWAS656893_H | neutrophil count QTL GWAS656893 (human) | | 3e-89 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24925121 | 24925122 | Human |
597297514 | GWAS1393588_H | solute carrier family 22 member 16 measurement QTL GWAS1393588 (human) | | 1e-12 | solute carrier family 22 member 16 measurement | | 10 | 19938338 | 19938339 | Human |
597289323 | GWAS1385397_H | inflammatory bowel disease QTL GWAS1385397 (human) | | 1e-15 | inflammatory bowel disease | | 10 | 30410871 | 30410872 | Human |
407007920 | GWAS656896_H | neutrophil count QTL GWAS656896 (human) | | 7e-24 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 44384812 | 44384813 | Human |
597170539 | GWAS1266613_H | torsin-1A-interacting protein 1 measurement QTL GWAS1266613 (human) | | 8e-23 | torsin-1A-interacting protein 1 measurement | | 10 | 19842685 | 19842686 | Human |
597023078 | GWAS1119152_H | response to carboplatin QTL GWAS1119152 (human) | | 0.000006 | response to carboplatin | | 10 | 25602315 | 25602316 | Human |
597137763 | GWAS1233837_H | diastolic blood pressure, systolic blood pressure QTL GWAS1233837 (human) | | 0.0000002 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19950566 | 19950567 | Human |
597100899 | GWAS1196973_H | diverticular disease QTL GWAS1196973 (human) | | 0.000009 | diverticular disease | | 10 | 28392609 | 28392610 | Human |
597137762 | GWAS1233836_H | diastolic blood pressure, systolic blood pressure QTL GWAS1233836 (human) | | 2e-08 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19950530 | 19950531 | Human |
597068131 | GWAS1164205_H | peripheral arterial disease, traffic air pollution measurement QTL GWAS1164205 (human) | | 0.000002 | peripheral arterial disease, traffic air pollution measurement | | 10 | 32518933 | 32518934 | Human |
597170542 | GWAS1266616_H | torsin-1A-interacting protein 1 measurement QTL GWAS1266616 (human) | | 2e-71 | torsin-1A-interacting protein 1 measurement | | 10 | 19931917 | 19931918 | Human |
597399917 | GWAS1495991_H | neuropilin-1 measurement QTL GWAS1495991 (human) | | 2e-19 | neuropilin-1 measurement | | 10 | 33194380 | 33194381 | Human |
597109088 | GWAS1205162_H | mathematical ability QTL GWAS1205162 (human) | | 5e-10 | mathematical ability | | 10 | 34277992 | 34277993 | Human |
597432676 | GWAS1528750_H | protein measurement QTL GWAS1528750 (human) | | 3e-10 | protein measurement | | 10 | 19803954 | 19803955 | Human |
597301602 | GWAS1397676_H | dizziness QTL GWAS1397676 (human) | | 4e-08 | dizziness | | 10 | 21540233 | 21540234 | Human |
597129583 | GWAS1225657_H | placenta growth factor measurement QTL GWAS1225657 (human) | | 8e-09 | placenta growth factor measurement | | 10 | 33477808 | 33477809 | Human |
597498214 | GWAS1594288_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1594288 (human) | | 2e-145 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 43077059 | 43077060 | Human |
407388855 | GWAS1037831_H | autosomal dominant compelling helio-ophthalmic outburst syndrome QTL GWAS1037831 (human) | | 6e-13 | autosomal dominant compelling helio-ophthalmic outburst syndrome | | 10 | 20763691 | 20763692 | Human |
597395812 | GWAS1491886_H | vaginal microbiome measurement QTL GWAS1491886 (human) | | 0.000005 | vaginal microbiome measurement | | 10 | 30354869 | 30354870 | Human |
597510301 | GWAS1606375_H | aortic measurement QTL GWAS1606375 (human) | | 4e-12 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29877054 | 29877055 | Human |
597112983 | GWAS1209057_H | platelet count QTL GWAS1209057 (human) | | 4e-15 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 30180073 | 30180074 | Human |
597112982 | GWAS1209056_H | platelet count QTL GWAS1209056 (human) | | 8e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 29794434 | 29794435 | Human |
597112981 | GWAS1209055_H | platelet count QTL GWAS1209055 (human) | | 3e-14 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 27103612 | 27103613 | Human |
597112980 | GWAS1209054_H | platelet count QTL GWAS1209054 (human) | | 4e-24 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 24911876 | 24911877 | Human |
597334169 | GWAS1430243_H | S-6-hydroxywarfarin measurement QTL GWAS1430243 (human) | | 0.000009 | S-6-hydroxywarfarin measurement | | 10 | 35466171 | 35466172 | Human |
597510297 | GWAS1606371_H | aortic measurement QTL GWAS1606371 (human) | | 9e-22 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29878080 | 29878081 | Human |
597514395 | GWAS1610469_H | smoking cessation QTL GWAS1610469 (human) | | 2e-09 | smoking cessation | | 10 | 24033580 | 24033581 | Human |
597022876 | GWAS1118950_H | breast carcinoma QTL GWAS1118950 (human) | | 6e-18 | mammary gland integrity trait (VT:0010552) | | 10 | 22026914 | 22026915 | Human |
597043357 | GWAS1139431_H | schizophrenia QTL GWAS1139431 (human) | | 4e-14 | schizophrenia | | 10 | 18436730 | 18436731 | Human |
597018777 | GWAS1114851_H | basophil count QTL GWAS1114851 (human) | | 1e-17 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 28491444 | 28491445 | Human |
597022872 | GWAS1118946_H | aging, epigenetic status QTL GWAS1118946 (human) | | 7e-11 | aging, epigenetic status | | 10 | 37681917 | 37681918 | Human |
597112984 | GWAS1209058_H | platelet count QTL GWAS1209058 (human) | | 6e-12 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 43474160 | 43474161 | Human |
406963024 | GWAS612000_H | granulocyte count QTL GWAS612000 (human) | | 2e-32 | granulocyte quantity (VT:0000334) | blood neutrophil count (CMO:0000030) | 10 | 24922362 | 24922363 | Human |
406987606 | GWAS636582_H | systemic juvenile idiopathic arthritis QTL GWAS636582 (human) | | 0.000001 | systemic juvenile idiopathic arthritis | | 10 | 42507600 | 42507601 | Human |
597485705 | GWAS1581779_H | cardiac troponin T measurement QTL GWAS1581779 (human) | | 0.000006 | cardiac troponin T measurement | blood troponin T level (CMO:0001284) | 10 | 21194332 | 21194333 | Human |
406893399 | GWAS542375_H | pulse pressure measurement QTL GWAS542375 (human) | | 3e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
406893400 | GWAS542376_H | pulse pressure measurement QTL GWAS542376 (human) | | 9e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597309571 | GWAS1405645_H | vaginal microbiome measurement QTL GWAS1405645 (human) | | 0.000003 | vaginal microbiome measurement | | 10 | 27434104 | 27434105 | Human |
407040856 | GWAS689832_H | small vessel stroke QTL GWAS689832 (human) | | 2e-08 | small vessel stroke | systolic blood pressure (CMO:0000004) | 10 | 18440926 | 18440927 | Human |
406963034 | GWAS612010_H | meningioma QTL GWAS612010 (human) | | 2e-14 | meningioma | | 10 | 21541175 | 21541176 | Human |
407135071 | GWAS784047_H | migraine disorder QTL GWAS784047 (human) | | 2e-09 | migraine disorder | | 10 | 33179196 | 33179197 | Human |
597416071 | GWAS1512145_H | mathematical ability QTL GWAS1512145 (human) | | 1e-09 | mathematical ability | | 10 | 31090917 | 31090918 | Human |
597203129 | GWAS1299203_H | white matter integrity QTL GWAS1299203 (human) | | 2e-10 | white matter integrity | | 10 | 21541175 | 21541176 | Human |
597280957 | GWAS1377031_H | Uterine leiomyoma, estrogen-receptor positive breast cancer QTL GWAS1377031 (human) | | 5e-21 | Uterine leiomyoma, estrogen-receptor positive breast cancer | | 10 | 21535690 | 21535691 | Human |
407057255 | GWAS706231_H | gut microbiome measurement QTL GWAS706231 (human) | | 0.000008 | gut microbiome measurement | | 10 | 33263058 | 33263059 | Human |
597051568 | GWAS1147642_H | response to norepinephrine-dopamine reuptake inhibitor QTL GWAS1147642 (human) | | 0.000001 | response to norepinephrine-dopamine reuptake inhibitor | | 10 | 37404613 | 37404614 | Human |
597280958 | GWAS1377032_H | Uterine leiomyoma, estrogen-receptor positive breast cancer QTL GWAS1377032 (human) | | 1e-08 | Uterine leiomyoma, estrogen-receptor positive breast cancer | | 10 | 21595802 | 21595803 | Human |
597416114 | GWAS1512188_H | cognitive function measurement QTL GWAS1512188 (human) | | 4e-08 | cognitive behavior trait (VT:0010450) | | 10 | 30806809 | 30806810 | Human |
597346486 | GWAS1442560_H | body mass index QTL GWAS1442560 (human) | | 2e-16 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21769208 | 21769209 | Human |
597031097 | GWAS1127171_H | BMI-adjusted waist-hip ratio QTL GWAS1127171 (human) | | 3e-18 | body size trait (VT:0100005) | | 10 | 32330644 | 32330645 | Human |
597604528 | GWAS1661388_H | prostate specific antigen amount QTL GWAS1661388 (human) | | 1e-28 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
597121208 | GWAS1217282_H | verbal-numerical reasoning measurement QTL GWAS1217282 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 10 | 25486813 | 25486814 | Human |
597403818 | GWAS1499892_H | inflammatory bowel disease QTL GWAS1499892 (human) | | 6e-25 | inflammatory bowel disease | | 10 | 35006503 | 35006504 | Human |
597346473 | GWAS1442547_H | peak expiratory flow QTL GWAS1442547 (human) | | 5e-13 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 29979336 | 29979337 | Human |
597612714 | GWAS1669574_H | response to xenobiotic stimulus QTL GWAS1669574 (human) | | 4e-12 | response to xenobiotic stimulus | | 10 | 27259697 | 27259698 | Human |
597022883 | GWAS1118957_H | aging, epigenetic status QTL GWAS1118957 (human) | | 1e-13 | aging, epigenetic status | | 10 | 37929331 | 37929332 | Human |
406950774 | GWAS599750_H | t-tau measurement QTL GWAS599750 (human) | | 0.000007 | t-tau measurement | | 10 | 27380268 | 27380269 | Human |
406922105 | GWAS571081_H | lean body mass QTL GWAS571081 (human) | | 1e-09 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 24889935 | 24889936 | Human |
597362851 | GWAS1458925_H | coronary artery disease QTL GWAS1458925 (human) | | 2e-09 | coronary artery disease | | 10 | 44280862 | 44280863 | Human |
597379233 | GWAS1475307_H | Crohn's disease QTL GWAS1475307 (human) | | 2e-09 | intestine integrity trait (VT:0010554) | | 10 | 34998722 | 34998723 | Human |
597018794 | GWAS1114868_H | multiple sclerosis QTL GWAS1114868 (human) | | 0.000002 | multiple sclerosis | | 10 | 30744074 | 30744075 | Human |
407085825 | GWAS734801_H | spontaneous preterm birth QTL GWAS734801 (human) | | 0.000007 | spontaneous preterm birth | | 10 | 24373280 | 24373281 | Human |
597502174 | GWAS1598248_H | rheumatoid arthritis QTL GWAS1598248 (human) | | 0.000004 | rheumatoid arthritis | | 10 | 31097045 | 31097046 | Human |
407044864 | GWAS693840_H | CCL2 measurement QTL GWAS693840 (human) | | 5e-08 | CCL2 measurement | | 10 | 43260306 | 43260307 | Human |
597268700 | GWAS1364774_H | taste liking measurement QTL GWAS1364774 (human) | | 6e-09 | taste liking measurement | | 10 | 21816106 | 21816107 | Human |
597272785 | GWAS1368859_H | schizophrenia QTL GWAS1368859 (human) | | 0.000002 | schizophrenia | | 10 | 23338134 | 23338135 | Human |
597346513 | GWAS1442587_H | neutrophil measurement QTL GWAS1442587 (human) | | 2e-10 | neutrophil measurement | | 10 | 28585602 | 28585603 | Human |
597432535 | GWAS1528609_H | alcohol use disorder measurement QTL GWAS1528609 (human) | | 1e-08 | alcohol use disorder measurement | | 10 | 30089934 | 30089935 | Human |
597485778 | GWAS1581852_H | Cleft palate, cleft lip QTL GWAS1581852 (human) | | 0.000002 | Cleft palate, cleft lip | | 10 | 28825522 | 28825523 | Human |
597272780 | GWAS1368854_H | type 2 diabetes mellitus QTL GWAS1368854 (human) | | 1e-09 | type 2 diabetes mellitus | | 10 | 26208775 | 26208776 | Human |
597022915 | GWAS1118989_H | breast carcinoma QTL GWAS1118989 (human) | | 0.000001 | mammary gland integrity trait (VT:0010552) | | 10 | 38234698 | 38234699 | Human |
597518538 | GWAS1614612_H | response to TNF antagonist QTL GWAS1614612 (human) | | 0.0000002 | response to TNF antagonist | | 10 | 26387307 | 26387308 | Human |
597379266 | GWAS1475340_H | non-alcoholic fatty liver disease, cirrhosis of liver QTL GWAS1475340 (human) | | 0.000003 | non-alcoholic fatty liver disease, cirrhosis of liver | | 10 | 29807699 | 29807700 | Human |
597043404 | GWAS1139478_H | B-cell acute lymphoblastic leukemia QTL GWAS1139478 (human) | | 3e-15 | leukocyte integrity trait (VT:0010898) | | 10 | 22568017 | 22568018 | Human |
597145804 | GWAS1241878_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1241878 (human) | | 0.0000004 | severe acute respiratory syndrome, COVID-19 | | 10 | 20136918 | 20136919 | Human |
597022922 | GWAS1118996_H | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel QTL GWAS1118996 (human) | | 0.000009 | overall survival, ovarian carcinoma, response to cisplatin, trait in response to paclitaxel | | 10 | 26722183 | 26722184 | Human |
597240057 | GWAS1336131_H | conotruncal heart malformations QTL GWAS1336131 (human) | | 0.000001 | conotruncal heart malformations | | 10 | 20986424 | 20986425 | Human |
407110439 | GWAS759415_H | waist-hip ratio QTL GWAS759415 (human) | | 6e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 24617214 | 24617215 | Human |
597387512 | GWAS1483586_H | heel bone mineral density QTL GWAS1483586 (human) | | 4e-15 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 27587468 | 27587469 | Human |
407020328 | GWAS669304_H | diabetic retinopathy QTL GWAS669304 (human) | | 9e-09 | diabetic retinopathy | | 10 | 20304158 | 20304159 | Human |
406962989 | GWAS611965_H | peripheral arterial disease QTL GWAS611965 (human) | | 0.000002 | peripheral arterial disease | | 10 | 20610679 | 20610680 | Human |
597022969 | GWAS1119043_H | antisaccade response measurement QTL GWAS1119043 (human) | | 0.000009 | antisaccade response measurement | | 10 | 32098880 | 32098881 | Human |
597498098 | GWAS1594172_H | memory performance, sex interaction measurement QTL GWAS1594172 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 33030912 | 33030913 | Human |
597285089 | GWAS1381163_H | calcium measurement QTL GWAS1381163 (human) | | 5e-13 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22171050 | 22171051 | Human |
597473508 | GWAS1569582_H | mathematical ability QTL GWAS1569582 (human) | | 9e-09 | mathematical ability | | 10 | 30708899 | 30708900 | Human |
597076206 | GWAS1172280_H | heel bone mineral density QTL GWAS1172280 (human) | | 1e-20 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
597473509 | GWAS1569583_H | mathematical ability QTL GWAS1569583 (human) | | 5e-11 | mathematical ability | | 10 | 31076645 | 31076646 | Human |
597612773 | GWAS1669633_H | poisoning QTL GWAS1669633 (human) | | 1e-11 | poisoning | | 10 | 27259697 | 27259698 | Human |
597522657 | GWAS1618731_H | obstructive sleep apnea QTL GWAS1618731 (human) | | 0.0000003 | obstructive sleep apnea | | 10 | 30087842 | 30087843 | Human |
406909758 | GWAS558734_H | bipolar disorder QTL GWAS558734 (human) | | 0.000005 | bipolar disorder | | 10 | 32020077 | 32020078 | Human |
597522461 | GWAS1618535_H | gallstones, coronary artery disease QTL GWAS1618535 (human) | | 9e-10 | gallstones, coronary artery disease | | 10 | 21508343 | 21508344 | Human |
597596190 | GWAS1653050_H | diastolic blood pressure change measurement QTL GWAS1653050 (human) | | 7e-39 | diastolic blood pressure change measurement | change in diastolic blood pressure (CMO:0001016) | 10 | 30028144 | 30028145 | Human |
597223454 | GWAS1319528_H | COVID-19 QTL GWAS1319528 (human) | | 0.000004 | COVID-19 | | 10 | 19510947 | 19510948 | Human |
597092368 | GWAS1188442_H | chronic kidney disease, Proteinuria QTL GWAS1188442 (human) | | 0.000001 | chronic kidney disease, Proteinuria | | 10 | 19875064 | 19875065 | Human |
407274432 | GWAS923408_H | essential hypertension, age at diagnosis QTL GWAS923408 (human) | | 1e-08 | essential hypertension, age at diagnosis | | 10 | 21809772 | 21809773 | Human |
597469211 | GWAS1565285_H | protein measurement QTL GWAS1565285 (human) | | 3e-10 | protein measurement | | 10 | 22458365 | 22458366 | Human |
597104664 | GWAS1200738_H | coronary artery disease QTL GWAS1200738 (human) | | 2e-08 | coronary artery disease | | 10 | 30037847 | 30037848 | Human |
597379083 | GWAS1475157_H | neutrophil count QTL GWAS1475157 (human) | | 1e-46 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597022721 | GWAS1118795_H | breast carcinoma QTL GWAS1118795 (human) | | 0.0000006 | mammary gland integrity trait (VT:0010552) | | 10 | 38338906 | 38338907 | Human |
597145613 | GWAS1241687_H | diet measurement QTL GWAS1241687 (human) | | 3e-10 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21478040 | 21478041 | Human |
407012323 | GWAS661299_H | platelet count QTL GWAS661299 (human) | | 5e-29 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 24909758 | 24909759 | Human |
407012326 | GWAS661302_H | platelet count QTL GWAS661302 (human) | | 5e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 43474160 | 43474161 | Human |
597366847 | GWAS1462921_H | hemoglobin measurement QTL GWAS1462921 (human) | | 9e-26 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 44363233 | 44363234 | Human |
597366846 | GWAS1462920_H | hemoglobin measurement QTL GWAS1462920 (human) | | 7e-14 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 36096603 | 36096604 | Human |
597170238 | GWAS1266312_H | protein measurement QTL GWAS1266312 (human) | | 7e-21 | protein measurement | | 10 | 19946534 | 19946535 | Human |
597055550 | GWAS1151624_H | metabolic syndrome QTL GWAS1151624 (human) | | 1e-13 | metabolic syndrome | | 10 | 33783775 | 33783776 | Human |
597055548 | GWAS1151622_H | metabolic syndrome QTL GWAS1151622 (human) | | 2e-08 | metabolic syndrome | | 10 | 33368310 | 33368311 | Human |
597055549 | GWAS1151623_H | metabolic syndrome QTL GWAS1151623 (human) | | 1e-12 | metabolic syndrome | | 10 | 33578096 | 33578097 | Human |
597403696 | GWAS1499770_H | myocardial infarction QTL GWAS1499770 (human) | | 4e-10 | myocardial infarction | | 10 | 44215482 | 44215483 | Human |
597055546 | GWAS1151620_H | metabolic syndrome QTL GWAS1151620 (human) | | 9e-11 | metabolic syndrome | | 10 | 20759753 | 20759754 | Human |
597055547 | GWAS1151621_H | metabolic syndrome QTL GWAS1151621 (human) | | 2e-17 | metabolic syndrome | | 10 | 21560840 | 21560841 | Human |
597055545 | GWAS1151619_H | metabolic syndrome QTL GWAS1151619 (human) | | 3e-11 | metabolic syndrome | | 10 | 20616340 | 20616341 | Human |
597309482 | GWAS1405556_H | vaginal microbiome measurement QTL GWAS1405556 (human) | | 0.000006 | vaginal microbiome measurement | | 10 | 18788993 | 18788994 | Human |
597129255 | GWAS1225329_H | physical activity measurement QTL GWAS1225329 (human) | | 1e-08 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 10 | 21596648 | 21596649 | Human |
597071908 | GWAS1167982_H | Hirschsprung disease QTL GWAS1167982 (human) | | 3e-15 | Hirschsprung disease | | 10 | 43379369 | 43379370 | Human |
597329966 | GWAS1426040_H | diastolic blood pressure QTL GWAS1426040 (human) | | 2e-09 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27939936 | 27939937 | Human |
597071907 | GWAS1167981_H | Hirschsprung disease QTL GWAS1167981 (human) | | 5e-10 | Hirschsprung disease | | 10 | 37546726 | 37546727 | Human |
597473318 | GWAS1569392_H | self reported educational attainment QTL GWAS1569392 (human) | | 4e-08 | self reported educational attainment | | 10 | 28486557 | 28486558 | Human |
597276707 | GWAS1372781_H | Alzheimer disease, polygenic risk score QTL GWAS1372781 (human) | | 7e-09 | Alzheimer disease, polygenic risk score | | 10 | 35581786 | 35581787 | Human |
597424160 | GWAS1520234_H | response to anticonvulsant QTL GWAS1520234 (human) | | 0.000004 | response to anticonvulsant | | 10 | 20633714 | 20633715 | Human |
407000060 | GWAS649036_H | pulse pressure measurement QTL GWAS649036 (human) | | 3e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31995897 | 31995898 | Human |
597219416 | GWAS1315490_H | cystatin C measurement QTL GWAS1315490 (human) | | 8e-10 | cystatin C measurement | blood cystatin C level (CMO:0002777) | 10 | 23561337 | 23561338 | Human |
597051476 | GWAS1147550_H | response to antidepressant QTL GWAS1147550 (human) | | 0.0000006 | response to antidepressant | | 10 | 42380308 | 42380310 | Human |
597051474 | GWAS1147548_H | response to antidepressant QTL GWAS1147548 (human) | | 8e-08 | response to antidepressant | | 10 | 37975294 | 37975295 | Human |
597469273 | GWAS1565347_H | appendicular lean mass QTL GWAS1565347 (human) | | 2e-21 | appendicular lean mass | | 10 | 27611953 | 27611954 | Human |
597481561 | GWAS1577635_H | rheumatoid arthritis QTL GWAS1577635 (human) | | 4e-09 | rheumatoid arthritis | | 10 | 31122426 | 31122427 | Human |
597051475 | GWAS1147549_H | response to antidepressant QTL GWAS1147549 (human) | | 8e-09 | response to antidepressant | | 10 | 38303852 | 38303853 | Human |
597469274 | GWAS1565348_H | appendicular lean mass QTL GWAS1565348 (human) | | 3e-09 | appendicular lean mass | | 10 | 30825049 | 30825051 | Human |
597325916 | GWAS1421990_H | FEV/FVC ratio QTL GWAS1421990 (human) | | 8e-11 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 32368477 | 32368478 | Human |
597051473 | GWAS1147547_H | response to antidepressant QTL GWAS1147547 (human) | | 0.0000004 | response to antidepressant | | 10 | 37770145 | 37770146 | Human |
597502038 | GWAS1598112_H | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement QTL GWAS1598112 (human) | | 0.000001 | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | | 10 | 31097045 | 31097046 | Human |
407102355 | GWAS751331_H | diabetic retinopathy QTL GWAS751331 (human) | | 0.0000003 | diabetic retinopathy | | 10 | 20253705 | 20253706 | Human |
597051463 | GWAS1147537_H | response to antidepressant QTL GWAS1147537 (human) | | 0.000001 | response to antidepressant | | 10 | 37650713 | 37650714 | Human |
597432398 | GWAS1528472_H | protein measurement QTL GWAS1528472 (human) | | 2e-13 | protein measurement | | 10 | 31097045 | 31097046 | Human |
597616712 | GWAS1673572_H | platelet count QTL GWAS1673572 (human) | | 3e-11 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 30194159 | 30194160 | Human |
407208870 | GWAS857846_H | mean corpuscular hemoglobin QTL GWAS857846 (human) | | 8e-19 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 24569461 | 24569462 | Human |
597071986 | GWAS1168060_H | breast carcinoma QTL GWAS1168060 (human) | | 8e-10 | mammary gland integrity trait (VT:0010552) | | 10 | 21744013 | 21744014 | Human |
597514361 | GWAS1610435_H | sex interaction measurement, inflammatory bowel disease QTL GWAS1610435 (human) | | 3e-08 | sex interaction measurement, inflammatory bowel disease | | 10 | 35259297 | 35259298 | Human |
597071987 | GWAS1168061_H | breast carcinoma QTL GWAS1168061 (human) | | 3e-13 | mammary gland integrity trait (VT:0010552) | | 10 | 22026914 | 22026915 | Human |
597203058 | GWAS1299132_H | glycine measurement QTL GWAS1299132 (human) | | 9e-09 | glycine measurement | blood amino acid measurement (CMO:0003730) | 10 | 31985952 | 31985953 | Human |
596957311 | GWAS1076830_H | schizophrenia, sex interaction measurement QTL GWAS1076830 (human) | | 0.000004 | bipolar disorder, schizophrenia, sex interaction measurement, major depressive disorder | | 10 | 36748480 | 36748481 | Human |
406995887 | GWAS644863_H | reticulocyte measurement QTL GWAS644863 (human) | | 3e-503 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 24929314 | 24929315 | Human |
597330036 | GWAS1426110_H | neuroticism measurement, cognitive function measurement QTL GWAS1426110 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 10 | 21738715 | 21738716 | Human |
597276791 | GWAS1372865_H | oral microbiome measurement QTL GWAS1372865 (human) | | 0.0000008 | mouth morphology trait (VT:0000452) | | 10 | 24392221 | 24392222 | Human |
597026917 | GWAS1122991_H | blood protein measurement QTL GWAS1122991 (human) | | 6e-57 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 43187542 | 43187543 | Human |
597022820 | GWAS1118894_H | breast carcinoma QTL GWAS1118894 (human) | | 1e-18 | mammary gland integrity trait (VT:0010552) | | 10 | 22212015 | 22212016 | Human |
406995889 | GWAS644865_H | reticulocyte measurement QTL GWAS644865 (human) | | 2e-12 | reticulocyte morphology trait (VT:0002424) | red blood cell measurement (CMO:0001356) | 10 | 26438707 | 26438708 | Human |
407212982 | GWAS861958_H | coronary artery disease QTL GWAS861958 (human) | | 2e-08 | coronary artery disease | | 10 | 44192332 | 44192333 | Human |
597317743 | GWAS1413817_H | diastolic blood pressure QTL GWAS1413817 (human) | | 4e-32 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
597309549 | GWAS1405623_H | Beta blocking agent use measurement QTL GWAS1405623 (human) | | 1e-10 | Beta blocking agent use measurement | | 10 | 18437125 | 18437126 | Human |
597239905 | GWAS1335979_H | Myopia QTL GWAS1335979 (human) | | 9e-08 | Myopia | | 10 | 22686699 | 22686700 | Human |
597026924 | GWAS1122998_H | blood protein measurement QTL GWAS1122998 (human) | | 4e-56 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 43097595 | 43097596 | Human |
597604453 | GWAS1661313_H | Red cell distribution width QTL GWAS1661313 (human) | | 1e-66 | Red cell distribution width | red blood cell distribution width- standard deviation (CMO:0003232) | 10 | 24569461 | 24569462 | Human |
407147450 | GWAS796426_H | schizophrenia QTL GWAS796426 (human) | | 1e-10 | schizophrenia | | 10 | 18445599 | 18445600 | Human |
597141608 | GWAS1237682_H | neuroimaging measurement QTL GWAS1237682 (human) | | 2e-08 | neuroimaging measurement | | 10 | 27705739 | 27705740 | Human |
407385160 | GWAS1034136_H | obsolete_red blood cell distribution width QTL GWAS1034136 (human) | | 1e-24 | obsolete_red blood cell distribution width | | 10 | 24911662 | 24911663 | Human |
407385161 | GWAS1034137_H | obsolete_red blood cell distribution width QTL GWAS1034137 (human) | | 2e-09 | obsolete_red blood cell distribution width | | 10 | 25497603 | 25497604 | Human |
406950979 | GWAS599955_H | femoral neck bone mineral density QTL GWAS599955 (human) | | 0.0000007 | bone mineralization trait (VT:0002896) | bone mineral density (CMO:0001226) | 10 | 19272031 | 19272032 | Human |
406979649 | GWAS628625_H | coronary artery disease QTL GWAS628625 (human) | | 3e-10 | coronary artery disease | | 10 | 44280376 | 44280377 | Human |
597327774 | GWAS1423848_H | breast cancer QTL GWAS1423848 (human) | | 0.000003 | breast cancer | | 10 | 30728307 | 30728308 | Human |
597340063 | GWAS1436137_H | neuroticism measurement, cognitive function measurement QTL GWAS1436137 (human) | | 3e-08 | cognitive behavior trait (VT:0010450) | | 10 | 22546994 | 22546995 | Human |
597098384 | GWAS1194458_H | myocardial infarction QTL GWAS1194458 (human) | | 7e-09 | myocardial infarction | | 10 | 30046193 | 30046194 | Human |
597118879 | GWAS1214953_H | biological sex QTL GWAS1214953 (human) | | 5e-08 | biological sex | | 10 | 34119708 | 34119709 | Human |
597405584 | GWAS1501658_H | cortical thickness QTL GWAS1501658 (human) | | 6e-12 | cortical thickness | | 10 | 19816294 | 19816295 | Human |
407385159 | GWAS1034135_H | obsolete_red blood cell distribution width QTL GWAS1034135 (human) | | 5e-215 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
597069702 | GWAS1165776_H | lean body mass QTL GWAS1165776 (human) | | 0.000006 | body lean mass (VT:0010483) | total body lean mass (CMO:0003950) | 10 | 26249308 | 26249309 | Human |
407159888 | GWAS808864_H | gut microbiome measurement QTL GWAS808864 (human) | | 0.0000007 | gut microbiome measurement | | 10 | 27852516 | 27852517 | Human |
597077889 | GWAS1173963_H | blood protein measurement QTL GWAS1173963 (human) | | 3e-25 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 33189289 | 33189290 | Human |
597589894 | GWAS1646754_H | diverticular disease QTL GWAS1646754 (human) | | 1e-40 | diverticular disease | | 10 | 25522506 | 25522507 | Human |
597397378 | GWAS1493452_H | disease recurrence, colon carcinoma QTL GWAS1493452 (human) | | 0.000004 | disease recurrence, colon carcinoma | | 10 | 26594755 | 26594756 | Human |
407020638 | GWAS669614_H | response to fenofibrate QTL GWAS669614 (human) | | 0.0000005 | response to fenofibrate | | 10 | 26485765 | 26485766 | Human |
597434240 | GWAS1530314_H | protein measurement QTL GWAS1530314 (human) | | 2e-10 | protein measurement | | 10 | 28035015 | 28035016 | Human |
597274556 | GWAS1370630_H | nidogen-2 measurement QTL GWAS1370630 (human) | | 4e-12 | nidogen-2 measurement | | 10 | 19937743 | 19937744 | Human |
597217200 | GWAS1313274_H | pulse pressure measurement QTL GWAS1313274 (human) | | 6e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20242491 | 20242492 | Human |
597217201 | GWAS1313275_H | pulse pressure measurement QTL GWAS1313275 (human) | | 8e-25 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20748365 | 20748366 | Human |
597077948 | GWAS1174022_H | smoking initiation QTL GWAS1174022 (human) | | 9e-09 | smoking initiation | | 10 | 21748880 | 21748881 | Human |
597217202 | GWAS1313276_H | pulse pressure measurement QTL GWAS1313276 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 22550699 | 22550700 | Human |
596983743 | GWAS1103262_H | memory performance QTL GWAS1103262 (human) | | 0.000008 | memory performance | | 10 | 25581343 | 25581344 | Human |
597217203 | GWAS1313277_H | pulse pressure measurement QTL GWAS1313277 (human) | | 9e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 24380948 | 24380949 | Human |
596983742 | GWAS1103261_H | memory performance QTL GWAS1103261 (human) | | 0.000007 | memory performance | | 10 | 25581070 | 25581071 | Human |
597217204 | GWAS1313278_H | pulse pressure measurement QTL GWAS1313278 (human) | | 4e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 27944540 | 27944541 | Human |
597217205 | GWAS1313279_H | pulse pressure measurement QTL GWAS1313279 (human) | | 1e-46 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597217206 | GWAS1313280_H | pulse pressure measurement QTL GWAS1313280 (human) | | 5e-13 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30197855 | 30197856 | Human |
597073830 | GWAS1169904_H | coronary artery disease QTL GWAS1169904 (human) | | 2e-17 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
407000179 | GWAS649155_H | diastolic blood pressure QTL GWAS649155 (human) | | 8e-25 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18448045 | 18448046 | Human |
597401514 | GWAS1497588_H | neutrophil percentage of leukocytes QTL GWAS1497588 (human) | | 1e-11 | neutrophil quantity (VT:0000222) | blood neutrophil count to total leukocyte count ratio (CMO:0000370) | 10 | 28492438 | 28492439 | Human |
597217197 | GWAS1313271_H | pulse pressure measurement QTL GWAS1313271 (human) | | 1e-10 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 18438972 | 18438973 | Human |
596950945 | GWAS1070464_H | dementia QTL GWAS1070464 (human) | | 0.0000005 | dementia | | 10 | 33410717 | 33410718 | Human |
597217198 | GWAS1313272_H | pulse pressure measurement QTL GWAS1313272 (human) | | 2e-37 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 18439030 | 18439031 | Human |
597217199 | GWAS1313273_H | pulse pressure measurement QTL GWAS1313273 (human) | | 3e-17 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 19645884 | 19645885 | Human |
597618601 | GWAS1675461_H | coronary atherosclerosis QTL GWAS1675461 (human) | | 8e-12 | coronary atherosclerosis | | 10 | 30028144 | 30028145 | Human |
597278627 | GWAS1374701_H | QT interval QTL GWAS1374701 (human) | | 1e-08 | QT interval | QT interval (CMO:0000235) | 10 | 22659386 | 22659387 | Human |
597278628 | GWAS1374702_H | QT interval QTL GWAS1374702 (human) | | 5e-09 | QT interval | QT interval (CMO:0000235) | 10 | 43359323 | 43359324 | Human |
597135319 | GWAS1231393_H | memory performance QTL GWAS1231393 (human) | | 0.000007 | memory performance | | 10 | 19822214 | 19822215 | Human |
597250009 | GWAS1346083_H | corneal resistance factor QTL GWAS1346083 (human) | | 6e-16 | corneal resistance factor | | 10 | 25531061 | 25531062 | Human |
597401563 | GWAS1497637_H | systolic blood pressure QTL GWAS1497637 (human) | | 4e-13 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 31805076 | 31805077 | Human |
597401562 | GWAS1497636_H | systolic blood pressure QTL GWAS1497636 (human) | | 7e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 21475540 | 21475541 | Human |
597163990 | GWAS1260064_H | cataract QTL GWAS1260064 (human) | | 4e-10 | cataract | | 10 | 28735201 | 28735202 | Human |
597426140 | GWAS1522214_H | trait in response to platinum QTL GWAS1522214 (human) | | 0.0000006 | trait in response to platinum | | 10 | 27800413 | 27800414 | Human |
597135327 | GWAS1231401_H | memory performance QTL GWAS1231401 (human) | | 0.000008 | memory performance | | 10 | 19821526 | 19821527 | Human |
596967388 | GWAS1086907_H | cortical thickness QTL GWAS1086907 (human) | | 2e-08 | cortical thickness | | 10 | 33972018 | 33972019 | Human |
597135326 | GWAS1231400_H | memory performance QTL GWAS1231400 (human) | | 0.000008 | memory performance | | 10 | 19832589 | 19832590 | Human |
597618647 | GWAS1675507_H | coronary atherosclerosis QTL GWAS1675507 (human) | | 8e-34 | coronary atherosclerosis | | 10 | 44245808 | 44245809 | Human |
597458897 | GWAS1554971_H | BMI-adjusted waist-hip ratio QTL GWAS1554971 (human) | | 2e-08 | body size trait (VT:0100005) | | 10 | 33871836 | 33871837 | Human |
597045208 | GWAS1141282_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1141282 (human) | | 0.000005 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 10 | 20743397 | 20743398 | Human |
597458898 | GWAS1554972_H | BMI-adjusted waist-hip ratio QTL GWAS1554972 (human) | | 1e-12 | body size trait (VT:0100005) | | 10 | 33877770 | 33877771 | Human |
597045209 | GWAS1141283_H | soluble triggering receptor expressed on myeloid cells 2 measurement QTL GWAS1141283 (human) | | 0.000004 | soluble triggering receptor expressed on myeloid cells 2 measurement | | 10 | 28694564 | 28694565 | Human |
597389268 | GWAS1485342_H | tuberculosis QTL GWAS1485342 (human) | | 0.000004 | tuberculosis | | 10 | 30812814 | 30812815 | Human |
406905874 | GWAS554850_H | apolipoprotein A 1 measurement QTL GWAS554850 (human) | | 0.000003 | apolipoprotein A 1 measurement | blood apolipoprotein AI level (CMO:0000520) | 10 | 36359112 | 36359113 | Human |
597405644 | GWAS1501718_H | cortical thickness QTL GWAS1501718 (human) | | 7e-09 | cortical thickness | | 10 | 43697907 | 43697908 | Human |
597581763 | GWAS1638623_H | pulse pressure measurement QTL GWAS1638623 (human) | | 3e-21 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
596979700 | GWAS1099219_H | body height QTL GWAS1099219 (human) | | 5e-23 | body height | | 10 | 27611953 | 27611954 | Human |
597037047 | GWAS1133121_H | pulse pressure measurement, alcohol drinking QTL GWAS1133121 (human) | | 1e-12 | pulse pressure measurement, alcohol drinking | pulse pressure (CMO:0000292) | 10 | 30046591 | 30046592 | Human |
407045153 | GWAS694129_H | triglyceride measurement, high density lipoprotein cholesterol measurement QTL GWAS694129 (human) | | 0.000008 | triglyceride measurement, high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 19116602 | 19116603 | Human |
597311486 | GWAS1407560_H | Diuretic use measurement QTL GWAS1407560 (human) | | 1e-11 | Diuretic use measurement | | 10 | 18439030 | 18439031 | Human |
597417982 | GWAS1514056_H | viral load QTL GWAS1514056 (human) | | 1e-15 | viral load | | 10 | 25728984 | 25728985 | Human |
597037040 | GWAS1133114_H | lung carcinoma, family history of lung cancer QTL GWAS1133114 (human) | | 0.000001 | lung carcinoma, family history of lung cancer | | 10 | 19072094 | 19072095 | Human |
597209072 | GWAS1305146_H | neuroimaging measurement QTL GWAS1305146 (human) | | 1e-08 | neuroimaging measurement | | 10 | 21540233 | 21540234 | Human |
596955132 | GWAS1074651_H | body mass index QTL GWAS1074651 (human) | | 2e-10 | body mass index | | 10 | 27029847 | 27029848 | Human |
596955133 | GWAS1074652_H | body mass index QTL GWAS1074652 (human) | | 2e-12 | body mass index | | 10 | 33666502 | 33666503 | Human |
597426161 | GWAS1522235_H | clear cell renal carcinoma QTL GWAS1522235 (human) | | 1e-10 | clear cell renal carcinoma | | 10 | 31096520 | 31096521 | Human |
406897706 | GWAS546682_H | emphysema QTL GWAS546682 (human) | | 0.0000008 | lung integrity trait (VT:0010906) | | 10 | 33942347 | 33942348 | Human |
596955134 | GWAS1074653_H | body mass index QTL GWAS1074653 (human) | | 2e-09 | body mass index | | 10 | 33974725 | 33974726 | Human |
597618676 | GWAS1675536_H | heart disease QTL GWAS1675536 (human) | | 2e-28 | heart disease | | 10 | 44245808 | 44245809 | Human |
596955130 | GWAS1074649_H | body mass index QTL GWAS1074649 (human) | | 5e-10 | body mass index | | 10 | 19487899 | 19487900 | Human |
596955131 | GWAS1074650_H | body mass index QTL GWAS1074650 (human) | | 4e-22 | body mass index | | 10 | 21535690 | 21535691 | Human |
597589998 | GWAS1646858_H | Hernia of the abdominal wall QTL GWAS1646858 (human) | | 8e-13 | Hernia of the abdominal wall | | 10 | 21540233 | 21540234 | Human |
597368811 | GWAS1464885_H | hematocrit QTL GWAS1464885 (human) | | 2e-12 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 36172832 | 36172833 | Human |
597094372 | GWAS1190446_H | schizophrenia QTL GWAS1190446 (human) | | 6e-11 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597393391 | GWAS1489465_H | eosinophil count QTL GWAS1489465 (human) | | 8e-51 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28492438 | 28492439 | Human |
597368812 | GWAS1464886_H | hematocrit QTL GWAS1464886 (human) | | 2e-23 | hematocrit | hematocrit (CMO:0000037) | 10 | 44363233 | 44363234 | Human |
597143535 | GWAS1239609_H | anterior thigh muscle fat infiltration measurement QTL GWAS1239609 (human) | | 4e-16 | anterior thigh muscle fat infiltration measurement | | 10 | 36169963 | 36169964 | Human |
597254112 | GWAS1350186_H | serum gamma-glutamyl transferase measurement QTL GWAS1350186 (human) | | 8e-19 | serum gamma-glutamyl transferase measurement | serum gamma-glutamyltransferase activity level (CMO:0002241) | 10 | 34769784 | 34769785 | Human |
597602279 | GWAS1659139_H | drug use measurement, myocardial infarction QTL GWAS1659139 (human) | | 4e-18 | drug use measurement, myocardial infarction | | 10 | 44247523 | 44247524 | Human |
597315552 | GWAS1411626_H | attention function measurement QTL GWAS1411626 (human) | | 0.000005 | attention function measurement | | 10 | 24423179 | 24423180 | Human |
597618460 | GWAS1675320_H | myocardial infarction QTL GWAS1675320 (human) | | 1e-17 | myocardial infarction | | 10 | 44247070 | 44247071 | Human |
597290778 | GWAS1386852_H | respiratory system disease QTL GWAS1386852 (human) | | 3e-08 | respiratory system disease | | 10 | 32268664 | 32268665 | Human |
597200670 | GWAS1296744_H | memory performance, sex interaction measurement QTL GWAS1296744 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 27050657 | 27050658 | Human |
597471002 | GWAS1567076_H | ovarian carcinoma QTL GWAS1567076 (human) | | 0.000004 | ovarian carcinoma | | 10 | 41850928 | 41850929 | Human |
597335826 | GWAS1431900_H | COVID-19 QTL GWAS1431900 (human) | | 0.000006 | COVID-19 | | 10 | 19427260 | 19427261 | Human |
597221137 | GWAS1317211_H | bipolar disorder QTL GWAS1317211 (human) | | 4e-08 | bipolar disorder | | 10 | 18462174 | 18462175 | Human |
596979487 | GWAS1099006_H | body height QTL GWAS1099006 (human) | | 1e-22 | body height | | 10 | 28635489 | 28635493 | Human |
597307152 | GWAS1403226_H | pulse pressure measurement QTL GWAS1403226 (human) | | 1e-20 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 30028144 | 30028145 | Human |
597307153 | GWAS1403227_H | pulse pressure measurement QTL GWAS1403227 (human) | | 2e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 32001058 | 32001059 | Human |
597466895 | GWAS1562969_H | body mass index QTL GWAS1562969 (human) | | 1e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33681003 | 33681004 | Human |
597307150 | GWAS1403224_H | pulse pressure measurement QTL GWAS1403224 (human) | | 2e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 19636275 | 19636276 | Human |
597307151 | GWAS1403225_H | pulse pressure measurement QTL GWAS1403225 (human) | | 9e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20748365 | 20748366 | Human |
597348108 | GWAS1444182_H | migraine disorder QTL GWAS1444182 (human) | | 6e-09 | migraine disorder | | 10 | 33179196 | 33179197 | Human |
597307149 | GWAS1403223_H | pulse pressure measurement QTL GWAS1403223 (human) | | 7e-24 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 18439030 | 18439031 | Human |
597487366 | GWAS1583440_H | type 1 diabetes mellitus QTL GWAS1583440 (human) | | 1e-08 | type 1 diabetes mellitus | | 10 | 33137219 | 33137220 | Human |
597487367 | GWAS1583441_H | type 1 diabetes mellitus QTL GWAS1583441 (human) | | 0.0000005 | type 1 diabetes mellitus | | 10 | 33140315 | 33140316 | Human |
597487361 | GWAS1583435_H | type 1 diabetes mellitus QTL GWAS1583435 (human) | | 0.000003 | type 1 diabetes mellitus | | 10 | 33137219 | 33137220 | Human |
597458689 | GWAS1554763_H | body mass index QTL GWAS1554763 (human) | | 2e-12 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33666502 | 33666503 | Human |
597581571 | GWAS1638431_H | coronary artery disease QTL GWAS1638431 (human) | | 1e-23 | coronary artery disease | | 10 | 44245808 | 44245809 | Human |
597172024 | GWAS1268098_H | intelligence QTL GWAS1268098 (human) | | 2e-09 | intelligence | | 10 | 22589024 | 22589025 | Human |
597045047 | GWAS1141121_H | lifestyle measurement QTL GWAS1141121 (human) | | 2e-15 | lifestyle measurement | | 10 | 21627799 | 21627800 | Human |
597311295 | GWAS1407369_H | Agents acting on the renin-angiotensin system use measurement QTL GWAS1407369 (human) | | 2e-14 | Agents acting on the renin-angiotensin system use measurement | | 10 | 18437125 | 18437126 | Human |
597200690 | GWAS1296764_H | B-cell acute lymphoblastic leukemia, Crohn's disease QTL GWAS1296764 (human) | | 5e-09 | intestine integrity trait (VT:0010554) | | 10 | 22170746 | 22170747 | Human |
597024575 | GWAS1120649_H | breast carcinoma QTL GWAS1120649 (human) | | 0.000008 | mammary gland integrity trait (VT:0010552) | | 10 | 27080233 | 27080234 | Human |
597200695 | GWAS1296769_H | B-cell acute lymphoblastic leukemia, rheumatoid arthritis QTL GWAS1296769 (human) | | 3e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 22567090 | 22567091 | Human |
597274409 | GWAS1370483_H | triglyceride measurement QTL GWAS1370483 (human) | | 7e-14 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 33344938 | 33344939 | Human |
597503791 | GWAS1599865_H | N-acetylserine measurement QTL GWAS1599865 (human) | | 0.000002 | N-acetylserine measurement | | 10 | 25931333 | 25931334 | Human |
597040933 | GWAS1137007_H | diet measurement QTL GWAS1137007 (human) | | 8e-17 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21517903 | 21517904 | Human |
597040940 | GWAS1137014_H | diet measurement QTL GWAS1137014 (human) | | 5e-11 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21545607 | 21545608 | Human |
597290786 | GWAS1386860_H | body mass index QTL GWAS1386860 (human) | | 3e-14 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21748880 | 21748881 | Human |
597073707 | GWAS1169781_H | systemic lupus erythematosus QTL GWAS1169781 (human) | | 0.000007 | systemic lupus erythematosus | | 10 | 23310629 | 23310630 | Human |
407139578 | GWAS788554_H | mean arterial pressure QTL GWAS788554 (human) | | 2e-16 | mean arterial pressure | mean arterial blood pressure (CMO:0000009) | 10 | 18439030 | 18439031 | Human |
597524259 | GWAS1620333_H | stromal cell-derived factor 1 measurement QTL GWAS1620333 (human) | | 2e-21 | stromal cell-derived factor 1 measurement | | 10 | 44398308 | 44398309 | Human |
597061462 | GWAS1157536_H | basophil count QTL GWAS1157536 (human) | | 9e-10 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 24917483 | 24917484 | Human |
407073923 | GWAS722899_H | low density lipoprotein cholesterol measurement QTL GWAS722899 (human) | | 0.0000004 | low density lipoprotein cholesterol measurement | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 35777511 | 35777512 | Human |
597061463 | GWAS1157537_H | basophil count QTL GWAS1157537 (human) | | 1e-29 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 26445589 | 26445590 | Human |
597032791 | GWAS1128865_H | pulse pressure measurement QTL GWAS1128865 (human) | | 7e-12 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 19645884 | 19645885 | Human |
406975619 | GWAS624595_H | cannabis dependence QTL GWAS624595 (human) | | 0.000003 | cannabis dependence | | 10 | 29000102 | 29000103 | Human |
597368670 | GWAS1464744_H | waist-hip ratio QTL GWAS1464744 (human) | | 2e-15 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33877770 | 33877771 | Human |
597368669 | GWAS1464743_H | waist-hip ratio QTL GWAS1464743 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 30112733 | 30112734 | Human |
597122909 | GWAS1218983_H | blood protein measurement QTL GWAS1218983 (human) | | 4e-17 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19931917 | 19931918 | Human |
596967256 | GWAS1086775_H | body height QTL GWAS1086775 (human) | | 2e-16 | body height | | 10 | 27871907 | 27871908 | Human |
596967257 | GWAS1086776_H | body height QTL GWAS1086776 (human) | | 4e-11 | body height | | 10 | 22629222 | 22629223 | Human |
597581648 | GWAS1638508_H | hypertension, Antihypertensive use measurement QTL GWAS1638508 (human) | | 2e-13 | hypertension, Antihypertensive use measurement | | 10 | 18431916 | 18431917 | Human |
596967258 | GWAS1086777_H | body height QTL GWAS1086777 (human) | | 3e-25 | body height | | 10 | 24889935 | 24889936 | Human |
597270347 | GWAS1366421_H | taste liking measurement QTL GWAS1366421 (human) | | 5e-08 | taste liking measurement | | 10 | 20841271 | 20841272 | Human |
406951061 | GWAS600037_H | platelet count QTL GWAS600037 (human) | | 4e-10 | platelet quantity (VT:0003179) | platelet count (CMO:0000029) | 10 | 24911876 | 24911877 | Human |
597610314 | GWAS1667174_H | monocyte count QTL GWAS1667174 (human) | | 1e-20 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 26439005 | 26439006 | Human |
597036867 | GWAS1132941_H | white matter volume measurement QTL GWAS1132941 (human) | | 0.000002 | brain size trait (VT:0000771) | | 10 | 25240824 | 25240825 | Human |
407061653 | GWAS710629_H | triacylglycerol 56:2 measurement QTL GWAS710629 (human) | | 0.000007 | blood triglyceride amount (VT:0002644) | | 10 | 43392745 | 43392746 | Human |
597610313 | GWAS1667173_H | monocyte count QTL GWAS1667173 (human) | | 8e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 21984604 | 21984605 | Human |
597167937 | GWAS1264011_H | radiation-induced disorder QTL GWAS1264011 (human) | | 0.00001 | radiation-induced disorder | | 10 | 22890838 | 22890839 | Human |
597163854 | GWAS1259928_H | coronary artery disease, factor VII measurement QTL GWAS1259928 (human) | | 7e-13 | coronary artery disease, factor VII measurement | | 10 | 30028144 | 30028145 | Human |
597450565 | GWAS1546639_H | COVID-19 QTL GWAS1546639 (human) | | 0.000008 | COVID-19 | | 10 | 43346616 | 43346623 | Human |
597335879 | GWAS1431953_H | COVID-19 QTL GWAS1431953 (human) | | 0.000003 | COVID-19 | | 10 | 20480567 | 20480568 | Human |
596983668 | GWAS1103187_H | memory performance QTL GWAS1103187 (human) | | 0.000004 | memory performance | | 10 | 19810364 | 19810365 | Human |
597450621 | GWAS1546695_H | alkaline phosphatase measurement QTL GWAS1546695 (human) | | 4e-11 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 28627964 | 28627965 | Human |
597434237 | GWAS1530311_H | sex hormone-binding globulin measurement QTL GWAS1530311 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 10 | 31318286 | 31318287 | Human |
597163891 | GWAS1259965_H | taurochenodeoxycholate measurement QTL GWAS1259965 (human) | | 0.000002 | taurochenodeoxycholate measurement | | 10 | 28053811 | 28053812 | Human |
406967463 | GWAS616439_H | reticulocyte count QTL GWAS616439 (human) | | 6e-202 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 24929314 | 24929315 | Human |
597376892 | GWAS1472966_H | inflammatory bowel disease QTL GWAS1472966 (human) | | 2e-25 | inflammatory bowel disease | | 10 | 35006503 | 35006504 | Human |
596983677 | GWAS1103196_H | memory performance QTL GWAS1103196 (human) | | 0.000005 | memory performance | | 10 | 19808667 | 19808668 | Human |
597180272 | GWAS1276346_H | protein SEC13 homolog measurement QTL GWAS1276346 (human) | | 5e-45 | protein SEC13 homolog measurement | | 10 | 19931917 | 19931918 | Human |
597073790 | GWAS1169864_H | intraocular pressure measurement QTL GWAS1169864 (human) | | 5e-08 | intraocular pressure measurement | | 10 | 25588722 | 25588723 | Human |
597512052 | GWAS1608126_H | color vision disorder QTL GWAS1608126 (human) | | 0.000003 | color vision disorder | | 10 | 23417931 | 23417932 | Human |
597237616 | GWAS1333690_H | neutrophil count QTL GWAS1333690 (human) | | 1e-48 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24909758 | 24909759 | Human |
597372786 | GWAS1468860_H | lumbar disc degeneration QTL GWAS1468860 (human) | | 0.000005 | lumbar disc degeneration | | 10 | 31223169 | 31223170 | Human |
597331824 | GWAS1427898_H | colorectal cancer QTL GWAS1427898 (human) | | 0.0000004 | colorectal cancer | | 10 | 30873422 | 30873423 | Human |
597372785 | GWAS1468859_H | lumbar disc degeneration QTL GWAS1468859 (human) | | 0.000004 | lumbar disc degeneration | | 10 | 31207045 | 31207046 | Human |
597372784 | GWAS1468858_H | lumbar disc degeneration QTL GWAS1468858 (human) | | 0.000004 | lumbar disc degeneration | | 10 | 31226203 | 31226204 | Human |
597512049 | GWAS1608123_H | color vision disorder QTL GWAS1608123 (human) | | 0.0000007 | color vision disorder | | 10 | 43886478 | 43886479 | Human |
597512048 | GWAS1608122_H | color vision disorder QTL GWAS1608122 (human) | | 0.0000006 | color vision disorder | | 10 | 23834935 | 23834936 | Human |
596983674 | GWAS1103193_H | memory performance QTL GWAS1103193 (human) | | 0.000004 | memory performance | | 10 | 19819940 | 19819941 | Human |
597245800 | GWAS1341874_H | IGF-1 measurement QTL GWAS1341874 (human) | | 1e-12 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 10 | 21447171 | 21447172 | Human |
407303349 | GWAS952325_H | lymphocyte count QTL GWAS952325 (human) | | 5e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44391767 | 44391768 | Human |
597323619 | GWAS1419693_H | colorectal cancer QTL GWAS1419693 (human) | | 0.000002 | colorectal cancer, inflammatory bowel disease | | 10 | 27395731 | 27395732 | Human |
596983663 | GWAS1103182_H | memory performance QTL GWAS1103182 (human) | | 0.000003 | memory performance | | 10 | 19806476 | 19806477 | Human |
597438304 | GWAS1534378_H | ulcerative colitis QTL GWAS1534378 (human) | | 2e-08 | ulcerative colitis | | 10 | 26890667 | 26890668 | Human |
597610142 | GWAS1667002_H | monocyte count QTL GWAS1667002 (human) | | 3e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 26439005 | 26439006 | Human |
597024405 | GWAS1120479_H | breast carcinoma QTL GWAS1120479 (human) | | 0.0000009 | mammary gland integrity trait (VT:0010552) | | 10 | 38105003 | 38105008 | Human |
597102238 | GWAS1198312_H | neutrophil count QTL GWAS1198312 (human) | | 6e-70 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 24917625 | 24917626 | Human |
597188246 | GWAS1284320_H | peak expiratory flow QTL GWAS1284320 (human) | | 3e-18 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 30024857 | 30024858 | Human |
597458572 | GWAS1554646_H | COVID-19 QTL GWAS1554646 (human) | | 0.000003 | COVID-19 | | 10 | 23927227 | 23927228 | Human |
597470863 | GWAS1566937_H | Ischemic stroke QTL GWAS1566937 (human) | | 0.0000003 | Ischemic stroke | | 10 | 24794643 | 24794644 | Human |
596987526 | GWAS1107045_H | memory performance, sex interaction measurement QTL GWAS1107045 (human) | | 0.000008 | memory performance, sex interaction measurement | | 10 | 33218133 | 33218134 | Human |
597335695 | GWAS1431769_H | COVID-19 QTL GWAS1431769 (human) | | 0.000001 | COVID-19 | | 10 | 24869292 | 24869293 | Human |
597057155 | GWAS1153229_H | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement QTL GWAS1153229 (human) | | 0.000002 | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | | 10 | 29305862 | 29305863 | Human |
597356175 | GWAS1452249_H | QT interval QTL GWAS1452249 (human) | | 0.000009 | QT interval | QT interval (CMO:0000235) | 10 | 30545703 | 30545704 | Human |
407041364 | GWAS690340_H | dental caries QTL GWAS690340 (human) | | 9e-09 | dental caries | | 10 | 30623101 | 30623102 | Human |
407029083 | GWAS678059_H | IGFBP-3 measurement QTL GWAS678059 (human) | | 0.000002 | IGFBP-3 measurement | | 10 | 43260306 | 43260307 | Human |
597073547 | GWAS1169621_H | coronary artery disease QTL GWAS1169621 (human) | | 0.000001 | coronary artery disease | | 10 | 37400135 | 37400136 | Human |
407147873 | GWAS796849_H | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement QTL GWAS796849 (human) | | 0.000008 | uridine diphosphate galactose measurement, uridine diphosphate glucose measurement | | 10 | 29973482 | 29973483 | Human |
597175998 | GWAS1272072_H | cadherin-7 measurement QTL GWAS1272072 (human) | | 8e-09 | cadherin-7 measurement | | 10 | 19868276 | 19868277 | Human |
406963559 | GWAS612535_H | atrial fibrillation QTL GWAS612535 (human) | | 2e-14 | atrial fibrillation | | 10 | 20868692 | 20868693 | Human |
597581497 | GWAS1638357_H | monocyte count QTL GWAS1638357 (human) | | 2e-52 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24922362 | 24922363 | Human |
597335732 | GWAS1431806_H | COVID-19 QTL GWAS1431806 (human) | | 0.00001 | COVID-19 | | 10 | 36984100 | 36984101 | Human |
597417643 | GWAS1513717_H | colorectal cancer, breast carcinoma QTL GWAS1513717 (human) | | 0.000006 | mammary gland integrity trait (VT:0010552) | | 10 | 23995722 | 23995723 | Human |
597077666 | GWAS1173740_H | osteoarthritis, knee QTL GWAS1173740 (human) | | 0.000001 | osteoarthritis, knee | | 10 | 24300978 | 24300979 | Human |
597171885 | GWAS1267959_H | neuropilin-1 measurement QTL GWAS1267959 (human) | | 0.0000001 | neuropilin-1 measurement | | 10 | 33347171 | 33347172 | Human |
597225126 | GWAS1321200_H | response to aromatase inhibitor QTL GWAS1321200 (human) | | 0.0000005 | response to aromatase inhibitor | | 10 | 29652692 | 29652693 | Human |
597225127 | GWAS1321201_H | response to aromatase inhibitor QTL GWAS1321201 (human) | | 0.000002 | response to aromatase inhibitor | | 10 | 29655323 | 29655324 | Human |
597106386 | GWAS1202460_H | cortex volume change measurement, age at assessment QTL GWAS1202460 (human) | | 0.000007 | cortex volume change measurement, age at assessment | | 10 | 42911232 | 42911233 | Human |
597057247 | GWAS1153321_H | adolescent idiopathic scoliosis QTL GWAS1153321 (human) | | 4e-40 | adolescent idiopathic scoliosis | | 10 | 18588058 | 18588059 | Human |
597335763 | GWAS1431837_H | atrial fibrillation QTL GWAS1431837 (human) | | 0.000006 | atrial fibrillation | | 10 | 20953453 | 20953454 | Human |
597081823 | GWAS1177897_H | monocyte count QTL GWAS1177897 (human) | | 9e-119 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24929314 | 24929315 | Human |
597581525 | GWAS1638385_H | monocyte count QTL GWAS1638385 (human) | | 2e-19 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44385546 | 44385547 | Human |
597393111 | GWAS1489185_H | adolescent idiopathic scoliosis QTL GWAS1489185 (human) | | 1e-09 | adolescent idiopathic scoliosis | | 10 | 28040755 | 28040756 | Human |
597511891 | GWAS1607965_H | diastolic blood pressure, systolic blood pressure QTL GWAS1607965 (human) | | 1e-18 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 19776147 | 19776148 | Human |
407016716 | GWAS665692_H | AIDS dementia QTL GWAS665692 (human) | | 0.0000001 | AIDS dementia | | 10 | 44029227 | 44029228 | Human |
597380810 | GWAS1476884_H | FEV/FVC ratio QTL GWAS1476884 (human) | | 1e-10 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 32380191 | 32380192 | Human |
407389466 | GWAS1038442_H | reticulocyte count QTL GWAS1038442 (human) | | 6e-12 | reticulocyte quantity (VT:0003135) | total reticulocyte count (CMO:0003020) | 10 | 26438309 | 26438310 | Human |
597380808 | GWAS1476882_H | FEV/FVC ratio QTL GWAS1476882 (human) | | 3e-08 | FEV/FVC ratio | forced expiratory volume to forced vital capacity ratio (CMO:0000241) | 10 | 31765476 | 31765477 | Human |
597614273 | GWAS1671133_H | laryngeal disease QTL GWAS1671133 (human) | | 4e-11 | laryngeal disease | | 10 | 24689219 | 24689220 | Human |
597163720 | GWAS1259794_H | tryptophan betaine measurement QTL GWAS1259794 (human) | | 0.000005 | tryptophan betaine measurement | | 10 | 35736418 | 35736419 | Human |
406971681 | GWAS620657_H | monocyte count QTL GWAS620657 (human) | | 8e-48 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24922362 | 24922363 | Human |
597532415 | GWAS1628489_H | Ischemic stroke QTL GWAS1628489 (human) | | 0.0000004 | Ischemic stroke | | 10 | 22779332 | 22779333 | Human |
597487358 | GWAS1583432_H | type 1 diabetes mellitus QTL GWAS1583432 (human) | | 0.000007 | type 1 diabetes mellitus | | 10 | 33140315 | 33140316 | Human |
406971682 | GWAS620658_H | monocyte count QTL GWAS620658 (human) | | 1e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30207976 | 30207977 | Human |
597040882 | GWAS1136956_H | diet measurement QTL GWAS1136956 (human) | | 2e-24 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21517903 | 21517904 | Human |
597044978 | GWAS1141052_H | Abnormality of refraction QTL GWAS1141052 (human) | | 4e-19 | Abnormality of refraction | | 10 | 30027943 | 30027944 | Human |
597425916 | GWAS1521990_H | clear cell renal carcinoma QTL GWAS1521990 (human) | | 1e-08 | clear cell renal carcinoma | | 10 | 21532345 | 21532346 | Human |
597303037 | GWAS1399111_H | t-tau measurement QTL GWAS1399111 (human) | | 0.0000004 | t-tau measurement | | 10 | 34117303 | 34117304 | Human |
597098225 | GWAS1194299_H | myocardial infarction QTL GWAS1194299 (human) | | 8e-11 | myocardial infarction | | 10 | 43985363 | 43985364 | Human |
597475060 | GWAS1571134_H | platelet crit QTL GWAS1571134 (human) | | 7e-12 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 29960224 | 29960225 | Human |
597360369 | GWAS1456443_H | granulocyte percentage of myeloid white cells QTL GWAS1456443 (human) | | 2e-11 | granulocyte quantity (VT:0000334) | | 10 | 28525363 | 28525364 | Human |
597458674 | GWAS1554748_H | dementia QTL GWAS1554748 (human) | | 0.0000005 | dementia | | 10 | 33410717 | 33410718 | Human |
597466863 | GWAS1562937_H | waist-hip ratio QTL GWAS1562937 (human) | | 4e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 27615392 | 27615393 | Human |
597348073 | GWAS1444147_H | Abdominal Aortic Aneurysm QTL GWAS1444147 (human) | | 1e-08 | Abdominal Aortic Aneurysm | | 10 | 29901169 | 29901170 | Human |
597606122 | GWAS1662982_H | obesity QTL GWAS1662982 (human) | | 2e-14 | obesity | | 10 | 21532345 | 21532346 | Human |
597266156 | GWAS1362230_H | nidogen-1 measurement QTL GWAS1362230 (human) | | 1e-15 | nidogen-1 measurement | | 10 | 19971440 | 19971441 | Human |
597425902 | GWAS1521976_H | trait in response to platinum QTL GWAS1521976 (human) | | 1e-09 | trait in response to platinum | | 10 | 27761911 | 27761912 | Human |
597286639 | GWAS1382713_H | glucose measurement QTL GWAS1382713 (human) | | 2e-11 | glucose measurement | blood glucose level (CMO:0000046) | 10 | 26305459 | 26305461 | Human |
597081824 | GWAS1177898_H | monocyte count QTL GWAS1177898 (human) | | 9e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30202478 | 30202479 | Human |
597425900 | GWAS1521974_H | trait in response to platinum QTL GWAS1521974 (human) | | 2e-08 | trait in response to platinum | | 10 | 27796896 | 27796897 | Human |
597081825 | GWAS1177899_H | monocyte count QTL GWAS1177899 (human) | | 2e-24 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44364170 | 44364171 | Human |
596975337 | GWAS1094856_H | triple-negative breast cancer, luminal A breast carcinoma QTL GWAS1094856 (human) | | 2e-13 | triple-negative breast cancer, luminal A breast carcinoma | | 10 | 21533927 | 21533928 | Human |
597057258 | GWAS1153332_H | adolescent idiopathic scoliosis QTL GWAS1153332 (human) | | 4e-28 | adolescent idiopathic scoliosis | | 10 | 27479154 | 27479155 | Human |
597044971 | GWAS1141045_H | aging, epigenetic status QTL GWAS1141045 (human) | | 2e-14 | aging, epigenetic status | | 10 | 37929331 | 37929332 | Human |
597057259 | GWAS1153333_H | adolescent idiopathic scoliosis QTL GWAS1153333 (human) | | 8e-28 | adolescent idiopathic scoliosis | | 10 | 44331285 | 44331286 | Human |
597393125 | GWAS1489199_H | gut microbiome measurement QTL GWAS1489199 (human) | | 0.000005 | gut microbiome measurement | | 10 | 33927588 | 33927589 | Human |
597143273 | GWAS1239347_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1239347 (human) | | 0.000001 | severe acute respiratory syndrome, COVID-19 | | 10 | 34268420 | 34268421 | Human |
597462556 | GWAS1558630_H | coronary artery disease QTL GWAS1558630 (human) | | 2e-12 | coronary artery disease | | 10 | 30034963 | 30034964 | Human |
597462557 | GWAS1558631_H | coronary artery disease QTL GWAS1558631 (human) | | 1e-16 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597462558 | GWAS1558632_H | coronary artery disease QTL GWAS1558632 (human) | | 2e-14 | coronary artery disease | | 10 | 44281740 | 44281741 | Human |
597175838 | GWAS1271912_H | cadherin-7 measurement QTL GWAS1271912 (human) | | 1e-28 | cadherin-7 measurement | | 10 | 19842685 | 19842686 | Human |
597327376 | GWAS1423450_H | prostate specific antigen amount QTL GWAS1423450 (human) | | 4e-11 | prostate specific antigen amount | | 10 | 23109519 | 23109520 | Human |
597073437 | GWAS1169511_H | coronary artery disease QTL GWAS1169511 (human) | | 1e-17 | coronary artery disease | | 10 | 30028144 | 30028145 | Human |
596971032 | GWAS1090551_H | major depressive disorder QTL GWAS1090551 (human) | | 0.0000001 | major depressive disorder | | 10 | 29945955 | 29945956 | Human |
407086541 | GWAS735517_H | obsolete_red blood cell distribution width QTL GWAS735517 (human) | | 7e-27 | obsolete_red blood cell distribution width | | 10 | 24934438 | 24934439 | Human |
407086540 | GWAS735516_H | obsolete_red blood cell distribution width QTL GWAS735516 (human) | | 6e-177 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
406889936 | GWAS538912_H | unipolar depression QTL GWAS538912 (human) | | 0.000007 | unipolar depression | | 10 | 33968684 | 33968685 | Human |
597110277 | GWAS1206351_H | Calcium channel blocker use measurement QTL GWAS1206351 (human) | | 3e-11 | Calcium channel blocker use measurement | | 10 | 18439030 | 18439031 | Human |
407127511 | GWAS776487_H | platelet crit QTL GWAS776487 (human) | | 1e-10 | platelet quantity (VT:0003179) | plateletcrit (CMO:0001349) | 10 | 27188019 | 27188020 | Human |
597372430 | GWAS1468504_H | schizophrenia QTL GWAS1468504 (human) | | 0.000001 | schizophrenia | | 10 | 21278636 | 21278637 | Human |
597327375 | GWAS1423449_H | prostate specific antigen amount QTL GWAS1423449 (human) | | 6e-20 | prostate specific antigen amount | | 10 | 22075050 | 22075051 | Human |
406967767 | GWAS616743_H | eosinophil percentage of granulocytes QTL GWAS616743 (human) | | 2e-17 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 26447311 | 26447312 | Human |
597618183 | GWAS1675043_H | body weight QTL GWAS1675043 (human) | | 3e-14 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 21508343 | 21508344 | Human |
597175809 | GWAS1271883_H | Tinnitus QTL GWAS1271883 (human) | | 0.000008 | Tinnitus | | 10 | 30486796 | 30486797 | Human |
597138958 | GWAS1235032_H | smoking initiation QTL GWAS1235032 (human) | | 3e-25 | smoking initiation | | 10 | 36319992 | 36319993 | Human |
597138957 | GWAS1235031_H | smoking initiation QTL GWAS1235031 (human) | | 3e-15 | smoking initiation | | 10 | 30011858 | 30011859 | Human |
597138956 | GWAS1235030_H | smoking initiation QTL GWAS1235030 (human) | | 2e-10 | smoking initiation | | 10 | 26755823 | 26755824 | Human |
597138955 | GWAS1235029_H | smoking initiation QTL GWAS1235029 (human) | | 4e-42 | smoking initiation | | 10 | 21744013 | 21744014 | Human |
597483008 | GWAS1579082_H | ubiquinone measurement QTL GWAS1579082 (human) | | 8e-09 | ubiquinone measurement | | 10 | 26667051 | 26667052 | Human |
597384711 | GWAS1480785_H | monocyte percentage of leukocytes QTL GWAS1480785 (human) | | 4e-13 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 28495554 | 28495555 | Human |
597138954 | GWAS1235028_H | smoking initiation QTL GWAS1235028 (human) | | 7e-24 | smoking initiation | | 10 | 21592450 | 21592451 | Human |
597138953 | GWAS1235027_H | smoking initiation QTL GWAS1235027 (human) | | 9e-13 | smoking initiation | | 10 | 20896123 | 20896124 | Human |
597024309 | GWAS1120383_H | breast carcinoma QTL GWAS1120383 (human) | | 2e-19 | mammary gland integrity trait (VT:0010552) | | 10 | 21744013 | 21744014 | Human |
597163572 | GWAS1259646_H | angina pectoris QTL GWAS1259646 (human) | | 2e-11 | angina pectoris | | 10 | 43985246 | 43985247 | Human |
596971056 | GWAS1090575_H | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder QTL GWAS1090575 (human) | | 1e-10 | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa, major depressive disorder | | 10 | 18437289 | 18437290 | Human |
406889957 | GWAS538933_H | hematocrit QTL GWAS538933 (human) | | 2e-10 | hematocrit | hematocrit (CMO:0000037) | 10 | 36171058 | 36171059 | Human |
597200434 | GWAS1296508_H | memory performance, sex interaction measurement QTL GWAS1296508 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 27036882 | 27036883 | Human |
597147174 | GWAS1243248_H | COVID-19 QTL GWAS1243248 (human) | | 1e-08 | COVID-19 | | 10 | 28549058 | 28549059 | Human |
597093924 | GWAS1189998_H | colorectal cancer, endometrial neoplasm QTL GWAS1189998 (human) | | 0.0000002 | colorectal cancer, endometrial neoplasm | | 10 | 19031157 | 19031158 | Human |
597130788 | GWAS1226862_H | memory performance QTL GWAS1226862 (human) | | 0.000008 | memory performance | | 10 | 19810364 | 19810365 | Human |
597388840 | GWAS1484914_H | QT interval, particulate matter air pollution measurement QTL GWAS1484914 (human) | | 2e-08 | QT interval, particulate matter air pollution measurement | QT interval (CMO:0000235) | 10 | 44237935 | 44237936 | Human |
597130785 | GWAS1226859_H | memory performance QTL GWAS1226859 (human) | | 0.000006 | memory performance | | 10 | 19806476 | 19806477 | Human |
596954668 | GWAS1074187_H | size QTL GWAS1074187 (human) | | 7e-10 | size | | 10 | 27611953 | 27611954 | Human |
407057913 | GWAS706889_H | glycodeoxycholate measurement QTL GWAS706889 (human) | | 0.000004 | glycodeoxycholate measurement | | 10 | 29609637 | 29609638 | Human |
597278247 | GWAS1374321_H | Alzheimer disease, polygenic risk score QTL GWAS1374321 (human) | | 2e-08 | Alzheimer disease, polygenic risk score | | 10 | 33272632 | 33272633 | Human |
407221637 | GWAS870613_H | response to antidepressant QTL GWAS870613 (human) | | 0.0000007 | response to antidepressant | | 10 | 20521596 | 20521597 | Human |
597122644 | GWAS1218718_H | blood protein measurement QTL GWAS1218718 (human) | | 2e-18 | blood protein amount (VT:0005416) | blood protein measurement (CMO:0000028) | 10 | 19971440 | 19971441 | Human |
596983388 | GWAS1102907_H | memory performance QTL GWAS1102907 (human) | | 0.000008 | memory performance | | 10 | 19821526 | 19821527 | Human |
597204562 | GWAS1300636_H | cognitive function measurement QTL GWAS1300636 (human) | | 0.000008 | cognitive behavior trait (VT:0010450) | | 10 | 24562781 | 24562782 | Human |
597327440 | GWAS1423514_H | coronary artery calcification QTL GWAS1423514 (human) | | 3e-08 | coronary artery calcification | | 10 | 44020268 | 44020269 | Human |
597335638 | GWAS1431712_H | COVID-19 QTL GWAS1431712 (human) | | 0.000007 | COVID-19 | | 10 | 36984100 | 36984101 | Human |
596983387 | GWAS1102906_H | memory performance QTL GWAS1102906 (human) | | 0.000008 | memory performance | | 10 | 19832589 | 19832590 | Human |
597073496 | GWAS1169570_H | coronary artery disease QTL GWAS1169570 (human) | | 5e-24 | coronary artery disease | | 10 | 44001523 | 44001524 | Human |
597360213 | GWAS1456287_H | pulse pressure measurement QTL GWAS1456287 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 20768616 | 20768617 | Human |
597528141 | GWAS1624215_H | carpal tunnel syndrome QTL GWAS1624215 (human) | | 3e-10 | carpal tunnel syndrome | | 10 | 30817960 | 30817961 | Human |
406988176 | GWAS637152_H | intelligence QTL GWAS637152 (human) | | 0.000006 | intelligence | | 10 | 34449119 | 34449120 | Human |
597200459 | GWAS1296533_H | B-cell acute lymphoblastic leukemia, inflammatory bowel disease QTL GWAS1296533 (human) | | 1e-08 | leukocyte integrity trait (VT:0010898) | | 10 | 22188629 | 22188630 | Human |
597204559 | GWAS1300633_H | cognitive function measurement QTL GWAS1300633 (human) | | 0.000004 | cognitive behavior trait (VT:0010450) | | 10 | 28999366 | 28999367 | Human |
597417548 | GWAS1513622_H | response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement, mortality QTL GWAS1513622 (human) | | 7e-09 | response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement, mortality | ratio of deaths to total study population during a period of time (CMO:0001023) | 10 | 33588436 | 33588437 | Human |
597020236 | GWAS1116310_H | pelvic organ prolapse QTL GWAS1116310 (human) | | 0.000005 | pelvic organ prolapse | | 10 | 28420676 | 28420677 | Human |
597368386 | GWAS1464460_H | gut microbiome measurement QTL GWAS1464460 (human) | | 0.000003 | gut microbiome measurement | | 10 | 28476870 | 28476871 | Human |
597245507 | GWAS1341581_H | IGF-1 measurement QTL GWAS1341581 (human) | | 2e-09 | IGF-1 measurement | blood insulin-like growth factor 1 level (CMO:0001297) | 10 | 38170065 | 38170066 | Human |
597212739 | GWAS1308813_H | protein measurement QTL GWAS1308813 (human) | | 2e-08 | protein measurement | | 10 | 33884184 | 33884185 | Human |
597200452 | GWAS1296526_H | memory performance QTL GWAS1296526 (human) | | 0.000006 | memory performance | | 10 | 22887883 | 22887884 | Human |
597024373 | GWAS1120447_H | coronary atherosclerosis measurement, traffic air pollution measurement QTL GWAS1120447 (human) | | 0.000009 | coronary artery integrity trait (VT:0010746) | blood vessel lesion measurement (CMO:0000962) | 10 | 20681548 | 20681549 | Human |
597433980 | GWAS1530054_H | protein measurement QTL GWAS1530054 (human) | | 4e-29 | protein measurement | | 10 | 33191785 | 33191786 | Human |
407070112 | GWAS719088_H | cognitive decline measurement QTL GWAS719088 (human) | | 0.000001 | cognitive behavior trait (VT:0010450) | | 10 | 20626156 | 20626157 | Human |
597290618 | GWAS1386692_H | aggressive periodontitis QTL GWAS1386692 (human) | | 0.000005 | aggressive periodontitis | | 10 | 37884551 | 37884552 | Human |
407070118 | GWAS719094_H | cognitive decline measurement QTL GWAS719094 (human) | | 7e-08 | cognitive behavior trait (VT:0010450) | | 10 | 20626156 | 20626157 | Human |
596987506 | GWAS1107025_H | memory performance, sex interaction measurement QTL GWAS1107025 (human) | | 0.000009 | memory performance, sex interaction measurement | | 10 | 33030912 | 33030913 | Human |
597307005 | GWAS1403079_H | monocyte count QTL GWAS1403079 (human) | | 1e-17 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44384263 | 44384264 | Human |
597220978 | GWAS1317052_H | cataract QTL GWAS1317052 (human) | | 5e-10 | cataract | | 10 | 28735201 | 28735202 | Human |
597212788 | GWAS1308862_H | body mass index QTL GWAS1308862 (human) | | 0.000001 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 28415284 | 28415285 | Human |
597094011 | GWAS1190085_H | 3-hydroxy-1-methylpropylmercapturic acid measurement QTL GWAS1190085 (human) | | 0.000003 | 3-hydroxy-1-methylpropylmercapturic acid measurement | | 10 | 38472310 | 38472311 | Human |
597208681 | GWAS1304755_H | diverticular disease QTL GWAS1304755 (human) | | 2e-22 | diverticular disease | | 10 | 25530299 | 25530300 | Human |
596975204 | GWAS1094723_H | myocardial infarction QTL GWAS1094723 (human) | | 8e-09 | myocardial infarction | | 10 | 44205784 | 44205785 | Human |
597343848 | GWAS1439922_H | carpal tunnel syndrome QTL GWAS1439922 (human) | | 4e-14 | carpal tunnel syndrome | | 10 | 27644947 | 27644948 | Human |
596983394 | GWAS1102913_H | memory performance QTL GWAS1102913 (human) | | 0.00001 | memory performance | | 10 | 19829435 | 19829436 | Human |
597306989 | GWAS1403063_H | spine bone mineral density QTL GWAS1403063 (human) | | 1e-11 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 28197253 | 28197254 | Human |
596962915 | GWAS1082434_H | atopic eczema QTL GWAS1082434 (human) | | 0.000004 | atopic eczema | | 10 | 30810758 | 30810759 | Human |
597364322 | GWAS1460396_H | neutrophil count QTL GWAS1460396 (human) | | 2e-21 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28491444 | 28491445 | Human |
597093997 | GWAS1190071_H | coronary artery disease QTL GWAS1190071 (human) | | 6e-15 | coronary artery disease | | 10 | 43985363 | 43985364 | Human |
597319270 | GWAS1415344_H | body surface area QTL GWAS1415344 (human) | | 1e-09 | body surface area | | 10 | 34346601 | 34346602 | Human |
597319269 | GWAS1415343_H | body surface area QTL GWAS1415343 (human) | | 4e-14 | body surface area | | 10 | 24889935 | 24889936 | Human |
597040534 | GWAS1136608_H | diet measurement QTL GWAS1136608 (human) | | 3e-08 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21580680 | 21580681 | Human |
597384602 | GWAS1480676_H | lymphocyte percentage of leukocytes QTL GWAS1480676 (human) | | 2e-16 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 28492438 | 28492439 | Human |
597310872 | GWAS1406946_H | body mass index QTL GWAS1406946 (human) | | 3e-21 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21540233 | 21540234 | Human |
597384601 | GWAS1480675_H | lymphocyte percentage of leukocytes QTL GWAS1480675 (human) | | 5e-10 | lymphocyte quantity (VT:0000717) | blood lymphocyte count to total leukocyte count ratio (CMO:0000371) | 10 | 26422970 | 26422971 | Human |
597114261 | GWAS1210335_H | protein measurement QTL GWAS1210335 (human) | | 2e-08 | protein measurement | | 10 | 29042438 | 29042439 | Human |
597335454 | GWAS1431528_H | educational attainment QTL GWAS1431528 (human) | | 4e-09 | educational attainment | | 10 | 26250754 | 26250755 | Human |
597491096 | GWAS1587170_H | neuroimaging measurement QTL GWAS1587170 (human) | | 1e-19 | neuroimaging measurement | | 10 | 30831584 | 30831585 | Human |
597335455 | GWAS1431529_H | educational attainment QTL GWAS1431529 (human) | | 9e-14 | educational attainment | | 10 | 30765257 | 30765258 | Human |
597429658 | GWAS1525732_H | erythrocyte count QTL GWAS1525732 (human) | | 6e-13 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 36173027 | 36173028 | Human |
407160387 | GWAS809363_H | gut microbiome measurement QTL GWAS809363 (human) | | 0.000005 | gut microbiome measurement | | 10 | 21082603 | 21082604 | Human |
597335453 | GWAS1431527_H | educational attainment QTL GWAS1431527 (human) | | 7e-13 | educational attainment | | 10 | 23654910 | 23654911 | Human |
597429659 | GWAS1525733_H | erythrocyte count QTL GWAS1525733 (human) | | 1e-17 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 44363233 | 44363234 | Human |
597290385 | GWAS1386459_H | metastasis measurement, colorectal cancer QTL GWAS1386459 (human) | | 0.000003 | metastasis measurement, colorectal cancer | | 10 | 36110736 | 36110737 | Human |
597589396 | GWAS1646256_H | monocyte count QTL GWAS1646256 (human) | | 8e-16 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44390354 | 44390355 | Human |
597589394 | GWAS1646254_H | monocyte count QTL GWAS1646254 (human) | | 4e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 21607891 | 21607892 | Human |
597589395 | GWAS1646255_H | monocyte count QTL GWAS1646255 (human) | | 2e-45 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24922362 | 24922363 | Human |
597171605 | GWAS1267679_H | response to methotrexate, drug-induced liver injury QTL GWAS1267679 (human) | | 0.000006 | response to methotrexate, drug-induced liver injury | | 10 | 25897158 | 25897159 | Human |
597368214 | GWAS1464288_H | pulse pressure measurement QTL GWAS1464288 (human) | | 8e-09 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31064371 | 31064372 | Human |
407045718 | GWAS694694_H | metabolic rate measurement QTL GWAS694694 (human) | | 0.000001 | metabolic rate measurement | metabolic rate (CMO:0003956) | 10 | 18493951 | 18493952 | Human |
597106061 | GWAS1202135_H | cancer QTL GWAS1202135 (human) | | 0.0000003 | cancer | | 10 | 21746395 | 21746396 | Human |
597511555 | GWAS1607629_H | diastolic blood pressure, systolic blood pressure QTL GWAS1607629 (human) | | 0.0000007 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 32068832 | 32068833 | Human |
597335485 | GWAS1431559_H | COVID-19 QTL GWAS1431559 (human) | | 0.000003 | COVID-19 | | 10 | 28259829 | 28259830 | Human |
597274037 | GWAS1370111_H | physical activity measurement QTL GWAS1370111 (human) | | 3e-22 | wellness/fitness trait (VT:1000152) | voluntary body movement measurement (CMO:0000954) | 10 | 21550891 | 21550913 | Human |
597495216 | GWAS1591290_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1591290 (human) | | 1e-17 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 37323688 | 37323689 | Human |
597245367 | GWAS1341441_H | aging QTL GWAS1341441 (human) | | 2e-17 | aging | | 10 | 37927435 | 37927436 | Human |
597335466 | GWAS1431540_H | educational attainment QTL GWAS1431540 (human) | | 1e-17 | educational attainment | | 10 | 34313836 | 34313837 | Human |
597335467 | GWAS1431541_H | educational attainment QTL GWAS1431541 (human) | | 8e-08 | educational attainment | | 10 | 43226014 | 43226015 | Human |
597335464 | GWAS1431538_H | educational attainment QTL GWAS1431538 (human) | | 8e-09 | educational attainment | | 10 | 34000634 | 34000635 | Human |
597495215 | GWAS1591289_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1591289 (human) | | 3e-68 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42963122 | 42963123 | Human |
597335465 | GWAS1431539_H | educational attainment QTL GWAS1431539 (human) | | 1e-10 | educational attainment | | 10 | 34292195 | 34292196 | Human |
597294509 | GWAS1390583_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1390583 (human) | | 2e-11 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42949086 | 42949087 | Human |
597024162 | GWAS1120236_H | breast carcinoma QTL GWAS1120236 (human) | | 3e-08 | mammary gland integrity trait (VT:0010552) | | 10 | 22581149 | 22581150 | Human |
407221874 | GWAS870850_H | lymphocyte count QTL GWAS870850 (human) | | 9e-17 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24916129 | 24916130 | Human |
597294510 | GWAS1390584_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1390584 (human) | | 3e-19 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 43097595 | 43097596 | Human |
597335458 | GWAS1431532_H | educational attainment QTL GWAS1431532 (human) | | 5e-14 | educational attainment | | 10 | 32042233 | 32042234 | Human |
597335459 | GWAS1431533_H | educational attainment QTL GWAS1431533 (human) | | 3e-08 | educational attainment | | 10 | 32180559 | 32180560 | Human |
597077420 | GWAS1173494_H | heel bone mineral density QTL GWAS1173494 (human) | | 5e-16 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28146986 | 28146987 | Human |
597335456 | GWAS1431530_H | educational attainment QTL GWAS1431530 (human) | | 6e-09 | educational attainment | | 10 | 30844652 | 30844653 | Human |
597581221 | GWAS1638081_H | calcium measurement QTL GWAS1638081 (human) | | 4e-24 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22207976 | 22207977 | Human |
597077421 | GWAS1173495_H | heel bone mineral density QTL GWAS1173495 (human) | | 6e-29 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 30765257 | 30765258 | Human |
597335457 | GWAS1431531_H | educational attainment QTL GWAS1431531 (human) | | 4e-13 | educational attainment | | 10 | 30886908 | 30886909 | Human |
597077418 | GWAS1173492_H | heel bone mineral density QTL GWAS1173492 (human) | | 1e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 19854180 | 19854181 | Human |
597335462 | GWAS1431536_H | educational attainment QTL GWAS1431536 (human) | | 8e-11 | educational attainment | | 10 | 33254774 | 33254775 | Human |
597077419 | GWAS1173493_H | heel bone mineral density QTL GWAS1173493 (human) | | 5e-12 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 20041014 | 20041015 | Human |
597335463 | GWAS1431537_H | educational attainment QTL GWAS1431537 (human) | | 0.0000009 | educational attainment | | 10 | 33320005 | 33320006 | Human |
597601696 | GWAS1658556_H | calcium measurement QTL GWAS1658556 (human) | | 2e-22 | calcium measurement | blood calcium level (CMO:0000502) | 10 | 22207976 | 22207977 | Human |
597335460 | GWAS1431534_H | educational attainment QTL GWAS1431534 (human) | | 4e-10 | educational attainment | | 10 | 32227992 | 32227993 | Human |
597335461 | GWAS1431535_H | educational attainment QTL GWAS1431535 (human) | | 6e-10 | educational attainment | | 10 | 33178180 | 33178181 | Human |
597315033 | GWAS1411107_H | cognitive function measurement QTL GWAS1411107 (human) | | 0.000009 | cognitive behavior trait (VT:0010450) | | 10 | 25870668 | 25870669 | Human |
597421520 | GWAS1517594_H | cognitive function measurement QTL GWAS1517594 (human) | | 4e-09 | cognitive behavior trait (VT:0010450) | | 10 | 22593152 | 22593153 | Human |
597138904 | GWAS1234978_H | trait in response to apixaban QTL GWAS1234978 (human) | | 4e-10 | trait in response to apixaban | | 10 | 35732235 | 35732236 | Human |
597265865 | GWAS1361939_H | phosphatidylcholine measurement QTL GWAS1361939 (human) | | 1e-08 | phosphatidylcholine measurement | | 10 | 19590656 | 19590657 | Human |
597421519 | GWAS1517593_H | cognitive function measurement QTL GWAS1517593 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 10 | 22035251 | 22035252 | Human |
597585352 | GWAS1642212_H | eosinophil count QTL GWAS1642212 (human) | | 1e-48 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 26454922 | 26454923 | Human |
597310925 | GWAS1406999_H | Calcium channel blocker use measurement QTL GWAS1406999 (human) | | 3e-11 | Calcium channel blocker use measurement | | 10 | 18437125 | 18437126 | Human |
597585353 | GWAS1642213_H | eosinophil count QTL GWAS1642213 (human) | | 7e-23 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28492438 | 28492439 | Human |
597343683 | GWAS1439757_H | diverticular disease QTL GWAS1439757 (human) | | 2e-09 | diverticular disease | | 10 | 21730283 | 21730284 | Human |
597519809 | GWAS1615883_H | body fat percentage QTL GWAS1615883 (human) | | 5e-10 | body fat mass (VT:0010482) | body fat percentage (CMO:0000302) | 10 | 21531721 | 21531722 | Human |
596966857 | GWAS1086376_H | diastolic blood pressure QTL GWAS1086376 (human) | | 4e-11 | diastolic blood pressure | | 10 | 21741274 | 21741275 | Human |
597343684 | GWAS1439758_H | diverticular disease QTL GWAS1439758 (human) | | 2e-22 | diverticular disease | | 10 | 25445130 | 25445131 | Human |
597343685 | GWAS1439759_H | diverticular disease QTL GWAS1439759 (human) | | 1e-38 | diverticular disease | | 10 | 25504373 | 25504374 | Human |
597511676 | GWAS1607750_H | insomnia QTL GWAS1607750 (human) | | 4e-15 | insomnia | | 10 | 21531524 | 21531525 | Human |
407234080 | GWAS883056_H | lung carcinoma QTL GWAS883056 (human) | | 0.000002 | lung carcinoma | | 10 | 28348731 | 28348732 | Human |
597093873 | GWAS1189947_H | coronary artery disease QTL GWAS1189947 (human) | | 4e-11 | coronary artery disease | | 10 | 30034963 | 30034964 | Human |
597368316 | GWAS1464390_H | hemoglobin measurement QTL GWAS1464390 (human) | | 1e-22 | hemoglobin measurement | hemoglobin measurement (CMO:0000508) | 10 | 44363233 | 44363234 | Human |
597380584 | GWAS1476658_H | serum IgG glycosylation measurement QTL GWAS1476658 (human) | | 0.000006 | serum IgG glycosylation measurement | | 10 | 23014324 | 23014325 | Human |
597163489 | GWAS1259563_H | breast carcinoma QTL GWAS1259563 (human) | | 3e-10 | mammary gland integrity trait (VT:0010552) | | 10 | 21522558 | 21522559 | Human |
597085678 | GWAS1181752_H | monocyte count QTL GWAS1181752 (human) | | 4e-121 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24929314 | 24929315 | Human |
597089774 | GWAS1185848_H | monocyte count QTL GWAS1185848 (human) | | 3e-18 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44384812 | 44384813 | Human |
597085679 | GWAS1181753_H | monocyte count QTL GWAS1181753 (human) | | 3e-15 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30207976 | 30207977 | Human |
597089775 | GWAS1185849_H | monocyte count QTL GWAS1185849 (human) | | 2e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44378805 | 44378806 | Human |
597089772 | GWAS1185846_H | monocyte count QTL GWAS1185846 (human) | | 1e-95 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24928854 | 24928855 | Human |
597089773 | GWAS1185847_H | monocyte count QTL GWAS1185847 (human) | | 9e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30216773 | 30216774 | Human |
597380582 | GWAS1476656_H | serum IgG glycosylation measurement QTL GWAS1476656 (human) | | 0.000003 | serum IgG glycosylation measurement | | 10 | 23014324 | 23014325 | Human |
597601566 | GWAS1658426_H | alanine measurement QTL GWAS1658426 (human) | | 0.000004 | alanine measurement | blood amino acid measurement (CMO:0003730) | 10 | 21280590 | 21280591 | Human |
407389896 | GWAS1038872_H | obsolete_red blood cell distribution width QTL GWAS1038872 (human) | | 6e-16 | obsolete_red blood cell distribution width | | 10 | 24934438 | 24934439 | Human |
597077271 | GWAS1173345_H | intelligence QTL GWAS1173345 (human) | | 9e-09 | intelligence | | 10 | 25484165 | 25484166 | Human |
597261595 | GWAS1357669_H | serum metabolite measurement QTL GWAS1357669 (human) | | 0.000006 | serum metabolite measurement | | 10 | 31729633 | 31729634 | Human |
597286172 | GWAS1382246_H | hypertension QTL GWAS1382246 (human) | | 3e-10 | hypertension | | 10 | 18438972 | 18438973 | Human |
597380380 | GWAS1476454_H | schizophrenia QTL GWAS1476454 (human) | | 0.000006 | schizophrenia | | 10 | 33799125 | 33799126 | Human |
597384465 | GWAS1480539_H | type 2 diabetes mellitus QTL GWAS1480539 (human) | | 2e-10 | type 2 diabetes mellitus | | 10 | 33708299 | 33708300 | Human |
597339414 | GWAS1435488_H | diastolic blood pressure QTL GWAS1435488 (human) | | 0.0000009 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 29788743 | 29788744 | Human |
597286167 | GWAS1382241_H | hypertension QTL GWAS1382241 (human) | | 1e-23 | hypertension | | 10 | 18439030 | 18439031 | Human |
407074509 | GWAS723485_H | sodium measurement QTL GWAS723485 (human) | | 7e-14 | sodium measurement | blood sodium level (CMO:0000499) | 10 | 21744013 | 21744014 | Human |
407389895 | GWAS1038871_H | obsolete_red blood cell distribution width QTL GWAS1038871 (human) | | 9e-70 | obsolete_red blood cell distribution width | | 10 | 24569461 | 24569462 | Human |
597155076 | GWAS1251150_H | diet measurement, testosterone measurement QTL GWAS1251150 (human) | | 0.000006 | eating behavior trait (VT:0001431) | serum testosterone level (CMO:0000568) | 10 | 38085505 | 38085506 | Human |
597327118 | GWAS1423192_H | schizophrenia QTL GWAS1423192 (human) | | 1e-17 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
406914773 | GWAS563749_H | pyroglutamine measurement QTL GWAS563749 (human) | | 0.000004 | pyroglutamine measurement | | 10 | 24935533 | 24935534 | Human |
597527816 | GWAS1623890_H | pulse pressure measurement QTL GWAS1623890 (human) | | 0.0000001 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31105964 | 31105965 | Human |
597015808 | GWAS1111882_H | Hirschsprung disease QTL GWAS1111882 (human) | | 4e-43 | Hirschsprung disease | | 10 | 43075477 | 43075478 | Human |
596966659 | GWAS1086178_H | diastolic blood pressure QTL GWAS1086178 (human) | | 4e-32 | diastolic blood pressure | | 10 | 18439030 | 18439031 | Human |
597449988 | GWAS1546062_H | systolic blood pressure QTL GWAS1546062 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 31995897 | 31995898 | Human |
596978959 | GWAS1098478_H | Red cell distribution width QTL GWAS1098478 (human) | | 7e-27 | Red cell distribution width | | 10 | 24934438 | 24934439 | Human |
597527815 | GWAS1623889_H | pulse pressure measurement QTL GWAS1623889 (human) | | 2e-16 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31080780 | 31080781 | Human |
597527814 | GWAS1623888_H | pulse pressure measurement QTL GWAS1623888 (human) | | 0.0000001 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 21475540 | 21475541 | Human |
596978958 | GWAS1098477_H | Red cell distribution width QTL GWAS1098477 (human) | | 6e-177 | Red cell distribution width | | 10 | 24569461 | 24569462 | Human |
597359873 | GWAS1455947_H | eosinophil count QTL GWAS1455947 (human) | | 9e-13 | eosinophil quantity (VT:0002602) | blood eosinophil count (CMO:0000033) | 10 | 28491444 | 28491445 | Human |
597449984 | GWAS1546058_H | systolic blood pressure QTL GWAS1546058 (human) | | 2e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18501798 | 18501799 | Human |
597449985 | GWAS1546059_H | systolic blood pressure QTL GWAS1546059 (human) | | 4e-09 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27639397 | 27639398 | Human |
597449986 | GWAS1546060_H | systolic blood pressure QTL GWAS1546060 (human) | | 6e-10 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27765111 | 27765112 | Human |
597449987 | GWAS1546061_H | systolic blood pressure QTL GWAS1546061 (human) | | 7e-16 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 27956491 | 27956492 | Human |
597105975 | GWAS1202049_H | hippocampus volume change measurement, age at assessment QTL GWAS1202049 (human) | | 0.000004 | hippocampus volume change measurement, age at assessment | | 10 | 44103565 | 44103566 | Human |
597466429 | GWAS1562503_H | body mass index QTL GWAS1562503 (human) | | 1e-25 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532989 | 21532990 | Human |
597593402 | GWAS1650262_H | prostate specific antigen amount QTL GWAS1650262 (human) | | 2e-26 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
597114172 | GWAS1210246_H | platelet component distribution width QTL GWAS1210246 (human) | | 1e-14 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 29962719 | 29962720 | Human |
597237034 | GWAS1333108_H | basophil count QTL GWAS1333108 (human) | | 9e-12 | basophil quantity (VT:0002607) | blood basophil count (CMO:0000034) | 10 | 26445588 | 26445589 | Human |
597249322 | GWAS1345396_H | ruminococcaceae seropositivity QTL GWAS1345396 (human) | | 3e-08 | ruminococcaceae seropositivity | | 10 | 33214251 | 33214252 | Human |
597253423 | GWAS1349497_H | complement factor H measurement QTL GWAS1349497 (human) | | 0.000009 | complement protein amount (VT:0010033) | | 10 | 33854805 | 33854806 | Human |
597404963 | GWAS1501037_H | cortical thickness QTL GWAS1501037 (human) | | 2e-52 | cortical thickness | | 10 | 21530895 | 21530896 | Human |
597384482 | GWAS1480556_H | cortical thickness, neuroimaging measurement QTL GWAS1480556 (human) | | 3e-08 | cortical thickness, neuroimaging measurement | | 10 | 30834006 | 30834007 | Human |
597024047 | GWAS1120121_H | breast carcinoma QTL GWAS1120121 (human) | | 0.000006 | mammary gland integrity trait (VT:0010552) | | 10 | 37101682 | 37101683 | Human |
597429543 | GWAS1525617_H | protein measurement QTL GWAS1525617 (human) | | 3e-30 | protein measurement | | 10 | 33191785 | 33191786 | Human |
597097770 | GWAS1193844_H | sex hormone-binding globulin measurement QTL GWAS1193844 (human) | | 8e-10 | sex hormone-binding globulin measurement | | 10 | 30882697 | 30882698 | Human |
597216600 | GWAS1312674_H | smoking initiation QTL GWAS1312674 (human) | | 1e-09 | smoking initiation | | 10 | 21744013 | 21744014 | Human |
596983127 | GWAS1102646_H | memory performance QTL GWAS1102646 (human) | | 0.000007 | memory performance | | 10 | 19822214 | 19822215 | Human |
597200218 | GWAS1296292_H | B-cell acute lymphoblastic leukemia, primary biliary cirrhosis QTL GWAS1296292 (human) | | 9e-10 | leukocyte integrity trait (VT:0010898) | | 10 | 22191007 | 22191008 | Human |
597146965 | GWAS1243039_H | smoking initiation QTL GWAS1243039 (human) | | 2e-26 | smoking initiation | | 10 | 36319992 | 36319993 | Human |
597212507 | GWAS1308581_H | schizophrenia QTL GWAS1308581 (human) | | 9e-14 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597269852 | GWAS1365926_H | taste liking measurement QTL GWAS1365926 (human) | | 2e-08 | taste liking measurement | | 10 | 21725718 | 21725719 | Human |
597208400 | GWAS1304474_H | sleep apnea measurement QTL GWAS1304474 (human) | | 6e-08 | sleep behavior trait (VT:0001501) | | 10 | 21064217 | 21064218 | Human |
597015902 | GWAS1111976_H | coronary artery disease QTL GWAS1111976 (human) | | 2e-24 | coronary artery disease | | 10 | 44282112 | 44282113 | Human |
597273929 | GWAS1370003_H | BMI-adjusted hip circumference QTL GWAS1370003 (human) | | 8e-09 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 43183348 | 43183349 | Human |
597093703 | GWAS1189777_H | atrial fibrillation QTL GWAS1189777 (human) | | 0.000007 | atrial fibrillation | | 10 | 18705654 | 18705655 | Human |
597273928 | GWAS1370002_H | BMI-adjusted hip circumference QTL GWAS1370002 (human) | | 4e-11 | BMI-adjusted hip circumference | hip circumference (CMO:0000014) | 10 | 27621853 | 27621854 | Human |
597282120 | GWAS1378194_H | proto-oncogene tyrosine-protein kinase receptor Ret measurement QTL GWAS1378194 (human) | | 3e-09 | proto-oncogene tyrosine-protein kinase receptor Ret measurement | | 10 | 42862706 | 42862707 | Human |
597114180 | GWAS1210254_H | platelet component distribution width QTL GWAS1210254 (human) | | 8e-18 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 32378193 | 32378194 | Human |
406972054 | GWAS621030_H | bone mineral content measurement QTL GWAS621030 (human) | | 0.000007 | bone mineral content measurement | | 10 | 42741770 | 42741771 | Human |
597400899 | GWAS1496973_H | protein measurement QTL GWAS1496973 (human) | | 2e-08 | protein measurement | | 10 | 22458365 | 22458366 | Human |
597601600 | GWAS1658460_H | acetate measurement QTL GWAS1658460 (human) | | 0.000003 | acetate measurement | | 10 | 22397276 | 22397277 | Human |
597081417 | GWAS1177491_H | monocyte count QTL GWAS1177491 (human) | | 2e-23 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44384812 | 44384813 | Human |
597396859 | GWAS1492933_H | vaginal microbiome measurement QTL GWAS1492933 (human) | | 0.000008 | vaginal microbiome measurement | | 10 | 25041265 | 25041266 | Human |
597519740 | GWAS1615814_H | diastolic blood pressure QTL GWAS1615814 (human) | | 2e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 31105964 | 31105965 | Human |
597220730 | GWAS1316804_H | bipolar I disorder QTL GWAS1316804 (human) | | 3e-08 | bipolar I disorder | | 10 | 18453325 | 18453326 | Human |
597093746 | GWAS1189820_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1189820 (human) | | 0.0000005 | 3-hydroxypropylmercapturic acid measurement | | 10 | 21405290 | 21405291 | Human |
597048690 | GWAS1144764_H | erythrocyte count QTL GWAS1144764 (human) | | 2e-16 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 44378805 | 44378806 | Human |
597519739 | GWAS1615813_H | diastolic blood pressure QTL GWAS1615813 (human) | | 0.0000004 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 31080780 | 31080781 | Human |
597048689 | GWAS1144763_H | erythrocyte count QTL GWAS1144763 (human) | | 2e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 27095178 | 27095179 | Human |
597400947 | GWAS1497021_H | mean reticulocyte volume QTL GWAS1497021 (human) | | 1e-15 | reticulocyte morphology trait (VT:0002424) | mean corpuscular volume (CMO:0000038) | 10 | 28624380 | 28624381 | Human |
597306736 | GWAS1402810_H | monocyte count QTL GWAS1402810 (human) | | 3e-09 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30207976 | 30207977 | Human |
597314928 | GWAS1411002_H | cortical thickness QTL GWAS1411002 (human) | | 7e-12 | cortical thickness | | 10 | 31978567 | 31978568 | Human |
597372267 | GWAS1468341_H | intelligence QTL GWAS1468341 (human) | | 0.0000001 | intelligence | | 10 | 33387727 | 33387728 | Human |
597384553 | GWAS1480627_H | body mass index QTL GWAS1480627 (human) | | 2e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33696506 | 33696507 | Human |
597306734 | GWAS1402808_H | monocyte count QTL GWAS1402808 (human) | | 3e-11 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 21618494 | 21618495 | Human |
597392751 | GWAS1488825_H | autoimmune thyroid disease, systemic lupus erythematosus, type 1 diabetes mellitus, ankylosing spondylitis, psoriasis, common variable immunodeficiency, celiac disease, ulcerative colitis, Crohn's disease, autoimmune disease, juvenile idiopathic arthritis QTL GWAS1488825 (human) | | 8e-11 | intestine integrity trait (VT:0010554) | | 10 | 37303610 | 37303611 | Human |
597306735 | GWAS1402809_H | monocyte count QTL GWAS1402809 (human) | | 3e-67 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24931570 | 24931571 | Human |
597581160 | GWAS1638020_H | monocyte count QTL GWAS1638020 (human) | | 2e-13 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 30194159 | 30194160 | Human |
597093729 | GWAS1189803_H | influenza A (H1N1) QTL GWAS1189803 (human) | | 9e-14 | influenza A (H1N1) | | 10 | 22549797 | 22549798 | Human |
597298541 | GWAS1394615_H | blood strontium measurement QTL GWAS1394615 (human) | | 0.000001 | blood strontium measurement | | 10 | 25499504 | 25499505 | Human |
597581158 | GWAS1638018_H | monocyte count QTL GWAS1638018 (human) | | 6e-71 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24922362 | 24922363 | Human |
597171553 | GWAS1267627_H | solute carrier family 22 member 16 measurement QTL GWAS1267627 (human) | | 3e-23 | solute carrier family 22 member 16 measurement | | 10 | 19792543 | 19792544 | Human |
597437798 | GWAS1533872_H | trait in response to paclitaxel QTL GWAS1533872 (human) | | 0.000006 | trait in response to paclitaxel | | 10 | 30080931 | 30080932 | Human |
597265763 | GWAS1361837_H | triglyceride measurement QTL GWAS1361837 (human) | | 2e-09 | triglyceride measurement | blood triglyceride level (CMO:0000118) | 10 | 33339134 | 33339135 | Human |
597265567 | GWAS1361641_H | diastolic blood pressure QTL GWAS1361641 (human) | | 8e-56 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 18439030 | 18439031 | Human |
597425298 | GWAS1521372_H | lymphocyte:monocyte ratio QTL GWAS1521372 (human) | | 2e-10 | leukocyte quantity (VT:0000217) | | 10 | 26423144 | 26423145 | Human |
597380242 | GWAS1476316_H | serum IgG glycosylation measurement QTL GWAS1476316 (human) | | 0.000008 | serum IgG glycosylation measurement | | 10 | 33116159 | 33116160 | Human |
597044381 | GWAS1140455_H | Abnormality of chromosome segregation QTL GWAS1140455 (human) | | 0.000005 | Abnormality of chromosome segregation | | 10 | 27958511 | 27958512 | Human |
597617810 | GWAS1674670_H | prothrombin time measurement QTL GWAS1674670 (human) | | 3e-16 | blood coagulation trait (VT:0002551) | prothrombin time (CMO:0000211) | 10 | 19931917 | 19931918 | Human |
597109895 | GWAS1205969_H | diabetic nephropathy QTL GWAS1205969 (human) | | 0.0000006 | kidney integrity trait (VT:0010580) | | 10 | 25424152 | 25424153 | Human |
597113989 | GWAS1210063_H | platelet component distribution width QTL GWAS1210063 (human) | | 1e-15 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 24911876 | 24911877 | Human |
597113988 | GWAS1210062_H | platelet component distribution width QTL GWAS1210062 (human) | | 5e-22 | platelet size trait (VT:0010457) | platelet distribution width (CMO:0001350) | 10 | 22884391 | 22884392 | Human |
597023874 | GWAS1119948_H | breast carcinoma QTL GWAS1119948 (human) | | 2e-19 | mammary gland integrity trait (VT:0010552) | | 10 | 22108073 | 22108074 | Human |
597314688 | GWAS1410762_H | cortical thickness QTL GWAS1410762 (human) | | 3e-09 | cortical thickness | | 10 | 24754064 | 24754065 | Human |
597163148 | GWAS1259222_H | atrial fibrillation QTL GWAS1259222 (human) | | 1e-08 | atrial fibrillation | | 10 | 20868692 | 20868693 | Human |
596970635 | GWAS1090154_H | progression free survival, response to tyrosine kinase inhibitor QTL GWAS1090154 (human) | | 0.0000002 | progression free survival, response to tyrosine kinase inhibitor | | 10 | 19119730 | 19119731 | Human |
597580929 | GWAS1637789_H | lymphocyte count QTL GWAS1637789 (human) | | 8e-19 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24925121 | 24925122 | Human |
597171385 | GWAS1267459_H | aortic measurement QTL GWAS1267459 (human) | | 2e-12 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29881558 | 29881559 | Human |
597359803 | GWAS1455877_H | pulse pressure measurement QTL GWAS1455877 (human) | | 1e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 31123632 | 31123633 | Human |
597380272 | GWAS1476346_H | Attached earlobe QTL GWAS1476346 (human) | | 0.0000003 | Attached earlobe | | 10 | 24206657 | 24206658 | Human |
597380279 | GWAS1476353_H | coronary artery disease QTL GWAS1476353 (human) | | 9e-08 | coronary artery disease | | 10 | 44258419 | 44258420 | Human |
597408949 | GWAS1505023_H | myocardial infarction QTL GWAS1505023 (human) | | 8e-09 | myocardial infarction | | 10 | 44205784 | 44205785 | Human |
597241005 | GWAS1337079_H | C-reactive protein measurement QTL GWAS1337079 (human) | | 8e-13 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 21541175 | 21541176 | Human |
597380259 | GWAS1476333_H | serum IgG glycosylation measurement QTL GWAS1476333 (human) | | 0.0000006 | serum IgG glycosylation measurement | | 10 | 23014324 | 23014325 | Human |
597507233 | GWAS1603307_H | aortic measurement QTL GWAS1603307 (human) | | 3e-11 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29878080 | 29878081 | Human |
597273765 | GWAS1369839_H | schizophrenia QTL GWAS1369839 (human) | | 0.000001 | schizophrenia | | 10 | 33568267 | 33568268 | Human |
597171365 | GWAS1267439_H | E3 ubiquitin-protein ligase DTX1 measurement QTL GWAS1267439 (human) | | 5e-37 | E3 ubiquitin-protein ligase DTX1 measurement | | 10 | 19931917 | 19931918 | Human |
597462178 | GWAS1558252_H | body mass index QTL GWAS1558252 (human) | | 6e-13 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33698401 | 33698402 | Human |
597146839 | GWAS1242913_H | smoking initiation QTL GWAS1242913 (human) | | 3e-14 | smoking initiation | | 10 | 30032669 | 30032670 | Human |
597146838 | GWAS1242912_H | smoking initiation QTL GWAS1242912 (human) | | 2e-14 | smoking initiation | | 10 | 30011858 | 30011859 | Human |
597146837 | GWAS1242911_H | smoking initiation QTL GWAS1242911 (human) | | 1e-10 | smoking initiation | | 10 | 27116847 | 27116848 | Human |
597466335 | GWAS1562409_H | breast carcinoma QTL GWAS1562409 (human) | | 0.000005 | mammary gland integrity trait (VT:0010552) | | 10 | 21230606 | 21230607 | Human |
597417181 | GWAS1513255_H | heel bone mineral density QTL GWAS1513255 (human) | | 6e-13 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28313714 | 28313715 | Human |
597347549 | GWAS1443623_H | cholelithiasis QTL GWAS1443623 (human) | | 8e-13 | cholelithiasis | | 10 | 21558249 | 21558250 | Human |
597159120 | GWAS1255194_H | dementia QTL GWAS1255194 (human) | | 0.000003 | dementia | | 10 | 24406435 | 24406436 | Human |
597425363 | GWAS1521437_H | electrocardiography QTL GWAS1521437 (human) | | 5e-11 | electrocardiography | | 10 | 33311370 | 33311371 | Human |
596974812 | GWAS1094331_H | mean arterial pressure, major depressive disorder QTL GWAS1094331 (human) | | 5e-12 | mean arterial pressure, major depressive disorder | | 10 | 18436124 | 18436125 | Human |
597146841 | GWAS1242915_H | smoking initiation QTL GWAS1242915 (human) | | 3e-26 | smoking initiation | | 10 | 36317434 | 36317435 | Human |
597146840 | GWAS1242914_H | smoking initiation QTL GWAS1242914 (human) | | 1e-09 | smoking initiation | | 10 | 30947519 | 30947520 | Human |
597347530 | GWAS1443604_H | myocardial infarction QTL GWAS1443604 (human) | | 0.000002 | myocardial infarction | | 10 | 24541142 | 24541143 | Human |
597347531 | GWAS1443605_H | myocardial infarction QTL GWAS1443605 (human) | | 2e-09 | myocardial infarction | | 10 | 30046193 | 30046194 | Human |
597109955 | GWAS1206029_H | diastolic blood pressure QTL GWAS1206029 (human) | | 2e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 28635972 | 28635973 | Human |
597347534 | GWAS1443608_H | myocardial infarction QTL GWAS1443608 (human) | | 1e-10 | myocardial infarction | | 10 | 44092409 | 44092410 | Human |
597347535 | GWAS1443609_H | myocardial infarction QTL GWAS1443609 (human) | | 1e-15 | myocardial infarction | | 10 | 44249867 | 44249868 | Human |
597347532 | GWAS1443606_H | myocardial infarction QTL GWAS1443606 (human) | | 0.000007 | myocardial infarction | | 10 | 30207976 | 30207977 | Human |
407381791 | GWAS1030767_H | peak expiratory flow QTL GWAS1030767 (human) | | 1e-10 | peak expiratory flow | maximum mid-expiratory flow (MMEF) (CMO:0000253) | 10 | 29979841 | 29979842 | Human |
597347533 | GWAS1443607_H | myocardial infarction QTL GWAS1443607 (human) | | 1e-14 | myocardial infarction | | 10 | 43985246 | 43985247 | Human |
597241024 | GWAS1337098_H | educational attainment QTL GWAS1337098 (human) | | 2e-08 | educational attainment | | 10 | 34287161 | 34287162 | Human |
597527751 | GWAS1623825_H | neuroticism measurement, cognitive function measurement QTL GWAS1623825 (human) | | 1e-08 | cognitive behavior trait (VT:0010450) | | 10 | 24020889 | 24020890 | Human |
597056716 | GWAS1152790_H | intelligence QTL GWAS1152790 (human) | | 7e-09 | intelligence | | 10 | 29280343 | 29280344 | Human |
597601477 | GWAS1658337_H | acetoacetate measurement QTL GWAS1658337 (human) | | 0.000001 | acetoacetate measurement | urine acetoacetate level (CMO:0002897) | 10 | 34982970 | 34982971 | Human |
597585088 | GWAS1641948_H | diastolic blood pressure QTL GWAS1641948 (human) | | 2e-16 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 30028144 | 30028145 | Human |
597527747 | GWAS1623821_H | neuroticism measurement, cognitive function measurement QTL GWAS1623821 (human) | | 2e-08 | cognitive behavior trait (VT:0010450) | | 10 | 33388395 | 33388396 | Human |
597449980 | GWAS1546054_H | systolic blood pressure QTL GWAS1546054 (human) | | 1e-66 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18437125 | 18437126 | Human |
597449981 | GWAS1546055_H | systolic blood pressure QTL GWAS1546055 (human) | | 9e-22 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18438972 | 18438973 | Human |
597449982 | GWAS1546056_H | systolic blood pressure QTL GWAS1546056 (human) | | 6e-12 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18448206 | 18448207 | Human |
597449983 | GWAS1546057_H | systolic blood pressure QTL GWAS1546057 (human) | | 2e-08 | systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 18466735 | 18466736 | Human |
597245178 | GWAS1341252_H | aging QTL GWAS1341252 (human) | | 2e-08 | aging | | 10 | 44079327 | 44079328 | Human |
596970737 | GWAS1090256_H | alcohol dependence, major depressive disorder QTL GWAS1090256 (human) | | 0.000009 | alcohol dependence, major depressive disorder | | 10 | 33274965 | 33274966 | Human |
596970736 | GWAS1090255_H | alcohol dependence, major depressive disorder QTL GWAS1090255 (human) | | 0.000006 | alcohol dependence, major depressive disorder | | 10 | 23381413 | 23381414 | Human |
597093631 | GWAS1189705_H | Pituitary Gland Adenoma QTL GWAS1189705 (human) | | 2e-10 | Pituitary Gland Adenoma | | 10 | 20610679 | 20610680 | Human |
597617908 | GWAS1674768_H | prostate specific antigen amount QTL GWAS1674768 (human) | | 3e-15 | prostate specific antigen amount | | 10 | 22031264 | 22031265 | Human |
597015807 | GWAS1111881_H | Hirschsprung disease QTL GWAS1111881 (human) | | 1e-28 | Hirschsprung disease | | 10 | 43075477 | 43075478 | Human |
597114108 | GWAS1210182_H | behavioural disinhibition measurement QTL GWAS1210182 (human) | | 0.0000008 | behavioural disinhibition measurement | | 10 | 22533989 | 22533991 | Human |
597617909 | GWAS1674769_H | prostate specific antigen amount QTL GWAS1674769 (human) | | 8e-23 | prostate specific antigen amount | | 10 | 27807825 | 27807826 | Human |
407226152 | GWAS875128_H | asthma, response to diisocyanate QTL GWAS875128 (human) | | 0.000001 | asthma, response to diisocyanate | | 10 | 28301454 | 28301455 | Human |
406976303 | GWAS625279_H | Rolandic epilepsy QTL GWAS625279 (human) | | 0.000002 | Rolandic epilepsy | | 10 | 27421604 | 27421605 | Human |
597318900 | GWAS1414974_H | JT interval QTL GWAS1414974 (human) | | 2e-14 | heart electrical impulse conduction trait (VT:2000017) | heart electrical conduction measurement (CMO:0000230) | 10 | 37893519 | 37893520 | Human |
597310702 | GWAS1406776_H | erythrocyte count QTL GWAS1406776 (human) | | 1e-10 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 36171058 | 36171059 | Human |
597310701 | GWAS1406775_H | erythrocyte count QTL GWAS1406775 (human) | | 1e-08 | erythrocyte count | red blood cell count (CMO:0000025) | 10 | 27095178 | 27095179 | Human |
406947641 | GWAS596617_H | eosinophil percentage of leukocytes QTL GWAS596617 (human) | | 2e-14 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 26446058 | 26446059 | Human |
406947642 | GWAS596618_H | eosinophil percentage of leukocytes QTL GWAS596618 (human) | | 9e-10 | eosinophil quantity (VT:0002602) | blood eosinophil count to total leukocyte count ratio (CMO:0000369) | 10 | 26446087 | 26446088 | Human |
597589218 | GWAS1646078_H | monocyte count QTL GWAS1646078 (human) | | 2e-33 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24929314 | 24929315 | Human |
597290213 | GWAS1386287_H | body weight QTL GWAS1386287 (human) | | 1e-08 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 27642341 | 27642342 | Human |
597290212 | GWAS1386286_H | body weight QTL GWAS1386286 (human) | | 9e-16 | body mass (VT:0001259) | body weight (CMO:0000012) | 10 | 21704611 | 21704612 | Human |
597482721 | GWAS1578795_H | mean corpuscular hemoglobin QTL GWAS1578795 (human) | | 2e-09 | mean corpuscular hemoglobin | mean corpuscular hemoglobin (CMO:0000290) | 10 | 24568949 | 24568950 | Human |
597589219 | GWAS1646079_H | monocyte count QTL GWAS1646079 (human) | | 7e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 44385546 | 44385547 | Human |
597363940 | GWAS1460014_H | lymphocyte count QTL GWAS1460014 (human) | | 6e-10 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 26423554 | 26423555 | Human |
406976449 | GWAS625425_H | basophil count QTL GWAS625425 (human) | | 3e-12 | basophil quantity (VT:0002607) | blood granulocyte count (CMO:0000111) | 10 | 26452245 | 26452246 | Human |
597093399 | GWAS1189473_H | Alzheimer disease, age at onset QTL GWAS1189473 (human) | | 0.0000001 | Alzheimer disease, age at onset | | 10 | 28563093 | 28563094 | Human |
597335067 | GWAS1431141_H | severe acute respiratory syndrome, COVID-19 QTL GWAS1431141 (human) | | 1e-10 | severe acute respiratory syndrome, COVID-19 | | 10 | 34297761 | 34297762 | Human |
597183515 | GWAS1279589_H | protein measurement QTL GWAS1279589 (human) | | 8e-39 | protein measurement | | 10 | 19946534 | 19946535 | Human |
597597213 | GWAS1654073_H | lymphocyte count QTL GWAS1654073 (human) | | 3e-11 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 44385546 | 44385547 | Human |
597142547 | GWAS1238621_H | educational attainment QTL GWAS1238621 (human) | | 5e-12 | educational attainment | | 10 | 20287861 | 20287862 | Human |
597072912 | GWAS1168986_H | schizophrenia QTL GWAS1168986 (human) | | 3e-13 | schizophrenia | | 10 | 18456176 | 18456177 | Human |
597142545 | GWAS1238619_H | educational attainment QTL GWAS1238619 (human) | | 4e-12 | educational attainment | | 10 | 20198773 | 20198774 | Human |
597142544 | GWAS1238618_H | educational attainment QTL GWAS1238618 (human) | | 0.0000003 | educational attainment | | 10 | 18942179 | 18942180 | Human |
597290014 | GWAS1386088_H | blood urea nitrogen measurement QTL GWAS1386088 (human) | | 1e-10 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 43393757 | 43393758 | Human |
597183504 | GWAS1279578_H | protein measurement QTL GWAS1279578 (human) | | 1e-12 | protein measurement | | 10 | 19829909 | 19829910 | Human |
597097498 | GWAS1193572_H | sex hormone-binding globulin measurement QTL GWAS1193572 (human) | | 1e-08 | sex hormone-binding globulin measurement | | 10 | 36184116 | 36184117 | Human |
597183509 | GWAS1279583_H | protein measurement QTL GWAS1279583 (human) | | 2e-49 | protein measurement | | 10 | 19931917 | 19931918 | Human |
597093400 | GWAS1189474_H | Alzheimer disease, age at onset QTL GWAS1189474 (human) | | 4e-08 | Alzheimer disease, age at onset | | 10 | 29940940 | 29940941 | Human |
597040153 | GWAS1136227_H | diet measurement QTL GWAS1136227 (human) | | 5e-20 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21517903 | 21517904 | Human |
597093401 | GWAS1189475_H | Alzheimer disease, age at onset QTL GWAS1189475 (human) | | 2e-08 | Alzheimer disease, age at onset | | 10 | 31991363 | 31991364 | Human |
597396491 | GWAS1492565_H | vaginal microbiome measurement QTL GWAS1492565 (human) | | 0.000002 | vaginal microbiome measurement | | 10 | 30354869 | 30354870 | Human |
597318667 | GWAS1414741_H | response to antidepressant QTL GWAS1414741 (human) | | 0.000005 | response to antidepressant | | 10 | 41857210 | 41857211 | Human |
597040132 | GWAS1136206_H | inflammatory biomarker measurement, YKL40 measurement QTL GWAS1136206 (human) | | 3e-08 | inflammatory biomarker measurement, YKL40 measurement | | 10 | 33811415 | 33811416 | Human |
597109761 | GWAS1205835_H | self reported educational attainment QTL GWAS1205835 (human) | | 9e-10 | self reported educational attainment | | 10 | 34297761 | 34297762 | Human |
597109760 | GWAS1205834_H | self reported educational attainment QTL GWAS1205834 (human) | | 5e-10 | self reported educational attainment | | 10 | 31997014 | 31997015 | Human |
597142543 | GWAS1238617_H | educational attainment QTL GWAS1238617 (human) | | 4e-08 | educational attainment | | 10 | 21847939 | 21847940 | Human |
596974605 | GWAS1094124_H | major depressive disorder QTL GWAS1094124 (human) | | 0.000008 | major depressive disorder | | 10 | 25694445 | 25694446 | Human |
597072910 | GWAS1168984_H | multiple sclerosis QTL GWAS1168984 (human) | | 0.0000003 | multiple sclerosis | | 10 | 43147362 | 43147363 | Human |
597142542 | GWAS1238616_H | educational attainment QTL GWAS1238616 (human) | | 7e-14 | educational attainment | | 10 | 21668300 | 21668301 | Human |
597142541 | GWAS1238615_H | educational attainment QTL GWAS1238615 (human) | | 5e-09 | educational attainment | | 10 | 20291313 | 20291314 | Human |
596974601 | GWAS1094120_H | major depressive disorder QTL GWAS1094120 (human) | | 0.000004 | major depressive disorder | | 10 | 25693234 | 25693235 | Human |
597044232 | GWAS1140306_H | smoking initiation QTL GWAS1140306 (human) | | 8e-11 | smoking initiation | | 10 | 21605099 | 21605100 | Human |
597470268 | GWAS1566342_H | body mass index QTL GWAS1566342 (human) | | 6e-09 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21494705 | 21494706 | Human |
597257273 | GWAS1353347_H | multiple myeloma QTL GWAS1353347 (human) | | 7e-10 | multiple myeloma | | 10 | 28509727 | 28509728 | Human |
597363771 | GWAS1459845_H | waist-hip ratio QTL GWAS1459845 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 33876771 | 33876772 | Human |
597093431 | GWAS1189505_H | 3-hydroxypropylmercapturic acid measurement QTL GWAS1189505 (human) | | 0.000004 | 3-hydroxypropylmercapturic acid measurement | | 10 | 30288009 | 30288010 | Human |
407115744 | GWAS764720_H | abdominal aortic calcification measurement QTL GWAS764720 (human) | | 0.0000008 | abdominal aortic calcification measurement | | 10 | 19864981 | 19864982 | Human |
596962352 | GWAS1081871_H | multiple myeloma QTL GWAS1081871 (human) | | 7e-10 | multiple myeloma | | 10 | 28509727 | 28509728 | Human |
597249087 | GWAS1345161_H | breast carcinoma QTL GWAS1345161 (human) | | 5e-08 | mammary gland integrity trait (VT:0010552) | | 10 | 21535798 | 21535799 | Human |
597306419 | GWAS1402493_H | breast cancer, ovarian carcinoma QTL GWAS1402493 (human) | | 4e-27 | breast cancer, ovarian carcinoma | | 10 | 21545607 | 21545608 | Human |
597597239 | GWAS1654099_H | lymphocyte count QTL GWAS1654099 (human) | | 1e-23 | lymphocyte count | blood lymphocyte count (CMO:0000031) | 10 | 24925121 | 24925122 | Human |
407226357 | GWAS875333_H | unipolar depression, alcohol dependence QTL GWAS875333 (human) | | 0.000009 | unipolar depression, alcohol dependence | | 10 | 33274965 | 33274966 | Human |
597240873 | GWAS1336947_H | aging QTL GWAS1336947 (human) | | 7e-13 | aging | | 10 | 37775141 | 37775142 | Human |
597527596 | GWAS1623670_H | gallstones QTL GWAS1623670 (human) | | 6e-10 | gallstones | | 10 | 21508638 | 21508639 | Human |
597445678 | GWAS1541752_H | diet measurement, low density lipoprotein cholesterol measurement QTL GWAS1541752 (human) | | 0.000005 | eating behavior trait (VT:0001431) | blood low density lipoprotein cholesterol level (CMO:0000053) | 10 | 34918225 | 34918226 | Human |
597470249 | GWAS1566323_H | eye colour measurement QTL GWAS1566323 (human) | | 0.000007 | eye colour measurement | eye morphological measurement (CMO:0003080) | 10 | 29342623 | 29342624 | Human |
597253167 | GWAS1349241_H | alkaline phosphatase measurement QTL GWAS1349241 (human) | | 7e-17 | alkaline phosphatase measurement | blood alkaline phosphatase activity level (CMO:0000576) | 10 | 25966623 | 25966624 | Human |
597433387 | GWAS1529461_H | protein measurement QTL GWAS1529461 (human) | | 1e-47 | protein measurement | | 10 | 24952573 | 24952574 | Human |
407103481 | GWAS752457_H | obsolete_prostate specific antigen measurement QTL GWAS752457 (human) | | 5e-15 | obsolete_prostate specific antigen measurement | | 10 | 27807825 | 27807826 | Human |
406976506 | GWAS625482_H | trait in response to rifampicin, trait in response to efavirenz, drug-induced liver injury QTL GWAS625482 (human) | | 0.000001 | trait in response to rifampicin, trait in response to efavirenz, drug-induced liver injury | | 10 | 21003994 | 21003995 | Human |
597466144 | GWAS1562218_H | waist-hip ratio QTL GWAS1562218 (human) | | 2e-09 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 35938728 | 35938729 | Human |
597204005 | GWAS1300079_H | upper aerodigestive tract neoplasm QTL GWAS1300079 (human) | | 0.000006 | upper aerodigestive tract neoplasm | | 10 | 26519434 | 26519435 | Human |
597232679 | GWAS1328753_H | Achilles tendon injury QTL GWAS1328753 (human) | | 2e-08 | hindlimb integrity trait (VT:0010563) | | 10 | 28215258 | 28215259 | Human |
597204006 | GWAS1300080_H | upper aerodigestive tract neoplasm QTL GWAS1300080 (human) | | 0.000007 | upper aerodigestive tract neoplasm | | 10 | 29690357 | 29690358 | Human |
597232678 | GWAS1328752_H | Achilles tendon injury QTL GWAS1328752 (human) | | 3e-09 | hindlimb integrity trait (VT:0010563) | | 10 | 28175021 | 28175022 | Human |
597019733 | GWAS1115807_H | spine bone mineral density QTL GWAS1115807 (human) | | 1e-09 | spine bone mineral density | bone mineral density (CMO:0001226) | 10 | 28189563 | 28189564 | Human |
597462110 | GWAS1558184_H | body mass index QTL GWAS1558184 (human) | | 5e-27 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21532345 | 21532346 | Human |
597302366 | GWAS1398440_H | T-cell surface glycoprotein CD3 epsilon chain measurement QTL GWAS1398440 (human) | | 3e-25 | T-cell surface glycoprotein CD3 epsilon chain measurement | | 10 | 19938338 | 19938339 | Human |
597437528 | GWAS1533602_H | aortic measurement QTL GWAS1533602 (human) | | 1e-09 | aortic measurement | aorta measurement (CMO:0001474) | 10 | 29878825 | 29878826 | Human |
596982867 | GWAS1102386_H | memory performance, sex interaction measurement QTL GWAS1102386 (human) | | 0.000004 | memory performance, sex interaction measurement | | 10 | 33196609 | 33196610 | Human |
407230349 | GWAS879325_H | asthma, response to diisocyanate QTL GWAS879325 (human) | | 0.000002 | asthma, response to diisocyanate | | 10 | 23104137 | 23104138 | Human |
597453908 | GWAS1549982_H | C-reactive protein measurement QTL GWAS1549982 (human) | | 8e-14 | C-reactive protein measurement | blood C-reactive protein level (CMO:0003160) | 10 | 30419512 | 30419513 | Human |
596966493 | GWAS1086012_H | diastolic blood pressure QTL GWAS1086012 (human) | | 4e-11 | diastolic blood pressure | | 10 | 18438972 | 18438973 | Human |
597589076 | GWAS1645936_H | monocyte count QTL GWAS1645936 (human) | | 5e-14 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 21984604 | 21984605 | Human |
597589077 | GWAS1645937_H | monocyte count QTL GWAS1645937 (human) | | 8e-12 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 26439005 | 26439006 | Human |
597089370 | GWAS1185444_H | monocyte percentage of leukocytes QTL GWAS1185444 (human) | | 2e-17 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 26434585 | 26434586 | Human |
597343316 | GWAS1439390_H | pulse pressure measurement QTL GWAS1439390 (human) | | 2e-08 | pulse pressure measurement | pulse pressure (CMO:0000292) | 10 | 24380948 | 24380949 | Human |
597023834 | GWAS1119908_H | pursuit maintenance gain measurement QTL GWAS1119908 (human) | | 0.000009 | pursuit maintenance gain measurement | | 10 | 20458493 | 20458494 | Human |
597089369 | GWAS1185443_H | monocyte percentage of leukocytes QTL GWAS1185443 (human) | | 2e-17 | monocyte quantity (VT:0000223) | blood monocyte count to total leukocyte count ratio (CMO:0000374) | 10 | 22109066 | 22109067 | Human |
597048391 | GWAS1144465_H | Hirschsprung disease QTL GWAS1144465 (human) | | 3e-21 | Hirschsprung disease | | 10 | 43086608 | 43086609 | Human |
597036100 | GWAS1132174_H | high density lipoprotein cholesterol measurement QTL GWAS1132174 (human) | | 2e-11 | high density lipoprotein cholesterol measurement | blood high density lipoprotein cholesterol level (CMO:0000052) | 10 | 33726753 | 33726754 | Human |
406972312 | GWAS621288_H | trait in response to paliperidone, schizophrenia symptom severity measurement QTL GWAS621288 (human) | | 0.000008 | trait in response to paliperidone, schizophrenia symptom severity measurement | | 10 | 33256536 | 33256537 | Human |
597511239 | GWAS1607313_H | diastolic blood pressure, systolic blood pressure QTL GWAS1607313 (human) | | 4e-09 | diastolic blood pressure, systolic blood pressure | systolic blood pressure (CMO:0000004) | 10 | 29515238 | 29515239 | Human |
406964122 | GWAS613098_H | basophil count, eosinophil count QTL GWAS613098 (human) | | 1e-25 | eosinophil quantity (VT:0002602) | blood granulocyte count (CMO:0000111) | 10 | 26447311 | 26447312 | Human |
597376068 | GWAS1472142_H | sorbitol measurement QTL GWAS1472142 (human) | | 0.000006 | sorbitol measurement | | 10 | 43027010 | 43027011 | Human |
407390120 | GWAS1039096_H | granulocyte percentage of myeloid white cells QTL GWAS1039096 (human) | | 2e-09 | granulocyte quantity (VT:0000334) | | 10 | 22104761 | 22104762 | Human |
597138551 | GWAS1234625_H | diastolic blood pressure QTL GWAS1234625 (human) | | 6e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 30028144 | 30028145 | Human |
597138550 | GWAS1234624_H | diastolic blood pressure QTL GWAS1234624 (human) | | 5e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 28635972 | 28635973 | Human |
597138549 | GWAS1234623_H | diastolic blood pressure QTL GWAS1234623 (human) | | 8e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27944540 | 27944541 | Human |
597138548 | GWAS1234622_H | diastolic blood pressure QTL GWAS1234622 (human) | | 8e-11 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 27624705 | 27624706 | Human |
597138547 | GWAS1234621_H | diastolic blood pressure QTL GWAS1234621 (human) | | 9e-08 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 22585454 | 22585455 | Human |
597462136 | GWAS1558210_H | body mass index QTL GWAS1558210 (human) | | 4e-10 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 33571587 | 33571588 | Human |
597040243 | GWAS1136317_H | diet measurement QTL GWAS1136317 (human) | | 2e-11 | eating behavior trait (VT:0001431) | food intake measurement (CMO:0000772) | 10 | 21993115 | 21993116 | Human |
597199985 | GWAS1296059_H | B-cell acute lymphoblastic leukemia, hypothyroidism QTL GWAS1296059 (human) | | 2e-10 | leukocyte integrity trait (VT:0010898) | | 10 | 22581604 | 22581605 | Human |
597589106 | GWAS1645966_H | monocyte count QTL GWAS1645966 (human) | | 1e-35 | monocyte quantity (VT:0000223) | blood monocyte count (CMO:0000032) | 10 | 24922362 | 24922363 | Human |
597601395 | GWAS1658255_H | blood urea nitrogen measurement QTL GWAS1658255 (human) | | 3e-14 | blood urea nitrogen measurement | blood urea nitrogen level (CMO:0000049) | 10 | 28907726 | 28907727 | Human |
597023867 | GWAS1119941_H | breast carcinoma QTL GWAS1119941 (human) | | 4e-13 | mammary gland integrity trait (VT:0010552) | | 10 | 22383039 | 22383040 | Human |
597249143 | GWAS1345217_H | central corneal thickness QTL GWAS1345217 (human) | | 8e-15 | central corneal thickness | | 10 | 25534015 | 25534016 | Human |
597138552 | GWAS1234626_H | diastolic blood pressure QTL GWAS1234626 (human) | | 2e-10 | diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 32301434 | 32301435 | Human |
597019747 | GWAS1115821_H | smoking status measurement, diastolic blood pressure QTL GWAS1115821 (human) | | 4e-10 | smoking status measurement, diastolic blood pressure | diastolic blood pressure (CMO:0000005) | 10 | 36024569 | 36024570 | Human |
597347437 | GWAS1443511_H | body mass index QTL GWAS1443511 (human) | | 2e-15 | body mass index | body mass index (BMI) (CMO:0000105) | 10 | 21825498 | 21825499 | Human |
597326957 | GWAS1423031_H | coronary artery disease QTL GWAS1423031 (human) | | 7e-08 | coronary artery disease | | 10 | 24765745 | 24765746 | Human |
597253230 | GWAS1349304_H | insomnia, total blood protein measurement QTL GWAS1349304 (human) | | 3e-10 | insomnia, total blood protein measurement | blood protein measurement (CMO:0000028) | 10 | 43250634 | 43250635 | Human |
597400672 | GWAS1496746_H | neutrophil count QTL GWAS1496746 (human) | | 6e-40 | neutrophil quantity (VT:0000222) | blood neutrophil count (CMO:0000030) | 10 | 28492438 | 28492439 | Human |
597474401 | GWAS1570475_H | heel bone mineral density QTL GWAS1570475 (human) | | 5e-21 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 28798274 | 28798277 | Human |
407070653 | GWAS719629_H | waist-hip ratio QTL GWAS719629 (human) | | 5e-08 | waist-hip ratio | waist to hip ratio (WHR) (CMO:0000020) | 10 | 32330644 | 32330645 | Human |
597474402 | GWAS1570476_H | heel bone mineral density QTL GWAS1570476 (human) | | 5e-11 | heel bone mineral density | bone mineral density (CMO:0001226) | 10 | 43871707 | 43871708 | Human |
597118056 | GWAS1214130_H | DNA methylation QTL GWAS1214130 (human) | | 9e-09 | DNA methylation | | 10 | 21476302 | 21476303 | Human |